1	Lung	NN	O	lung	nn	2	SENT_1	[p1l48t81r114b113],
2	Cancer	NN	O	cancer	_	0	SENT_1	[p1l126t81r228b106],
3	(	CD	NUMBER	(	num	4	SENT_1	[p1l241t81r330b113],
4	2006	CD	DATE	2006	dep	2	SENT_1	[p1l241t81r330b113],
5	)	CD	NUMBER	)	number	6	SENT_1	[p1l241t81r330b113],
6	54	CD	NUMBER	54	dep	4	SENT_1	[p1l345t81r389b112],
7	,	,	O	,	_	0	SENT_1	[p1l345t81r389b112],
8	201-207	CD	NUMBER	201-207	appos	4	SENT_1	[p1l404t81r532b106],

1	available	JJ	O	available	_	0	SENT_2	[p1l739t200r910b225],
2	at	IN	O	at	_	0	SENT_2	[p1l930t203r962b225],
3	www.sciencedirect.com	NNP	O	www.sciencedirect.com	prep_at	1	SENT_2	[p1l980t200r1435b225],

1	4	CD	NUMBER	4	_	0	SENT_3	[p1l880t322r960b340],
2	,	,	O	,	_	0	SENT_3	[p1l880t322r960b340],
3	’	CD	NUMBER	’	number	4	SENT_3	[p1l880t322r960b340],
4	‘	CD	NUMBER	‘	appos	1	SENT_3	[p1l834t336r930b404],
5	:3	CD	NUMBER	:3	num	7	SENT_3	[p1l834t336r930b404],
6	’	NN	O	’	nn	7	SENT_3	[p1l834t336r930b404],
7	ScienceDirect	NN	O	sciencedirect	dep	1	SENT_3	[p1l964t349r1343b401],

1	P	NN	O	p	_	0	SENT_4	[p1l55t440r348b513],
2	f	SYM	O	f	dep	1	SENT_4	[p1l55t440r348b513],
3	*	CD	NUMBER	*	num	5	SENT_4	[p1l55t440r348b513],
4	journal	NN	O	journal	nn	5	SENT_4	[p1l568t464r701b495],
5	homepage	NN	O	homepage	dep	1	SENT_4	[p1l724t464r929b495],
6	:	:	O	:	_	0	SENT_4	[p1l724t464r929b495],
7	www	NN	O	www	dep	1	SENT_4	[p1l950t464r1601b495],
8	.	.	O	.	_	0	SENT_4	[p1l950t464r1601b495],

1	e	LS	O	e	dep	2	SENT_5	[p1l950t464r1601b495],
2	|	SYM	O	|	_	0	SENT_5	[p1l950t464r1601b495],
3	sevier.com/locate/lungcan	SYM	O	sevier.com/locate/lungcan	dep	2	SENT_5	[p1l950t464r1601b495],

1	Clinical	JJ	O	clinical	amod	2	SENT_6	[p1l48t638r328b701],
2	predictors	NNS	O	predictor	_	0	SENT_6	[p1l360t638r751b717],
3	versus	CC	O	versus	prep	2	SENT_6	[p1l779t656r1024b701],
4	epidermal	JJ	O	epidermal	amod	5	SENT_6	[p1l1054t638r1441b717],
5	growth	NN	O	growth	dep	3	SENT_6	[p1l1471t638r1735b717],
6	factor	NN	O	factor	nn	8	SENT_6	[p1l1766t639r1997b701],
7	receptor	NN	O	receptor	nn	8	SENT_6	[p1l51t743r382b817],
8	mutation	NN	O	mutation	dep	2	SENT_6	[p1l413t739r754b801],
9	in	IN	O	in	_	0	SENT_6	[p1l786t739r852b800],
10	geﬁtinib-treated	JJ	O	geﬁtinib-treated	amod	16	SENT_6	[p1l884t737r1519b817],
11	non-small	JJ	O	non-small	amod	16	SENT_6	[p1l51t837r589b900],
12	—	NN	O	—	nn	16	SENT_6	[p1l51t837r589b900],
13	cell	NN	O	cell	nn	16	SENT_6	[p1l51t837r589b900],
14	lung	NN	O	lung	nn	16	SENT_6	[p1l623t837r779b916],
15	cancer	NN	O	cancer	nn	16	SENT_6	[p1l808t854r1066b900],
16	patients	NNS	O	patient	prep_in	8	SENT_6	[p1l1096t838r1405b916],

1	Sae-Won	NNP	O	Sae-Won	nn	2	SENT_7	[p1l48t988r275b1032],
2	Han	NNP	O	Han	_	0	SENT_7	[p1l300t989r397b1032],
3	5	CD	NUMBER	5	dep	2	SENT_7	[p1l409t988r443b1042],
4	,	,	O	,	_	0	SENT_7	[p1l409t988r443b1042],
5	Tae-You	NNP	O	Tae-You	nn	11	SENT_7	[p1l467t989r675b1032],
6	Kim	NNP	PERSON	Kim	nn	11	SENT_7	[p1l700t988r917b1042],
7	"	``	O	"	punct	11	SENT_7	[p1l700t988r917b1042],
8	“	CD	NUMBER	“	num	11	SENT_7	[p1l700t988r917b1042],
9	"	``	O	"	punct	11	SENT_7	[p1l700t988r917b1042],
10	’	NN	O	’	nn	11	SENT_7	[p1l700t988r917b1042],
11	*	NN	O	*	appos	3	SENT_7	[p1l700t988r917b1042],
12	,	,	O	,	_	0	SENT_7	[p1l700t988r917b1042],
13	Kyung-Hun	NNP	PERSON	Kyung-Hun	nn	14	SENT_7	[p1l944t989r1231b1043],
14	Leea	NNP	PERSON	Leea	rcmod	11	SENT_7	[p1l1256t988r1393b1042],
15	,	,	O	,	_	0	SENT_7	[p1l1256t988r1393b1042],
16	Pil	NNP	PERSON	Pil	nn	18	SENT_7	[p1l1420t987r1483b1032],
17	Gyu	NNP	PERSON	Gyu	nn	18	SENT_7	[p1l1505t988r1603b1043],
18	Hwangb	NNP	PERSON	Hwangb	appos	14	SENT_7	[p1l1628t979r1849b1043],
19	,	,	O	,	_	0	SENT_7	[p1l1628t979r1849b1043],
20	Yoon	NNP	PERSON	Yoon	nn	22	SENT_7	[p1l46t1055r172b1098],
21	Kyung	NNP	PERSON	Kyung	nn	22	SENT_7	[p1l197t1055r357b1109],
22	Jeon	NNP	PERSON	Jeon	appos	14	SENT_7	[p1l376t1055r503b1098],
23	"	``	O	"	punct	46	SENT_7	[p1l516t1045r551b1107],
24	,	,	O	,	_	0	SENT_7	[p1l516t1045r551b1107],
25	Do-Youn	NNP	O	Do-Youn	dep	46	SENT_7	[p1l579t1054r794b1098],
26	Oh	UH	O	oh	dep	27	SENT_7	[p1l818t1053r887b1098],
27	5	CD	NUMBER	5	rcmod	25	SENT_7	[p1l899t1054r970b1108],
28	,	,	O	,	_	0	SENT_7	[p1l899t1054r970b1108],
29	‘	CD	NUMBER	‘	appos	25	SENT_7	[p1l899t1054r970b1108],
30	,	,	O	,	_	0	SENT_7	[p1l899t1054r970b1108],
31	Se-Hoon	NNP	PERSON	Se-Hoon	nn	33	SENT_7	[p1l996t1054r1214b1098],
32	Lee	NNP	PERSON	Lee	nn	33	SENT_7	[p1l1239t1054r1413b1107],
33	“	NNP	O	“	appos	29	SENT_7	[p1l1239t1054r1413b1107],
34	,	,	O	,	_	0	SENT_7	[p1l1239t1054r1413b1107],
35	Dong-Wan	NNP	PERSON	Dong-Wan	nn	37	SENT_7	[p1l1441t1054r1703b1109],
36	Kim	NNP	PERSON	Kim	nn	37	SENT_7	[p1l1728t1054r1906b1108],
37	“	NNP	O	“	appos	25	SENT_7	[p1l1728t1054r1906b1108],
38	,	,	O	,	_	0	SENT_7	[p1l1728t1054r1906b1108],
39	Seock-Ah	NNP	O	Seock-Ah	nn	40	SENT_7	[p1l48t1119r292b1164],
40	|	NNP	O	|	appos	25	SENT_7	[p1l317t1119r458b1173],
41	ma	FW	O	ma	dep	40	SENT_7	[p1l317t1119r458b1173],
42	"	``	O	"	punct	41	SENT_7	[p1l317t1119r458b1173],
43	‘	NN	O	‘	dep	41	SENT_7	[p1l317t1119r458b1173],
44	,	,	O	,	_	0	SENT_7	[p1l317t1119r458b1173],
45	Doo	NNP	PERSON	Doo	nn	46	SENT_7	[p1l486t1120r583b1164],
46	Hyun	NNP	PERSON	Hyun	dep	22	SENT_7	[p1l606t1121r738b1175],
47	Chung	NNP	PERSON	Chung	nn	48	SENT_7	[p1l761t1111r971b1175],
48	”	NNP	O	”	dep	46	SENT_7	[p1l761t1111r971b1175],
49	,	,	O	,	_	0	SENT_7	[p1l761t1111r971b1175],
50	Dae	NNP	PERSON	Dae	nn	52	SENT_7	[p1l999t1120r1095b1164],
51	Seog	NNP	PERSON	Seog	nn	52	SENT_7	[p1l1116t1120r1239b1175],
52	Heoa	NNP	PERSON	Heoa	appos	46	SENT_7	[p1l1261t1119r1442b1174],
53	’	CD	NUMBER	’	number	54	SENT_7	[p1l1261t1119r1442b1174],
54	°	CD	NUMBER	°	dep	52	SENT_7	[p1l1261t1119r1442b1174],
55	,	,	O	,	_	0	SENT_7	[p1l1261t1119r1442b1174],
56	Yung-Jue	NNP	O	Yung-Jue	nn	57	SENT_7	[p1l1465t1121r1714b1175],
57	Bang	NNP	O	Bang	appos	14	SENT_7	[p1l1737t1119r1926b1175],
58	“	IN	O	“	dep	14	SENT_7	[p1l1737t1119r1926b1175],

1	3	CD	NUMBER	3	_	0	SENT_8	[p1l46t1250r58b1264],
2	Department	NNP	ORGANIZATION	Department	rcmod	1	SENT_8	[p1l70t1250r259b1284],
3	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l271t1250r305b1283],
4	Internal	NNP	ORGANIZATION	Internal	nn	5	SENT_8	[p1l315t1250r439b1277],
5	Medicine	NNP	ORGANIZATION	Medicine	prep_of	2	SENT_8	[p1l451t1250r602b1282],
6	,	,	O	,	_	0	SENT_8	[p1l451t1250r602b1282],
7	Seoul	NNP	ORGANIZATION	Seoul	nn	10	SENT_8	[p1l618t1250r701b1277],
8	National	NNP	ORGANIZATION	National	nn	10	SENT_8	[p1l714t1250r846b1277],
9	University	NNP	ORGANIZATION	University	nn	10	SENT_8	[p1l860t1250r1021b1284],
10	College	NNP	ORGANIZATION	College	appos	2	SENT_8	[p1l1032t1250r1148b1284],
11	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l1160t1250r1194b1284],
12	Medicine	NNP	ORGANIZATION	Medicine	prep_of	10	SENT_8	[p1l1203t1250r1353b1282],
13	,	,	O	,	_	0	SENT_8	[p1l1203t1250r1353b1282],
14	28	CD	NUMBER	28	num	17	SENT_8	[p1l46t1295r83b1322],
15	Yongon-Dong	NNP	O	Yongon-Dong	nn	17	SENT_8	[p1l96t1295r303b1329],
16	,	,	O	,	_	0	SENT_8	[p1l96t1295r303b1329],
17	Chongno-Gu	NNP	O	Chongno-Gu	appos	2	SENT_8	[p1l320t1295r518b1329],
18	,	,	O	,	_	0	SENT_8	[p1l320t1295r518b1329],
19	Seoul	NNP	LOCATION	Seoul	appos	2	SENT_8	[p1l534t1295r618b1322],
20	110-744	CD	NUMBER	110-744	num	19	SENT_8	[p1l635t1295r762b1327],
21	,	,	O	,	_	0	SENT_8	[p1l635t1295r762b1327],
22	Republic	NNP	O	Republic	appos	2	SENT_8	[p1l778t1295r913b1329],
23	of	IN	O	of	_	0	SENT_8	[p1l925t1295r959b1329],
24	Korea	NNP	LOCATION	Korea	poss	27	SENT_8	[p1l969t1296r1059b1322],
25	'	POS	O	'	_	0	SENT_8	[p1l47t1335r58b1354],
26	’	NNP	O	’	nn	27	SENT_8	[p1l47t1335r58b1354],
27	Department	NNP	ORGANIZATION	Department	prep_of	22	SENT_8	[p1l71t1340r260b1374],
28	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l272t1340r306b1374],
29	Pathology	NNP	ORGANIZATION	Pathology	prep_of	27	SENT_8	[p1l315t1340r476b1374],
30	,	,	O	,	_	0	SENT_8	[p1l315t1340r476b1374],
31	Seoul	NNP	ORGANIZATION	Seoul	nn	34	SENT_8	[p1l492t1340r575b1367],
32	National	NNP	ORGANIZATION	National	nn	34	SENT_8	[p1l588t1340r721b1367],
33	University	NNP	ORGANIZATION	University	nn	34	SENT_8	[p1l734t1340r895b1374],
34	College	NNP	ORGANIZATION	College	appos	2	SENT_8	[p1l906t1340r1022b1374],
35	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l1034t1340r1068b1374],
36	Medicine	NNP	ORGANIZATION	Medicine	prep_of	34	SENT_8	[p1l1077t1340r1227b1372],
37	,	,	O	,	_	0	SENT_8	[p1l1077t1340r1227b1372],
38	Seoul	NNP	LOCATION	Seoul	appos	2	SENT_8	[p1l1243t1340r1337b1372],
39	,	,	O	,	_	0	SENT_8	[p1l1243t1340r1337b1372],
40	Republic	NNP	ORGANIZATION	Republic	appos	2	SENT_8	[p1l1353t1340r1488b1374],
41	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l1500t1340r1534b1374],
42	Korea	NNP	ORGANIZATION	Korea	nn	46	SENT_8	[p1l1544t1341r1634b1367],
43	C	NNP	ORGANIZATION	C	nn	46	SENT_8	[p1l46t1386r57b1400],
44	Cancer	NNP	ORGANIZATION	Cancer	nn	46	SENT_8	[p1l70t1386r177b1413],
45	Research	NNP	ORGANIZATION	Research	nn	46	SENT_8	[p1l189t1386r328b1413],
46	Institute	NNP	ORGANIZATION	Institute	prep_of	40	SENT_8	[p1l341t1386r486b1418],
47	,	,	O	,	_	0	SENT_8	[p1l341t1386r486b1418],
48	Seoul	NNP	ORGANIZATION	Seoul	nn	51	SENT_8	[p1l502t1386r586b1413],
49	National	NNP	ORGANIZATION	National	nn	51	SENT_8	[p1l598t1386r731b1413],
50	University	NNP	ORGANIZATION	University	nn	51	SENT_8	[p1l745t1386r905b1420],
51	College	NNP	ORGANIZATION	College	appos	2	SENT_8	[p1l917t1386r1032b1420],
52	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l1045t1386r1079b1420],
53	Medicine	NNP	ORGANIZATION	Medicine	prep_of	51	SENT_8	[p1l1087t1386r1238b1418],
54	,	,	O	,	_	0	SENT_8	[p1l1087t1386r1238b1418],
55	Seoul	NNP	LOCATION	Seoul	appos	2	SENT_8	[p1l1254t1386r1347b1418],
56	,	,	O	,	_	0	SENT_8	[p1l1254t1386r1347b1418],
57	Republic	NNP	O	Republic	dep	1	SENT_8	[p1l1363t1386r1499b1420],
58	of	IN	O	of	_	0	SENT_8	[p1l1510t1386r1544b1420],
59	Korea	NNP	LOCATION	Korea	prep_of	57	SENT_8	[p1l1554t1386r1644b1413],

1	Received	VBN	O	receive	_	0	SENT_9	[p1l48t1487r185b1514],
2	24	CD	DATE	24	dobj	1	SENT_9	[p1l198t1487r234b1514],
3	June	NNP	DATE	June	tmod	1	SENT_9	[p1l246t1488r319b1514],
4	2006	CD	DATE	2006	num	3	SENT_9	[p1l331t1487r413b1520],
5	;	:	O	;	_	0	SENT_9	[p1l331t1487r413b1520],
6	received	VBN	O	receive	parataxis	1	SENT_9	[p1l430t1487r561b1514],
7	in	IN	O	in	_	0	SENT_9	[p1l575t1488r601b1514],
8	revised	JJ	O	revised	amod	9	SENT_9	[p1l616t1487r726b1514],
9	form	NN	O	form	prep_in	6	SENT_9	[p1l739t1487r811b1514],
10	12	CD	DATE	12	num	9	SENT_9	[p1l827t1487r859b1514],
11	July	NNP	DATE	July	tmod	9	SENT_9	[p1l872t1487r935b1521],
12	2006	CD	DATE	2006	num	11	SENT_9	[p1l947t1487r1029b1520],
13	;	:	O	;	_	0	SENT_9	[p1l947t1487r1029b1520],
14	accepted	VBN	O	accept	parataxis	1	SENT_9	[p1l1045t1487r1187b1521],
15	12	CD	DATE	12	dobj	14	SENT_9	[p1l1203t1487r1235b1514],
16	July	NNP	DATE	July	tmod	14	SENT_9	[p1l1248t1487r1311b1521],
17	2006	CD	DATE	2006	num	16	SENT_9	[p1l1323t1487r1394b1514],

1	KEYWORDS	NNS	O	keyword	_	0	SENT_10	[p1l88t1646r297b1678],
2	Summary	JJ	O	summary	amod	5	SENT_10	[p1l620t1644r771b1678],
3	Non_smau_Ceu	NN	O	non_smau_ceu	nn	5	SENT_10	[p1l86t1699r323b1728],
4	lung	NN	O	lung	nn	5	SENT_10	[p1l338t1699r405b1735],
5	Background	NN	O	background	dep	1	SENT_10	[p1l620t1690r812b1724],
6	:	:	O	:	_	0	SENT_10	[p1l620t1690r812b1724],
7	Clinical	JJ	O	clinical	amod	8	SENT_10	[p1l823t1690r938b1717],
8	predictors	NNS	O	predictor	dep	1	SENT_10	[p1l949t1690r1107b1724],
9	including	VBG	O	include	_	0	SENT_10	[p1l1117t1690r1258b1724],
10	Asian	JJ	LOCATION	asian	prep_including	8	SENT_10	[p1l1267t1690r1359b1723],
11	,	,	O	,	_	0	SENT_10	[p1l1267t1690r1359b1723],
12	female	JJ	O	female	conj_and	10	SENT_10	[p1l1372t1690r1490b1723],
13	,	,	O	,	_	0	SENT_10	[p1l1372t1690r1490b1723],
14	adenocarcinoma	NN	O	adenocarcinoma	prep_including	8	SENT_10	[p1l1502t1690r1759b1717],
15	and	CC	O	and	_	0	SENT_10	[p1l1769t1690r1823b1717],
16	never-smoker	NN	O	never-smoker	prep_including	8	SENT_10	[p1l1835t1690r2048b1717],
17	and	CC	O	and	_	0	SENT_10	[p1l2057t1690r2111b1717],
18	cancer	NN	O	cancer	conj_and	10	SENT_10	[p1l86t1753r206b1780],
19	;	:	O	;	_	0	SENT_10	[p1l86t1753r206b1780],
20	epidermal	JJ	O	epidermal	amod	23	SENT_10	[p1l620t1736r777b1770],
21	growth	NN	O	growth	nn	23	SENT_10	[p1l794t1736r901b1770],
22	factor	NN	O	factor	nn	23	SENT_10	[p1l918t1736r1012b1763],
23	mutation	NN	O	mutation	dep	1	SENT_10	[p1l1029t1737r1168b1763],
24	are	VBP	O	be	auxpass	25	SENT_10	[p1l1185t1743r1234b1763],
25	associated	VBN	O	associate	rcmod	23	SENT_10	[p1l1251t1736r1412b1763],
26	with	IN	O	with	_	0	SENT_10	[p1l1429t1736r1496b1763],
27	geﬁtinib	NN	O	geﬁtinib	nn	28	SENT_10	[p1l1513t1736r1642b1770],
28	responsiveness	NN	O	responsiveness	prep_with	25	SENT_10	[p1l1659t1737r1889b1770],
29	in	IN	O	in	_	0	SENT_10	[p1l1905t1737r1931b1763],
30	nonsmallGeﬁtim-b	NN	O	nonsmallgeﬁtim-b	prep_in	28	SENT_10	[p1l1949t1736r2111b1763, p1l86t1803r239b1837],
31	;	:	O	;	_	0	SENT_10	[p1l1949t1736r2111b1763, p1l86t1803r239b1837],
32	cell	NN	O	cell	nn	34	SENT_10	[p1l620t1794r675b1821],
33	lung	NN	O	lung	nn	34	SENT_10	[p1l692t1794r756b1827],
34	cancer	NN	O	cancer	dep	28	SENT_10	[p1l771t1801r880b1821],
35	.	.	O	.	_	0	SENT_10	[p1l771t1801r880b1821],

1	Direct	JJ	O	direct	amod	2	SENT_11	[p1l900t1794r993b1821],
2	comparison	NN	O	comparison	nsubjpass	19	SENT_11	[p1l1009t1794r1186b1827],
3	between	IN	O	between	_	0	SENT_11	[p1l1204t1794r1337b1821],
4	clinical	JJ	O	clinical	amod	5	SENT_11	[p1l1353t1794r1465b1821],
5	predictors	NNS	O	predictor	prep_between	2	SENT_11	[p1l1482t1794r1640b1827],
6	and	CC	O	and	_	0	SENT_11	[p1l1655t1794r1710b1820],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_11	[p1l1728t1794r1807b1821],
8	mutation	NN	O	mutation	prep_between	2	SENT_11	[p1l1823t1794r1962b1821],
9	for	IN	O	for	_	0	SENT_11	[p1l1979t1794r2024b1820],
10	their	PRP$	O	they	poss	12	SENT_11	[p1l2039t1794r2114b1821],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_11	[p1l87t1848r171b1876],
12	mutation	NN	O	mutation	prep_for	8	SENT_11	[p1l185t1849r344b1882],
13	;	:	O	;	_	0	SENT_11	[p1l185t1849r344b1882],
14	predictive	JJ	O	predictive	amod	15	SENT_11	[p1l621t1839r778b1873],
15	power	NN	O	power	conj_and	5	SENT_11	[p1l792t1846r888b1873],
16	has	VBZ	O	have	aux	19	SENT_11	[p1l900t1839r949b1866],
17	not	RB	O	not	neg	19	SENT_11	[p1l963t1842r1013b1866],
18	been	VBN	O	be	auxpass	19	SENT_11	[p1l1026t1839r1099b1866],
19	reported	VBN	O	report	_	0	SENT_11	[p1l1114t1839r1259b1873],
20	.	.	O	.	_	0	SENT_11	[p1l1114t1839r1259b1873],

1	pharmacogenomics	NNS	O	pharmacogenomic	nn	2	SENT_12	[p1l87t1893r402b1929],
2	Patients	NNS	O	patient	_	0	SENT_12	[p1l620t1885r749b1911],
3	and	CC	O	and	_	0	SENT_12	[p1l760t1884r817b1911],
4	methods	NNS	O	method	conj_and	2	SENT_12	[p1l827t1884r972b1911],
5	:	:	O	:	_	0	SENT_12	[p1l827t1884r972b1911],
6	For	IN	O	for	_	0	SENT_12	[p1l986t1885r1035b1911],
7	120	CD	NUMBER	120	num	10	SENT_12	[p1l1048t1884r1099b1911],
8	Korean	JJ	MISC	korean	amod	10	SENT_12	[p1l1112t1885r1216b1911],
9	NSCLC	NN	O	nsclc	nn	10	SENT_12	[p1l1230t1884r1326b1911],
10	patients	NNS	O	patient	prep_for	17	SENT_12	[p1l1339t1885r1465b1918],
11	treated	VBN	O	treat	partmod	10	SENT_12	[p1l1477t1884r1592b1911],
12	with	IN	O	with	_	0	SENT_12	[p1l1604t1884r1671b1911],
13	geﬁtinib	NN	O	geﬁtinib	prep_with	11	SENT_12	[p1l1684t1884r1822b1918],
14	,	,	O	,	_	0	SENT_12	[p1l1684t1884r1822b1918],
15	we	PRP	O	we	nsubj	17	SENT_12	[p1l1835t1891r1880b1911],
16	have	VBP	O	have	aux	17	SENT_12	[p1l1892t1884r1963b1911],
17	analyzed	VBN	O	analyze	dep	2	SENT_12	[p1l1975t1884r2111b1918],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_12	[p1l621t1930r701b1956],
19	mutational	JJ	O	mutational	amod	20	SENT_12	[p1l712t1930r881b1956],
20	status	NN	O	status	dobj	17	SENT_12	[p1l893t1932r985b1956],
21	in	IN	O	in	_	0	SENT_12	[p1l997t1930r1023b1956],
22	exons	NNS	O	exon	prep_in	20	SENT_12	[p1l1035t1937r1123b1956],
23	18	CD	NUMBER	18	tmod	17	SENT_12	[p1l1136t1930r1179b1962],
24	,	,	O	,	_	0	SENT_12	[p1l1136t1930r1179b1962],
25	19	CD	NUMBER	19	num	23	SENT_12	[p1l1195t1930r1228b1956],
26	and	CC	O	and	_	0	SENT_12	[p1l1240t1930r1294b1956],
27	21	CD	NUMBER	21	tmod	17	SENT_12	[p1l1306t1930r1351b1956],
28	.	.	O	.	_	0	SENT_12	[p1l1306t1930r1351b1956],

1	Patients	NNS	O	patient	nsubj	11	SENT_13	[p1l1367t1930r1491b1956],
2	were	VBD	O	be	auxpass	3	SENT_13	[p1l1502t1937r1579b1956],
3	grouped	VBN	O	group	rcmod	1	SENT_13	[p1l1591t1930r1715b1963],
4	according	VBG	O	accord	_	0	SENT_13	[p1l1728t1930r1879b1963],
5	to	TO	O	to	prepc_according_to	3	SENT_13	[p1l1890t1932r1921b1956],
6	the	DT	O	the	det	7	SENT_13	[p1l1932t1930r1983b1956],
7	number	NN	O	number	pobj	3	SENT_13	[p1l1995t1930r2114b1956],
8	of	IN	O	of	_	0	SENT_13	[p1l620t1975r651b2002],
9	clinical	JJ	O	clinical	amod	10	SENT_13	[p1l659t1975r771b2002],
10	predictors	NNS	O	predictor	prep_of	7	SENT_13	[p1l782t1975r939b2009],
11	(	VBP	O	(	_	0	SENT_13	[p1l951t1975r1079b2009],
12	female	JJ	O	female	amod	14	SENT_13	[p1l951t1975r1079b2009],
13	,	,	O	,	_	0	SENT_13	[p1l951t1975r1079b2009],
14	adenocarcinoma	NN	O	adenocarcinoma	nn	17	SENT_13	[p1l1092t1975r1349b2002],
15	and	CC	O	and	_	0	SENT_13	[p1l1358t1975r1413b2002],
16	never-smoker	JJ	O	never-smoker	conj_and	14	SENT_13	[p1l1424t1975r1659b2009],
17	)	NN	O	)	dobj	11	SENT_13	[p1l1424t1975r1659b2009],
18	.	.	O	.	_	0	SENT_13	[p1l1424t1975r1659b2009],

1	Response	NN	O	response	nn	2	SENT_14	[p1l1673t1975r1814b2009],
2	rate	NN	O	rate	dep	11	SENT_14	[p1l1824t1978r1886b2002],
3	(	CD	NUMBER	(	num	5	SENT_14	[p1l1898t1975r1971b2009],
4	RR	NN	O	rr	nn	5	SENT_14	[p1l1898t1975r1971b2009],
5	)	NN	O	)	nn	8	SENT_14	[p1l1898t1975r1971b2009],
6	,	,	O	,	_	0	SENT_14	[p1l1898t1975r1971b2009],
7	timetoprogression	NN	O	timetoprogression	appos	5	SENT_14	[p1l1983t1976r2111b2002, p1l621t2021r797b2054],
8	(	NN	O	(	dep	2	SENT_14	[p1l811t2021r893b2054],
9	'	''	O	'	_	0	SENT_14	[p1l811t2021r893b2054],
10	I	PRP	O	I	nsubj	11	SENT_14	[p1l811t2021r893b2054],
11	‘	VBP	O	‘	_	0	SENT_14	[p1l811t2021r893b2054],
12	|	NN	O	|	dobj	11	SENT_14	[p1l811t2021r893b2054],
13	'	''	O	'	_	0	SENT_14	[p1l811t2021r893b2054],
14	P	NN	O	p	nn	15	SENT_14	[p1l811t2021r893b2054],
15	)	NN	O	)	nsubjpass	23	SENT_14	[p1l811t2021r893b2054],
16	and	CC	O	and	_	0	SENT_14	[p1l906t2020r960b2047],
17	overall	JJ	O	overall	amod	18	SENT_14	[p1l972t2020r1079b2047],
18	survival	NN	O	survival	nsubjpass	23	SENT_14	[p1l1091t2020r1209b2047],
19	(	CD	NUMBER	(	num	21	SENT_14	[p1l1223t2020r1284b2054],
20	OS	NN	O	os	nn	21	SENT_14	[p1l1223t2020r1284b2054],
21	)	NN	O	)	dep	18	SENT_14	[p1l1223t2020r1284b2054],
22	were	VBD	O	be	auxpass	23	SENT_14	[p1l1296t2027r1374b2047],
23	analyzed	VBN	O	analyze	rcmod	12	SENT_14	[p1l1385t2020r1533b2054],
24	.	.	O	.	_	0	SENT_14	[p1l1385t2020r1533b2054],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_15	[p1l1547t2020r1736b2047],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_15	[p1l1747t2020r1868b2054],
3	was	VBD	O	be	auxpass	4	SENT_15	[p1l1879t2027r1937b2047],
4	performed	VBN	O	perform	_	0	SENT_15	[p1l1949t2020r2111b2054],
5	to	TO	O	to	aux	6	SENT_15	[p1l620t2068r651b2092],
6	investigate	VB	O	investigate	xcomp	4	SENT_15	[p1l664t2066r835b2099],
7	which	WDT	O	which	dobj	9	SENT_15	[p1l847t2066r937b2092],
8	approach	NN	O	approach	nsubj	9	SENT_15	[p1l951t2066r1093b2099],
9	yielded	VBD	O	yield	ccomp	6	SENT_15	[p1l1106t2066r1220b2099],
10	better	JJR	O	better	amod	11	SENT_15	[p1l1235t2066r1332b2092],
11	prediction	NN	O	prediction	dobj	9	SENT_15	[p1l1345t2066r1514b2099],
12	.	.	O	.	_	0	SENT_15	[p1l1345t2066r1514b2099],

1	Results	NNS	O	result	nsubj	34	SENT_16	[p1l620t2111r743b2138],
2	:	:	O	:	_	0	SENT_16	[p1l620t2111r743b2138],
3	RRs	NNS	O	rr	dep	1	SENT_16	[p1l758t2111r810b2138],
4	according	VBG	O	accord	_	0	SENT_16	[p1l823t2111r973b2145],
5	to	TO	O	to	prepc_according_to	3	SENT_16	[p1l985t2114r1016b2138],
6	number	NN	O	number	pobj	3	SENT_16	[p1l1029t2111r1148b2138],
7	of	IN	O	of	_	0	SENT_16	[p1l1159t2111r1190b2138],
8	clinical	JJ	O	clinical	amod	9	SENT_16	[p1l1201t2111r1312b2138],
9	predictors	NNS	O	predictor	prep_of	6	SENT_16	[p1l1326t2111r1484b2145],
10	were	VBD	O	be	cop	34	SENT_16	[p1l1495t2118r1572b2138],
11	o	NN	O	o	nn	34	SENT_16	[p1l1584t2111r1611b2138],
12	:	:	O	:	_	0	SENT_16	[p1l1584t2111r1611b2138],
13	3.4	CD	PERCENT	3.4	num	14	SENT_16	[p1l1627t2111r1705b2144],
14	%	NN	PERCENT	%	dep	11	SENT_16	[p1l1627t2111r1705b2144],
15	,	,	O	,	_	0	SENT_16	[p1l1627t2111r1705b2144],
16	1	CD	NUMBER	1	appos	14	SENT_16	[p1l1722t2112r1746b2138],
17	:	:	O	:	_	0	SENT_16	[p1l1722t2112r1746b2138],
18	17.1	CD	PERCENT	17.1	num	19	SENT_16	[p1l1764t2111r1859b2144],
19	%	NN	PERCENT	%	dep	14	SENT_16	[p1l1764t2111r1859b2144],
20	,	,	O	,	_	0	SENT_16	[p1l1764t2111r1859b2144],
21	2	CD	NUMBER	2	appos	19	SENT_16	[p1l1874t2111r1901b2138],
22	:	:	O	:	_	0	SENT_16	[p1l1874t2111r1901b2138],
23	29.4	CD	PERCENT	29.4	num	24	SENT_16	[p1l1916t2111r2003b2138],
24	%	NN	PERCENT	%	dep	14	SENT_16	[p1l1916t2111r2003b2138],
25	and	CC	O	and	_	0	SENT_16	[p1l2016t2111r2070b2138],
26	3	CD	NUMBER	3	dep	14	SENT_16	[p1l2084t2111r2109b2138],
27	:	:	O	:	_	0	SENT_16	[p1l2084t2111r2109b2138],
28	33.3	CD	PERCENT	33.3	num	29	SENT_16	[p1l621t2156r707b2183],
29	%	NN	PERCENT	%	dep	14	SENT_16	[p1l621t2156r707b2183],
30	(	CD	NUMBER	(	num	31	SENT_16	[p1l724t2156r892b2190],
31	p	NN	O	p	dep	29	SENT_16	[p1l724t2156r892b2190],
32	=	JJ	O	=	amod	34	SENT_16	[p1l724t2156r892b2190],
33	0.002	CD	NUMBER	0.002	tmod	32	SENT_16	[p1l724t2156r892b2190],
34	)	NN	O	)	_	0	SENT_16	[p1l724t2156r892b2190],
35	.	.	O	.	_	0	SENT_16	[p1l724t2156r892b2190],

1	Patients	NNS	O	patient	nsubj	6	SENT_17	[p1l911t2157r1035b2183],
2	with	IN	O	with	_	0	SENT_17	[p1l1048t2156r1115b2183],
3	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	5	SENT_17	[p1l1131t2156r1410b2190],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_17	[p1l1425t2156r1505b2183],
5	mutation	NN	O	mutation	prep_with	1	SENT_17	[p1l1519t2157r1658b2183],
6	showed	VBD	O	show	_	0	SENT_17	[p1l1673t2156r1788b2183],
7	61.9	CD	PERCENT	61.9	num	8	SENT_17	[p1l1803t2156r1891b2183],
8	%	NN	PERCENT	%	iobj	6	SENT_17	[p1l1803t2156r1891b2183],
9	RR	NN	O	rr	dobj	6	SENT_17	[p1l1906t2157r1945b2183],
10	compared	VBN	O	compare	_	0	SENT_17	[p1l1958t2156r2111b2190],
11	with	IN	O	with	prepc_compared_with	9	SENT_17	[p1l619t2202r686b2229],
12	12.1	CD	PERCENT	12.1	num	13	SENT_17	[p1l706t2202r791b2229],
13	%	NN	PERCENT	%	pobj	9	SENT_17	[p1l706t2202r791b2229],
14	in	IN	O	in	_	0	SENT_17	[p1l807t2202r833b2229],
15	the	DT	O	the	det	17	SENT_17	[p1l851t2202r901b2229],
16	remaining	VBG	O	remain	amod	17	SENT_17	[p1l918t2202r1072b2236],
17	patients	NNS	O	patient	prep_in	13	SENT_17	[p1l1089t2202r1215b2236],
18	(	CD	NUMBER	(	num	19	SENT_17	[p1l1233t2202r1402b2236],
19	p	NN	O	p	npadvmod	20	SENT_17	[p1l1233t2202r1402b2236],
20	<	JJR	O	<	amod	17	SENT_17	[p1l1233t2202r1402b2236],
21	0.001	CD	NUMBER	0.001	num	22	SENT_17	[p1l1233t2202r1402b2236],
22	)	NN	O	)	dep	9	SENT_17	[p1l1233t2202r1402b2236],
23	.	.	O	.	_	0	SENT_17	[p1l1233t2202r1402b2236],

1	RRs	NNS	O	rr	nsubj	3	SENT_18	[p1l1423t2202r1474b2229],
2	were	VBD	O	be	cop	3	SENT_18	[p1l1490t2209r1567b2229],
3	higher	JJR	O	higher	_	0	SENT_18	[p1l1584t2202r1681b2236],
4	in	IN	O	in	_	0	SENT_18	[p1l1696t2202r1722b2229],
5	patients	NNS	O	patient	prep_in	3	SENT_18	[p1l1741t2202r1867b2236],
6	with	IN	O	with	_	0	SENT_18	[p1l1882t2202r1949b2229],
7	the	DT	O	the	det	8	SENT_18	[p1l1966t2202r2017b2229],
8	EGFR	NN	ORGANIZATION	egfr	prep_with	5	SENT_18	[p1l2034t2202r2113b2229],
9	mutations	NNS	O	mutation	npadvmod	8	SENT_18	[p1l621t2248r775b2274],
10	regardless	RB	O	regardless	_	0	SENT_18	[p1l792t2247r950b2281],
11	of	IN	O	of	_	0	SENT_18	[p1l966t2247r997b2274],
12	the	DT	O	the	det	13	SENT_18	[p1l1011t2247r1062b2274],
13	number	NN	O	number	prep_regardless_of	8	SENT_18	[p1l1078t2247r1196b2274],
14	of	IN	O	of	_	0	SENT_18	[p1l1211t2247r1242b2274],
15	clinical	JJ	O	clinical	amod	16	SENT_18	[p1l1257t2247r1368b2274],
16	predictors	NNS	O	predictor	prep_of	13	SENT_18	[p1l1385t2247r1553b2281],
17	.	.	O	.	_	0	SENT_18	[p1l1385t2247r1553b2281],

1	In	IN	O	in	_	0	SENT_19	[p1l1573t2248r1597b2274],
2	multivariate	JJ	O	multivariate	amod	3	SENT_19	[p1l1615t2247r1806b2274],
3	analysis	NN	O	analysis	prep_in	34	SENT_19	[p1l1822t2247r1953b2281],
4	,	,	O	,	_	0	SENT_19	[p1l1822t2247r1953b2281],
5	geﬁtinibsensitive	JJ	O	geﬁtinibsensitive	amod	7	SENT_19	[p1l1971t2247r2111b2281, p1l620t2293r756b2319],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_19	[p1l773t2292r852b2319],
7	mutation	NN	O	mutation	nsubj	34	SENT_19	[p1l869t2293r1008b2319],
8	showed	VBD	O	show	partmod	7	SENT_19	[p1l1025t2292r1139b2319],
9	higher	JJR	O	higher	amod	10	SENT_19	[p1l1158t2292r1255b2326],
10	odds	NNS	O	odds	dobj	8	SENT_19	[p1l1270t2292r1341b2319],
11	ratio	NN	O	ratio	dep	23	SENT_19	[p1l1358t2293r1430b2319],
12	of	IN	O	of	_	0	SENT_19	[p1l1446t2292r1477b2319],
13	response	NN	O	response	prep_of	11	SENT_19	[p1l1494t2299r1629b2326],
14	(	CD	NUMBER	(	number	15	SENT_19	[p1l1647t2292r1716b2326],
15	9.6	CD	NUMBER	9.6	dep	13	SENT_19	[p1l1647t2292r1716b2326],
16	,	,	O	,	_	0	SENT_19	[p1l1647t2292r1716b2326],
17	95	CD	PERCENT	95	number	18	SENT_19	[p1l1735t2292r1791b2319],
18	%	NN	PERCENT	%	amod	19	SENT_19	[p1l1735t2292r1791b2319],
19	conﬁdence	NN	O	conﬁdence	appos	13	SENT_19	[p1l1807t2292r1976b2319],
20	interval	NN	O	interval	dep	23	SENT_19	[p1l1992t2292r2112b2319],
21	[	CD	NUMBER	[	num	20	SENT_19	[p1l622t2338r672b2371],
22	CI	NN	O	ci	nn	23	SENT_19	[p1l622t2338r672b2371],
23	]	NN	O	]	dep	8	SENT_19	[p1l622t2338r672b2371],
24	3.2	CD	NUMBER	3.2	number	25	SENT_19	[p1l687t2338r840b2371],
25	—	CD	NUMBER	—	dep	23	SENT_19	[p1l687t2338r840b2371],
26	28.7	CD	NUMBER	28.7	num	27	SENT_19	[p1l687t2338r840b2371],
27	)	NN	O	)	dep	25	SENT_19	[p1l687t2338r840b2371],
28	compared	VBN	O	compare	_	0	SENT_19	[p1l853t2338r1007b2371],
29	with	IN	O	with	prepc_compared_with	8	SENT_19	[p1l1019t2338r1086b2364],
30	number	NN	O	number	pobj	8	SENT_19	[p1l1100t2338r1218b2364],
31	of	IN	O	of	_	0	SENT_19	[p1l1229t2338r1260b2364],
32	clinical	JJ	O	clinical	amod	33	SENT_19	[p1l1270t2338r1382b2364],
33	predictors	NNS	O	predictor	prep_of	30	SENT_19	[p1l1395t2338r1553b2371],
34	(	VBP	O	(	_	0	SENT_19	[p1l1566t2338r1635b2371],
35	1.7	CD	NUMBER	1.7	dobj	34	SENT_19	[p1l1566t2338r1635b2371],
36	,	,	O	,	_	0	SENT_19	[p1l1566t2338r1635b2371],
37	95	CD	PERCENT	95	number	38	SENT_19	[p1l1650t2338r1706b2364],
38	%	NN	PERCENT	%	amod	39	SENT_19	[p1l1650t2338r1706b2364],
39	CI	NN	O	ci	appos	35	SENT_19	[p1l1718t2338r1744b2364],
40	1.1-2	CD	NUMBER	1.1-2	num	42	SENT_19	[p1l1760t2338r1905b2371],
41	.7	CD	NUMBER	.7	num	42	SENT_19	[p1l1760t2338r1905b2371],
42	)	NN	O	)	dep	39	SENT_19	[p1l1760t2338r1905b2371],
43	.	.	O	.	_	0	SENT_19	[p1l1760t2338r1905b2371],

1	Hazard	NN	O	hazard	nn	2	SENT_20	[p1l1921t2338r2027b2364],
2	ratio	NN	O	ratio	nsubj	34	SENT_20	[p1l2041t2338r2113b2364],
3	(	CD	NUMBER	(	num	5	SENT_20	[p1l622t2383r686b2417],
4	HR	NN	DURATION	hr	nn	5	SENT_20	[p1l622t2383r686b2417],
5	)	NN	O	)	nsubj	9	SENT_20	[p1l622t2383r686b2417],
6	of	IN	O	of	_	0	SENT_20	[p1l700t2383r731b2410],
7	'	''	O	'	_	0	SENT_20	[p1l741t2384r801b2410],
8	I	PRP	O	I	prep_of	5	SENT_20	[p1l741t2384r801b2410],
9	‘	VBP	O	‘	rcmod	2	SENT_20	[p1l741t2384r801b2410],
10	|	NN	O	|	dobj	9	SENT_20	[p1l741t2384r801b2410],
11	'	''	O	'	_	0	SENT_20	[p1l741t2384r801b2410],
12	P	NN	O	p	nsubj	13	SENT_20	[p1l741t2384r801b2410],
13	was	VBD	O	be	rcmod	10	SENT_20	[p1l813t2390r870b2410],
14	also	RB	O	also	advmod	13	SENT_20	[p1l883t2383r943b2410],
15	better	RBR	O	better	advmod	13	SENT_20	[p1l957t2383r1054b2410],
16	in	IN	O	in	_	0	SENT_20	[p1l1066t2384r1092b2410],
17	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	19	SENT_20	[p1l1106t2383r1385b2417],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_20	[p1l1398t2383r1477b2410],
19	mutation	NN	O	mutation	prep_in	13	SENT_20	[p1l1490t2384r1629b2410],
20	(	CD	NUMBER	(	num	21	SENT_20	[p1l1645t2383r1732b2417],
21	0.24	CD	NUMBER	0.24	dep	19	SENT_20	[p1l1645t2383r1732b2417],
22	,	,	O	,	_	0	SENT_20	[p1l1645t2383r1732b2417],
23	95	CD	PERCENT	95	number	24	SENT_20	[p1l1748t2383r1804b2410],
24	%	NN	PERCENT	%	amod	25	SENT_20	[p1l1748t2383r1804b2410],
25	CI	NN	O	ci	appos	19	SENT_20	[p1l1816t2383r1843b2410],
26	0.12-0	CD	NUMBER	0.12-0	num	28	SENT_20	[p1l1857t2383r2030b2417],
27	.47	CD	NUMBER	.47	num	28	SENT_20	[p1l1857t2383r2030b2417],
28	)	NN	O	)	dep	25	SENT_20	[p1l1857t2383r2030b2417],
29	than	IN	O	than	_	0	SENT_20	[p1l2044t2383r2112b2410],
30	number	NN	O	number	prep_than	13	SENT_20	[p1l621t2428r739b2455],
31	of	IN	O	of	_	0	SENT_20	[p1l751t2428r782b2455],
32	clinical	JJ	O	clinical	amod	33	SENT_20	[p1l794t2428r905b2455],
33	predictors	NNS	O	predictor	prep_of	30	SENT_20	[p1l919t2428r1077b2462],
34	(	VBP	O	(	_	0	SENT_20	[p1l1092t2428r1179b2462],
35	0.83	CD	NUMBER	0.83	dobj	34	SENT_20	[p1l1092t2428r1179b2462],
36	,	,	O	,	_	0	SENT_20	[p1l1092t2428r1179b2462],
37	95	CD	PERCENT	95	number	38	SENT_20	[p1l1195t2428r1251b2455],
38	%	NN	PERCENT	%	amod	39	SENT_20	[p1l1195t2428r1251b2455],
39	CI	NN	O	ci	appos	35	SENT_20	[p1l1264t2428r1291b2455],
40	0.69-0	CD	NUMBER	0.69-0	num	42	SENT_20	[p1l1306t2428r1489b2462],
41	.99	CD	NUMBER	.99	num	42	SENT_20	[p1l1306t2428r1489b2462],
42	)	NN	O	)	dep	39	SENT_20	[p1l1306t2428r1489b2462],
43	.	.	O	.	_	0	SENT_20	[p1l1306t2428r1489b2462],

1	Only	RB	O	only	advmod	6	SENT_21	[p1l1505t2428r1575b2462],
2	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	4	SENT_21	[p1l1587t2428r1866b2462],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_21	[p1l1880t2428r1959b2455],
4	mutation	NN	O	mutation	nsubjpass	6	SENT_21	[p1l1973t2429r2112b2455],
5	was	VBD	O	be	auxpass	6	SENT_21	[p1l619t2481r677b2500],
6	associated	VBN	O	associate	_	0	SENT_21	[p1l690t2474r851b2500],
7	with	IN	O	with	_	0	SENT_21	[p1l865t2474r932b2500],
8	improved	VBN	O	improve	prepc_with	6	SENT_21	[p1l946t2474r1090b2507],
9	OS	NNP	O	OS	dobj	8	SENT_21	[p1l1104t2474r1142b2500],
10	(	CD	NUMBER	(	num	9	SENT_21	[p1l1157t2474r1211b2507],
11	HR	NN	DURATION	hr	dep	9	SENT_21	[p1l1157t2474r1211b2507],
12	0.25	CD	NUMBER	0.25	num	11	SENT_21	[p1l1222t2474r1299b2506],
13	,	,	O	,	_	0	SENT_21	[p1l1222t2474r1299b2506],
14	95	CD	PERCENT	95	number	15	SENT_21	[p1l1315t2474r1371b2500],
15	%	NN	PERCENT	%	amod	16	SENT_21	[p1l1315t2474r1371b2500],
16	CI	NN	O	ci	appos	9	SENT_21	[p1l1383t2474r1410b2500],
17	0.12-0	CD	NUMBER	0.12-0	num	19	SENT_21	[p1l1425t2474r1608b2507],
18	.52	CD	NUMBER	.52	num	19	SENT_21	[p1l1425t2474r1608b2507],
19	)	NN	O	)	dep	16	SENT_21	[p1l1425t2474r1608b2507],
20	.	.	O	.	_	0	SENT_21	[p1l1425t2474r1608b2507],

1	*	NN	O	*	_	0	SENT_22	[p1l69t2605r79b2617],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_22	[p1l96t2604r307b2636],
3	author	NN	O	author	dobj	2	SENT_22	[p1l316t2604r416b2630],
4	.	.	O	.	_	0	SENT_22	[p1l316t2604r416b2630],

1	Tel.	NNP	O	Tel.	_	0	SENT_23	[p1l427t2604r491b2630],
2	:	:	O	:	_	0	SENT_23	[p1l427t2604r491b2630],
3	+82	CD	NUMBER	+82	number	4	SENT_23	[p1l503t2604r552b2630],
4	2	CD	NUMBER	2	dep	1	SENT_23	[p1l562t2604r577b2629],
5	2072	CD	DATE	2072	num	6	SENT_23	[p1l587t2604r654b2630],
6	3943	CD	NUMBER	3943	dep	4	SENT_23	[p1l664t2604r740b2635],
7	;	:	O	;	_	0	SENT_23	[p1l664t2604r740b2635],
8	fax	NN	O	fax	dep	1	SENT_23	[p1l752t2604r806b2630],
9	:	:	O	:	_	0	SENT_23	[p1l752t2604r806b2630],
10	+82	CD	NUMBER	+82	number	11	SENT_23	[p1l819t2604r868b2630],
11	2	CD	NUMBER	2	dep	8	SENT_23	[p1l877t2604r892b2629],
12	762	CD	NUMBER	762	num	13	SENT_23	[p1l902t2604r952b2630],
13	9662	NN	DATE	9662	dep	11	SENT_23	[p1l961t2604r1038b2630],
14	.	.	O	.	_	0	SENT_23	[p1l961t2604r1038b2630],

1	E-mail	NN	O	e-mail	nn	2	SENT_24	[p1l98t2652r192b2678],
2	address	NN	O	address	_	0	SENT_24	[p1l204t2652r326b2678],
3	:	:	O	:	_	0	SENT_24	[p1l204t2652r326b2678],
4	kimty@snu.ac.kr	NN	O	kimty@snu.ac.kr	dep	2	SENT_24	[p1l340t2652r585b2684],
5	(	NN	O	(	dep	4	SENT_24	[p1l598t2653r667b2684],
6	'	''	O	'	_	0	SENT_24	[p1l598t2653r667b2684],
7	|	NN	O	|	dep	4	SENT_24	[p1l598t2653r667b2684],
8	'	''	O	'	_	0	SENT_24	[p1l598t2653r667b2684],
9	.	.	O	.	_	0	SENT_24	[p1l598t2653r667b2684],

1	-	:	O	-	_	0	SENT_25	[p1l598t2653r667b2684],
2	Y.	NNP	PERSON	Y.	nn	3	SENT_25	[p1l598t2653r667b2684],
3	Kim	NNP	PERSON	Kim	_	0	SENT_25	[p1l683t2653r757b2684],
4	)	NN	O	)	dep	3	SENT_25	[p1l683t2653r757b2684],
5	.	.	O	.	_	0	SENT_25	[p1l683t2653r757b2684],

1	0169-5002	CD	DURATION	0169-5002	_	0	SENT_26	[p1l46t2744r211b2770],
2	/	:	O	/	punct	1	SENT_26	[p1l46t2744r211b2770],
3	S	NN	O	s	nsubj	5	SENT_26	[p1l216t2742r230b2773],
4	—	CD	NUMBER	—	num	3	SENT_26	[p1l243t2758r265b2760],
5	see	VBP	O	see	dep	1	SENT_26	[p1l277t2751r325b2769],
6	front	JJ	O	front	amod	7	SENT_26	[p1l336t2744r409b2769],
7	matter	NN	O	matter	dobj	5	SENT_26	[p1l422t2746r522b2769],
8	©	CD	NUMBER	©	num	12	SENT_26	[p1l534t2747r556b2769],
9	2006	CD	DATE	2006	num	12	SENT_26	[p1l567t2744r634b2770],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	12	SENT_26	[p1l648t2744r762b2769],
11	Ireland	NNP	ORGANIZATION	Ireland	nn	12	SENT_26	[p1l774t2744r874b2769],
12	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_26	[p1l888t2744r943b2769],
13	.	.	O	.	_	0	SENT_26	[p1l888t2744r943b2769],

1	All	DT	O	all	det	2	SENT_27	[p1l956t2744r994b2769],
2	rights	NNS	O	rights	nsubj	3	SENT_27	[p1l1008t2744r1088b2776],
3	reserved	VBN	O	reserve	_	0	SENT_27	[p1l1102t2744r1236b2769],
4	.	.	O	.	_	0	SENT_27	[p1l1102t2744r1236b2769],

1	doi	FW	O	doi	_	0	SENT_28	[p1l46t2785r569b2817],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_28	[p1l46t2785r569b2817],
3	/	:	O	/	punct	5	SENT_28	[p1l46t2785r569b2817],
4	j.	NN	O	j.	nn	5	SENT_28	[p1l46t2785r569b2817],
5	lungcan	NN	O	lungcan	dep	2	SENT_28	[p1l46t2785r569b2817],
6	.2006.07.007	CD	NUMBER	.2006.07.007	number	7	SENT_28	[p1l46t2785r569b2817],
7	202	CD	NUMBER	202	num	8	SENT_28	[p1l47t2834r103b2862],
8	S.-W	NN	O	s.-w	dep	2	SENT_28	[p1l1852t2834r1934b2862],
9	.	.	O	.	_	0	SENT_28	[p1l1852t2834r1934b2862],

1	Han	NNP	O	Han	_	0	SENT_29	[p1l1952t2835r2012b2862],
2	et	FW	O	et	nn	3	SENT_29	[p1l2026t2837r2060b2862],
3	al.	FW	O	al.	dep	1	SENT_29	[p1l2073t2834r2111b2862],
4	.	.	O	.	_	0	SENT_29	[p1l2073t2834r2111b2862],

1	Conclusion	NN	O	conclusion	_	0	SENT_30	[p1l596t2928r774b2955],
2	:	:	O	:	_	0	SENT_30	[p1l596t2928r774b2955],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_30	[p1l807t2928r887b2955],
4	mutation	NN	O	mutation	nsubjpass	7	SENT_30	[p1l903t2928r1042b2955],
5	should	MD	O	should	aux	7	SENT_30	[p1l1059t2928r1158b2955],
6	be	VB	O	be	auxpass	7	SENT_30	[p1l1176t2928r1212b2955],
7	analyzed	VBN	O	analyze	dep	1	SENT_30	[p1l1228t2928r1365b2962],
8	whenever	WRB	O	whenever	advmod	9	SENT_30	[p1l1381t2928r1534b2955],
9	possible	JJ	O	possible	advcl	7	SENT_30	[p1l1551t2928r1674b2962],
10	for	IN	O	for	_	0	SENT_30	[p1l1690t2928r1735b2955],
11	effective	JJ	O	effective	amod	12	SENT_30	[p1l1750t2928r1891b2955],
12	prediction	NN	O	prediction	prep_for	9	SENT_30	[p1l1908t2928r2066b2962],
13	of	IN	O	of	_	0	SENT_30	[p1l2083t2928r2114b2955],
14	objective	JJ	O	objective	amod	15	SENT_30	[p1l595t2973r742b3007],
15	beneﬁt	NN	O	beneﬁt	prep_of	12	SENT_30	[p1l756t2973r865b3000],
16	from	IN	O	from	_	0	SENT_30	[p1l877t2973r949b3000],
17	geﬁtinib	NN	O	geﬁtinib	prep_from	15	SENT_30	[p1l963t2973r1091b3007],
18	in	IN	O	in	_	0	SENT_30	[p1l1104t2974r1130b3000],
19	NSCLC	NN	O	nsclc	nn	20	SENT_30	[p1l1145t2973r1241b3000],
20	patients	NNS	O	patient	prep_in	17	SENT_30	[p1l1255t2974r1381b3007],
21	with	IN	O	with	_	0	SENT_30	[p1l1393t2973r1460b3000],
22	one	CD	NUMBER	one	num	26	SENT_30	[p1l1474t2980r1529b3000],
23	or	CC	O	or	_	0	SENT_30	[p1l1542t2980r1573b3000],
24	more	JJR	O	more	conj_or	22	SENT_30	[p1l1586t2980r1664b3000],
25	clinical	JJ	O	clinical	amod	26	SENT_30	[p1l1677t2973r1788b3000],
26	predictors	NNS	O	predictor	prep_with	20	SENT_30	[p1l1802t2973r1970b3007],
27	.	.	O	.	_	0	SENT_30	[p1l1802t2973r1970b3007],

1	©	RB	O	©	advmod	2	SENT_31	[p1l596t3021r619b3045],
2	2006	CD	DATE	2006	_	0	SENT_31	[p1l631t3018r703b3045],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	5	SENT_31	[p1l717t3018r838b3045],
4	Ireland	NNP	ORGANIZATION	Ireland	nn	5	SENT_31	[p1l851t3018r957b3045],
5	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_31	[p1l972t3018r1030b3045],
6	.	.	O	.	_	0	SENT_31	[p1l972t3018r1030b3045],

1	All	DT	O	all	det	2	SENT_32	[p1l1045t3018r1085b3045],
2	rights	NNS	O	rights	nsubj	3	SENT_32	[p1l1099t3018r1185b3052],
3	reserved	VBN	O	reserve	_	0	SENT_32	[p1l1199t3018r1342b3045],
4	.	.	O	.	_	0	SENT_32	[p1l1199t3018r1342b3045],

1	1	LS	NUMBER	1	_	0	SENT_33	[p1l20t3257r91b3330],
2	.	.	O	.	_	0	SENT_33	[p1l20t3257r91b3330],

1	Introduction	NN	O	introduction	_	0	SENT_34	[p1l153t3255r709b3329],

1	Epidermal	JJ	O	epidermal	amod	4	SENT_35	[p1l12t3480r368b3556],
2	growth	NN	O	growth	nn	4	SENT_35	[p1l424t3480r666b3556],
3	factor	NN	O	factor	nn	4	SENT_35	[p1l723t3480r939b3540],
4	receptor	NN	O	receptor	nsubjpass	7	SENT_35	[p1l994t3486r1299b3556],
5	is	VBZ	O	be	auxpass	7	SENT_35	[p1l1352t3481r1402b3540],
6	frequently	RB	O	frequently	advmod	7	SENT_35	[p1l1457t3480r1831b3556],
7	overexpressed	VBN	O	overexpress	_	0	SENT_35	[p1l1884t3496r2147b3540, p1l12t3575r275b3651],
8	in	IN	O	in	_	0	SENT_35	[p1l333t3577r392b3635],
9	various	JJ	O	various	amod	10	SENT_35	[p1l447t3577r700b3635],
10	malignancies	NNS	O	malignancy	prep_in	7	SENT_35	[p1l756t3575r1214b3651],
11	including	VBG	O	include	_	0	SENT_35	[p1l1269t3575r1591b3651],
12	non-small	JJ	O	non-small	amod	15	SENT_35	[p1l1647t3575r2150b3635],
13	—	NN	O	—	nn	15	SENT_35	[p1l1647t3575r2150b3635],
14	cell	NN	O	cell	nn	15	SENT_35	[p1l1647t3575r2150b3635],
15	lung	NN	O	lung	prep_including	10	SENT_35	[p1l12t3673r157b3748],
16	cancer	NN	O	cancer	nn	19	SENT_35	[p1l199t3689r438b3733],
17	(	CD	NUMBER	(	num	19	SENT_35	[p1l483t3673r782b3748],
18	NSCLC	NN	O	nsclc	nn	19	SENT_35	[p1l483t3673r782b3748],
19	)	NN	O	)	dep	15	SENT_35	[p1l483t3673r782b3748],
20	.	.	O	.	_	0	SENT_35	[p1l483t3673r782b3748],

1	Its	PRP$	O	its	poss	2	SENT_36	[p1l836t3674r914b3733],
2	activation	NN	O	activation	nsubj	3	SENT_36	[p1l957t3674r1309b3733],
3	has	VBZ	O	have	_	0	SENT_36	[p1l1357t3673r1468b3733],
4	important	JJ	O	important	amod	5	SENT_36	[p1l1512t3674r1866b3748],
5	role	NN	O	role	dobj	3	SENT_36	[p1l1912t3673r2046b3733],
6	in	IN	O	in	_	0	SENT_36	[p1l2088t3674r2148b3732],
7	various	JJ	O	various	amod	8	SENT_36	[p2l7t18r260b77],
8	steps	NNS	O	step	prep_in	5	SENT_36	[p2l301t22r482b93],
9	of	IN	O	of	_	0	SENT_36	[p2l522t17r593b77],
10	carcinogenesis	NN	O	carcinogenesis	prep_of	8	SENT_36	[p2l630t18r1149b93],
11	and	CC	O	and	_	0	SENT_36	[p2l1190t17r1313b77],
12	progression	NN	O	progression	nn	13	SENT_36	[p2l1359t18r1759b93],
13	[	NN	O	[	prep_in	5	SENT_36	[p2l1807t17r1921b93],
14	1	CD	NUMBER	1	num	15	SENT_36	[p2l1807t17r1921b93],
15	]	NN	O	]	dep	13	SENT_36	[p2l1807t17r1921b93],
16	.	.	O	.	_	0	SENT_36	[p2l1807t17r1921b93],

1	EGFR	NN	ORGANIZATION	egfr	nsubj	18	SENT_37	[p2l1972t18r2152b77],
2	targeted	VBN	O	target	partmod	1	SENT_37	[p2l10t112r312b188],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_37	[p2l353t112r767b188],
4	approach	NN	O	approach	dobj	2	SENT_37	[p2l806t112r1130b188],
5	by	IN	O	by	_	0	SENT_37	[p2l1173t112r1252b188],
6	inhibition	NN	O	inhibition	agent	2	SENT_37	[p2l1288t112r1623b173],
7	of	IN	O	of	_	0	SENT_37	[p2l1663t112r1734b172],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_37	[p2l1773t113r1953b173],
9	activation	NN	O	activation	prep_of	6	SENT_37	[p2l1989t114r2147b172, p2l8t211r226b270],
10	with	IN	O	with	_	0	SENT_37	[p2l267t210r420b270],
11	the	DT	O	the	det	16	SENT_37	[p2l464t210r579b270],
12	speciﬁc	NN	O	speciﬁc	nn	16	SENT_37	[p2l620t210r885b285],
13	tyrosine	NN	O	tyrosine	nn	16	SENT_37	[p2l926t211r1211b285],
14	kinase	NN	O	kinase	nn	16	SENT_37	[p2l1254t210r1473b270],
15	inhibitor	NN	O	inhibitor	nn	16	SENT_37	[p2l1514t210r1819b270],
16	geﬁtinib	NN	O	geﬁtinib	prep_with	2	SENT_37	[p2l1858t210r2150b285],
17	has	VBZ	O	have	aux	18	SENT_37	[p2l12t306r123b366],
18	proven	VBN	O	prove	_	0	SENT_37	[p2l155t322r392b382],
19	clinically	RB	O	clinically	advmod	20	SENT_37	[p2l424t306r744b382],
20	successful	JJ	O	successful	acomp	18	SENT_37	[p2l771t306r1128b366],
21	especially	RB	O	especially	advmod	18	SENT_37	[p2l1158t306r1513b382],
22	in	IN	O	in	_	0	SENT_37	[p2l1541t307r1600b365],
23	NSCLC	NNP	O	NSCLC	prep_in	18	SENT_37	[p2l1635t307r1876b366],
24	.	.	O	.	_	0	SENT_37	[p2l1635t307r1876b366],

1	Objective	NN	O	objective	nn	2	SENT_38	[p2l1914t306r2147b382, p2l10t403r143b461],
2	responses	NNS	O	response	nsubjpass	6	SENT_38	[p2l183t418r524b477],
3	were	VBD	O	be	auxpass	6	SENT_38	[p2l558t418r735b462],
4	more	RBR	O	more	advmod	5	SENT_38	[p2l774t418r952b462],
5	frequently	RB	O	frequently	advmod	6	SENT_38	[p2l988t401r1362b477],
6	seen	VBN	O	see	_	0	SENT_38	[p2l1397t418r1554b461],
7	in	IN	O	in	_	0	SENT_38	[p2l1594t403r1653b461],
8	subgroups	NNS	O	subgroup	prep_in	6	SENT_38	[p2l1693t401r2045b477],
9	of	IN	O	of	_	0	SENT_38	[p2l2082t401r2153b461],
10	patients	NNS	O	patient	prep_of	8	SENT_38	[p2l12t500r299b574],
11	[	CD	NUMBER	[	number	12	SENT_38	[p2l345t499r530b574],
12	2,3	CD	NUMBER	2,3	num	13	SENT_38	[p2l345t499r530b574],
13	]	NN	O	]	dep	10	SENT_38	[p2l345t499r530b574],
14	.	.	O	.	_	0	SENT_38	[p2l345t499r530b574],

1	Therefore	RB	O	therefore	advmod	12	SENT_39	[p2l576t499r955b572],
2	,	,	O	,	_	0	SENT_39	[p2l576t499r955b572],
3	selection	NN	O	selection	nsubj	12	SENT_39	[p2l1002t499r1321b559],
4	of	IN	O	of	_	0	SENT_39	[p2l1365t499r1436b559],
5	appropriate	JJ	O	appropriate	amod	7	SENT_39	[p2l1474t500r1893b574],
6	target	NN	O	target	nn	7	SENT_39	[p2l1934t504r2151b574],
7	population	NN	O	population	prep_of	3	SENT_39	[p2l12t595r386b671],
8	for	IN	O	for	_	0	SENT_39	[p2l424t595r526b655],
9	the	DT	O	the	det	10	SENT_39	[p2l559t595r674b655],
10	treatment	NN	O	treatment	prep_for	7	SENT_39	[p2l710t600r1073b655],
11	may	MD	O	may	aux	12	SENT_39	[p2l1109t611r1253b671],
12	lead	VB	O	lead	_	0	SENT_39	[p2l1289t595r1434b655],
13	to	TO	O	to	_	0	SENT_39	[p2l1471t600r1542b655],
14	improved	JJ	O	improved	amod	16	SENT_39	[p2l1577t595r1907b671],
15	treatment	NN	O	treatment	nn	16	SENT_39	[p2l1945t600r2147b655, p2l12t679r192b734],
16	outcomes	NNS	O	outcome	prep_to	12	SENT_39	[p2l220t680r583b734],
17	.	.	O	.	_	0	SENT_39	[p2l220t680r583b734],

1	Clinical	JJ	O	clinical	amod	2	SENT_40	[p2l120t771r381b831],
2	predictors	NNS	O	predictor	nsubj	9	SENT_40	[p2l406t771r766b846],
3	of	IN	O	of	_	0	SENT_40	[p2l788t771r859b831],
4	better	JJR	O	better	amod	5	SENT_40	[p2l881t771r1103b831],
5	outcome	NN	O	outcome	prep_of	2	SENT_40	[p2l1123t776r1432b831],
6	with	IN	O	with	_	0	SENT_40	[p2l1452t771r1605b831],
7	geﬁti	NNS	O	geﬁti	nn	8	SENT_40	[p2l1630t771r1808b846],
8	ni	NNS	O	nus	prep_with	5	SENT_40	[p2l1818t772r1874b830],
9	b	NN	O	b	_	0	SENT_40	[p2l1885t771r1922b831],
10	treatment	NN	O	treatment	nsubjpass	15	SENT_40	[p2l1945t776r2147b831, p2l12t873r192b928],
11	in	IN	O	in	_	0	SENT_40	[p2l222t869r281b927],
12	NSCLC	NNP	O	NSCLC	prep_in	10	SENT_40	[p2l317t869r535b928],
13	have	VBP	O	have	aux	15	SENT_40	[p2l569t868r731b928],
14	been	VBN	O	be	auxpass	15	SENT_40	[p2l764t868r930b928],
15	identiﬁed	VBN	O	identiﬁed	ccomp	9	SENT_40	[p2l964t868r1302b928],
16	in	IN	O	in	_	0	SENT_40	[p2l1335t869r1394b927],
17	the	DT	O	the	det	18	SENT_40	[p2l1427t868r1542b928],
18	two	CD	NUMBER	two	prep_in	15	SENT_40	[p2l1573t874r1703b928],
19	randomized	VBN	O	randomize	partmod	18	SENT_40	[p2l1736t868r2148b928],
20	phase	NN	O	phase	dobj	19	SENT_40	[p2l12t963r212b1039],
21	II	CD	NUMBER	ii	num	22	SENT_40	[p2l246t965r277b1023],
22	trials	NNS	O	trial	dep	20	SENT_40	[p2l312t963r491b1023],
23	and	CC	O	and	_	0	SENT_40	[p2l521t963r645b1023],
24	the	DT	O	the	det	28	SENT_40	[p2l677t963r792b1023],
25	compassionate	JJ	O	compassionate	amod	28	SENT_40	[p2l821t964r1347b1039],
26	Expanded	NNP	O	Expanded	nn	28	SENT_40	[p2l1379t963r1716b1039],
27	Access	NN	O	access	nn	28	SENT_40	[p2l1747t964r1980b1023],
28	Program	NN	O	program	conj_and	20	SENT_40	[p2l2013t964r2147b1023, p2l10t1075r183b1136],
29	[	CD	NUMBER	[	number	30	SENT_40	[p2l238t1061r495b1136],
30	4	CD	NUMBER	4	num	31	SENT_40	[p2l238t1061r495b1136],
31	—	NN	O	—	dep	28	SENT_40	[p2l238t1061r495b1136],
32	10	CD	NUMBER	10	num	33	SENT_40	[p2l238t1061r495b1136],
33	]	NN	O	]	dep	28	SENT_40	[p2l238t1061r495b1136],
34	.	.	O	.	_	0	SENT_40	[p2l238t1061r495b1136],

1	These	DT	O	these	nsubj	2	SENT_41	[p2l548t1061r757b1121],
2	include	VBP	O	include	_	0	SENT_41	[p2l805t1061r1062b1121],
3	East-Asian	JJ	MISC	east-asian	amod	4	SENT_41	[p2l1113t1061r1471b1121],
4	ethnicity	NN	O	ethnicity	dobj	2	SENT_41	[p2l1521t1061r1851b1136],
5	,	,	O	,	_	0	SENT_41	[p2l1521t1061r1851b1136],
6	female	JJ	O	female	amod	7	SENT_41	[p2l1904t1061r2150b1121],
7	sex	NN	O	sex	dobj	2	SENT_41	[p2l9t1174r144b1231],
8	,	,	O	,	_	0	SENT_41	[p2l9t1174r144b1231],
9	adenocarcinoma	NN	O	adenocarcinoma	nn	13	SENT_41	[p2l189t1158r774b1218],
10	or	CC	O	or	_	0	SENT_41	[p2l811t1174r884b1218],
11	bronchioloalveolar	JJ	O	bronchioloalveolar	nn	13	SENT_41	[p2l921t1158r1586b1218],
12	carcinoma	NN	O	carcinoma	nn	13	SENT_41	[p2l1621t1159r1988b1218],
13	histology	NN	O	histology	dobj	2	SENT_41	[p2l2029t1158r2147b1218, p2l10t1253r229b1329],
14	and	CC	O	and	_	0	SENT_41	[p2l267t1253r390b1313],
15	never-smoking	JJ	O	never-smoking	amod	16	SENT_41	[p2l435t1253r950b1329],
16	history	NN	O	history	conj_and	4	SENT_41	[p2l993t1253r1243b1329],
17	.	.	O	.	_	0	SENT_41	[p2l993t1253r1243b1329],

1	Planned	NNP	O	Planned	nn	3	SENT_42	[p2l1294t1253r1571b1313],
2	subgroup	NN	O	subgroup	nn	3	SENT_42	[p2l1613t1253r1933b1329],
3	analysis	NN	O	analysis	nsubj	18	SENT_42	[p2l1974t1253r2147b1313, p2l8t1352r132b1426],
4	of	IN	O	of	_	0	SENT_42	[p2l173t1351r244b1411],
5	the	DT	O	the	det	9	SENT_42	[p2l282t1351r396b1411],
6	phase	NN	O	phase	nn	9	SENT_42	[p2l439t1351r639b1426],
7	III	CD	NUMBER	iii	num	9	SENT_42	[p2l684t1352r737b1410],
8	geﬁtinib	NN	O	geﬁtinib	nn	9	SENT_42	[p2l783t1351r1075b1426],
9	trial	NN	O	trial	prep_of	3	SENT_42	[p2l1116t1351r1286b1424],
10	,	,	O	,	_	0	SENT_42	[p2l1116t1351r1286b1424],
11	lressa	NN	O	lressa	nn	13	SENT_42	[p2l1337t1352r1533b1411],
12	Survival	NNP	O	Survival	nn	13	SENT_42	[p2l1574t1351r1850b1411],
13	Evaluation	NN	O	evaluation	appos	9	SENT_42	[p2l1894t1351r2147b1411, p2l10t1449r144b1508],
14	in	IN	O	in	_	0	SENT_42	[p2l185t1449r244b1507],
15	Lung	NN	O	lung	nn	16	SENT_42	[p2l288t1449r450b1523],
16	Cancer	NN	O	cancer	prep_in	13	SENT_42	[p2l488t1448r743b1521],
17	,	,	O	,	_	0	SENT_42	[p2l488t1448r743b1521],
18	showed	VBD	O	show	_	0	SENT_42	[p2l788t1448r1049b1508],
19	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_42	[p2l1090t1448r1453b1523],
20	survival	NN	O	survival	nn	21	SENT_42	[p2l1491t1448r1760b1508],
21	beneﬁt	NN	O	beneﬁt	dobj	18	SENT_42	[p2l1802t1448r2051b1508],
22	in	IN	O	in	_	0	SENT_42	[p2l2088t1449r2148b1507],
23	never-smokers	NNS	O	never-smoker	prep_in	18	SENT_42	[p2l12t1543r527b1603],
24	and	CC	O	and	_	0	SENT_42	[p2l553t1543r676b1603],
25	Asians	NNPS	MISC	Asians	conj_and	23	SENT_42	[p2l700t1544r920b1603],
26	[	CD	NUMBER	[	number	27	SENT_42	[p2l950t1543r1105b1619],
27	11	CD	NUMBER	11	num	28	SENT_42	[p2l950t1543r1105b1619],
28	]	NN	O	]	dep	25	SENT_42	[p2l950t1543r1105b1619],
29	.	.	O	.	_	0	SENT_42	[p2l950t1543r1105b1619],

1	In	IN	O	in	_	0	SENT_43	[p2l1142t1545r1196b1603],
2	addition	NN	O	addition	prep_in	8	SENT_43	[p2l1224t1543r1538b1616],
3	,	,	O	,	_	0	SENT_43	[p2l1224t1543r1538b1616],
4	higher	JJR	O	higher	amod	6	SENT_43	[p2l1572t1543r1794b1619],
5	objective	JJ	O	objective	amod	6	SENT_43	[p2l1816t1543r2150b1619],
6	responses	NNS	O	response	nsubjpass	8	SENT_43	[p2l12t1657r354b1716],
7	were	VBD	O	be	auxpass	8	SENT_43	[p2l388t1657r564b1701],
8	seen	VBN	O	see	_	0	SENT_43	[p2l600t1657r757b1701],
9	in	IN	O	in	_	0	SENT_43	[p2l797t1642r856b1700],
10	females	NNS	O	female	prep_in	8	SENT_43	[p2l895t1641r1196b1714],
11	,	,	O	,	_	0	SENT_43	[p2l895t1641r1196b1714],
12	adenocarcinomas	NNS	O	adenocarcinoma	conj_and	10	SENT_43	[p2l1240t1641r1880b1714],
13	,	,	O	,	_	0	SENT_43	[p2l1240t1641r1880b1714],
14	neversmokers	NNS	O	neversmoker	conj_and	10	SENT_43	[p2l1926t1657r2147b1701, p2l9t1737r296b1797],
15	and	CC	O	and	_	0	SENT_43	[p2l331t1737r454b1797],
16	Asians	NNPS	MISC	Asians	conj_and	10	SENT_43	[p2l490t1738r709b1797],
17	[	CD	NUMBER	[	number	18	SENT_43	[p2l750t1737r905b1813],
18	11	CD	NUMBER	11	num	19	SENT_43	[p2l750t1737r905b1813],
19	]	NN	O	]	dep	16	SENT_43	[p2l750t1737r905b1813],
20	.	.	O	.	_	0	SENT_43	[p2l750t1737r905b1813],

1	In	IN	O	in	_	0	SENT_44	[p2l952t1738r1007b1796],
2	the	DT	O	the	det	5	SENT_44	[p2l1046t1737r1160b1797],
3	phase	NN	O	phase	nn	5	SENT_44	[p2l1198t1737r1398b1812],
4	III	CD	NUMBER	iii	num	5	SENT_44	[p2l1438t1738r1491b1796],
5	trial	NN	O	trial	prep_in	13	SENT_44	[p2l1531t1737r1677b1797],
6	of	IN	O	of	_	0	SENT_44	[p2l1713t1737r1785b1797],
7	erlotinib	NN	O	erlotinib	prep_of	5	SENT_44	[p2l1817t1737r2144b1810],
8	,	,	O	,	_	0	SENT_44	[p2l1817t1737r2144b1810],
9	response	NN	O	response	nn	10	SENT_44	[p2l12t1849r321b1909],
10	rates	NNS	O	rate	nsubj	13	SENT_44	[p2l359t1839r533b1893],
11	were	VBD	O	be	cop	13	SENT_44	[p2l566t1849r742b1893],
12	also	RB	O	also	advmod	13	SENT_44	[p2l777t1833r914b1893],
13	higher	JJR	O	higher	_	0	SENT_44	[p2l951t1833r1172b1909],
14	in	IN	O	in	_	0	SENT_44	[p2l1205t1834r1264b1893],
15	females	NNS	O	female	prep_in	13	SENT_44	[p2l1301t1833r1603b1906],
16	,	,	O	,	_	0	SENT_44	[p2l1301t1833r1603b1906],
17	adenocarcinomas	NNS	O	adenocarcinoma	prep_in	13	SENT_44	[p2l1645t1833r2147b1893, p2l12t1945r169b2002],
18	,	,	O	,	_	0	SENT_44	[p2l1645t1833r2147b1893, p2l12t1945r169b2002],
19	never-smokers	NNS	O	never-smoker	prep_in	13	SENT_44	[p2l203t1928r718b1988],
20	and	CC	O	and	_	0	SENT_44	[p2l742t1928r865b1988],
21	Asians	NNPS	MISC	Asians	prep_in	13	SENT_44	[p2l890t1929r1109b1988],
22	although	IN	O	although	mark	31	SENT_44	[p2l1134t1928r1439b2004],
23	the	DT	O	the	det	25	SENT_44	[p2l1467t1928r1581b1988],
24	survival	NN	O	survival	nn	25	SENT_44	[p2l1605t1928r1875b1989],
25	beneﬁt	NN	O	beneﬁt	nsubjpass	31	SENT_44	[p2l1903t1928r2151b1989],
26	of	IN	O	of	_	0	SENT_44	[p2l9t2025r80b2085],
27	erlotinib	NN	O	erlotinib	nn	28	SENT_44	[p2l114t2025r418b2085],
28	treatment	NN	O	treatment	prep_of	25	SENT_44	[p2l456t2030r819b2085],
29	was	VBD	O	be	auxpass	31	SENT_44	[p2l853t2041r985b2085],
30	not	RB	O	not	neg	31	SENT_44	[p2l1024t2030r1137b2085],
31	limited	VBN	O	limit	advcl	13	SENT_44	[p2l1176t2025r1422b2085],
32	to	TO	O	to	_	0	SENT_44	[p2l1463t2030r1532b2085],
33	these	DT	O	these	det	34	SENT_44	[p2l1569t2025r1761b2085],
34	subgroups	NNS	O	subgroup	prep_to	31	SENT_44	[p2l1797t2025r2150b2101],
35	[	VBP	O	[	dep	34	SENT_44	[p2l14t2120r171b2196],
36	12	CD	NUMBER	12	num	37	SENT_44	[p2l14t2120r171b2196],
37	]	CD	NUMBER	]	dobj	35	SENT_44	[p2l14t2120r171b2196],
38	.	.	O	.	_	0	SENT_44	[p2l14t2120r171b2196],

1	Moreover	RB	O	moreover	advmod	15	SENT_45	[p2l206t2122r547b2193],
2	,	,	O	,	_	0	SENT_45	[p2l206t2122r547b2193],
3	phase	NN	O	phase	nn	5	SENT_45	[p2l586t2120r787b2196],
4	II	CD	NUMBER	ii	num	5	SENT_45	[p2l821t2122r851b2180],
5	trial	NN	O	trial	nsubj	15	SENT_45	[p2l886t2120r1032b2180],
6	of	IN	O	of	_	0	SENT_45	[p2l1063t2120r1134b2180],
7	ﬁrst-line	JJ	O	ﬁrst-line	amod	8	SENT_45	[p2l1160t2120r1463b2180],
8	geﬁtinib	NN	O	geﬁtinib	prep_of	5	SENT_45	[p2l1493t2120r1785b2196],
9	in	IN	O	in	_	0	SENT_45	[p2l1815t2121r1874b2180],
10	Korean	JJ	MISC	korean	amod	11	SENT_45	[p2l1910t2122r2148b2180],
11	never-smokers	NNS	O	never-smoker	prep_in	8	SENT_45	[p2l12t2217r527b2278],
12	with	IN	O	with	_	0	SENT_45	[p2l551t2217r703b2278],
13	adenocarcinomas	NNS	O	adenocarcinoma	prep_with	11	SENT_45	[p2l731t2217r1349b2277],
14	have	VBP	O	have	aux	15	SENT_45	[p2l1376t2217r1538b2278],
15	shown	VBN	O	show	_	0	SENT_45	[p2l1563t2217r1779b2278],
16	promising	JJ	O	promising	amod	17	SENT_45	[p2l1809t2219r2150b2293],
17	results	NNS	O	result	dobj	15	SENT_45	[p2l12t2313r244b2373],
18	suggesting	VBG	O	suggest	xcomp	15	SENT_45	[p2l265t2314r634b2388],
19	that	IN	O	that	complm	33	SENT_45	[p2l655t2313r800b2373],
20	patient	NN	O	patient	nn	21	SENT_45	[p2l823t2314r1078b2389],
21	selection	NN	O	selection	nsubj	33	SENT_45	[p2l1098t2313r1417b2373],
22	according	VBG	O	accord	_	0	SENT_45	[p2l1440t2313r1784b2388],
23	to	TO	O	to	prepc_according_to	21	SENT_45	[p2l1805t2318r1875b2373],
24	clinical	JJ	O	clinical	amod	25	SENT_45	[p2l1895t2313r2150b2373],
25	parameters	NNS	O	parameter	pobj	21	SENT_45	[p2l12t2415r415b2485],
26	may	MD	O	may	aux	33	SENT_45	[p2l447t2425r590b2485],
27	be	VB	O	be	cop	33	SENT_45	[p2l620t2409r702b2469],
28	an	DT	O	a	det	33	SENT_45	[p2l731t2425r809b2469],
29	effective	JJ	O	effective	amod	33	SENT_45	[p2l840t2409r1161b2469],
30	strategy	NN	O	strategy	nn	33	SENT_45	[p2l1190t2414r1481b2485],
31	[	CD	NUMBER	[	number	32	SENT_45	[p2l1513t2409r1669b2485],
32	13	CD	NUMBER	13	num	33	SENT_45	[p2l1513t2409r1669b2485],
33	]	NN	O	]	ccomp	18	SENT_45	[p2l1513t2409r1669b2485],
34	.	.	O	.	_	0	SENT_45	[p2l1513t2409r1669b2485],

1	Molecular	JJ	O	molecular	amod	2	SENT_46	[p2l118t2504r466b2565],
2	predictors	NNS	O	predictor	nsubj	6	SENT_46	[p2l489t2504r848b2580],
3	of	IN	O	of	_	0	SENT_46	[p2l870t2504r942b2564],
4	geﬁtinib	NN	O	geﬁtinib	nn	5	SENT_46	[p2l962t2504r1254b2580],
5	sensitivity	NN	O	sensitivity	prep_of	2	SENT_46	[p2l1277t2506r1639b2580],
6	include	VBP	O	include	_	0	SENT_46	[p2l1660t2504r1918b2564],
7	mutations	NNS	O	mutation	dobj	6	SENT_46	[p2l1943t2510r2147b2564, p2l10t2603r179b2662],
8	in	IN	O	in	_	0	SENT_46	[p2l219t2603r278b2661],
9	the	DT	O	the	det	12	SENT_46	[p2l321t2602r436b2662],
10	tyrosine	NN	O	tyrosine	nn	12	SENT_46	[p2l475t2603r760b2677],
11	kinase	NN	O	kinase	nn	12	SENT_46	[p2l802t2602r1021b2662],
12	domain	NN	O	domain	prep_in	7	SENT_46	[p2l1061t2602r1317b2662],
13	of	IN	O	of	_	0	SENT_46	[p2l1359t2602r1430b2662],
14	EGFR	NN	ORGANIZATION	egfr	prep_of	12	SENT_46	[p2l1470t2602r1651b2662],
15	and	CC	O	and	_	0	SENT_46	[p2l1689t2602r1812b2662],
16	increase	NN	O	increase	prep_of	12	SENT_46	[p2l1855t2603r2150b2662],
17	in	IN	O	in	_	0	SENT_46	[p2l10t2699r69b2757],
18	gene	NN	O	gene	nn	20	SENT_46	[p2l111t2713r278b2774],
19	copy	NN	O	copy	nn	20	SENT_46	[p2l317t2714r482b2774],
20	number	NN	O	number	prep_in	7	SENT_46	[p2l521t2698r791b2758],
21	of	IN	O	of	_	0	SENT_46	[p2l827t2698r899b2758],
22	EGFR	NN	ORGANIZATION	egfr	prep_of	20	SENT_46	[p2l938t2699r1119b2758],
23	[	CD	NUMBER	[	num	22	SENT_46	[p2l1161t2698r1460b2774],
24	14	CD	NUMBER	14	num	25	SENT_46	[p2l1161t2698r1460b2774],
25	—	NN	O	—	tmod	6	SENT_46	[p2l1161t2698r1460b2774],
26	22	CD	NUMBER	22	num	27	SENT_46	[p2l1161t2698r1460b2774],
27	]	NN	O	]	dep	25	SENT_46	[p2l1161t2698r1460b2774],
28	.	.	O	.	_	0	SENT_46	[p2l1161t2698r1460b2774],

1	Presence	NN	O	presence	nsubjpass	14	SENT_47	[p2l1510t2699r1822b2758],
2	of	IN	O	of	_	0	SENT_47	[p2l1861t2698r1932b2758],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_47	[p2l1972t2699r2152b2758],
4	mutation	NN	O	mutation	prep_of	1	SENT_47	[p2l12t2795r329b2853],
5	in	IN	O	in	_	0	SENT_47	[p2l358t2795r417b2853],
6	exons	NNS	O	exon	prep_in	4	SENT_47	[p2l446t2810r645b2853],
7	18	CD	NUMBER	18	num	6	SENT_47	[p2l677t2794r774b2867],
8	,	,	O	,	_	0	SENT_47	[p2l677t2794r774b2867],
9	19	CD	NUMBER	19	prep_in	4	SENT_47	[p2l812t2794r885b2853],
10	and	CC	O	and	_	0	SENT_47	[p2l913t2793r1036b2853],
11	21	CD	NUMBER	21	prep_in	4	SENT_47	[p2l1065t2794r1132b2853],
12	was	VBD	O	be	auxpass	14	SENT_47	[p2l1169t2810r1300b2854],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_47	[p2l1327t2793r1754b2869],
14	associated	VBN	O	associate	dep	23	SENT_47	[p2l1779t2793r2148b2853],
15	with	IN	O	with	_	0	SENT_47	[p2l8t2890r161b2950],
16	higher	JJR	O	higher	amod	18	SENT_47	[p2l187t2890r408b2965],
17	response	NN	O	response	nn	18	SENT_47	[p2l429t2906r737b2966],
18	rate	NN	O	rate	prep_with	14	SENT_47	[p2l761t2895r903b2950],
19	in	IN	O	in	_	0	SENT_47	[p2l923t2891r983b2949],
20	geﬁtinib-treated	JJ	O	geﬁtinib-treated	amod	22	SENT_47	[p2l1006t2890r1595b2965],
21	NSCLC	NN	O	nsclc	nn	22	SENT_47	[p2l1621t2890r1840b2950],
22	patients	NNS	O	patient	prep_in	18	SENT_47	[p2l1863t2891r2150b2966],
23	[	VBP	O	[	_	0	SENT_47	[p2l14t2986r314b3062],
24	14	CD	NUMBER	14	num	25	SENT_47	[p2l14t2986r314b3062],
25	—	CD	NUMBER	—	dobj	23	SENT_47	[p2l14t2986r314b3062],
26	19	CD	NUMBER	19	num	27	SENT_47	[p2l14t2986r314b3062],
27	]	NN	O	]	nsubj	23	SENT_47	[p2l14t2986r314b3062],
28	.	.	O	.	_	0	SENT_47	[p2l14t2986r314b3062],

1	Although	IN	O	although	mark	6	SENT_48	[p2l356t2986r669b3062],
2	its	PRP$	O	its	poss	4	SENT_48	[p2l710t2987r792b3046],
3	prognostic	JJ	O	prognostic	amod	4	SENT_48	[p2l833t2987r1199b3062],
4	signiﬁcance	NN	O	signiﬁcance	nsubj	6	SENT_48	[p2l1237t2986r1651b3062],
5	is	VBZ	O	be	cop	6	SENT_48	[p2l1690t2987r1740b3046],
6	controversial	JJ	O	controversial	advcl	14	SENT_48	[p2l1777t2992r2147b3046, p2l10t3081r149b3155],
7	,	,	O	,	_	0	SENT_48	[p2l1777t2992r2147b3046, p2l10t3081r149b3155],
8	geﬁtinib-treated	JJ	O	geﬁtinib-treated	amod	10	SENT_48	[p2l190t3081r778b3157],
9	NSCLC	NN	O	nsclc	nn	10	SENT_48	[p2l818t3082r1036b3142],
10	patients	NNS	O	patient	nsubj	14	SENT_48	[p2l1073t3083r1360b3157],
11	with	IN	O	with	_	0	SENT_48	[p2l1391t3081r1544b3142],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_48	[p2l1583t3082r1764b3142],
13	mutations	NNS	O	mutation	prep_with	10	SENT_48	[p2l1798t3083r2150b3142],
14	seem	VBP	O	seem	dep	25	SENT_48	[p2l10t3195r189b3239],
15	to	TO	O	to	aux	16	SENT_48	[p2l232t3184r302b3239],
16	have	VB	O	have	xcomp	14	SENT_48	[p2l345t3179r507b3239],
17	longer	JJR	O	longer	amod	18	SENT_48	[p2l550t3179r771b3254],
18	survival	NN	O	survival	dobj	16	SENT_48	[p2l809t3179r1079b3239],
19	compared	VBN	O	compare	_	0	SENT_48	[p2l1120t3179r1469b3254],
20	with	IN	O	with	prepc_compared_with	16	SENT_48	[p2l1510t3179r1663b3239],
21	the	DT	O	the	det	22	SENT_48	[p2l1706t3179r1821b3239],
22	patients	NNS	O	patient	pobj	16	SENT_48	[p2l1863t3180r2150b3254],
23	without	IN	O	without	_	0	SENT_48	[p2l7t3275r283b3335],
24	mutations	NNS	O	mutation	prep_without	16	SENT_48	[p2l317t3276r669b3335],
25	[	VBP	O	[	_	0	SENT_48	[p2l706t3275r1005b3351],
26	17	CD	NUMBER	17	num	27	SENT_48	[p2l706t3275r1005b3351],
27	—	CD	NUMBER	—	dobj	25	SENT_48	[p2l706t3275r1005b3351],
28	19	CD	NUMBER	19	num	29	SENT_48	[p2l706t3275r1005b3351],
29	]	NN	O	]	nsubj	25	SENT_48	[p2l706t3275r1005b3351],
30	.	.	O	.	_	0	SENT_48	[p2l706t3275r1005b3351],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_49	[p2l1047t3276r1228b3335],
2	mutations	NNS	O	mutation	nsubjpass	5	SENT_49	[p2l1260t3276r1613b3335],
3	were	VBD	O	be	auxpass	5	SENT_49	[p2l1642t3291r1819b3335],
4	predominantly	RB	O	predominantly	advmod	5	SENT_49	[p2l1853t3275r2147b3351, p2l10t3370r255b3446],
5	found	VBN	O	find	_	0	SENT_49	[p2l309t3370r507b3430],
6	in	IN	O	in	_	0	SENT_49	[p2l566t3372r625b3430],
7	Asians	NNPS	MISC	Asians	prep_in	5	SENT_49	[p2l682t3371r924b3444],
8	,	,	O	,	_	0	SENT_49	[p2l682t3371r924b3444],
9	females	NNS	O	female	appos	7	SENT_49	[p2l986t3370r1287b3443],
10	,	,	O	,	_	0	SENT_49	[p2l986t3370r1287b3443],
11	adenocarcinomas	NNS	O	adenocarcinoma	appos	7	SENT_49	[p2l1350t3370r1968b3431],
12	and	CC	O	and	_	0	SENT_49	[p2l2025t3370r2148b3430],
13	never-smokers	NNS	O	never-smoker	appos	7	SENT_49	[p2l12t3468r550b3541],
14	,	,	O	,	_	0	SENT_49	[p2l12t3468r550b3541],
15	which	WDT	O	which	nsubj	16	SENT_49	[p2l583t3468r788b3528],
16	explains	VBZ	O	explain	rcmod	7	SENT_49	[p2l819t3468r1108b3543],
17	the	DT	O	the	det	18	SENT_49	[p2l1137t3468r1251b3528],
18	association	NN	O	association	dobj	16	SENT_49	[p2l1280t3469r1669b3528],
19	between	IN	O	between	_	0	SENT_49	[p2l1703t3468r2005b3528],
20	the	DT	O	the	det	22	SENT_49	[p2l2035t3468r2150b3528],
21	clinical	JJ	O	clinical	amod	22	SENT_49	[p2l9t3564r263b3624],
22	predictors	NNS	O	predictor	prep_between	18	SENT_49	[p2l292t3564r651b3640],
23	and	CC	O	and	_	0	SENT_49	[p2l677t3564r800b3624],
24	geﬁtinib	NN	O	geﬁtinib	nn	25	SENT_49	[p2l829t3564r1121b3640],
25	sensitivity	NN	O	sensitivity	prep_between	18	SENT_49	[p2l1147t3565r1508b3640],
26	[	CD	NUMBER	[	number	27	SENT_49	[p2l1538t3564r1837b3640],
27	14	CD	NUMBER	14	num	28	SENT_49	[p2l1538t3564r1837b3640],
28	—	NN	O	—	dep	22	SENT_49	[p2l1538t3564r1837b3640],
29	19	CD	NUMBER	19	num	30	SENT_49	[p2l1538t3564r1837b3640],
30	]	NN	O	]	dep	28	SENT_49	[p2l1538t3564r1837b3640],
31	.	.	O	.	_	0	SENT_49	[p2l1538t3564r1837b3640],

1	Another	DT	O	another	det	3	SENT_50	[p2l1867t3564r2153b3624],
2	molecular	JJ	O	molecular	amod	3	SENT_50	[p2l12t3660r366b3720],
3	predictor	NN	O	predictor	nsubj	8	SENT_50	[p2l386t3660r715b3736],
4	of	IN	O	of	_	0	SENT_50	[p2l733t3660r804b3720],
5	geﬁtinib	NN	O	geﬁtinib	nn	6	SENT_50	[p2l822t3660r1113b3736],
6	sensitivity	NN	O	sensitivity	prep_of	3	SENT_50	[p2l1134t3661r1495b3736],
7	is	VBZ	O	be	cop	8	SENT_50	[p2l1514t3661r1564b3720],
8	increase	NN	O	increase	_	0	SENT_50	[p2l1585t3661r1881b3720],
9	in	IN	O	in	_	0	SENT_50	[p2l1901t3661r1960b3720],
10	gene	NN	O	gene	nn	12	SENT_50	[p2l1984t3675r2150b3736],
11	copy	NN	O	copy	nn	12	SENT_50	[p3l9t33r174b92],
12	number	NN	O	number	prep_in	8	SENT_50	[p3l207t17r477b77],
13	of	IN	O	of	_	0	SENT_50	[p3l507t17r579b77],
14	EGFR	NN	ORGANIZATION	egfr	prep_of	12	SENT_50	[p3l612t17r793b77],
15	[	CD	NUMBER	[	number	16	SENT_50	[p3l828t17r1127b92],
16	19	CD	NUMBER	19	num	17	SENT_50	[p3l828t17r1127b92],
17	—	NN	O	—	dep	14	SENT_50	[p3l828t17r1127b92],
18	22	CD	NUMBER	22	num	19	SENT_50	[p3l828t17r1127b92],
19	]	NN	O	]	dep	17	SENT_50	[p3l828t17r1127b92],
20	.	.	O	.	_	0	SENT_50	[p3l828t17r1127b92],

1	As	IN	O	as	mark	11	SENT_51	[p3l1165t17r1243b77],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_51	[p3l1279t17r1460b77],
3	mutation	NN	O	mutation	nsubjpass	11	SENT_51	[p3l1493t18r1810b77],
4	and	CC	O	and	_	0	SENT_51	[p3l1845t17r1968b77],
5	high	JJ	O	high	amod	8	SENT_51	[p3l2006t17r2148b92],
6	gene	NN	O	gene	nn	8	SENT_51	[p3l10t128r177b189],
7	copy	NN	O	copy	nn	8	SENT_51	[p3l221t129r386b189],
8	number	NN	O	number	nsubjpass	11	SENT_51	[p3l431t113r701b173],
9	are	VBP	O	be	auxpass	11	SENT_51	[p3l743t129r856b173],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_51	[p3l901t113r1328b189],
11	associated	VBN	O	associate	advcl	23	SENT_51	[p3l1371t113r1740b173],
12	with	IN	O	with	_	0	SENT_51	[p3l1785t113r1938b173],
13	each	DT	O	each	det	17	SENT_51	[p3l1985t113r2148b173],
14	other	JJ	O	other	amod	17	SENT_51	[p3l9t208r201b268],
15	[	CD	NUMBER	[	number	16	SENT_51	[p3l232t208r615b284],
16	19,20,22	CD	NUMBER	19,20,22	num	17	SENT_51	[p3l232t208r615b284],
17	]	NN	O	]	prep_with	11	SENT_51	[p3l232t208r615b284],
18	,	,	O	,	_	0	SENT_51	[p3l232t208r615b284],
19	appropriately	RB	O	appropriately	advmod	20	SENT_51	[p3l650t208r1133b284],
20	designed	VBN	O	design	amod	21	SENT_51	[p3l1159t208r1468b284],
21	study	NN	O	study	nsubjpass	23	SENT_51	[p3l1499t208r1688b284],
22	is	VBZ	O	be	auxpass	23	SENT_51	[p3l1715t209r1765b268],
23	needed	VBN	O	need	_	0	SENT_51	[p3l1795t208r2050b268],
24	to	TO	O	to	aux	25	SENT_51	[p3l2080t214r2150b268],
25	uncover	VB	O	uncover	xcomp	23	SENT_51	[p3l11t322r292b366],
26	which	WDT	O	which	dobj	29	SENT_51	[p3l329t306r534b366],
27	molecular	JJ	O	molecular	amod	28	SENT_51	[p3l579t306r932b366],
28	marker	NN	O	marker	nsubj	29	SENT_51	[p3l973t306r1224b366],
29	has	VBZ	O	have	ccomp	25	SENT_51	[p3l1264t306r1376b366],
30	predominant	JJ	O	predominant	amod	31	SENT_51	[p3l1418t306r1871b381],
31	role	NN	O	role	dobj	29	SENT_51	[p3l1914t306r2048b366],
32	in	IN	O	in	_	0	SENT_51	[p3l2088t307r2148b365],
33	determining	VBG	O	determine	prepc_in	31	SENT_51	[p3l10t402r441b478],
34	geﬁtinib-sensitivity	NN	O	geﬁtinib-sensitivity	dobj	33	SENT_51	[p3l483t402r1182b478],
35	.	.	O	.	_	0	SENT_51	[p3l483t402r1182b478],

1	It	PRP	O	it	nsubj	3	SENT_52	[p3l1234t404r1280b462],
2	is	VBZ	O	be	cop	3	SENT_52	[p3l1321t403r1371b462],
3	possible	JJ	O	possible	_	0	SENT_52	[p3l1414t402r1696b478],
4	that	IN	O	that	complm	7	SENT_52	[p3l1737t402r1883b462],
5	different	JJ	O	different	amod	6	SENT_52	[p3l1923t402r2147b462, p3l9t503r125b557],
6	ethnicities	NNS	O	ethnicity	nsubj	7	SENT_52	[p3l151t497r527b557],
7	have	VBP	O	have	ccomp	3	SENT_52	[p3l556t497r718b557],
8	different	JJ	O	different	amod	9	SENT_52	[p3l745t497r1063b557],
9	mechanisms	NNS	O	mechanism	dobj	7	SENT_52	[p3l1092t497r1520b557],
10	of	IN	O	of	_	0	SENT_52	[p3l1547t497r1618b557],
11	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_52	[p3l1645t498r1826b557],
12	pathway	NN	O	pathway	nn	13	SENT_52	[p3l1853t497r2152b573],
13	addiction	NN	O	addiction	prep_of	9	SENT_52	[p3l10t595r339b655],
14	and	CC	O	and	_	0	SENT_52	[p3l366t595r490b655],
15	resulting	VBG	O	result	amod	16	SENT_52	[p3l519t595r827b670],
16	geﬁtinib-sensitivity	NN	O	geﬁtinib-sensitivity	conj_and	13	SENT_52	[p3l851t595r1550b670],
17	.	.	O	.	_	0	SENT_52	[p3l851t595r1550b670],

1	Identiﬁcation	NN	O	identiﬁcation	nsubj	13	SENT_53	[p3l1586t595r2055b655],
2	of	IN	O	of	_	0	SENT_53	[p3l2082t595r2153b655],
3	resistance	NN	O	resistance	nn	4	SENT_53	[p3l12t693r370b752],
4	mechanism	NN	O	mechanism	prep_of	1	SENT_53	[p3l399t692r818b765],
5	,	,	O	,	_	0	SENT_53	[p3l399t692r818b765],
6	such	JJ	O	such	_	0	SENT_53	[p3l851t692r1004b752],
7	as	IN	O	as	_	0	SENT_53	[p3l1034t708r1104b752],
8	K-ras	NN	O	k-ra	nn	9	SENT_53	[p3l1134t693r1308b752],
9	mutation	NN	O	mutation	prep_such_as	4	SENT_53	[p3l1338t693r1655b752],
10	could	MD	O	could	aux	13	SENT_53	[p3l1684t692r1872b752],
11	also	RB	O	also	advmod	13	SENT_53	[p3l1903t692r2039b752],
12	be	VB	O	be	cop	13	SENT_53	[p3l2069t692r2150b752],
13	helpful	JJ	O	helpful	_	0	SENT_53	[p3l12t787r258b863],
14	in	IN	O	in	_	0	SENT_53	[p3l285t788r343b847],
15	selecting	VBG	O	select	prepc_in	13	SENT_53	[p3l372t787r691b863],
16	most	RBS	O	most	advmod	17	SENT_53	[p3l719t793r887b847],
17	suitable	JJ	O	suitable	amod	18	SENT_53	[p3l911t787r1193b847],
18	patient	NN	O	patient	dobj	15	SENT_53	[p3l1221t788r1476b863],
19	for	IN	O	for	_	0	SENT_53	[p3l1500t787r1603b847],
20	geﬁtinib	NN	O	geﬁtinib	nn	21	SENT_53	[p3l1626t787r1918b863],
21	treatment	NN	O	treatment	prep_for	15	SENT_53	[p3l1945t793r2147b847, p3l12t890r192b945],
22	[	CD	NUMBER	[	number	23	SENT_53	[p3l225t885r524b960],
23	22	CD	NUMBER	22	num	24	SENT_53	[p3l225t885r524b960],
24	—	NN	O	—	dep	21	SENT_53	[p3l225t885r524b960],
25	24	CD	NUMBER	24	num	26	SENT_53	[p3l225t885r524b960],
26	]	NN	O	]	dep	24	SENT_53	[p3l225t885r524b960],
27	.	.	O	.	_	0	SENT_53	[p3l225t885r524b960],

1	Geﬁtinib	NN	O	geﬁtinib	nsubj	2	SENT_54	[p3l120t982r426b1042],
2	shows	VBZ	O	show	_	0	SENT_54	[p3l474t982r681b1042],
3	favorable	JJ	O	favorable	amod	4	SENT_54	[p3l729t982r1066b1042],
4	outcome	NN	O	outcome	dobj	2	SENT_54	[p3l1113t987r1421b1042],
5	in	IN	O	in	_	0	SENT_54	[p3l1470t983r1529b1041],
6	aforementioned	JJ	O	aforementioned	amod	9	SENT_54	[p3l1580t982r2148b1042],
7	selected	VBN	O	select	amod	9	SENT_54	[p3l10t1077r306b1137],
8	patient	NN	O	patient	nn	9	SENT_54	[p3l357t1078r612b1153],
9	population	NN	O	population	prep_in	2	SENT_54	[p3l659t1077r1033b1153],
10	among	IN	O	among	_	0	SENT_54	[p3l1082t1092r1313b1153],
11	NSCLC	NN	O	nsclc	nn	12	SENT_54	[p3l1362t1078r1580b1137],
12	patients	NNS	O	patient	prep_among	9	SENT_54	[p3l1629t1078r1938b1153],
13	.	.	O	.	_	0	SENT_54	[p3l1629t1078r1938b1153],

1	Considering	VBG	O	consider	_	0	SENT_55	[p3l1991t1078r2147b1137, p3l7t1175r286b1252],
2	the	DT	O	the	det	5	SENT_55	[p3l320t1175r434b1236],
3	dramatic	JJ	O	dramatic	amod	5	SENT_55	[p3l468t1175r786b1236],
4	clinical	JJ	O	clinical	amod	5	SENT_55	[p3l819t1175r1074b1236],
5	responses	NNS	O	response	prep_considering	10	SENT_55	[p3l1111t1191r1475b1252],
6	,	,	O	,	_	0	SENT_55	[p3l1111t1191r1475b1252],
7	geﬁtinib	NN	O	geﬁtinib	nsubjpass	10	SENT_55	[p3l1516t1175r1808b1252],
8	could	MD	O	could	aux	10	SENT_55	[p3l1842t1175r2031b1236],
9	be	VB	O	be	auxpass	10	SENT_55	[p3l2070t1175r2151b1236],
10	considered	VBN	O	consider	_	0	SENT_55	[p3l7t1272r391b1333],
11	prior	RB	O	prior	_	0	SENT_55	[p3l445t1274r614b1349],
12	to	TO	O	to	_	0	SENT_55	[p3l660t1278r730b1333],
13	other	JJ	O	other	amod	14	SENT_55	[p3l778t1272r970b1333],
14	chemotherapeutics	NNS	O	chemotherapeutic	prep_prior_to	10	SENT_55	[p3l1016t1272r1703b1349],
15	in	IN	O	in	_	0	SENT_55	[p3l1752t1274r1810b1333],
16	patients	NNS	O	patient	prep_in	10	SENT_55	[p3l1864t1274r2151b1349],
17	with	IN	O	with	_	0	SENT_55	[p3l6t1371r159b1432],
18	clinical	JJ	O	clinical	amod	19	SENT_55	[p3l194t1371r448b1432],
19	predictors	NNS	O	predictor	prep_with	16	SENT_55	[p3l485t1371r845b1448],
20	of	IN	O	of	_	0	SENT_55	[p3l878t1371r949b1432],
21	geﬁtinib	NN	O	geﬁtinib	nn	22	SENT_55	[p3l980t1371r1272b1447],
22	responsiveness	NN	O	responsiveness	prep_of	19	SENT_55	[p3l1308t1372r1833b1448],
23	or	CC	O	or	_	0	SENT_55	[p3l1866t1387r1938b1432],
24	EGFR	NN	ORGANIZATION	egfr	nn	25	SENT_55	[p3l1972t1371r2153b1432],
25	mutation	NN	O	mutation	conj_or	22	SENT_55	[p3l10t1470r352b1530],
26	.	.	O	.	_	0	SENT_55	[p3l10t1470r352b1530],

1	However	RB	O	however	advmod	19	SENT_56	[p3l409t1471r727b1543],
2	,	,	O	,	_	0	SENT_56	[p3l409t1471r727b1543],
3	no	DT	O	no	det	5	SENT_56	[p3l783t1485r862b1530],
4	direct	JJ	O	direct	amod	5	SENT_56	[p3l909t1469r1120b1530],
5	comparison	NN	O	comparison	nsubjpass	19	SENT_56	[p3l1165t1470r1570b1546],
6	between	IN	O	between	_	0	SENT_56	[p3l1621t1469r1924b1530],
7	clinical	JJ	O	clinical	amod	8	SENT_56	[p3l1973t1469r2148b1530, p3l7t1566r108b1627],
8	predictors	NNS	O	predictor	prep_between	5	SENT_56	[p3l156t1566r516b1643],
9	and	CC	O	and	_	0	SENT_56	[p3l561t1566r685b1627],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_56	[p3l736t1567r916b1628],
11	mutation	NN	O	mutation	prep_between	5	SENT_56	[p3l962t1568r1279b1627],
12	for	IN	O	for	_	0	SENT_56	[p3l1327t1566r1429b1627],
13	prediction	NN	O	prediction	prep_for	8	SENT_56	[p3l1474t1566r1834b1643],
14	of	IN	O	of	_	0	SENT_56	[p3l1882t1566r1953b1627],
15	geﬁtinib	NN	O	geﬁtinib	nn	16	SENT_56	[p3l1996t1566r2148b1643, p3l8t1665r169b1726],
16	responsiveness	NN	O	responsiveness	prep_of	13	SENT_56	[p3l218t1666r743b1741],
17	has	VBZ	O	have	aux	19	SENT_56	[p3l791t1665r902b1726],
18	been	VBN	O	be	auxpass	19	SENT_56	[p3l950t1665r1117b1726],
19	reported	VBN	O	report	_	0	SENT_56	[p3l1169t1665r1474b1742],
20	and	CC	O	and	_	0	SENT_56	[p3l1523t1665r1646b1726],
21	it	PRP	O	it	nsubj	23	SENT_56	[p3l1695t1666r1745b1726],
22	is	VBZ	O	be	cop	23	SENT_56	[p3l1791t1666r1841b1726],
23	unclear	JJ	O	unclear	conj_and	19	SENT_56	[p3l1889t1665r2153b1726],
24	whether	IN	O	whether	complm	29	SENT_56	[p3l6t1763r304b1824],
25	patient	NN	O	patient	nn	26	SENT_56	[p3l325t1764r580b1840],
26	selection	NN	O	selection	nsubjpass	29	SENT_56	[p3l600t1763r919b1824],
27	should	MD	O	should	aux	29	SENT_56	[p3l942t1763r1167b1824],
28	be	VB	O	be	auxpass	29	SENT_56	[p3l1193t1763r1275b1824],
29	based	VBN	O	base	ccomp	23	SENT_56	[p3l1298t1763r1496b1824],
30	on	IN	O	on	_	0	SENT_56	[p3l1520t1780r1600b1824],
31	clinical	JJ	O	clinical	amod	32	SENT_56	[p3l1623t1763r1877b1824],
32	predictors	NNS	O	predictor	prep_on	29	SENT_56	[p3l1901t1763r2148b1840, p3l8t1866r142b1921],
33	or	CC	O	or	_	0	SENT_56	[p3l165t1877r237b1921],
34	EGFR	NN	ORGANIZATION	egfr	nn	35	SENT_56	[p3l262t1861r443b1922],
35	mutation	NN	O	mutation	prep_on	29	SENT_56	[p3l467t1862r809b1921],
36	.	.	O	.	_	0	SENT_56	[p3l467t1862r809b1921],

1	Therefore	RB	O	therefore	advmod	5	SENT_57	[p3l838t1860r1217b1935],
2	,	,	O	,	_	0	SENT_57	[p3l838t1860r1217b1935],
3	we	PRP	O	we	nsubj	5	SENT_57	[p3l1245t1877r1346b1921],
4	have	VBP	O	have	aux	5	SENT_57	[p3l1372t1860r1535b1921],
5	analyzed	VBN	O	analyze	_	0	SENT_57	[p3l1559t1860r1870b1937],
6	clinical	JJ	O	clinical	amod	7	SENT_57	[p3l1896t1860r2150b1921],
7	predictors	NNS	O	predictor	dobj	5	SENT_57	[p3l10t1959r370b2035],
8	and	CC	O	and	_	0	SENT_57	[p3l412t1959r535b2020],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_57	[p3l583t1959r764b2020],
10	mutation	NN	O	mutation	dobj	5	SENT_57	[p3l807t1960r1124b2020],
11	in	IN	O	in	_	0	SENT_57	[p3l1169t1960r1228b2019],
12	geﬁtinib-treated	JJ	O	geﬁtinib-treated	amod	15	SENT_57	[p3l1273t1959r1863b2035],
13	Korean	JJ	MISC	korean	amod	15	SENT_57	[p3l1910t1960r2149b2020],
14	NSCLC	NN	ORGANIZATION	nsclc	nn	15	SENT_57	[p3l10t2058r229b2118],
15	patients	NNS	O	patient	prep_in	7	SENT_57	[p3l261t2058r548b2134],
16	to	TO	O	to	aux	17	SENT_57	[p3l577t2063r648b2118],
17	investigate	VB	O	investigate	xcomp	5	SENT_57	[p3l677t2058r1068b2134],
18	which	WDT	O	which	nsubj	19	SENT_57	[p3l1095t2057r1300b2118],
19	leads	VBZ	O	lead	ccomp	17	SENT_57	[p3l1334t2057r1514b2118],
20	to	TO	O	to	_	0	SENT_57	[p3l1544t2063r1614b2118],
21	better	JJR	O	better	amod	23	SENT_57	[p3l1645t2057r1868b2118],
22	patient	NN	O	patient	nn	23	SENT_57	[p3l1897t2058r2152b2134],
23	selection	NN	O	selection	prep_to	19	SENT_57	[p3l7t2153r351b2213],
24	.	.	O	.	_	0	SENT_57	[p3l7t2153r351b2213],

1	2	LS	NUMBER	2	_	0	SENT_58	[p3l11t2365r88b2440],
2	.	.	O	.	_	0	SENT_58	[p3l11t2365r88b2440],

1	Patients	NNS	O	patient	_	0	SENT_59	[p3l150t2365r511b2439],
2	and	CC	O	and	_	0	SENT_59	[p3l546t2363r706b2439],
3	methods	NNS	O	method	conj_and	1	SENT_59	[p3l747t2363r1132b2439],

1	2.1	CD	NUMBER	2.1	_	0	SENT_60	[p3l11t2594r166b2662],
2	.	.	O	.	_	0	SENT_60	[p3l11t2594r166b2662],

1	Patients	NNS	O	patient	_	0	SENT_61	[p3l227t2594r554b2660],

1	One	CD	NUMBER	one	num	2	SENT_62	[p3l8t2806r145b2866],
2	hundred	CD	NUMBER	hundred	nsubjpass	25	SENT_62	[p3l168t2805r455b2866],
3	and	CC	NUMBER	and	_	0	SENT_62	[p3l478t2805r601b2866],
4	twenty	CD	NUMBER	twenty	num	7	SENT_62	[p3l625t2811r873b2882],
5	consecutive	JJ	O	consecutive	amod	7	SENT_62	[p3l891t2806r1313b2866],
6	NSCLC	NN	O	nsclc	nn	7	SENT_62	[p3l1336t2806r1555b2866],
7	patients	NNS	O	patient	nsubjpass	25	SENT_62	[p3l1578t2806r1865b2882],
8	treated	VBN	O	treat	partmod	7	SENT_62	[p3l1886t2805r2149b2866],
9	with	IN	O	with	_	0	SENT_62	[p3l6t2903r159b2964],
10	geﬁtinib	NN	O	geﬁtinib	prep_with	8	SENT_62	[p3l194t2903r487b2980],
11	and	CC	O	and	_	0	SENT_62	[p3l520t2903r643b2964],
12	assessable	JJ	O	assessable	amod	16	SENT_62	[p3l679t2903r1046b2965],
13	for	IN	O	for	_	0	SENT_62	[p3l1078t2903r1180b2964],
14	EGFR	NN	ORGANIZATION	egfr	prep_for	12	SENT_62	[p3l1213t2904r1394b2965],
15	mutational	JJ	O	mutational	amod	16	SENT_62	[p3l1427t2903r1812b2964],
16	status	NN	O	status	conj_and	10	SENT_62	[p3l1846t2909r2056b2964],
17	in	IN	O	in	_	0	SENT_62	[p3l2089t2905r2149b2964],
18	exons	NNS	O	exon	prep_in	16	SENT_62	[p3l7t3018r207b3063],
19	18	CD	NUMBER	18	tmod	8	SENT_62	[p3l244t3002r341b3076],
20	,	,	O	,	_	0	SENT_62	[p3l244t3002r341b3076],
21	19	CD	NUMBER	19	num	19	SENT_62	[p3l385t3002r459b3063],
22	and	CC	O	and	_	0	SENT_62	[p3l493t3002r616b3063],
23	21	CD	NUMBER	21	tmod	8	SENT_62	[p3l651t3002r718b3062],
24	were	VBD	O	be	auxpass	25	SENT_62	[p3l761t3018r937b3063],
25	included	VBN	O	include	_	0	SENT_62	[p3l970t3002r1270b3063],
26	in	IN	O	in	_	0	SENT_62	[p3l1305t3003r1364b3062],
27	the	DT	O	the	det	29	SENT_62	[p3l1399t3002r1514b3063],
28	present	JJ	DATE	present	amod	29	SENT_62	[p3l1549t3007r1815b3079],
29	analysis	NN	O	analysis	prep_in	25	SENT_62	[p3l1847t3002r2144b3079],
30	.	.	O	.	_	0	SENT_62	[p3l1847t3002r2144b3079],

1	Mutational	JJ	O	mutational	amod	2	SENT_63	[p3l6t3099r386b3160],
2	data	NNS	O	datum	nsubjpass	8	SENT_63	[p3l431t3099r586b3160],
3	of	IN	O	of	_	0	SENT_63	[p3l631t3099r703b3160],
4	90	CD	NUMBER	90	num	5	SENT_63	[p3l744t3100r824b3160],
5	patients	NNS	O	patient	prep_of	2	SENT_63	[p3l871t3100r1158b3176],
6	had	VBD	O	have	aux	8	SENT_63	[p3l1205t3099r1326b3160],
7	been	VBN	O	be	auxpass	8	SENT_63	[p3l1375t3099r1542b3160],
8	reported	VBN	O	report	_	0	SENT_63	[p3l1592t3099r1897b3176],
9	previously	RB	DATE	previously	advmod	8	SENT_63	[p3l1947t3100r2148b3176, p3l7t3197r187b3274],
10	elsewhere	RB	O	elsewhere	advmod	8	SENT_63	[p3l212t3197r575b3258],
11	[	CD	NUMBER	[	number	12	SENT_63	[p3l606t3197r762b3274],
12	17	CD	NUMBER	17	num	13	SENT_63	[p3l606t3197r762b3274],
13	]	NN	O	]	pobj	10	SENT_63	[p3l606t3197r762b3274],
14	.	.	O	.	_	0	SENT_63	[p3l606t3197r762b3274],

1	All	DT	O	all	det	2	SENT_64	[p3l794t3197r885b3258],
2	patients	NNS	O	patient	nsubj	5	SENT_64	[p3l915t3199r1202b3274],
3	had	VBD	O	have	aux	5	SENT_64	[p3l1231t3197r1352b3258],
4	pathologically	RB	O	pathologically	advmod	5	SENT_64	[p3l1384t3197r1885b3274],
5	proven	VBN	O	prove	_	0	SENT_64	[p3l1912t3214r2149b3274],
6	locally	RB	O	locally	advmod	7	SENT_64	[p3l10t3296r241b3372],
7	advanced	VBN	O	advance	amod	10	SENT_64	[p3l293t3296r626b3357],
8	or	CC	O	or	_	0	SENT_64	[p3l682t3312r755b3357],
9	metastatic	JJ	O	metastatic	amod	10	SENT_64	[p3l808t3297r1187b3357],
10	NSCLC	NN	O	nsclc	dobj	5	SENT_64	[p3l1244t3296r1486b3357],
11	.	.	O	.	_	0	SENT_64	[p3l1244t3296r1486b3357],

1	Baseline	NN	O	baseline	nn	3	SENT_65	[p3l1549t3296r1841b3357],
2	patient	NN	O	patient	nn	3	SENT_65	[p3l1897t3297r2152b3372],
3	characteristics	NNS	O	characteristic	nsubjpass	5	SENT_65	[p3l7t3394r532b3454],
4	are	VBP	O	be	auxpass	5	SENT_65	[p3l575t3410r688b3454],
5	listed	VBN	O	list	_	0	SENT_65	[p3l733t3394r922b3454],
6	in	IN	O	in	_	0	SENT_65	[p3l967t3395r1026b3453],
7	Table	NNP	O	Table	prep_in	5	SENT_65	[p3l1069t3394r1258b3454],
8	1	CD	NUMBER	1	num	7	SENT_65	[p3l1305t3395r1360b3454],
9	.	.	O	.	_	0	SENT_65	[p3l1305t3395r1360b3454],

1	Treatment	NN	O	treatment	nsubj	2	SENT_66	[p3l1407t3396r1779b3454],
2	consisted	VBD	O	consist	_	0	SENT_66	[p3l1820t3394r2149b3454],
3	of	IN	O	of	_	0	SENT_66	[p3l7t3490r78b3551],
4	250	CD	NUMBER	250	num	5	SENT_66	[p3l105t3491r227b3551],
5	mg	NN	O	mg	prep_of	2	SENT_66	[p3l248t3505r348b3567],
6	of	IN	O	of	_	0	SENT_66	[p3l377t3490r448b3551],
7	geﬁtinib	NN	O	geﬁtinib	prep_of	5	SENT_66	[p3l475t3490r768b3567],
8	daily	JJ	SET	daily	amod	7	SENT_66	[p3l798t3490r968b3567],
9	continued	VBN	O	continue	partmod	7	SENT_66	[p3l996t3490r1347b3551],
10	until	IN	O	until	_	0	SENT_66	[p3l1382t3490r1541b3551],
11	disease	NN	O	disease	nn	12	SENT_66	[p3l1571t3490r1830b3551],
12	progression	NN	O	progression	prep_until	9	SENT_66	[p3l1861t3505r2148b3567, p3l7t3590r168b3663],
13	,	,	O	,	_	0	SENT_66	[p3l1861t3505r2148b3567, p3l7t3590r168b3663],
14	intolerable	JJ	O	intolerable	amod	15	SENT_66	[p3l213t3589r604b3650],
15	toxicity	NN	O	toxicity	prep_until	9	SENT_66	[p3l641t3590r911b3665],
16	or	CC	O	or	_	0	SENT_66	[p3l946t3605r1019b3650],
17	patient	NN	O	patient	nn	18	SENT_66	[p3l1056t3590r1311b3665],
18	refusal	NN	O	refusal	prep_until	9	SENT_66	[p3l1352t3589r1614b3650],
19	.	.	O	.	_	0	SENT_66	[p3l1352t3589r1614b3650],

1	Patients	NNS	O	patient	nsubj	2	SENT_67	[p3l1661t3590r1944b3650],
2	initiated	VBD	O	initiate	_	0	SENT_67	[p3l1982t3590r2148b3650, p3l8t3687r163b3748],
3	geﬁtinib	JJ	O	geﬁtinib	amod	4	SENT_67	[p3l202t3687r495b3764],
4	treatment	NN	O	treatment	dobj	2	SENT_67	[p3l532t3692r895b3748],
5	from	IN	O	from	_	0	SENT_67	[p3l930t3687r1094b3748],
6	February	NNP	DATE	February	prep_from	2	SENT_67	[p3l1137t3687r1450b3764],
7	2002	CD	DATE	2002	num	6	SENT_67	[p3l1485t3688r1647b3748],
8	to	TO	O	to	_	0	SENT_67	[p3l1686t3693r1756b3748],
9	December	NNP	DATE	December	prep_to	2	SENT_67	[p3l1795t3687r2153b3748],

1	Table	NNP	O	Table	_	0	SENT_68	[p4l59t134r246b192],
2	1	CD	NUMBER	1	num	5	SENT_68	[p4l280t136r302b191],
3	Baseline	NN	O	baseline	nn	5	SENT_68	[p4l428t135r703b192],
4	patient	NN	O	patient	nn	5	SENT_68	[p4l733t136r974b206],
5	characteristics	NNS	O	characteristic	dep	1	SENT_68	[p4l1000t135r1497b192],

1	Characteristic	JJ	O	characteristic	amod	2	SENT_69	[p4l61t293r534b351],
2	No.	NN	O	no.	_	0	SENT_69	[p4l1277t295r1381b351],
3	of	IN	O	of	_	0	SENT_69	[p4l1412t293r1479b350],
4	patients	NNS	O	patient	num	5	SENT_69	[p4l1504t295r1775b365],
5	%	NN	O	%	prep_of	2	SENT_69	[p4l1961t294r2002b351],

1	(	NN	O	(	nn	2	SENT_70	[p4l1279t392r1340b462],
2	n	NN	O	n	_	0	SENT_70	[p4l1279t392r1340b462],
3	=	JJ	O	=	dep	2	SENT_70	[p4l1358t414r1391b432],
4	120	CD	NUMBER	120	num	5	SENT_70	[p4l1414t391r1550b462],
5	)	NN	O	)	dep	2	SENT_70	[p4l1414t391r1550b462],

1	Sex	NN	O	sex	_	0	SENT_71	[p4l61t543r174b600],

1	Male	JJ	O	male	_	0	SENT_72	[p4l135t640r290b697],
2	70	CD	NUMBER	70	number	3	SENT_72	[p4l1275t640r1350b697],
3	58.3	CD	NUMBER	58.3	dep	1	SENT_72	[p4l1964t640r2102b697],
4	Female	JJ	O	female	dep	1	SENT_72	[p4l140t737r381b794],
5	50	CD	NUMBER	50	number	6	SENT_72	[p4l1277t738r1350b794],
6	41.7	CD	NUMBER	41.7	dep	4	SENT_72	[p4l1960t738r2106b794],

1	Age	NNP	O	Age	_	0	SENT_73	[p4l59t881r202b952],
2	,	,	O	,	_	0	SENT_73	[p4l59t881r202b952],
3	median	JJ	O	median	amod	4	SENT_73	[p4l239t880r480b937],
4	years	NNS	DURATION	year	appos	1	SENT_73	[p4l507t895r684b952],
5	(	JJ	O	(	amod	7	SENT_73	[p4l716t881r952b952],
6	range	NN	O	range	nn	7	SENT_73	[p4l716t881r952b952],
7	)	NN	O	)	dep	4	SENT_73	[p4l716t881r952b952],
8	60	CD	NUMBER	60	number	9	SENT_73	[p4l1275t880r1350b937],
9	(	CD	NUMBER	(	dep	1	SENT_73	[p4l1382t880r1641b952],
10	30-87	CD	NUMBER	30-87	num	12	SENT_73	[p4l1382t880r1641b952],
11	)	NN	O	)	nn	12	SENT_73	[p4l1382t880r1641b952],
12	Male	NN	O	male	dep	9	SENT_73	[p4l135t977r291b1034],
13	61	CD	NUMBER	61	number	14	SENT_73	[p4l1275t978r1338b1034],
14	(	CD	NUMBER	(	num	16	SENT_73	[p4l1382t978r1641b1049],
15	33-87	CD	NUMBER	33-87	number	16	SENT_73	[p4l1382t978r1641b1049],
16	)	CD	NUMBER	)	npadvmod	17	SENT_73	[p4l1382t978r1641b1049],
17	Female	JJ	O	female	amod	9	SENT_73	[p4l140t1074r381b1131],
18	58	CD	NUMBER	58	number	19	SENT_73	[p4l1277t1075r1349b1131],
19	(	CD	NUMBER	(	dep	9	SENT_73	[p4l1382t1075r1641b1146],
20	30-77	CD	NUMBER	30-77	num	21	SENT_73	[p4l1382t1075r1641b1146],
21	)	NN	O	)	dep	19	SENT_73	[p4l1382t1075r1641b1146],

1	Stage	NN	O	stage	_	0	SENT_74	[p4l61t1192r243b1263],

1	3B	NN	O	3b	_	0	SENT_75	[p4l139t1289r215b1346],
2	10	CD	NUMBER	10	num	1	SENT_75	[p4l1279t1289r1350b1346],
3	8.3	CD	NUMBER	8.3	num	4	SENT_75	[p4l2002t1289r2102b1346],
4	4	CD	NUMBER	4	dep	1	SENT_75	[p4l135t1387r173b1442],
5	110	CD	NUMBER	110	number	6	SENT_75	[p4l1279t1387r1390b1443],
6	91.7	CD	NUMBER	91.7	dep	4	SENT_75	[p4l1962t1387r2106b1443],

1	ECOG	NN	ORGANIZATION	ecog	_	0	SENT_76	[p4l64t1529r242b1586],
2	performance	NN	O	performance	nn	3	SENT_76	[p4l275t1529r704b1601],
3	status	NN	O	status	dep	1	SENT_76	[p4l732t1534r930b1586],

1	Histology	NNP	O	Histology	_	0	SENT_77	[p4l64t1866r371b1938],

1	Adenocarcinoma	NN	O	adenocarcinoma	dep	10	SENT_78	[p4l135t1964r695b2021],
2	71	CD	NUMBER	71	num	1	SENT_78	[p4l1275t1965r1338b2020],
3	59.2	CD	NUMBER	59.2	num	5	SENT_78	[p4l1964t1964r2103b2021],
4	Bronchioloalveolar	JJ	O	bronchioloalveolar	amod	5	SENT_78	[p4l140t2061r769b2118],
5	carcinoma	NN	O	carcinoma	dep	1	SENT_78	[p4l794t2062r1141b2118],
6	12	CD	NUMBER	12	dep	10	SENT_78	[p4l1279t2061r1349b2117],
7	10.0	CD	NUMBER	10.0	num	10	SENT_78	[p4l1966t2061r2105b2118],
8	Squamous	JJ	O	squamous	amod	10	SENT_78	[p4l137t2158r470b2229],
9	cell	NN	O	cell	nn	10	SENT_78	[p4l497t2157r616b2214],
10	carcinoma	NN	O	carcinoma	dep	15	SENT_78	[p4l643t2158r991b2214],
11	30	CD	NUMBER	30	num	13	SENT_78	[p4l1276t2158r1350b2214],
12	25.0	CD	NUMBER	25.0	num	13	SENT_78	[p4l1962t2158r2105b2214],
13	Others	NNS	O	other	dep	10	SENT_78	[p4l137t2255r358b2312],
14	7	CD	NUMBER	7	num	15	SENT_78	[p4l1275t2256r1311b2311],
15	5.8	CD	NUMBER	5.8	_	0	SENT_78	[p4l2004t2255r2104b2312],

1	Smoking	NN	MISC	smoking	nn	2	SENT_79	[p4l61t2397r337b2469],
2	history	NN	O	history	_	0	SENT_79	[p4l366t2397r594b2469],

1	Never-smoked	JJ	O	never-smoked	amod	3	SENT_80	[p4l140t2495r613b2552],
2	53	CD	NUMBER	53	number	3	SENT_80	[p4l1277t2495r1347b2552],
3	44.2	CD	NUMBER	44.2	_	0	SENT_80	[p4l1960t2495r2103b2552],
4	Smoked	VBN	O	smoke	partmod	3	SENT_80	[p4l137t2592r393b2649],
5	67	CD	NUMBER	67	number	6	SENT_80	[p4l1275t2593r1351b2649],
6	55.8	CD	NUMBER	55.8	dobj	4	SENT_80	[p4l1964t2593r2104b2649],

1	ECOG	NNP	ORGANIZATION	ECOG	_	0	SENT_81	[p4l63t2776r255b2841],
2	,	,	O	,	_	0	SENT_81	[p4l63t2776r255b2841],
3	Eastern	NNP	ORGANIZATION	Eastern	nn	6	SENT_81	[p4l289t2777r519b2829],
4	Cooperative	NNP	ORGANIZATION	Cooperative	nn	6	SENT_81	[p4l548t2776r930b2843],
5	Oncology	NNP	ORGANIZATION	Oncology	nn	6	SENT_81	[p4l956t2775r1246b2843],
6	Group	NNP	ORGANIZATION	Group	appos	1	SENT_81	[p4l1270t2776r1479b2843],
7	.	.	O	.	_	0	SENT_81	[p4l1270t2776r1479b2843],

1	Clinical	JJ	O	clinical	amod	2	SENT_82	[p4l46t2918r168b2947],
2	predictors	NNS	O	predictor	_	0	SENT_82	[p4l182t2918r349b2954],
3	versus	CC	O	versus	prep	2	SENT_82	[p4l362t2926r464b2947],
4	epidermal	JJ	O	epidermal	amod	7	SENT_82	[p4l478t2918r645b2954],
5	growth	NN	O	growth	nn	7	SENT_82	[p4l658t2918r771b2954],
6	factor	NN	O	factor	nn	7	SENT_82	[p4l786t2918r886b2947],
7	receptor	NN	O	receptor	dep	3	SENT_82	[p4l900t2921r1041b2954],
8	mutation	NN	O	mutation	dep	2	SENT_82	[p4l1055t2919r1202b2947],
9	203	CD	NUMBER	203	num	8	SENT_82	[p4l2058t2918r2113b2947],

1	2004	CD	DATE	2004	_	0	SENT_83	[p4l9t3070r186b3127],
2	.	.	O	.	_	0	SENT_83	[p4l9t3070r186b3127],

1	Survival	NN	O	survival	nn	2	SENT_84	[p4l232t3069r493b3127],
2	status	NN	O	status	nsubjpass	4	SENT_84	[p4l533t3074r733b3127],
3	was	VBD	O	be	auxpass	4	SENT_84	[p4l769t3084r894b3127],
4	collected	VBN	O	collect	_	0	SENT_84	[p4l932t3069r1243b3127],
5	until	IN	O	until	_	0	SENT_84	[p4l1286t3069r1437b3127],
6	the	DT	DATE	the	det	7	SENT_84	[p4l1476t3069r1585b3127],
7	end	NN	DATE	end	prep_until	4	SENT_84	[p4l1624t3069r1743b3127],
8	of	IN	DATE	of	_	0	SENT_84	[p4l1783t3069r1851b3127],
9	April	NNP	DATE	April	prep_of	7	SENT_84	[p4l1885t3069r2043b3142],
10	2006	CD	DATE	2006	num	9	SENT_84	[p4l9t3162r186b3219],
11	.	.	O	.	_	0	SENT_84	[p4l9t3162r186b3219],

1	Median	JJ	O	median	amod	2	SENT_85	[p4l219t3161r455b3219],
2	duration	NN	O	duration	nsubj	7	SENT_85	[p4l485t3161r767b3219],
3	of	IN	O	of	_	0	SENT_85	[p4l796t3161r864b3219],
4	follow-up	NN	O	follow-up	prep_of	2	SENT_85	[p4l888t3161r1208b3234],
5	was	VBD	O	be	cop	7	SENT_85	[p4l1234t3177r1359b3219],
6	27.2	CD	DURATION	27.2	num	7	SENT_85	[p4l1386t3162r1528b3219],
7	months	NNS	NUMBER	month	_	0	SENT_85	[p4l1559t3161r1801b3219],
8	(	JJ	O	(	amod	9	SENT_85	[p4l1833t3163r2044b3234],
9	range	NN	O	range	attr	7	SENT_85	[p4l1833t3163r2044b3234],
10	4.8-52	CD	NUMBER	4.8-52	number	11	SENT_85	[p4l8t3255r318b3312],
11	.7	CD	DURATION	.7	num	12	SENT_85	[p4l8t3255r318b3312],
12	months	NNS	NUMBER	month	tmod	13	SENT_85	[p4l347t3255r639b3327],
13	)	RB	O	)	amod	9	SENT_85	[p4l347t3255r639b3327],
14	.	.	O	.	_	0	SENT_85	[p4l347t3255r639b3327],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_86	[p4l117t3349r385b3406],
2	were	VBD	O	be	auxpass	3	SENT_86	[p4l409t3363r577b3406],
3	re-evaluated	VBN	O	re-evaluate	_	0	SENT_86	[p4l605t3348r1033b3406],
4	every	DT	SET	every	det	6	SENT_86	[p4l1062t3363r1247b3421],
5	4	CD	SET	4	num	6	SENT_86	[p4l1270t3349r1308b3405],
6	weeks	NNS	NUMBER	week	tmod	3	SENT_86	[p4l1331t3348r1538b3406],
7	by	IN	O	by	_	0	SENT_86	[p4l1567t3348r1642b3421],
8	chest	NN	O	chest	nn	9	SENT_86	[p4l1666t3348r1844b3406],
9	X-ray	NN	O	x-ray	agent	3	SENT_86	[p4l1868t3350r2046b3421],
10	or	CC	O	or	_	0	SENT_86	[p4l9t3457r78b3499],
11	computed	JJ	O	computed	amod	12	SENT_86	[p4l113t3441r447b3514],
12	tomography	NN	O	tomography	agent	3	SENT_86	[p4l488t3441r901b3514],
13	,	,	O	,	_	0	SENT_86	[p4l488t3441r901b3514],
14	and	CC	O	and	_	0	SENT_86	[p4l946t3441r1062b3499],
15	tumor	NN	O	tumor	nn	16	SENT_86	[p4l1103t3447r1307b3499],
16	response	NN	O	response	nsubjpass	18	SENT_86	[p4l1345t3457r1638b3514],
17	was	VBD	O	be	auxpass	18	SENT_86	[p4l1674t3457r1799b3499],
18	evaluated	VBN	O	evaluate	conj_and	3	SENT_86	[p4l1837t3441r2040b3499, p4l10t3534r157b3591],
19	according	VBG	O	accord	_	0	SENT_86	[p4l197t3534r523b3606],
20	to	TO	O	to	prepc_according_to	18	SENT_86	[p4l561t3539r627b3591],
21	the	DT	O	the	det	25	SENT_86	[p4l665t3534r774b3591],
22	World	NNP	ORGANIZATION	World	nn	25	SENT_86	[p4l809t3534r1001b3592],
23	Health	NNP	ORGANIZATION	Health	nn	25	SENT_86	[p4l1044t3534r1260b3591],
24	Organization	NNP	ORGANIZATION	Organization	nn	25	SENT_86	[p4l1300t3534r1727b3606],
25	criteria	NNS	O	criterion	pobj	18	SENT_86	[p4l1767t3535r2037b3591],
26	.	.	O	.	_	0	SENT_86	[p4l1767t3535r2037b3591],

1	All	DT	O	all	det	2	SENT_87	[p4l7t3627r94b3685],
2	responses	NNS	O	response	nsubjpass	4	SENT_87	[p4l140t3642r464b3699],
3	were	VBD	O	be	auxpass	4	SENT_87	[p4l503t3642r671b3685],
4	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_87	[p4l713t3627r1048b3685],
5	at	IN	DURATION	at	quantmod	7	SENT_87	[p4l1093t3632r1159b3685],
6	least	JJS	DURATION	least	mwe	5	SENT_87	[p4l1203t3627r1362b3685],
7	4	CD	DURATION	4	num	8	SENT_87	[p4l1401t3628r1439b3684],
8	weeks	NNS	NUMBER	week	tmod	4	SENT_87	[p4l1479t3627r1686b3685],
9	after	IN	O	after	_	0	SENT_87	[p4l1728t3627r1895b3685],
10	initial	JJ	O	initial	prep_after	4	SENT_87	[p4l1935t3628r2040b3684, p5l10t17r119b75],

1	assessment	NN	O	assessment	_	0	SENT_88	[p5l158t23r557b75],
2	.	.	O	.	_	0	SENT_88	[p5l158t23r557b75],

1	Formalin-ﬁxed	JJ	O	formalin-ﬁxed	amod	3	SENT_89	[p5l605t17r1091b75],
2	parafﬁn-embedded	JJ	O	parafﬁn-embedded	amod	3	SENT_89	[p5l1135t17r1779b90],
3	tissues	NNS	O	tissue	nsubjpass	13	SENT_89	[p5l1820t19r2044b75],
4	obtained	VBN	O	obtain	partmod	3	SENT_89	[p5l9t110r304b168],
5	prior	JJ	O	prior	_	0	SENT_89	[p5l339t111r499b182],
6	to	TO	O	to	_	0	SENT_89	[p5l528t115r594b167],
7	any	DT	O	any	det	9	SENT_89	[p5l625t125r741b182],
8	systemic	JJ	O	systemic	amod	9	SENT_89	[p5l769t111r1059b182],
9	chemotherapy	NN	O	chemotherapy	prep_prior_to	4	SENT_89	[p5l1090t110r1576b182],
10	or	CC	O	or	_	0	SENT_89	[p5l1605t125r1673b167],
11	radiotherapy	NN	O	radiotherapy	prep_prior_to	4	SENT_89	[p5l1705t110r2040b167, p5l10t218r127b275],
12	were	VBD	O	be	auxpass	13	SENT_89	[p5l151t218r319b261],
13	retrieved	VBN	O	retrieve	_	0	SENT_89	[p5l350t203r657b261],
14	from	IN	O	from	_	0	SENT_89	[p5l687t203r843b261],
15	the	DT	O	the	det	16	SENT_89	[p5l874t203r983b261],
16	archives	NNS	O	archive	prep_from	13	SENT_89	[p5l1012t203r1288b261],
17	of	IN	O	of	_	0	SENT_89	[p5l1316t203r1384b261],
18	the	DT	O	the	det	19	SENT_89	[p5l1410t203r1519b261],
19	Department	NNP	O	Department	prep_of	16	SENT_89	[p5l1550t204r1951b275],
20	of	IN	O	of	_	0	SENT_89	[p5l1979t203r2046b261],
21	Pathology	NNP	O	Pathology	prep_of	19	SENT_89	[p5l12t296r349b369],
22	.	.	O	.	_	0	SENT_89	[p5l12t296r349b369],

1	The	DT	O	the	det	3	SENT_90	[p5l387t296r513b354],
2	study	NN	O	study	nn	3	SENT_90	[p5l547t296r727b369],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_90	[p5l762t296r1041b369],
4	was	VBD	O	be	auxpass	5	SENT_90	[p5l1074t312r1199b354],
5	reviewed	VBN	O	review	_	0	SENT_90	[p5l1236t296r1539b354],
6	and	CC	O	and	_	0	SENT_90	[p5l1577t296r1694b354],
7	approved	VBN	O	approve	conj_and	5	SENT_90	[p5l1731t296r2041b369],
8	by	IN	O	by	_	0	SENT_90	[p5l12t388r87b461],
9	the	DT	O	the	det	12	SENT_90	[p5l113t388r222b446],
10	institutional	JJ	O	institutional	amod	12	SENT_90	[p5l249t388r660b446],
11	review	NN	O	review	nn	12	SENT_90	[p5l692t390r915b446],
12	board	NN	O	board	agent	5	SENT_90	[p5l943t388r1130b446],
13	at	IN	O	at	_	0	SENT_90	[p5l1161t394r1227b446],
14	the	DT	O	the	det	18	SENT_90	[p5l1254t388r1363b446],
15	Seoul	NNP	ORGANIZATION	Seoul	nn	18	SENT_90	[p5l1391t388r1569b446],
16	National	NNP	ORGANIZATION	National	nn	18	SENT_90	[p5l1600t388r1879b446],
17	University	NNP	ORGANIZATION	University	nn	18	SENT_90	[p5l1910t390r2040b446, p5l7t483r236b554],
18	Hospital	NNP	ORGANIZATION	Hospital	prep_at	12	SENT_90	[p5l265t482r558b554],
19	.	.	O	.	_	0	SENT_90	[p5l265t482r558b554],

1	2.2	CD	NUMBER	2.2	_	0	SENT_91	[p5l13t702r160b766],
2	.	.	O	.	_	0	SENT_91	[p5l13t702r160b766],

1	DNA	NN	O	dna	nn	2	SENT_92	[p5l217t702r376b765],
2	sequencing	NN	O	sequencing	_	0	SENT_92	[p5l404t702r846b782],

1	Sequencing	NN	O	sequencing	nn	2	SENT_93	[p5l10t903r391b975],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_93	[p5l420t902r681b975],
3	was	VBD	O	be	auxpass	4	SENT_93	[p5l709t918r834b960],
4	performed	VBN	O	perform	_	0	SENT_93	[p5l866t902r1217b975],
5	as	IN	O	as	mark	7	SENT_93	[p5l1249t918r1315b960],
6	previously	RB	DATE	previously	advmod	7	SENT_93	[p5l1347t902r1689b975],
7	described	VBN	O	describe	advcl	4	SENT_93	[p5l1717t902r2041b960],
8	[	NN	O	[	nn	10	SENT_93	[p5l14t995r162b1067],
9	17	CD	NUMBER	17	num	10	SENT_93	[p5l14t995r162b1067],
10	]	NN	O	]	dobj	7	SENT_93	[p5l14t995r162b1067],
11	.	.	O	.	_	0	SENT_93	[p5l14t995r162b1067],

1	DNA	NN	O	dna	nsubjpass	3	SENT_94	[p5l223t995r358b1053],
2	was	VBD	O	be	auxpass	3	SENT_94	[p5l406t1010r531b1053],
3	extracted	VBN	O	extract	dep	23	SENT_94	[p5l582t995r908b1053],
4	from	IN	O	from	_	0	SENT_94	[p5l962t995r1118b1053],
5	ﬁve	FW	O	ﬁve	nn	7	SENT_94	[p5l1171t995r1291b1053],
6	parafﬁn	FW	O	parafﬁn	nn	7	SENT_94	[p5l1344t995r1602b1067],
7	sections	NNS	O	section	prep_from	3	SENT_94	[p5l1656t996r1928b1053],
8	of	IN	O	of	_	0	SENT_94	[p5l1979t995r2046b1053],
9	10-um	JJ	O	10-um	amod	10	SENT_94	[p5l14t1088r225b1161],
10	thickness	NN	O	thickness	prep_of	7	SENT_94	[p5l280t1088r591b1146],
11	containing	VBG	O	contain	ccomp	3	SENT_94	[p5l642t1089r995b1160],
12	a	DT	O	a	det	14	SENT_94	[p5l1047t1103r1082b1146],
13	representative	JJ	O	representative	amod	14	SENT_94	[p5l1137t1089r1631b1161],
14	portion	NN	O	portion	dobj	11	SENT_94	[p5l1685t1089r1924b1161],
15	of	IN	O	of	_	0	SENT_94	[p5l1979t1088r2047b1146],
16	each	DT	O	each	det	18	SENT_94	[p5l9t1180r164b1238],
17	tumor	NN	O	tumor	nn	18	SENT_94	[p5l212t1186r415b1238],
18	block	NN	O	block	prep_of	14	SENT_94	[p5l461t1180r658b1250],
19	,	,	O	,	_	0	SENT_94	[p5l461t1180r658b1250],
20	using	VBG	O	use	dep	11	SENT_94	[p5l712t1181r880b1253],
21	the	DT	O	the	det	22	SENT_94	[p5l926t1180r1035b1238],
22	Q	NNP	O	Q	dobj	20	SENT_94	[p5l1080t1181r1340b1253],
23	|	VBD	O	|	_	0	SENT_94	[p5l1080t1181r1340b1253],
24	Aamp	NNP	O	Aamp	nn	26	SENT_94	[p5l1080t1181r1340b1253],
25	DNA	NNP	O	DNA	nn	26	SENT_94	[p5l1388t1181r1523b1238],
26	Mini	NNP	O	Mini	dobj	23	SENT_94	[p5l1565t1181r1699b1238],
27	kit	NN	O	kit	nn	29	SENT_94	[p5l1750t1180r1834b1238],
28	(	CD	NUMBER	(	num	29	SENT_94	[p5l1883t1181r2040b1253, p5l10t1288r148b1346],
29	Qiagen	NNP	ORGANIZATION	Qiagen	nsubj	23	SENT_94	[p5l1883t1181r2040b1253, p5l10t1288r148b1346],
30	,	,	O	,	_	0	SENT_94	[p5l1883t1181r2040b1253, p5l10t1288r148b1346],
31	Hilden	NNP	PERSON	Hilden	appos	29	SENT_94	[p5l203t1274r438b1344],
32	,	,	O	,	_	0	SENT_94	[p5l203t1274r438b1344],
33	Germany	NNP	LOCATION	Germany	appos	31	SENT_94	[p5l490t1274r841b1346],
34	)	CD	NUMBER	)	num	33	SENT_94	[p5l490t1274r841b1346],
35	.	.	O	.	_	0	SENT_94	[p5l490t1274r841b1346],

1	One	CD	NUMBER	one	dep	106	SENT_95	[p5l894t1274r1024b1332],
2	hundred	CD	NUMBER	hundred	dep	106	SENT_95	[p5l1072t1274r1344b1332],
3	nanograms	NNS	O	nanogram	dep	106	SENT_95	[p5l1395t1288r1756b1346],
4	(	CD	NUMBER	(	dep	106	SENT_95	[p5l1806t1275r1931b1346],
5	ng	NN	O	ng	dep	106	SENT_95	[p5l1806t1275r1931b1346],
6	)	NN	O	)	dep	106	SENT_95	[p5l1806t1275r1931b1346],
7	of	IN	O	of	dep	106	SENT_95	[p5l1979t1274r2047b1332],
8	DNA	NN	MISC	dna	dep	106	SENT_95	[p5l12t1368r147b1425],
9	were	VBD	O	be	dep	106	SENT_95	[p5l202t1382r370b1425],
10	ampliﬁed	VBN	O	ampliﬁed	dep	106	SENT_95	[p5l429t1367r741b1440],
11	in	IN	O	in	dep	106	SENT_95	[p5l802t1368r859b1424],
12	a	DT	O	a	dep	106	SENT_95	[p5l921t1382r955b1425],
13	20	CD	NUMBER	20	dep	106	SENT_95	[p5l1014t1367r1090b1425],
14	pl	NN	O	pl	dep	106	SENT_95	[p5l1111t1367r1176b1440],
15	reaction	NN	O	reaction	dep	106	SENT_95	[p5l1238t1368r1513b1425],
16	solution	NN	O	solution	dep	106	SENT_95	[p5l1574t1367r1838b1425],
17	containing	VBG	O	contain	dep	106	SENT_95	[p5l1899t1382r2040b1425, p5l10t1460r241b1532],
18	Zltl	NN	O	zltl	dep	106	SENT_95	[p5l282t1459r403b1532],
19	of	IN	O	of	dep	106	SENT_95	[p5l445t1459r513b1517],
20	10x	CD	NUMBER	10x	dep	106	SENT_95	[p5l556t1460r679b1517],
21	buffer	NN	O	buffer	dep	106	SENT_95	[p5l731t1459r938b1517],
22	(	CD	NUMBER	(	dep	106	SENT_95	[p5l982t1459r1227b1532],
23	Roche	NNP	PERSON	Roche	dep	106	SENT_95	[p5l982t1459r1227b1532],
24	,	,	O	,	_	0	SENT_95	[p5l982t1459r1227b1532],
25	Mannheim	NNP	LOCATION	Mannheim	dep	106	SENT_95	[p5l1273t1459r1638b1529],
26	,	,	O	,	_	0	SENT_95	[p5l1273t1459r1638b1529],
27	Germany	NNP	LOCATION	Germany	dep	106	SENT_95	[p5l1686t1460r2037b1532],
28	)	NNP	O	)	dep	106	SENT_95	[p5l1686t1460r2037b1532],
29	,	,	O	,	_	0	SENT_95	[p5l1686t1460r2037b1532],
30	1.7-2	CD	NUMBER	1.7-2	dep	106	SENT_95	[p5l14t1553r275b1610],
31	.5	CD	NUMBER	.5	dep	106	SENT_95	[p5l14t1553r275b1610],
32	mM	NN	O	mm	dep	106	SENT_95	[p5l297t1554r409b1610],
33	of	IN	O	of	dep	106	SENT_95	[p5l457t1552r524b1610],
34	MgCl2	NN	O	mgcl2	dep	106	SENT_95	[p5l570t1552r780b1625],
35	,	,	O	,	_	0	SENT_95	[p5l570t1552r780b1625],
36	0.3	CD	NUMBER	0.3	dep	106	SENT_95	[p5l836t1553r937b1610],
37	pM	NN	O	pm	dep	106	SENT_95	[p5l961t1554r1060b1625],
38	of	IN	O	of	dep	106	SENT_95	[p5l1107t1552r1175b1610],
39	each	DT	O	each	dep	106	SENT_95	[p5l1222t1552r1376b1610],
40	primer	NN	O	primer	dep	106	SENT_95	[p5l1430t1554r1655b1625],
41	pairs	NNS	O	pair	dep	106	SENT_95	[p5l1705t1554r1863b1625],
42	(	VBP	O	(	dep	106	SENT_95	[p5l1917t1554r2040b1625, p5l9t1661r85b1704],
43	exon	NN	O	exon	dep	106	SENT_95	[p5l1917t1554r2040b1625, p5l9t1661r85b1704],
44	18	CD	NUMBER	18	dep	106	SENT_95	[p5l139t1646r231b1716],
45	,	,	O	,	_	0	SENT_95	[p5l139t1646r231b1716],
46	F	NN	O	f	dep	106	SENT_95	[p5l286t1647r341b1704],
47	:	:	O	:	_	0	SENT_95	[p5l286t1647r341b1704],
48	5	CD	NUMBER	5	dep	106	SENT_95	[p5l396t1647r1240b1718],
49	’	SYM	O	’	dep	106	SENT_95	[p5l396t1647r1240b1718],
50	-	:	O	-	_	0	SENT_95	[p5l396t1647r1240b1718],
51	tccaaatgagctggcaagtg	NN	O	tccaaatgagctggcaagtg	dep	106	SENT_95	[p5l396t1647r1240b1718],
52	,	,	O	,	_	0	SENT_95	[p5l396t1647r1240b1718],
53	R	NN	O	r	dep	106	SENT_95	[p5l1296t1647r1354b1704],
54	:	:	O	:	_	0	SENT_95	[p5l1296t1647r1354b1704],
55	5	CD	NUMBER	5	dep	106	SENT_95	[p5l1410t1647r2040b1718, p5l10t1744r374b1811],
56	’	NN	O	’	dep	106	SENT_95	[p5l1410t1647r2040b1718, p5l10t1744r374b1811],
57	tcccaaacactcagtgaaacaaa	NN	O	tcccaaacactcagtgaaacaaa	dep	106	SENT_95	[p5l1410t1647r2040b1718, p5l10t1744r374b1811],
58	;	:	O	;	_	0	SENT_95	[p5l1410t1647r2040b1718, p5l10t1744r374b1811],
59	exon	NN	O	exon	dep	106	SENT_95	[p5l436t1754r592b1796],
60	19	CD	NUMBER	19	dep	106	SENT_95	[p5l656t1739r748b1808],
61	,	,	O	,	_	0	SENT_95	[p5l656t1739r748b1808],
62	F	NN	O	f	dep	106	SENT_95	[p5l814t1740r868b1796],
63	:	:	O	:	_	0	SENT_95	[p5l814t1740r868b1796],
64	5	CD	NUMBER	5	dep	106	SENT_95	[p5l933t1740r1913b1811],
65	’	SYM	O	’	dep	106	SENT_95	[p5l933t1740r1913b1811],
66	-	:	O	-	_	0	SENT_95	[p5l933t1740r1913b1811],
67	atgtggcaccatctcacaattgcc	NN	O	atgtggcaccatctcacaattgcc	dep	106	SENT_95	[p5l933t1740r1913b1811],
68	,	,	O	,	_	0	SENT_95	[p5l933t1740r1913b1811],
69	R	NN	O	r	dep	106	SENT_95	[p5l1979t1739r2037b1796],
70	:	:	O	:	_	0	SENT_95	[p5l1979t1739r2037b1796],
71	5	CD	NUMBER	5	dep	106	SENT_95	[p5l12t1833r1040b1904],
72	’	SYM	O	’	dep	106	SENT_95	[p5l12t1833r1040b1904],
73	-	:	O	-	_	0	SENT_95	[p5l12t1833r1040b1904],
74	ccacacagcaaagcagaaactcac	NN	O	ccacacagcaaagcagaaactcac	dep	106	SENT_95	[p5l12t1833r1040b1904],
75	;	:	O	;	_	0	SENT_95	[p5l12t1833r1040b1904],
76	exon	NN	O	exon	dep	106	SENT_95	[p5l1093t1847r1248b1889],
77	21	CD	NUMBER	21	dep	106	SENT_95	[p5l1297t1832r1395b1902],
78	,	,	O	,	_	0	SENT_95	[p5l1297t1832r1395b1902],
79	F	NN	O	f	dep	106	SENT_95	[p5l1450t1833r1504b1889],
80	:	:	O	:	_	0	SENT_95	[p5l1450t1833r1504b1889],
81	5	CD	NUMBER	5	dep	106	SENT_95	[p5l1559t1833r2040b1904, p5l10t1930r360b1997],
82	’	NN	O	’	dep	106	SENT_95	[p5l1559t1833r2040b1904, p5l10t1930r360b1997],
83	gctcagagcctggcatgaa	NN	O	gctcagagcctggcatgaa	dep	106	SENT_95	[p5l1559t1833r2040b1904, p5l10t1930r360b1997],
84	,	,	O	,	_	0	SENT_95	[p5l1559t1833r2040b1904, p5l10t1930r360b1997],
85	R	NN	O	r	dep	106	SENT_95	[p5l407t1926r465b1983],
86	:	:	O	:	_	0	SENT_95	[p5l407t1926r465b1983],
87	5	CD	NUMBER	5	dep	106	SENT_95	[p5l511t1926r1320b1997],
88	’	SYM	O	’	dep	106	SENT_95	[p5l511t1926r1320b1997],
89	-	:	O	-	_	0	SENT_95	[p5l511t1926r1320b1997],
90	catcctcccctgcatgtgt	NN	O	catcctcccctgcatgtgt	dep	106	SENT_95	[p5l511t1926r1320b1997],
91	)	NN	O	)	dep	106	SENT_95	[p5l511t1926r1320b1997],
92	,	,	O	,	_	0	SENT_95	[p5l511t1926r1320b1997],
93	250	CD	NUMBER	250	dep	106	SENT_95	[p5l1363t1925r1479b1983],
94	uM	NN	O	um	dep	106	SENT_95	[p5l1500t1926r1599b1998],
95	of	IN	O	of	dep	106	SENT_95	[p5l1633t1925r1701b1983],
96	deoxynucleoside	NN	O	deoxynucleoside	dep	106	SENT_95	[p5l1735t1925r2040b1997, p5l9t2017r285b2075],
97	triphosphate	NN	O	triphosphate	dep	106	SENT_95	[p5l341t2017r771b2090],
98	and	CC	O	and	dep	106	SENT_95	[p5l828t2017r945b2075],
99	2.5	CD	NUMBER	2.5	dep	106	SENT_95	[p5l1004t2018r1105b2075],
100	units	NNS	O	unit	dep	106	SENT_95	[p5l1126t2018r1287b2075],
101	of	IN	O	of	dep	106	SENT_95	[p5l1343t2017r1410b2075],
102	DNA	NN	O	dna	dep	106	SENT_95	[p5l1467t2018r1602b2075],
103	polymerase	NN	O	polymerase	dep	106	SENT_95	[p5l1659t2017r2044b2090],
104	(	CD	NUMBER	(	dep	106	SENT_95	[p5l14t2110r286b2183],
105	Roche	NNP	O	Roche	dep	106	SENT_95	[p5l14t2110r286b2183],
106	)	CD	NUMBER	)	_	0	SENT_95	[p5l14t2110r286b2183],
107	.	.	O	.	_	0	SENT_95	[p5l14t2110r286b2183],

1	Ampliﬁcations	NNS	MISC	ampliﬁcations	nsubjpass	3	SENT_96	[p5l318t2110r799b2183],
2	were	VBD	O	be	auxpass	3	SENT_96	[p5l824t2126r992b2168],
3	performed	VBN	O	perform	dep	60	SENT_96	[p5l1021t2110r1372b2183],
4	using	VBG	O	use	xcomp	3	SENT_96	[p5l1405t2112r1573b2183],
5	a	DT	O	a	det	12	SENT_96	[p5l1600t2126r1635b2168],
6	5	CD	DURATION	5	num	12	SENT_96	[p5l1665t2112r1696b2168],
7	min	NN	DURATION	min	nn	12	SENT_96	[p5l1718t2112r1835b2168],
8	(	CD	NUMBER	(	num	12	SENT_96	[p5l1869t2112r2041b2183],
9	min	NN	DURATION	min	nn	12	SENT_96	[p5l1869t2112r2041b2183],
10	)	CD	NUMBER	)	num	12	SENT_96	[p5l1869t2112r2041b2183],
11	initial	JJ	O	initial	amod	12	SENT_96	[p5l10t2204r204b2262],
12	denaturation	NN	O	denaturation	dobj	4	SENT_96	[p5l233t2204r669b2262],
13	at	IN	O	at	_	0	SENT_96	[p5l700t2209r766b2262],
14	94	CD	NUMBER	94	number	15	SENT_96	[p5l794t2204r979b2274],
15	°	CD	NUMBER	°	num	16	SENT_96	[p5l794t2204r979b2274],
16	C	NN	O	c	prep_at	4	SENT_96	[p5l794t2204r979b2274],
17	;	:	O	;	_	0	SENT_96	[p5l794t2204r979b2274],
18	followed	VBN	O	follow	_	0	SENT_96	[p5l1014t2204r1304b2262],
19	by	IN	O	by	prepc_followed_by	56	SENT_96	[p5l1337t2204r1412b2276],
20	30	CD	NUMBER	30	num	21	SENT_96	[p5l1441t2204r1515b2262],
21	cycles	NNS	O	cycle	pobj	56	SENT_96	[p5l1543t2204r1747b2276],
22	of	IN	O	of	_	0	SENT_96	[p5l1775t2204r1843b2262],
23	1	CD	DURATION	1	num	24	SENT_96	[p5l1873t2205r1892b2261],
24	min	NN	DURATION	min	prep_of	21	SENT_96	[p5l1924t2205r2041b2261],
25	at	IN	O	at	_	0	SENT_96	[p5l10t2303r76b2355],
26	94	CD	NUMBER	94	number	27	SENT_96	[p5l114t2298r299b2367],
27	°	CD	NUMBER	°	num	28	SENT_96	[p5l114t2298r299b2367],
28	C	NN	O	c	prep_at	24	SENT_96	[p5l114t2298r299b2367],
29	,	,	O	,	_	0	SENT_96	[p5l114t2298r299b2367],
30	1min	NN	O	1min	nsubj	56	SENT_96	[p5l349t2298r517b2354],
31	at	IN	O	at	_	0	SENT_96	[p5l558t2302r624b2355],
32	55	CD	NUMBER	55	number	33	SENT_96	[p5l665t2298r825b2355],
33	°	CD	NUMBER	°	num	34	SENT_96	[p5l665t2298r825b2355],
34	C	NN	O	c	prep_at	30	SENT_96	[p5l665t2298r825b2355],
35	and	CC	O	and	_	0	SENT_96	[p5l865t2297r982b2355],
36	1min	NN	O	1min	conj_and	34	SENT_96	[p5l1028t2298r1196b2354],
37	at	IN	O	at	_	0	SENT_96	[p5l1237t2302r1303b2355],
38	72	CD	NUMBER	72	number	39	SENT_96	[p5l1341t2298r1527b2367],
39	°	CD	NUMBER	°	num	40	SENT_96	[p5l1341t2298r1527b2367],
40	C	NN	O	c	prep_at	34	SENT_96	[p5l1341t2298r1527b2367],
41	;	:	O	;	_	0	SENT_96	[p5l1341t2298r1527b2367],
42	a	DT	O	a	det	45	SENT_96	[p5l1572t2312r1607b2355],
43	10min	JJ	O	10min	amod	45	SENT_96	[p5l1650t2298r1858b2355],
44	ﬁnal	JJ	O	ﬁnal	amod	45	SENT_96	[p5l1899t2297r2043b2355],
45	extension	NN	O	extension	dep	34	SENT_96	[p5l9t2391r332b2447],
46	at	IN	O	at	_	0	SENT_96	[p5l365t2395r431b2447],
47	72	CD	NUMBER	72	number	48	SENT_96	[p5l461t2390r646b2447],
48	°	CD	NUMBER	°	num	51	SENT_96	[p5l461t2390r646b2447],
49	C.	NNP	O	C.	nn	51	SENT_96	[p5l461t2390r646b2447],
50	PCR	NN	O	pcr	nn	51	SENT_96	[p5l685t2390r813b2447],
51	products	NNS	O	product	prep_at	45	SENT_96	[p5l844t2389r1134b2462],
52	were	VBD	O	be	cop	56	SENT_96	[p5l1162t2405r1329b2447],
53	then	RB	O	then	advmod	56	SENT_96	[p5l1360t2389r1508b2447],
54	2	CD	PERCENT	2	num	55	SENT_96	[p5l1541t2390r1623b2447],
55	%	NN	PERCENT	%	npadvmod	56	SENT_96	[p5l1541t2390r1623b2447],
56	gel-puriﬁed	JJ	O	gel-puriﬁed	parataxis	3	SENT_96	[p5l1653t2389r2041b2462],
57	with	IN	O	with	_	0	SENT_96	[p5l7t2483r153b2541],
58	a	DT	O	a	det	59	SENT_96	[p5l192t2498r227b2541],
59	Q	NNP	O	Q	prep_with	56	SENT_96	[p5l265t2483r497b2555],
60	|	VBD	O	|	_	0	SENT_96	[p5l265t2483r497b2555],
61	Agen	NNP	O	Agen	nn	64	SENT_96	[p5l265t2483r497b2555],
62	gel	NN	O	gel	nn	64	SENT_96	[p5l537t2483r634b2555],
63	extraction	NN	O	extraction	nn	64	SENT_96	[p5l671t2484r1017b2541],
64	kit	NN	O	kit	dobj	60	SENT_96	[p5l1059t2483r1143b2541],
65	(	CD	NUMBER	(	num	67	SENT_96	[p5l1184t2483r1488b2555],
66	Qiagen	NNP	ORGANIZATION	Qiagen	nn	67	SENT_96	[p5l1184t2483r1488b2555],
67	)	NN	O	)	nsubj	60	SENT_96	[p5l1184t2483r1488b2555],
68	.	.	O	.	_	0	SENT_96	[p5l1184t2483r1488b2555],

1	DNA	NN	O	dna	nn	2	SENT_97	[p5l1535t2484r1670b2541],
2	templates	NNS	O	template	nsubj	29	SENT_97	[p5l1705t2483r2044b2556],
3	were	VBD	O	be	auxpass	4	SENT_97	[p5l7t2591r175b2634],
4	processed	VBN	O	process	_	0	SENT_97	[p5l209t2576r539b2649],
5	for	IN	O	for	_	0	SENT_97	[p5l574t2576r671b2634],
6	the	DT	O	the	det	9	SENT_97	[p5l702t2576r811b2634],
7	DNA	NN	O	dna	nn	9	SENT_97	[p5l846t2577r981b2634],
8	sequencing	NN	O	sequencing	nn	9	SENT_97	[p5l1012t2577r1388b2649],
9	reaction	NN	O	reaction	prep_for	4	SENT_97	[p5l1423t2577r1697b2634],
10	using	VBG	O	use	xcomp	4	SENT_97	[p5l1734t2577r1902b2649],
11	the	DT	O	the	det	15	SENT_97	[p5l1935t2576r2044b2634],
12	ABI-PRISM	NN	MISC	abi-prism	nn	15	SENT_97	[p5l7t2669r344b2726],
13	BigDye	NNP	MISC	BigDye	nn	15	SENT_97	[p5l370t2669r592b2741],
14	Terminator	NNP	MISC	Terminator	nn	15	SENT_97	[p5l616t2670r990b2726],
15	v3	NN	O	v3	dobj	10	SENT_97	[p5l1011t2669r1142b2726],
16	.1	CD	NUMBER	.1	number	17	SENT_97	[p5l1011t2669r1142b2726],
17	(	CD	NUMBER	(	dep	15	SENT_97	[p5l1184t2668r1459b2741],
18	Applied	NNP	O	Applied	nn	23	SENT_97	[p5l1184t2668r1459b2741],
19	Biosystems	NNP	O	Biosystems	nn	23	SENT_97	[p5l1490t2669r1876b2741],
20	,	,	O	,	_	0	SENT_97	[p5l1490t2669r1876b2741],
21	Foster	NNP	PERSON	Foster	appos	23	SENT_97	[p5l1911t2670r2040b2726, p5l10t2767r117b2832],
22	,	,	O	,	_	0	SENT_97	[p5l1911t2670r2040b2726, p5l10t2767r117b2832],
23	CA	NNP	LOCATION	CA	dep	17	SENT_97	[p5l163t2762r275b2834],
24	)	CD	NUMBER	)	num	23	SENT_97	[p5l163t2762r275b2834],
25	with	IN	O	with	prep	10	SENT_97	[p5l315t2762r460b2820],
26	both	CC	O	both	dep	27	SENT_97	[p5l504t2762r651b2820],
27	forward	RB	O	forward	dep	25	SENT_97	[p5l692t2762r954b2820],
28	and	CC	O	and	_	0	SENT_97	[p5l996t2762r1114b2820],
29	reverse	VB	O	reverse	conj_and	4	SENT_97	[p5l1158t2777r1404b2820],
30	sequence-speciﬁc	JJ	O	sequence-speciﬁc	amod	31	SENT_97	[p5l1443t2762r2044b2835],
31	primers	NNS	O	primer	dobj	29	SENT_97	[p5l12t2856r286b2928],
32	.	.	O	.	_	0	SENT_97	[p5l12t2856r286b2928],

1	Twenty	CD	NUMBER	twenty	num	2	SENT_98	[p5l325t2857r566b2928],
2	nanograms	NNS	O	nanogram	nsubjpass	8	SENT_98	[p5l601t2869r962b2928],
3	of	IN	O	of	_	0	SENT_98	[p5l996t2855r1063b2913],
4	puriﬁed	JJ	O	puriﬁed	amod	6	SENT_98	[p5l1097t2855r1352b2928],
5	PCR	NN	O	pcr	nn	6	SENT_98	[p5l1392t2856r1520b2913],
6	products	NNS	O	product	prep_of	2	SENT_98	[p5l1554t2855r1844b2928],
7	were	VBD	O	be	auxpass	8	SENT_98	[p5l1876t2870r2044b2913],
8	used	VBN	O	use	_	0	SENT_98	[p5l11t2947r159b3005],
9	in	IN	O	in	_	0	SENT_98	[p5l191t2949r247b3005],
10	a	DT	O	a	quantmod	11	SENT_98	[p5l278t2963r313b3005],
11	20	CD	NUMBER	20	num	15	SENT_98	[p5l342t2948r418b3005],
12	pl	NN	O	pl	nn	15	SENT_98	[p5l439t2947r504b3020],
13	sequencing	NN	O	sequencing	nn	15	SENT_98	[p5l533t2949r909b3020],
14	reaction	NN	O	reaction	nn	15	SENT_98	[p5l940t2949r1215b3005],
15	solution	NN	O	solution	prep_in	8	SENT_98	[p5l1246t2947r1510b3005],
16	containing	VBG	O	contain	partmod	15	SENT_98	[p5l1541t2949r1893b3020],
17	8	CD	NUMBER	8	num	18	SENT_98	[p5l1923t2948r1957b3005],
18	pl	NN	O	pl	dobj	16	SENT_98	[p5l1978t2947r2043b3020],
19	of	IN	O	of	_	0	SENT_98	[p5l9t3041r77b3099],
20	BigDye	NNP	O	BigDye	nn	23	SENT_98	[p5l123t3042r346b3113],
21	Terminator	NNP	O	Terminator	nn	23	SENT_98	[p5l390t3042r764b3099],
22	v3	NN	O	v3	nn	23	SENT_98	[p5l807t3041r938b3099],
23	.1	NN	NUMBER	.1	prep_of	18	SENT_98	[p5l807t3041r938b3099],
24	and	CC	O	and	_	0	SENT_98	[p5l996t3041r1113b3099],
25	0.1	CD	NUMBER	0.1	num	26	SENT_98	[p5l1162t3041r1255b3099],
26	pM	NN	O	pm	conj_and	18	SENT_98	[p5l1287t3042r1386b3114],
27	of	IN	O	of	_	0	SENT_98	[p5l1430t3041r1498b3099],
28	the	DT	O	the	det	31	SENT_98	[p5l1542t3041r1651b3099],
29	same	JJ	O	same	amod	31	SENT_98	[p5l1697t3056r1869b3099],
30	PCR	NN	O	pcr	nn	31	SENT_98	[p5l1918t3041r2046b3099],
31	primer	NN	O	primer	prep_of	26	SENT_98	[p5l12t3135r245b3207],
32	.	.	O	.	_	0	SENT_98	[p5l12t3135r245b3207],

1	Sequencing	NN	O	sequencing	nn	2	SENT_99	[p5l280t3135r661b3207],
2	reactions	NNS	O	reaction	nsubjpass	4	SENT_99	[p5l692t3135r1000b3192],
3	were	VBD	O	be	auxpass	4	SENT_99	[p5l1026t3149r1194b3192],
4	performed	VBN	O	perform	_	0	SENT_99	[p5l1224t3134r1576b3207],
5	using	VBG	O	use	xcomp	4	SENT_99	[p5l1608t3135r1777b3207],
6	a	DT	O	a	det	8	SENT_99	[p5l1805t3149r1840b3192],
7	2	CD	DURATION	2	num	8	SENT_99	[p5l1868t3135r1903b3191],
8	min	NN	DURATION	min	dobj	5	SENT_99	[p5l1924t3135r2041b3191],
9	initial	JJ	O	initial	amod	10	SENT_99	[p5l10t3226r204b3284],
10	denaturation	NN	O	denaturation	nsubjpass	47	SENT_99	[p5l228t3226r663b3284],
11	at	IN	O	at	_	0	SENT_99	[p5l689t3232r755b3284],
12	96	CD	NUMBER	96	number	13	SENT_99	[p5l778t3227r852b3284],
13	°	CD	NUMBER	°	num	14	SENT_99	[p5l871t3227r963b3297],
14	C	NN	O	c	prep_at	10	SENT_99	[p5l871t3227r963b3297],
15	,	,	O	,	_	0	SENT_99	[p5l871t3227r963b3297],
16	followed	VBN	O	follow	partmod	14	SENT_99	[p5l992t3226r1282b3284],
17	by	IN	O	by	_	0	SENT_99	[p5l1310t3226r1385b3299],
18	25	CD	NUMBER	25	num	19	SENT_99	[p5l1406t3227r1480b3284],
19	cycles	NNS	O	cycle	agent	16	SENT_99	[p5l1504t3226r1709b3299],
20	of	IN	O	of	_	0	SENT_99	[p5l1731t3226r1799b3284],
21	10	CD	NUMBER	10	num	22	SENT_99	[p5l1824t3227r1895b3284],
22	s	NNS	O	s	prep_of	19	SENT_99	[p5l1912t3242r1938b3284],
23	(	CD	NUMBER	(	num	24	SENT_99	[p5l1966t3228r2041b3299],
24	s	NNS	O	s	nsubj	25	SENT_99	[p5l1966t3228r2041b3299],
25	)	VBP	O	)	rcmod	22	SENT_99	[p5l1966t3228r2041b3299],
26	at	IN	O	at	_	0	SENT_99	[p5l10t3325r76b3378],
27	94	CD	NUMBER	94	number	28	SENT_99	[p5l97t3320r173b3377],
28	°	CD	NUMBER	°	num	29	SENT_99	[p5l190t3320r282b3390],
29	C	NN	O	c	prep_at	25	SENT_99	[p5l190t3320r282b3390],
30	,	,	O	,	_	0	SENT_99	[p5l190t3320r282b3390],
31	15	CD	NUMBER	15	num	32	SENT_99	[p5l315t3321r384b3378],
32	s	NNS	O	s	conj_and	22	SENT_99	[p5l403t3335r430b3378],
33	at	IN	O	at	_	0	SENT_99	[p5l452t3325r518b3378],
34	50	CD	NUMBER	50	number	35	SENT_99	[p5l542t3320r615b3378],
35	°	CD	NUMBER	°	num	36	SENT_99	[p5l632t3320r702b3378],
36	C	NN	O	c	prep_at	32	SENT_99	[p5l632t3320r702b3378],
37	and	CC	O	and	_	0	SENT_99	[p5l725t3320r842b3378],
38	3	CD	DURATION	3	num	39	SENT_99	[p5l868t3320r900b3378],
39	min	NN	DURATION	min	npadvmod	40	SENT_99	[p5l922t3321r1039b3377],
40	at	IN	O	at	advmod	22	SENT_99	[p5l1064t3325r1130b3378],
41	60	CD	NUMBER	60	number	42	SENT_99	[p5l1152t3320r1227b3378],
42	°	CD	NUMBER	°	num	45	SENT_99	[p5l1244t3320r1336b3378],
43	C.	NNP	O	C.	nn	45	SENT_99	[p5l1244t3320r1336b3378],
44	Sequence	NN	O	sequence	nn	45	SENT_99	[p5l1365t3320r1686b3392],
45	data	NNS	O	datum	conj_and	22	SENT_99	[p5l1708t3320r1856b3378],
46	were	VBD	O	be	auxpass	47	SENT_99	[p5l1877t3335r2044b3378],
47	generated	VBN	O	generate	rcmod	8	SENT_99	[p5l10t3413r350b3486],
48	with	IN	O	with	_	0	SENT_99	[p5l384t3413r530b3471],
49	the	DT	O	the	det	54	SENT_99	[p5l567t3413r676b3471],
50	ABI	NNP	O	ABI	nn	54	SENT_99	[p5l708t3414r810b3470],
51	PRISM	NNP	O	PRISM	nn	54	SENT_99	[p5l851t3414r1045b3471],
52	3100	CD	NUMBER	3100	num	54	SENT_99	[p5l1079t3414r1233b3471],
53	DNA	NN	O	dna	nn	54	SENT_99	[p5l1270t3414r1405b3471],
54	Analyzer	NN	O	analyzer	prep_with	47	SENT_99	[p5l1435t3413r1730b3486],
55	(	CD	NUMBER	(	num	58	SENT_99	[p5l1766t3413r2041b3486],
56	Applied	NNP	O	Applied	nn	58	SENT_99	[p5l1766t3413r2041b3486],
57	Biosystems	NNP	O	Biosystems	nn	58	SENT_99	[p5l12t3507r426b3578],
58	)	NN	O	)	dep	54	SENT_99	[p5l12t3507r426b3578],
59	.	.	O	.	_	0	SENT_99	[p5l12t3507r426b3578],

1	Sequences	NNS	O	sequence	nsubjpass	3	SENT_100	[p5l461t3506r813b3578],
2	were	VBD	O	be	auxpass	3	SENT_100	[p5l839t3521r1007b3563],
3	analyzed	VBN	O	analyze	_	0	SENT_100	[p5l1035t3505r1330b3578],
4	by	IN	O	by	_	0	SENT_100	[p5l1364t3505r1438b3578],
5	Sequencer	NNP	O	Sequencer	agent	3	SENT_100	[p5l1465t3506r1818b3578],
6	3.1.1	CD	NUMBER	3.1.1	num	5	SENT_100	[p5l1846t3506r2037b3563],
7	.	.	O	.	_	0	SENT_100	[p5l1846t3506r2037b3563],

1	software	NN	O	software	_	0	SENT_101	[p5l9t3599r304b3657],
2	(	CD	NUMBER	(	num	5	SENT_101	[p5l336t3599r611b3671],
3	Applied	NNP	O	Applied	nn	5	SENT_101	[p5l336t3599r611b3671],
4	Biosystems	NNP	O	Biosystems	nn	5	SENT_101	[p5l644t3600r1058b3671],
5	)	NN	O	)	dep	1	SENT_101	[p5l644t3600r1058b3671],
6	.	.	O	.	_	0	SENT_101	[p5l644t3600r1058b3671],

1	2.3	CD	NUMBER	2.3	_	0	SENT_102	[p6l13t82r160b146],
2	.	.	O	.	_	0	SENT_102	[p6l13t82r160b146],

1	Statistical	JJ	O	statistical	amod	2	SENT_103	[p6l215t80r599b145],
2	analysis	NN	O	analysis	_	0	SENT_103	[p6l630t80r935b161],

1	The	DT	O	the	det	3	SENT_104	[p6l7t282r133b340],
2	statistical	JJ	O	statistical	amod	3	SENT_104	[p6l160t282r492b340],
3	analyses	NNS	O	analysis	nsubj	6	SENT_104	[p6l521t282r802b355],
4	of	IN	O	of	_	0	SENT_104	[p6l830t282r897b340],
5	2	CD	NUMBER	2	prep_of	3	SENT_104	[p6l922t283r956b339],
6	x	NN	O	x	_	0	SENT_104	[p6l983t303r1022b338],
7	2	CD	NUMBER	2	num	9	SENT_104	[p6l1048t283r1082b339],
8	contingency	NN	O	contingency	nn	9	SENT_104	[p6l1111t283r1520b355],
9	tables	NNS	O	table	nsubjpass	14	SENT_104	[p6l1547t282r1750b340],
10	of	IN	O	of	_	0	SENT_104	[p6l1777t282r1845b340],
11	categorical	JJ	O	categorical	amod	12	SENT_104	[p6l1870t287r2040b340, p6l10t373r235b446],
12	variables	NNS	O	variable	prep_of	9	SENT_104	[p6l257t373r561b431],
13	were	VBD	O	be	auxpass	14	SENT_104	[p6l582t389r749b431],
14	performed	VBN	O	perform	ccomp	6	SENT_104	[p6l774t373r1125b446],
15	using	VBG	O	use	xcomp	14	SENT_104	[p6l1152t375r1321b446],
16	the	DT	O	the	det	17	SENT_104	[p6l1343t373r1452b431],
17	Pearson	NNP	PERSON	Pearson	poss	21	SENT_104	[p6l1478t373r1789b431],
18	’s	POS	O	’s	_	0	SENT_104	[p6l1478t373r1789b431],
19	x2	NN	O	x2	nn	21	SENT_104	[p6l1812t365r2044b445],
20	—	CD	NUMBER	—	num	21	SENT_104	[p6l1812t365r2044b445],
21	test	NN	O	test	dobj	15	SENT_104	[p6l1812t365r2044b445],
22	or	CC	O	or	_	0	SENT_104	[p6l9t482r78b525],
23	the	DT	O	the	det	24	SENT_104	[p6l99t467r208b525],
24	Fisher	NNP	PERSON	Fisher	poss	27	SENT_104	[p6l234t467r485b525],
25	’s	POS	O	’s	_	0	SENT_104	[p6l234t467r485b525],
26	exact	JJ	O	exact	amod	27	SENT_104	[p6l508t472r693b525],
27	test	NN	O	test	conj_or	21	SENT_104	[p6l716t472r845b525],
28	where	WRB	O	where	advmod	29	SENT_104	[p6l866t467r1075b525],
29	appropriate	JJ	O	appropriate	dep	15	SENT_104	[p6l1099t468r1517b539],
30	.	.	O	.	_	0	SENT_104	[p6l1099t468r1517b539],

1	Trends	NNS	O	trend	nsubjpass	16	SENT_105	[p6l1545t467r1766b525],
2	of	IN	O	of	_	0	SENT_105	[p6l1789t467r1856b525],
3	association	NN	O	association	prep_of	1	SENT_105	[p6l1877t482r2040b525, p6l9t561r236b618],
4	between	IN	O	between	_	0	SENT_105	[p6l275t560r562b618],
5	number	NN	O	number	prep_between	3	SENT_105	[p6l599t560r856b618],
6	of	IN	O	of	_	0	SENT_105	[p6l887t560r954b618],
7	clinical	JJ	O	clinical	amod	8	SENT_105	[p6l984t560r1226b618],
8	variables	NNS	O	variable	prep_of	5	SENT_105	[p6l1257t560r1562b618],
9	and	CC	O	and	_	0	SENT_105	[p6l1595t560r1712b618],
10	response	NN	O	response	nn	11	SENT_105	[p6l1751t575r2044b633],
11	rate	NN	O	rate	conj_and	5	SENT_105	[p6l12t658r146b710],
12	or	CC	O	or	_	0	SENT_105	[p6l166t668r235b710],
13	mutational	JJ	O	mutational	amod	14	SENT_105	[p6l255t652r620b710],
14	frequency	NN	O	frequency	conj_and	5	SENT_105	[p6l641t652r981b725],
15	were	VBD	O	be	auxpass	16	SENT_105	[p6l998t668r1165b710],
16	analyzed	VBN	O	analyze	_	0	SENT_105	[p6l1186t652r1481b725],
17	using	VBG	O	use	xcomp	16	SENT_105	[p6l1505t654r1673b725],
18	the	DT	O	the	det	21	SENT_105	[p6l1694t652r1803b710],
19	linearby-linear	JJ	O	linearby-linear	amod	21	SENT_105	[p6l1825t652r2040b710, p6l12t746r313b818],
20	association	NN	O	association	nn	21	SENT_105	[p6l343t747r713b804],
21	test	NN	O	test	dobj	17	SENT_105	[p6l748t751r897b804],
22	.	.	O	.	_	0	SENT_105	[p6l748t751r897b804],

1	The	DT	O	the	det	3	SENT_106	[p6l934t746r1059b804],
2	median	JJ	O	median	amod	3	SENT_106	[p6l1093t746r1335b804],
3	durations	NNS	O	duration	nsubjpass	16	SENT_106	[p6l1369t746r1685b804],
4	of	IN	O	of	_	0	SENT_106	[p6l1716t746r1784b804],
5	overall	JJ	O	overall	amod	6	SENT_106	[p6l1813t746r2043b804],
6	survival	NN	O	survival	prep_of	3	SENT_106	[p6l9t839r266b897],
7	(	CD	NUMBER	(	num	9	SENT_106	[p6l295t840r428b912],
8	OS	NN	O	os	nn	9	SENT_106	[p6l295t840r428b912],
9	)	NN	O	)	dep	6	SENT_106	[p6l295t840r428b912],
10	and	CC	O	and	_	0	SENT_106	[p6l455t839r572b897],
11	time-to-progression	NN	O	time-to-progression	nn	14	SENT_106	[p6l600t840r1267b912],
12	(	CD	NUMBER	(	num	14	SENT_106	[p6l1298t840r1474b912],
13	TTP	NN	O	ttp	nn	14	SENT_106	[p6l1298t840r1474b912],
14	)	NN	O	)	conj_and	6	SENT_106	[p6l1298t840r1474b912],
15	were	VBD	O	be	auxpass	16	SENT_106	[p6l1499t854r1667b897],
16	calculated	VBN	O	calculate	_	0	SENT_106	[p6l1690t839r2041b897],
17	using	VBG	O	use	xcomp	16	SENT_106	[p6l11t932r179b1004],
18	the	DT	O	the	det	19	SENT_106	[p6l207t931r316b989],
19	Kaplan	NNP	PERSON	Kaplan	dobj	17	SENT_106	[p6l347t931r818b1004],
20	.	.	O	.	_	0	SENT_106	[p6l347t931r818b1004],

1	—	NN	O	—	_	0	SENT_107	[p6l347t931r818b1004],
2	.	.	O	.	_	0	SENT_107	[p6l347t931r818b1004],

1	Meier	JJR	PERSON	meier	_	0	SENT_108	[p6l347t931r818b1004],
2	method	NN	O	method	dep	1	SENT_108	[p6l846t931r1121b989],
3	.	.	O	.	_	0	SENT_108	[p6l846t931r1121b989],

1	Comparisons	NNS	O	comparison	nsubjpass	6	SENT_109	[p6l1156t932r1580b1004],
2	between	IN	O	between	_	0	SENT_109	[p6l1610t931r1897b989],
3	different	JJ	O	different	amod	4	SENT_109	[p6l1928t931r2040b989, p6l9t1025r219b1083],
4	groups	NNS	O	group	prep_between	1	SENT_109	[p6l259t1039r478b1097],
5	were	VBD	O	be	auxpass	6	SENT_109	[p6l516t1040r684b1083],
6	made	VBN	O	make	_	0	SENT_109	[p6l726t1025r907b1083],
7	using	VBG	O	use	xcomp	6	SENT_109	[p6l949t1026r1117b1097],
8	the	DT	O	the	det	10	SENT_109	[p6l1157t1025r1266b1083],
9	log-rank	JJ	O	log-rank	amod	10	SENT_109	[p6l1309t1025r1584b1097],
10	tests	NNS	O	test	dobj	7	SENT_109	[p6l1622t1030r1803b1083],
11	.	.	O	.	_	0	SENT_109	[p6l1622t1030r1803b1083],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_110	[p6l1848t1025r2040b1083, p6l7t1119r246b1176],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_110	[p6l276t1118r557b1191],
3	were	VBD	O	be	auxpass	4	SENT_110	[p6l584t1133r751b1176],
4	performed	VBN	O	perform	_	0	SENT_110	[p6l783t1118r1135b1191],
5	using	VBG	O	use	xcomp	4	SENT_110	[p6l1168t1119r1337b1191],
6	a	DT	O	a	det	9	SENT_110	[p6l1366t1133r1401b1176],
7	logistic	JJ	O	logistic	amod	9	SENT_110	[p6l1434t1118r1671b1191],
8	regression	NN	O	regression	nn	9	SENT_110	[p6l1703t1119r2041b1191],
9	model	NN	O	model	dobj	5	SENT_110	[p6l12t1211r215b1269],
10	for	IN	O	for	_	0	SENT_110	[p6l244t1211r341b1269],
11	response	NN	O	response	nn	16	SENT_110	[p6l371t1227r664b1284],
12	and	CC	O	and	_	0	SENT_110	[p6l692t1211r810b1269],
13	stepwise	JJ	O	stepwise	nn	16	SENT_110	[p6l841t1212r1133b1284],
14	Cox	NN	O	cox	nn	16	SENT_110	[p6l1162t1212r1283b1269],
15	regression	NN	O	regression	nn	16	SENT_110	[p6l1314t1212r1652b1284],
16	models	NNS	O	model	prep_for	9	SENT_110	[p6l1685t1211r1921b1269],
17	for	IN	O	for	_	0	SENT_110	[p6l1949t1211r2046b1269],
18	TTP	NN	O	ttp	prep_for	5	SENT_110	[p6l7t1305r135b1361],
19	and	CC	O	and	_	0	SENT_110	[p6l163t1304r280b1362],
20	OS	NN	O	os	conj_and	18	SENT_110	[p6l311t1304r415b1362],
21	.	.	O	.	_	0	SENT_110	[p6l311t1304r415b1362],

1	Number	NN	O	number	nsubjpass	6	SENT_111	[p6l452t1304r715b1362],
2	of	IN	O	of	_	0	SENT_111	[p6l740t1304r807b1362],
3	clinical	JJ	O	clinical	amod	4	SENT_111	[p6l832t1304r1073b1362],
4	predictors	NNS	O	predictor	prep_of	1	SENT_111	[p6l1103t1304r1445b1376],
5	was	VBD	O	be	auxpass	6	SENT_111	[p6l1470t1319r1595b1362],
6	entered	VBN	O	enter	_	0	SENT_111	[p6l1622t1304r1885b1362],
7	as	IN	O	as	_	0	SENT_111	[p6l1915t1319r1981b1362],
8	a	DT	O	a	det	10	SENT_111	[p6l2009t1319r2043b1362],
9	continuous	JJ	O	continuous	amod	10	SENT_111	[p6l55t1644r432b1702],
10	variable	NN	O	variable	prep_as	6	SENT_111	[p6l452t1643r756b1702],
11	.	.	O	.	_	0	SENT_111	[p6l452t1643r756b1702],

1	Analysis	NN	O	analysis	nsubjpass	7	SENT_112	[p6l783t1643r1060b1718],
2	of	IN	O	of	_	0	SENT_112	[p6l1081t1643r1151b1702],
3	TTP	NN	O	ttp	prep_of	1	SENT_112	[p6l1169t1644r1301b1701],
4	and	CC	O	and	_	0	SENT_112	[p6l1325t1643r1445b1702],
5	OS	NN	O	os	conj_and	3	SENT_112	[p6l1470t1644r1556b1702],
6	was	VBD	O	be	auxpass	7	SENT_112	[p6l1577t1659r1705b1702],
7	adjusted	VBN	O	adjust	_	0	SENT_112	[p6l1728t1643r2028b1718],
8	for	IN	O	for	_	0	SENT_112	[p6l2053t1643r2152b1702],
9	performance	NN	O	performance	nn	10	SENT_112	[p6l58t1738r502b1813],
10	status	NN	O	status	prep_for	7	SENT_112	[p6l539t1744r745b1797],
11	(	CD	NUMBER	(	num	12	SENT_112	[p6l786t1739r998b1813],
12	ECOG	NN	O	ecog	dep	10	SENT_112	[p6l786t1739r998b1813],
13	PS	NNP	O	PS	dobj	7	SENT_112	[p6l1040t1739r1114b1798],
14	0-1	CD	NUMBER	0-1	num	13	SENT_112	[p6l1151t1739r1276b1797],
15	versus	CC	O	versus	prep	13	SENT_112	[p6l1322t1754r1538b1797],
16	2-3	CD	NUMBER	2-3	num	17	SENT_112	[p6l1575t1739r1761b1813],
17	)	NN	O	)	dep	15	SENT_112	[p6l1575t1739r1761b1813],
18	.	.	O	.	_	0	SENT_112	[p6l1575t1739r1761b1813],

1	Two-sided	JJ	O	two-sided	amod	2	SENT_113	[p6l1803t1738r2147b1797],
2	p-values	NNS	O	p-value	nsubjpass	8	SENT_113	[p6l52t1835r344b1910],
3	of	IN	O	of	_	0	SENT_113	[p6l381t1835r451b1894],
4	less	JJR	O	less	mwe	5	SENT_113	[p6l487t1835r609b1894],
5	than	IN	O	than	quantmod	6	SENT_113	[p6l646t1835r797b1894],
6	0.05	CD	NUMBER	0.05	prep_of	2	SENT_113	[p6l836t1835r982b1894],
7	were	VBD	O	be	auxpass	8	SENT_113	[p6l1019t1851r1191b1894],
8	considered	VBN	O	consider	_	0	SENT_113	[p6l1227t1835r1602b1894],
9	signiﬁcant	NN	O	signiﬁcant	dobj	8	SENT_113	[p6l1642t1835r2018b1909],
10	.	.	O	.	_	0	SENT_113	[p6l1642t1835r2018b1909],

1	All	DT	O	all	det	2	SENT_114	[p6l2059t1835r2149b1894],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_114	[p6l56t1931r345b2005],
3	were	VBD	O	be	auxpass	4	SENT_114	[p6l381t1947r553b1990],
4	performed	VBN	O	perform	_	0	SENT_114	[p6l593t1931r955b2006],
5	using	VBG	O	use	xcomp	4	SENT_114	[p6l997t1932r1170b2005],
6	SPSS	NNP	ORGANIZATION	SPSS	dobj	5	SENT_114	[p6l1208t1931r1360b1990],
7	for	IN	O	for	_	0	SENT_114	[p6l1398t1931r1498b1990],
8	Windows	NNP	MISC	Windows	prep_for	6	SENT_114	[p6l1531t1931r1859b2003],
9	,	,	O	,	_	0	SENT_114	[p6l1531t1931r1859b2003],
10	version	NN	O	version	nn	14	SENT_114	[p6l1901t1932r2147b1990],
11	12.0	CD	NUMBER	12.0	num	14	SENT_114	[p6l61t2027r204b2085],
12	(	CD	NUMBER	(	num	14	SENT_114	[p6l237t2027r413b2101],
13	SPSS	NNP	ORGANIZATION	SPSS	nn	14	SENT_114	[p6l237t2027r413b2101],
14	Inc.	NNP	ORGANIZATION	Inc.	appos	8	SENT_114	[p6l446t2028r592b2098],
15	,	,	O	,	_	0	SENT_114	[p6l446t2028r592b2098],
16	Chicago	NNP	LOCATION	Chicago	appos	8	SENT_114	[p6l627t2026r920b2101],
17	,	,	O	,	_	0	SENT_114	[p6l627t2026r920b2101],
18	IL	NN	LOCATION	il	nn	19	SENT_114	[p6l959t2028r1062b2101],
19	)	NN	O	)	appos	8	SENT_114	[p6l959t2028r1062b2101],
20	.	.	O	.	_	0	SENT_114	[p6l959t2028r1062b2101],

1	3	LS	NUMBER	3	_	0	SENT_115	[p6l60t2240r135b2313],
2	.	.	O	.	_	0	SENT_115	[p6l60t2240r135b2313],

1	Results	NNS	O	result	_	0	SENT_116	[p6l195t2238r506b2311],

1	3.1	CD	NUMBER	3.1	_	0	SENT_117	[p6l59t2463r211b2529],
2	.	.	O	.	_	0	SENT_117	[p6l59t2463r211b2529],

1	Clinical	JJ	O	clinical	amod	2	SENT_118	[p6l267t2461r561b2528],
2	predictors	NNS	O	predictor	_	0	SENT_118	[p6l595t2461r1007b2545],

1	In	IN	O	in	_	0	SENT_119	[p6l60t2671r113b2727],
2	accordance	NN	O	accordance	prep_in	11	SENT_119	[p6l167t2669r564b2728],
3	of	IN	O	of	_	0	SENT_119	[p6l614t2669r684b2728],
4	previous	JJ	O	previous	amod	5	SENT_119	[p6l734t2670r1022b2744],
5	reports	NNS	O	report	prep_of	2	SENT_119	[p6l1076t2675r1344b2744],
6	,	,	O	,	_	0	SENT_119	[p6l1076t2675r1344b2744],
7	response	NN	O	response	nn	8	SENT_119	[p6l1404t2685r1705b2744],
8	rates	NNS	O	rate	nsubj	11	SENT_119	[p6l1759t2675r1929b2728],
9	were	VBD	O	be	cop	11	SENT_119	[p6l1978t2685r2150b2728],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_119	[p6l55t2763r474b2838],
11	higher	JJR	O	higher	_	0	SENT_119	[p6l510t2763r727b2838],
12	in	IN	O	in	_	0	SENT_119	[p6l760t2765r818b2822],
13	female	NN	O	female	prep_in	11	SENT_119	[p6l856t2763r1119b2836],
14	,	,	O	,	_	0	SENT_119	[p6l856t2763r1119b2836],
15	adenocarcinoma	NN	O	adenocarcinoma	conj_and	13	SENT_119	[p6l1161t2763r1733b2823],
16	and	CC	O	and	_	0	SENT_119	[p6l1769t2763r1890b2823],
17	neversmokers	NNS	O	neversmoker	conj_and	13	SENT_119	[p6l1930t2780r2146b2823, p6l55t2859r336b2918],
18	(	CD	NUMBER	(	num	19	SENT_119	[p6l368t2859r575b2933],
19	Table	NNP	O	Table	dep	11	SENT_119	[p6l368t2859r575b2933],
20	2	CD	NUMBER	2	number	21	SENT_119	[p6l603t2859r691b2933],
21	)	CD	NUMBER	)	num	19	SENT_119	[p6l603t2859r691b2933],
22	.	.	O	.	_	0	SENT_119	[p6l603t2859r691b2933],

1	For	IN	O	for	_	0	SENT_120	[p6l729t2860r838b2918],
2	more	JJR	O	more	amod	4	SENT_120	[p6l866t2875r1041b2918],
3	detailed	JJ	O	detailed	amod	4	SENT_120	[p6l1069t2859r1353b2918],
4	prediction	NN	O	prediction	prep_for	11	SENT_120	[p6l1386t2859r1738b2934],
5	of	IN	O	of	_	0	SENT_120	[p6l1768t2859r1838b2918],
6	geﬁtinib	NN	O	geﬁtinib	nn	7	SENT_120	[p6l1864t2859r2150b2933],
7	responsiveness	NN	O	responsiveness	prep_of	4	SENT_120	[p6l58t2955r593b3029],
8	,	,	O	,	_	0	SENT_120	[p6l58t2955r593b3029],
9	we	PRP	O	we	nsubj	11	SENT_120	[p6l645t2970r745b3013],
10	have	VBP	O	have	aux	11	SENT_120	[p6l795t2954r953b3013],
11	classiﬁed	VBN	O	classiﬁed	_	0	SENT_120	[p6l1001t2954r1316b3013],
12	patients	NNS	O	patient	dobj	11	SENT_120	[p6l1369t2955r1650b3029],
13	according	VBG	O	accord	_	0	SENT_120	[p6l1698t2954r2034b3029],
14	to	TO	O	to	prepc_according_to	11	SENT_120	[p6l2081t2959r2150b3013],
15	the	DT	O	the	det	16	SENT_120	[p6l56t3048r168b3108],
16	number	NN	O	number	pobj	11	SENT_120	[p6l209t3048r473b3108],
17	of	IN	O	of	_	0	SENT_120	[p6l509t3048r578b3108],
18	favorable	JJ	O	favorable	amod	20	SENT_120	[p6l614t3048r943b3108],
19	clinical	JJ	O	clinical	amod	20	SENT_120	[p6l981t3048r1229b3108],
20	predictors	NNS	O	predictor	prep_of	16	SENT_120	[p6l1271t3048r1623b3123],
21	(	VBP	O	(	dep	20	SENT_120	[p6l1666t3048r1953b3123],
22	female	JJ	O	female	amod	24	SENT_120	[p6l1666t3048r1953b3123],
23	,	,	O	,	_	0	SENT_120	[p6l1666t3048r1953b3123],
24	adenocarcinoma	NN	O	adenocarcinoma	nn	27	SENT_120	[p6l1998t3048r2146b3108, p6l58t3145r500b3203],
25	and	CC	O	and	_	0	SENT_120	[p6l541t3144r662b3203],
26	never-smoker	JJ	O	never-smoker	nn	27	SENT_120	[p6l706t3144r1230b3218],
27	)	NN	O	)	dobj	21	SENT_120	[p6l706t3144r1230b3218],
28	.	.	O	.	_	0	SENT_120	[p6l706t3144r1230b3218],

1	Response	NN	O	response	nn	2	SENT_121	[p6l1280t3145r1594b3218],
2	rate	NN	O	rate	nsubj	3	SENT_121	[p6l1637t3149r1775b3203],
3	showed	VBD	O	show	_	0	SENT_121	[p6l1815t3144r2071b3203],
4	a	DT	O	a	det	6	SENT_121	[p6l2114t3160r2149b3203],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_121	[p6l55t3239r411b3314],
6	trend	NN	O	trend	dobj	3	SENT_121	[p6l439t3239r623b3298],
7	towards	IN	O	towards	_	0	SENT_121	[p6l655t3239r929b3298],
8	increase	NN	O	increase	prep_towards	3	SENT_121	[p6l958t3240r1247b3298],
9	as	IN	O	as	mark	15	SENT_121	[p6l1276t3255r1344b3298],
10	the	DT	O	the	det	11	SENT_121	[p6l1373t3239r1485b3298],
11	number	NN	O	number	nsubj	15	SENT_121	[p6l1516t3239r1780b3298],
12	of	IN	O	of	_	0	SENT_121	[p6l1806t3239r1875b3298],
13	clinical	JJ	O	clinical	amod	14	SENT_121	[p6l1901t3239r2149b3298],
14	predictors	NNS	O	predictor	prep_of	11	SENT_121	[p6l58t3333r410b3408],
15	increased	VBD	O	increase	advcl	3	SENT_121	[p6l480t3333r810b3393],
16	(	CD	NUMBER	(	num	17	SENT_121	[p6l888t3335r1032b3408],
17	Fig	NN	O	fig	dobj	15	SENT_121	[p6l888t3335r1032b3408],
18	.	.	O	.	_	0	SENT_121	[p6l888t3335r1032b3408],

1	1A	NN	O	1a	_	0	SENT_122	[p6l1115t3334r1243b3408],
2	)	NN	O	)	dep	1	SENT_122	[p6l1115t3334r1243b3408],
3	.	.	O	.	_	0	SENT_122	[p6l1115t3334r1243b3408],

1	Female	JJ	O	female	amod	2	SENT_123	[p6l1324t3333r1573b3393],
2	never-smokers	NNS	O	never-smoker	nsubj	10	SENT_123	[p6l1646t3333r2150b3393],
3	with	IN	O	with	_	0	SENT_123	[p6l54t3429r203b3488],
4	adenocarcinoma	NN	O	adenocarcinoma	nn	9	SENT_123	[p6l260t3429r832b3488],
5	(	CD	NUMBER	(	number	6	SENT_123	[p6l891t3429r1101b3503],
6	three	CD	NUMBER	three	num	8	SENT_123	[p6l891t3429r1101b3503],
7	clinical	JJ	O	clinical	amod	8	SENT_123	[p6l1153t3429r1402b3488],
8	predictors	NNS	O	predictor	dep	4	SENT_123	[p6l1459t3429r1836b3503],
9	)	NN	O	)	prep_with	2	SENT_123	[p6l1459t3429r1836b3503],
10	showed	VBD	O	show	_	0	SENT_123	[p6l1892t3429r2147b3488],
11	a	DT	O	a	det	15	SENT_123	[p6l56t3540r92b3583],
12	33.3	CD	PERCENT	33.3	num	15	SENT_123	[p6l138t3525r331b3583],
13	%	NN	PERCENT	%	nn	15	SENT_123	[p6l138t3525r331b3583],
14	response	NN	O	response	nn	15	SENT_123	[p6l378t3540r679b3599],
15	rate	NN	O	rate	dobj	10	SENT_123	[p6l726t3530r887b3596],
16	,	,	O	,	_	0	SENT_123	[p6l726t3530r887b3596],
17	whereas	IN	O	whereas	mark	27	SENT_123	[p6l935t3524r1224b3583],
18	male	JJ	O	male	amod	19	SENT_123	[p6l1270t3524r1436b3583],
19	smokers	NNS	O	smoker	nsubj	27	SENT_123	[p6l1480t3524r1759b3583],
20	with	IN	O	with	_	0	SENT_123	[p6l1801t3524r1951b3583],
21	nonadenocarcinoma	NN	O	nonadenocarcinoma	prep_with	19	SENT_123	[p6l2000t3540r2146b3583, p6l56t3618r628b3677],
22	(	CD	NUMBER	(	num	25	SENT_123	[p6l677t3620r850b3693],
23	zero	CD	NUMBER	zero	num	25	SENT_123	[p6l677t3620r850b3693],
24	clinical	JJ	O	clinical	amod	25	SENT_123	[p6l894t3618r1142b3677],
25	predictors	NNS	O	predictor	dep	21	SENT_123	[p6l1189t3618r1567b3693],
26	)	NN	O	)	dep	25	SENT_123	[p6l1189t3618r1567b3693],
27	showed	VBD	O	show	dep	15	SENT_123	[p6l1613t3618r1869b3677],
28	a	DT	O	a	det	32	SENT_123	[p6l1916t3634r1952b3677],
29	3.4	CD	PERCENT	3.4	number	30	SENT_123	[p6l1998t3619r2150b3677],
30	%	NN	PERCENT	%	amod	32	SENT_123	[p6l1998t3619r2150b3677],
31	response	NN	O	response	nn	32	SENT_123	[p6l58t3730r360b3788],
32	rate	NN	O	rate	dobj	27	SENT_123	[p6l400t3719r560b3773],
33	.	.	O	.	_	0	SENT_123	[p6l400t3719r560b3773],

1	The	DT	O	the	det	3	SENT_124	[p6l603t3714r732b3773],
2	univariate	JJ	O	univariate	amod	3	SENT_124	[p6l771t3715r1121b3773],
3	odds	NNS	O	odds	nsubj	21	SENT_124	[p6l1158t3714r1315b3773],
4	ratio	NN	O	ratio	nn	7	SENT_124	[p6l1355t3715r1516b3773],
5	(	CD	NUMBER	(	num	7	SENT_124	[p6l1557t3714r1702b3788],
6	OR	NN	O	or	nn	7	SENT_124	[p6l1557t3714r1702b3788],
7	)	NN	O	)	npadvmod	3	SENT_124	[p6l1557t3714r1702b3788],
8	of	IN	O	of	_	0	SENT_124	[p6l1741t3714r1811b3773],
9	response	NN	O	response	prep_of	3	SENT_124	[p6l1848t3730r2150b3788],
10	according	VBG	O	accord	_	0	SENT_124	[p7l56t17r392b92],
11	to	TO	O	to	prepc_according_to	9	SENT_124	[p7l433t22r501b76],
12	number	NN	O	number	pobj	9	SENT_124	[p7l545t17r809b76],
13	of	IN	O	of	_	0	SENT_124	[p7l847t17r917b76],
14	clinical	JJ	O	clinical	amod	15	SENT_124	[p7l955t17r1203b76],
15	predictors	NNS	O	predictor	prep_of	12	SENT_124	[p7l1247t17r1598b92],
16	was	VBD	O	be	cop	21	SENT_124	[p7l1637t33r1766b76],
17	1.96	CD	PERCENT	1.96	number	18	SENT_124	[p7l1813t18r1954b76],
18	(	CD	PERCENT	(	amod	21	SENT_124	[p7l2001t18r2150b91],
19	95	CD	PERCENT	95	num	20	SENT_124	[p7l2001t18r2150b91],
20	%	NN	PERCENT	%	dep	18	SENT_124	[p7l2001t18r2150b91],
21	CI	NN	O	ci	_	0	SENT_124	[p7l56t112r115b171],
22	1.25-2	CD	NUMBER	1.25-2	num	23	SENT_124	[p7l152t112r529b183],
23	.92	CD	NUMBER	.92	dep	21	SENT_124	[p7l152t112r529b183],
24	,	,	O	,	_	0	SENT_124	[p7l152t112r529b183],
25	p	NN	O	p	appos	21	SENT_124	[p7l560t128r654b186],
26	=	JJ	O	=	amod	28	SENT_124	[p7l560t128r654b186],
27	0.003	CD	NUMBER	0.003	tmod	26	SENT_124	[p7l674t112r914b186],
28	)	NN	O	)	dep	25	SENT_124	[p7l674t112r914b186],
29	.	.	O	.	_	0	SENT_124	[p7l674t112r914b186],

1	Time	NNP	O	Time	nsubj	5	SENT_125	[p7l947t112r1117b170],
2	to	TO	O	to	_	0	SENT_125	[p7l1146t117r1214b170],
3	progression	NN	O	progression	prep_to	1	SENT_125	[p7l1244t112r1636b186],
4	also	RB	O	also	advmod	5	SENT_125	[p7l1666t111r1800b170],
5	showed	VBD	O	show	_	0	SENT_125	[p7l1828t111r2083b170],
6	a	DT	O	a	det	7	SENT_125	[p7l2114t127r2149b170],
7	trend	NN	O	trend	dobj	5	SENT_125	[p7l56t207r240b266],
8	of	IN	O	of	_	0	SENT_125	[p7l269t207r339b266],
9	increase	NN	O	increase	prep_of	7	SENT_125	[p7l364t208r653b266],
10	as	IN	O	as	mark	15	SENT_125	[p7l680t223r748b266],
11	number	NN	O	number	nsubj	15	SENT_125	[p7l778t207r1042b266],
12	of	IN	O	of	_	0	SENT_125	[p7l1066t207r1136b266],
13	clinical	JJ	O	clinical	amod	14	SENT_125	[p7l1159t207r1408b266],
14	predictors	NNS	O	predictor	prep_of	11	SENT_125	[p7l1438t207r1790b281],
15	increased	VBD	O	increase	advcl	5	SENT_125	[p7l1817t207r2147b266],
16	(	CD	NUMBER	(	num	17	SENT_125	[p7l61t303r205b377],
17	Fig	NN	O	fig	dobj	15	SENT_125	[p7l61t303r205b377],
18	.	.	O	.	_	0	SENT_125	[p7l61t303r205b377],

1	2A	NN	O	2a	_	0	SENT_126	[p7l248t303r382b377],
2	)	NN	O	)	dep	1	SENT_126	[p7l248t303r382b377],
3	.	.	O	.	_	0	SENT_126	[p7l248t303r382b377],

1	However	RB	O	however	dep	3	SENT_127	[p7l428t304r739b374],
2	,	,	O	,	_	0	SENT_127	[p7l428t304r739b374],
3	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_127	[p7l785t302r1270b377],
4	.	.	O	.	_	0	SENT_127	[p7l785t302r1270b377],

1	—	NN	O	—	_	0	SENT_128	[p7l785t302r1270b377],
2	.	.	O	.	_	0	SENT_128	[p7l785t302r1270b377],

1	Meier	JJR	PERSON	meier	amod	2	SENT_129	[p7l785t302r1270b377],
2	plots	NNS	O	plot	nsubj	10	SENT_129	[p7l1307t302r1472b377],
3	of	IN	O	of	_	0	SENT_129	[p7l1508t302r1578b361],
4	overall	JJ	O	overall	amod	5	SENT_129	[p7l1611t302r1848b361],
5	survival	NN	O	survival	prep_of	2	SENT_129	[p7l1885t302r2149b361],
6	of	IN	O	of	_	0	SENT_129	[p7l55t397r125b456],
7	each	DT	O	each	det	9	SENT_129	[p7l170t397r329b456],
8	patient	NN	O	patient	nn	9	SENT_129	[p7l381t398r631b472],
9	group	NN	O	group	prep_of	5	SENT_129	[p7l678t412r871b472],
10	showed	VBD	O	show	_	0	SENT_129	[p7l919t397r1175b456],
11	similar	JJ	O	similar	amod	12	SENT_129	[p7l1225t397r1459b456],
12	trends	NNS	O	trend	dobj	10	SENT_129	[p7l1505t397r1723b456],
13	except	IN	O	except	_	0	SENT_129	[p7l1770t403r2006b472],
14	for	IN	O	for	_	0	SENT_129	[p7l2053t397r2152b456],
15	the	DT	O	the	det	19	SENT_129	[p7l56t492r168b551],
16	zero	CD	NUMBER	zero	num	19	SENT_129	[p7l205t508r355b551],
17	clinical	JJ	O	clinical	amod	19	SENT_129	[p7l393t492r641b551],
18	predictor	NN	O	predictor	nn	19	SENT_129	[p7l683t492r1005b566],
19	group	NN	O	group	prep_except_for	10	SENT_129	[p7l1041t506r1235b566],
20	which	WDT	O	which	nsubj	21	SENT_129	[p7l1272t492r1473b551],
21	showed	VBD	O	show	rcmod	19	SENT_129	[p7l1513t492r1769b551],
22	the	DT	O	the	det	24	SENT_129	[p7l1810t492r1922b551],
23	worst	JJS	O	worst	amod	24	SENT_129	[p7l1958t497r2151b551],
24	survival	NN	O	survival	iobj	21	SENT_129	[p7l55t587r320b646],
25	(	CD	NUMBER	(	num	26	SENT_129	[p7l356t588r500b661],
26	Fig	NN	O	fig	dobj	21	SENT_129	[p7l356t588r500b661],
27	.	.	O	.	_	0	SENT_129	[p7l356t588r500b661],

1	2B	NN	O	2b	_	0	SENT_130	[p7l537t587r669b661],
2	)	NN	O	)	dep	1	SENT_130	[p7l537t587r669b661],
3	.	.	O	.	_	0	SENT_130	[p7l537t587r669b661],

1	After	IN	O	after	mark	12	SENT_131	[p7l704t587r884b646],
2	adjustment	NN	O	adjustment	dep	8	SENT_131	[p7l913t587r1310b661],
3	for	IN	O	for	_	0	SENT_131	[p7l1340t587r1440b646],
4	performance	NN	O	performance	nn	5	SENT_131	[p7l1470t587r1914b661],
5	status	NN	O	status	prep_for	2	SENT_131	[p7l1944t592r2150b646],
6	(	CD	NUMBER	(	num	7	SENT_131	[p7l61t682r272b756],
7	ECOG	NN	O	ecog	dep	8	SENT_131	[p7l61t682r272b756],
8	PS	NNP	O	PS	dep	12	SENT_131	[p7l319t682r392b741],
9	0-1	CD	NUMBER	0-1	num	8	SENT_131	[p7l432t682r556b740],
10	versus	CC	O	versus	prep	8	SENT_131	[p7l606t697r823b740],
11	2-3	CD	NUMBER	2-3	dep	10	SENT_131	[p7l862t682r1049b756],
12	)	NN	O	)	advcl	20	SENT_131	[p7l862t682r1049b756],
13	,	,	O	,	_	0	SENT_131	[p7l862t682r1049b756],
14	number	NN	O	number	nsubjpass	20	SENT_131	[p7l1099t681r1362b740],
15	of	IN	O	of	_	0	SENT_131	[p7l1400t681r1470b740],
16	clinical	JJ	O	clinical	amod	17	SENT_131	[p7l1507t681r1755b740],
17	predictors	NNS	O	predictor	prep_of	14	SENT_131	[p7l1799t681r2150b756],
18	was	VBD	O	be	auxpass	20	SENT_131	[p7l54t793r183b836],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_131	[p7l216t777r634b851],
20	associated	VBN	O	associate	_	0	SENT_131	[p7l666t777r1026b836],
21	with	IN	O	with	_	0	SENT_131	[p7l1060t777r1210b836],
22	better	JJR	O	better	advmod	23	SENT_131	[p7l1248t777r1466b836],
23	TTP	NN	O	ttp	prep_with	20	SENT_131	[p7l1494t778r1627b835],
24	(	CD	NUMBER	(	num	23	SENT_131	[p7l1665t778r1784b851],
25	HR	NN	DURATION	hr	dep	23	SENT_131	[p7l1665t778r1784b851],
26	0.74	CD	NUMBER	0.74	num	25	SENT_131	[p7l1815t777r1985b849],
27	,	,	O	,	_	0	SENT_131	[p7l1815t777r1985b849],
28	95	CD	PERCENT	95	number	29	SENT_131	[p7l2025t777r2150b836],
29	%	NN	PERCENT	%	amod	30	SENT_131	[p7l2025t777r2150b836],
30	CI	NN	O	ci	appos	23	SENT_131	[p7l56t872r116b931],
31	0.62-0	CD	NUMBER	0.62-0	num	32	SENT_131	[p7l145t872r526b944],
32	.89	CD	NUMBER	.89	dep	30	SENT_131	[p7l145t872r526b944],
33	;	:	O	;	_	0	SENT_131	[p7l145t872r526b944],
34	p	NN	O	p	dep	30	SENT_131	[p7l555t872r885b947],
35	=	JJ	O	=	amod	37	SENT_131	[p7l555t872r885b947],
36	0.001	CD	NUMBER	0.001	tmod	35	SENT_131	[p7l555t872r885b947],
37	)	NN	O	)	dep	34	SENT_131	[p7l555t872r885b947],
38	and	CC	O	and	_	0	SENT_131	[p7l913t872r1034b931],
39	OS	NN	O	os	dep	30	SENT_131	[p7l1062t872r1147b931],
40	(	CD	NUMBER	(	num	39	SENT_131	[p7l1178t873r1297b946],
41	HR	NN	DURATION	hr	dep	39	SENT_131	[p7l1178t873r1297b946],
42	0.78	CD	NUMBER	0.78	num	41	SENT_131	[p7l1320t872r1491b944],
43	,	,	O	,	_	0	SENT_131	[p7l1320t872r1491b944],
44	95	CD	PERCENT	95	number	45	SENT_131	[p7l1523t872r1647b931],
45	%	NN	PERCENT	%	amod	46	SENT_131	[p7l1523t872r1647b931],
46	CI	NN	O	ci	appos	23	SENT_131	[p7l1673t872r1733b931],
47	0.65-0	CD	NUMBER	0.65-0	num	48	SENT_131	[p7l1762t872r2143b944],
48	.94	CD	NUMBER	.94	dep	46	SENT_131	[p7l1762t872r2143b944],
49	;	:	O	;	_	0	SENT_131	[p7l1762t872r2143b944],
50	p	NN	O	p	dep	23	SENT_131	[p7l52t967r365b1041],
51	=	JJ	O	=	amod	53	SENT_131	[p7l52t967r365b1041],
52	0.01	CD	NUMBER	0.01	tmod	51	SENT_131	[p7l52t967r365b1041],
53	)	NN	O	)	dep	50	SENT_131	[p7l52t967r365b1041],
54	.	.	O	.	_	0	SENT_131	[p7l52t967r365b1041],

1	3.2	CD	NUMBER	3.2	_	0	SENT_132	[p7l59t1187r211b1253],
2	.	.	O	.	_	0	SENT_132	[p7l59t1187r211b1253],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_133	[p7l270t1187r477b1252],
2	mutation	NN	O	mutation	_	0	SENT_133	[p7l508t1187r867b1251],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_134	[p7l58t1394r236b1453],
2	mutation	NN	O	mutation	nsubjpass	4	SENT_134	[p7l285t1394r595b1452],
3	was	VBD	O	be	auxpass	4	SENT_134	[p7l644t1409r774b1452],
4	found	VBN	O	find	_	0	SENT_134	[p7l823t1393r1017b1452],
5	in	IN	O	in	_	0	SENT_134	[p7l1069t1394r1127b1452],
6	23	CD	NUMBER	23	num	7	SENT_134	[p7l1178t1394r1254b1452],
7	patients	NNS	O	patient	prep_in	4	SENT_134	[p7l1308t1394r1589b1468],
8	(	IN	O	(	_	0	SENT_134	[p7l1642t1394r1912b1468],
9	19.2	CD	PERCENT	19.2	num	10	SENT_134	[p7l1642t1394r1912b1468],
10	%	NN	PERCENT	%	prep_(	4	SENT_134	[p7l1642t1394r1912b1468],
11	)	CD	NUMBER	)	dep	10	SENT_134	[p7l1642t1394r1912b1468],
12	.	.	O	.	_	0	SENT_134	[p7l1642t1394r1912b1468],

1	Deletion	NN	O	deletion	nsubj	9	SENT_135	[p7l1972t1393r2146b1452, p7l56t1490r187b1548],
2	in	IN	O	in	_	0	SENT_135	[p7l230t1490r287b1547],
3	exon	NN	O	exon	prep_in	1	SENT_135	[p7l330t1505r491b1548],
4	19	CD	NUMBER	19	num	3	SENT_135	[p7l538t1489r610b1547],
5	was	VBD	O	be	cop	9	SENT_135	[p7l649t1505r778b1548],
6	the	DT	O	the	det	9	SENT_135	[p7l818t1488r930b1548],
7	most	RBS	O	most	advmod	8	SENT_135	[p7l973t1494r1137b1548],
8	predominant	JJ	O	predominant	amod	9	SENT_135	[p7l1178t1488r1622b1563],
9	type	NN	O	type	_	0	SENT_135	[p7l1661t1494r1813b1563],
10	found	VBN	O	find	partmod	9	SENT_135	[p7l1853t1488r2047b1548],
11	in	IN	O	in	_	0	SENT_135	[p7l2090t1490r2148b1547],
12	12	CD	NUMBER	12	num	13	SENT_135	[p7l61t1584r132b1642],
13	patients	NNS	O	patient	prep_in	10	SENT_135	[p7l181t1585r462b1659],
14	followed	VBN	O	follow	partmod	13	SENT_135	[p7l507t1584r806b1643],
15	by	IN	O	by	_	0	SENT_135	[p7l856t1584r933b1658],
16	L858R	NN	O	l858r	agent	14	SENT_135	[p7l980t1584r1184b1643],
17	in	IN	O	in	_	0	SENT_135	[p7l1228t1585r1285b1642],
18	six	CD	NUMBER	six	num	19	SENT_135	[p7l1333t1585r1424b1643],
19	patients	NNS	O	patient	prep_in	16	SENT_135	[p7l1470t1585r1773b1658],
20	,	,	O	,	_	0	SENT_135	[p7l1470t1585r1773b1658],
21	G719A	NN	O	g719a	agent	14	SENT_135	[p7l1825t1584r2046b1643],
22	in	IN	O	in	_	0	SENT_135	[p7l2090t1585r2147b1642],
23	three	CD	NUMBER	three	num	24	SENT_135	[p7l56t1679r242b1738],
24	patients	NNS	O	patient	prep_in	21	SENT_135	[p7l281t1680r561b1754],
25	and	CC	O	and	_	0	SENT_135	[p7l598t1679r718b1738],
26	A859T	NN	O	a859t	agent	14	SENT_135	[p7l756t1680r971b1738],
27	and	CC	O	and	_	0	SENT_135	[p7l1006t1679r1126b1738],
28	L861Q	NN	O	l861q	conj_and	16	SENT_135	[p7l1169t1680r1385b1749],
29	in	IN	O	in	_	0	SENT_135	[p7l1415t1680r1473b1737],
30	one	CD	NUMBER	one	num	31	SENT_135	[p7l1511t1695r1635b1738],
31	patient	NN	O	patient	prep_in	26	SENT_135	[p7l1674t1680r1924b1754],
32	each	DT	O	each	dep	31	SENT_135	[p7l1959t1679r2143b1738],
33	.	.	O	.	_	0	SENT_135	[p7l1959t1679r2143b1738],

1	One	CD	NUMBER	one	num	2	SENT_136	[p7l56t1774r190b1833],
2	patient	NN	O	patient	nsubj	3	SENT_136	[p7l240t1775r489b1848],
3	had	VBD	O	have	_	0	SENT_136	[p7l539t1773r657b1833],
4	an	DT	O	a	det	6	SENT_136	[p7l708t1790r784b1833],
5	additional	JJ	O	additional	amod	6	SENT_136	[p7l835t1773r1184b1833],
6	mutation	NN	O	mutation	dobj	3	SENT_136	[p7l1234t1775r1569b1833],
7	:	:	O	:	_	0	SENT_136	[p7l1234t1775r1569b1833],
8	G719A	NN	O	g719a	dep	6	SENT_136	[p7l1624t1774r2143b1833],
9	+	CC	O	+	_	0	SENT_136	[p7l1624t1774r2143b1833],
10	E709K	NN	O	e709k	dep	6	SENT_136	[p7l1624t1774r2143b1833],
11	.	.	O	.	_	0	SENT_136	[p7l1624t1774r2143b1833],

1	Response	NN	O	response	nn	2	SENT_137	[p7l59t1870r372b1944],
2	rates	NNS	O	rate	nsubj	12	SENT_137	[p7l419t1874r589b1928],
3	in	IN	O	in	_	0	SENT_137	[p7l634t1870r691b1927],
4	patients	NNS	O	patient	prep_in	2	SENT_137	[p7l740t1870r1021b1943],
5	with	IN	O	with	_	0	SENT_137	[p7l1062t1869r1212b1928],
6	deletion	NN	O	deletion	prep_with	4	SENT_137	[p7l1259t1869r1543b1928],
7	in	IN	O	in	_	0	SENT_137	[p7l1590t1870r1648b1927],
8	exon	NN	O	exon	prep_in	6	SENT_137	[p7l1694t1885r1855b1928],
9	19	CD	NUMBER	19	num	8	SENT_137	[p7l1906t1869r1978b1928],
10	was	VBD	O	be	cop	12	SENT_137	[p7l2021t1885r2150b1928],
11	50	CD	PERCENT	50	num	12	SENT_137	[p7l58t1965r180b2023],
12	%	NN	PERCENT	%	_	0	SENT_137	[p7l58t1965r180b2023],
13	(	CD	NUMBER	(	number	14	SENT_137	[p7l235t1965r471b2038],
14	6/12	CD	NUMBER	6/12	num	15	SENT_137	[p7l235t1965r471b2038],
15	)	NN	O	)	dep	12	SENT_137	[p7l235t1965r471b2038],
16	,	,	O	,	_	0	SENT_137	[p7l235t1965r471b2038],
17	L858R	NN	O	l858r	conj_and	12	SENT_137	[p7l531t1965r735b2023],
18	83.3	CD	PERCENT	83.3	num	19	SENT_137	[p7l784t1965r978b2023],
19	%	NN	PERCENT	%	dep	17	SENT_137	[p7l784t1965r978b2023],
20	(	CD	NUMBER	(	number	21	SENT_137	[p7l1033t1965r1203b2039],
21	5/6	CD	NUMBER	5/6	num	22	SENT_137	[p7l1033t1965r1203b2039],
22	)	NN	O	)	dep	19	SENT_137	[p7l1033t1965r1203b2039],
23	and	CC	O	and	_	0	SENT_137	[p7l1256t1964r1377b2023],
24	G719A	NN	PERCENT	g719a	conj_and	12	SENT_137	[p7l1430t1965r1651b2023],
25	66.7	CD	PERCENT	66.7	number	26	SENT_137	[p7l1700t1965r1894b2023],
26	%	NN	PERCENT	%	amod	24	SENT_137	[p7l1700t1965r1894b2023],
27	(	CD	NUMBER	(	number	28	SENT_137	[p7l1949t1965r2143b2038],
28	2/3	CD	NUMBER	2/3	num	29	SENT_137	[p7l1949t1965r2143b2038],
29	)	NN	O	)	dep	24	SENT_137	[p7l1949t1965r2143b2038],
30	.	.	O	.	_	0	SENT_137	[p7l1949t1965r2143b2038],

1	Table	NNP	O	Table	_	0	SENT_138	[p7l106t2197r288b2253],
2	2	CD	NUMBER	2	num	4	SENT_138	[p7l318t2198r354b2253],
3	Clinical	JJ	O	clinical	amod	4	SENT_138	[p7l464t2197r706b2254],
4	predictors	NNS	O	predictor	dep	1	SENT_138	[p7l735t2197r1067b2268],
5	of	IN	O	of	_	0	SENT_138	[p7l1094t2197r1160b2253],
6	geﬁtinib	NN	O	geﬁtinib	nn	7	SENT_138	[p7l1184t2197r1454b2268],
7	responsiveness	NN	O	responsiveness	prep_of	4	SENT_138	[p7l1484t2198r1968b2268],

1	Total	JJ	O	total	amod	2	SENT_139	[p7l816t2351r978b2407],
2	No.	NN	O	no.	_	0	SENT_139	[p7l1170t2353r1270b2407],
3	of	IN	O	of	_	0	SENT_139	[p7l1304t2351r1369b2407],
4	p-Value	NN	O	p-value	nn	7	SENT_139	[p7l1827t2342r2094b2422],
5	*	CD	NUMBER	*	num	7	SENT_139	[p7l1827t2342r2094b2422],
6	no.	NN	O	no.	nn	7	SENT_139	[p7l821t2462r915b2502],
7	responders	NNS	O	responder	prep_of	2	SENT_139	[p7l1170t2446r1525b2517],
8	(	CD	PERCENT	(	num	9	SENT_139	[p7l1556t2447r1644b2517],
9	%	NN	PERCENT	%	dep	2	SENT_139	[p7l1556t2447r1644b2517],
10	)	CD	NUMBER	)	dep	9	SENT_139	[p7l1556t2447r1644b2517],

1	Sex	NN	O	sex	_	0	SENT_140	[p7l108t2597r219b2652],

1	Male	JJ	O	male	amod	4	SENT_141	[p7l181t2691r332b2747],
2	70	CD	NUMBER	70	number	3	SENT_141	[p7l819t2692r892b2747],
3	9	CD	NUMBER	9	amod	4	SENT_141	[p7l1195t2692r1229b2747],
4	(	NN	O	(	_	0	SENT_141	[p7l1261t2692r1448b2762],
5	12.9	CD	NUMBER	12.9	number	6	SENT_141	[p7l1261t2692r1448b2762],
6	)	CD	NUMBER	)	num	4	SENT_141	[p7l1261t2692r1448b2762],
7	0.011	CD	NUMBER	0.011	npadvmod	8	SENT_141	[p7l1829t2692r1997b2747],
8	Female	JJ	O	female	amod	4	SENT_141	[p7l185t2788r420b2844],
9	50	CD	NUMBER	50	number	10	SENT_141	[p7l820t2788r892b2844],
10	16	CD	NUMBER	16	num	11	SENT_141	[p7l1161t2788r1229b2844],
11	(	NN	O	(	dep	4	SENT_141	[p7l1261t2788r1448b2858],
12	32.0	CD	NUMBER	32.0	num	13	SENT_141	[p7l1261t2788r1448b2858],
13	)	NN	O	)	dep	11	SENT_141	[p7l1261t2788r1448b2858],

1	Histology	NNP	O	Histology	_	0	SENT_142	[p7l111t2927r411b2998],

1	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_143	[p7l180t3023r728b3079],
2	83	CD	NUMBER	83	num	1	SENT_143	[p7l819t3023r890b3079],
3	22	CD	NUMBER	22	num	4	SENT_143	[p7l1156t3023r1228b3078],
4	(	NN	O	(	dep	1	SENT_143	[p7l1261t3023r1448b3094],
5	26.5	CD	NUMBER	26.5	num	8	SENT_143	[p7l1261t3023r1448b3094],
6	)	CD	NUMBER	)	num	8	SENT_143	[p7l1261t3023r1448b3094],
7	0.022	CD	NUMBER	0.022	num	8	SENT_143	[p7l1829t3023r2008b3079],
8	Others	NNS	O	other	dep	4	SENT_143	[p7l183t3118r397b3174],
9	37	CD	NUMBER	37	number	10	SENT_143	[p7l820t3119r893b3174],
10	3	CD	NUMBER	3	num	11	SENT_143	[p7l1235t3119r1266b3174],
11	(	NN	O	(	dep	8	SENT_143	[p7l1300t3119r1448b3189],
12	8.1	CD	NUMBER	8.1	num	13	SENT_143	[p7l1300t3119r1448b3189],
13	)	NN	O	)	dep	1	SENT_143	[p7l1300t3119r1448b3189],

1	Smoking	NN	O	smoking	_	0	SENT_144	[p7l108t3258r378b3329],

1	Never-smoker	JJR	O	never-smoker	dep	8	SENT_145	[p7l185t3353r640b3409],
2	53	CD	NUMBER	53	num	3	SENT_145	[p7l821t3354r890b3409],
3	17	CD	NUMBER	17	dep	1	SENT_145	[p7l1161t3354r1231b3409],
4	(	NN	O	(	dep	8	SENT_145	[p7l1261t3354r1448b3424],
5	32.1	CD	NUMBER	32.1	num	4	SENT_145	[p7l1261t3354r1448b3424],
6	)	CD	NUMBER	)	num	8	SENT_145	[p7l1261t3354r1448b3424],
7	0.007	CD	NUMBER	0.007	num	8	SENT_145	[p7l1829t3354r2010b3409],
8	Smoker	NN	O	smoker	dep	13	SENT_145	[p7l183t3450r424b3506],
9	67	CD	NUMBER	67	number	10	SENT_145	[p7l819t3450r893b3506],
10	8	CD	NUMBER	8	dep	8	SENT_145	[p7l1196t3450r1229b3506],
11	(	NN	O	(	dep	10	SENT_145	[p7l1261t3450r1448b3520],
12	11.9	CD	NUMBER	11.9	num	13	SENT_145	[p7l1261t3450r1448b3520],
13	)	NN	O	)	_	0	SENT_145	[p7l1261t3450r1448b3520],

1	*	RB	O	*	advmod	4	SENT_146	[p7l156t3582r172b3598],
2	Pearson	NNP	PERSON	Pearson	poss	4	SENT_146	[p7l213t3593r498b3647],
3	’s	POS	O	’s	_	0	SENT_146	[p7l213t3593r498b3647],
4	X2-test	NN	O	x2-test	_	0	SENT_146	[p7l525t3582r759b3659],
5	.	.	O	.	_	0	SENT_146	[p7l525t3582r759b3659],

1	Response	NN	O	response	nn	2	SENT_147	[p8l614t492r679b815],
2	Hate	NN	O	hate	dep	10	SENT_147	[p8l614t326r666b471],
3	in	IN	O	in	_	0	SENT_147	[p8l1028t1119r1059b1165],
4	1	CD	NUMBER	1	number	5	SENT_147	[p8l1301t1119r1323b1162],
5	2	CD	NUMBER	2	prep_in	2	SENT_147	[p8l1563t1094r1596b1162],
6	3	CD	NUMBER	3	num	7	SENT_147	[p8l1833t1119r1866b1165],
7	(	NN	O	(	dep	10	SENT_147	[p8l614t1183r697b1251],
8	A	DT	O	a	det	10	SENT_147	[p8l614t1183r697b1251],
9	)	NN	O	)	nn	10	SENT_147	[p8l614t1183r697b1251],
10	Number	NN	O	number	_	0	SENT_147	[p8l948t1202r1203b1254],
11	of	IN	O	of	_	0	SENT_147	[p8l1222t1201r1286b1254],
12	Clinical	JJ	O	clinical	amod	13	SENT_147	[p8l1307t1201r1544b1254],
13	Predictors	NNS	O	predictor	prep_of	10	SENT_147	[p8l1571t1201r1903b1254],

1	S.-W	NN	O	s.-w	_	0	SENT_148	[p8l1601t1306r1773b1364],
2	.	.	O	.	_	0	SENT_148	[p8l1601t1306r1773b1364],

1	Han	NNP	O	Han	_	0	SENT_149	[p8l1811t1307r1937b1364],
2	et	FW	O	et	nn	3	SENT_149	[p8l1968t1310r2038b1364],
3	al.	FW	O	al.	dep	1	SENT_149	[p8l2066t1305r2148b1364],
4	.	.	O	.	_	0	SENT_149	[p8l2066t1305r2148b1364],

1	Response	NN	O	response	nn	2	SENT_150	[p8l63t1931r133b2260],
2	Flate	NN	O	flate	_	0	SENT_150	[p8l63t1758r120b1906],
3	60	CD	NUMBER	60	dep	2	SENT_150	[p8l174t1899r240b1944],

1	M	NN	O	m	nn	5	SENT_151	[p8l69t2626r84b2630],
2	Negative	JJ	O	negative	amod	5	SENT_151	[p8l518t2554r774b2617],
3	Positive	JJ	O	positive	amod	5	SENT_151	[p8l1084t2554r1318b2604],
4	(	NN	O	(	nn	5	SENT_151	[p8l60t2623r145b2693],
5	B	NN	O	b	_	0	SENT_151	[p8l60t2623r145b2693],
6	)	CD	NUMBER	)	num	9	SENT_151	[p8l60t2623r145b2693],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_151	[p8l657t2642r847b2696],
8	Mutation	NN	O	mutation	nn	9	SENT_151	[p8l872t2642r1157b2696],
9	Fig	NN	O	fig	dep	5	SENT_151	[p8l48t2745r104b2779],
10	.	.	O	.	_	0	SENT_151	[p8l48t2745r104b2779],

1	1	CD	NUMBER	1	num	3	SENT_152	[p8l126t2745r136b2772],
2	Response	NN	O	response	nn	3	SENT_152	[p8l194t2745r335b2779],
3	rates	NNS	O	rate	nsubj	10	SENT_152	[p8l352t2747r429b2772],
4	according	VBG	O	accord	_	0	SENT_152	[p8l445t2745r595b2779],
5	to	TO	O	to	prepc_according_to	3	SENT_152	[p8l611t2747r642b2772],
6	number	NN	O	number	pobj	3	SENT_152	[p8l659t2745r777b2772],
7	of	IN	O	of	_	0	SENT_152	[p8l792t2745r824b2772],
8	clinical	JJ	O	clinical	amod	9	SENT_152	[p8l838t2745r950b2772],
9	predictors	NNS	O	predictor	prep_of	6	SENT_152	[p8l967t2745r1125b2779],
10	(	VBP	O	(	_	0	SENT_152	[p8l1143t2745r1184b2779],
11	A	DT	O	a	det	12	SENT_152	[p8l1143t2745r1184b2779],
12	)	NN	O	)	nsubj	19	SENT_152	[p8l1143t2745r1184b2779],
13	and	CC	O	and	_	0	SENT_152	[p8l1202t2745r1256b2772],
14	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_152	[p8l1274t2745r1354b2772],
15	mutational	JJ	O	mutational	amod	18	SENT_152	[p8l1370t2745r1539b2772],
16	status	NN	O	status	nn	18	SENT_152	[p8l1555t2747r1647b2772],
17	(	NN	O	(	nn	18	SENT_152	[p8l1665t2745r1717b2779],
18	B	NN	O	b	nsubj	19	SENT_152	[p8l1665t2745r1717b2779],
19	)	NN	O	)	xcomp	10	SENT_152	[p8l1665t2745r1717b2779],
20	.	.	O	.	_	0	SENT_152	[p8l1665t2745r1717b2779],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_153	[p8l1737t2745r1817b2772],
2	mutation	NN	O	mutation	nsubj	3	SENT_153	[p8l1833t2745r1972b2772],
3	denotes	VBZ	O	denote	_	0	SENT_153	[p8l1989t2745r2112b2772],
4	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	6	SENT_153	[p8l47t2790r326b2824],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_153	[p8l338t2790r417b2817],
6	mutation	NN	O	mutation	dobj	3	SENT_153	[p8l428t2791r578b2817],
7	.	.	O	.	_	0	SENT_153	[p8l428t2791r578b2817],

1	Positive	JJ	O	positive	nsubj	2	SENT_154	[p8l593t2791r712b2817],
2	includes	VBZ	O	include	_	0	SENT_154	[p8l723t2790r850b2817],
3	deletion	NN	O	deletion	dobj	2	SENT_154	[p8l861t2790r989b2817],
4	in	IN	O	in	_	0	SENT_154	[p8l1001t2791r1027b2817],
5	exon	NN	O	exon	prep_in	2	SENT_154	[p8l1039t2797r1111b2817],
6	19	CD	NUMBER	19	num	5	SENT_154	[p8l1125t2790r1168b2823],
7	,	,	O	,	_	0	SENT_154	[p8l1125t2790r1168b2823],
8	L858R	NN	O	l858r	prep_in	2	SENT_154	[p8l1183t2790r1274b2817],
9	and	CC	O	and	_	0	SENT_154	[p8l1284t2790r1339b2817],
10	G719A	NN	O	g719a	prep_in	2	SENT_154	[p8l1351t2790r1459b2823],
11	;	:	O	;	_	0	SENT_154	[p8l1351t2790r1459b2823],
12	negative	JJ	O	negative	nsubj	13	SENT_154	[p8l1473t2791r1606b2824],
13	includes	VBZ	O	include	parataxis	2	SENT_154	[p8l1617t2790r1744b2817],
14	wild-type	JJ	O	wild-type	amod	15	SENT_154	[p8l1754t2790r1903b2824],
15	EGFR	NN	ORGANIZATION	egfr	dobj	13	SENT_154	[p8l1915t2790r2003b2823],
16	,	,	O	,	_	0	SENT_154	[p8l1915t2790r2003b2823],
17	A859T	NN	O	a859t	conj_and	15	SENT_154	[p8l2016t2790r2113b2817],
18	and	CC	O	and	_	0	SENT_154	[p8l47t2836r101b2863],
19	L861Q	NN	O	l861q	dobj	13	SENT_154	[p8l120t2836r223b2868],
20	.	.	O	.	_	0	SENT_154	[p8l120t2836r223b2868],

1	Numbers	NNS	O	number	nsubj	5	SENT_155	[p8l244t2836r379b2863],
2	in	IN	O	in	_	0	SENT_155	[p8l395t2836r421b2863],
3	the	DT	O	the	det	4	SENT_155	[p8l439t2836r489b2863],
4	parentheses	NNS	O	parenthesis	prep_in	1	SENT_155	[p8l506t2836r694b2870],
5	indicate	VBP	O	indicate	_	0	SENT_155	[p8l710t2836r837b2863],
6	numbers	NNS	O	number	dobj	5	SENT_155	[p8l854t2836r986b2863],
7	of	IN	O	of	_	0	SENT_155	[p8l1002t2836r1033b2863],
8	responders/total	JJ	O	responders/total	amod	9	SENT_155	[p8l1049t2836r1312b2870],
9	patients	NNS	O	patient	prep_of	6	SENT_155	[p8l1330t2836r1456b2870],
10	in	IN	O	in	_	0	SENT_155	[p8l1472t2836r1498b2863],
11	each	DT	O	each	det	13	SENT_155	[p8l1515t2836r1587b2863],
12	patient	NN	O	patient	nn	13	SENT_155	[p8l1605t2836r1717b2870],
13	group	NN	O	group	prep_in	9	SENT_155	[p8l1733t2842r1830b2870],
14	.	.	O	.	_	0	SENT_155	[p8l1733t2842r1830b2870],
15	'	''	O	'	_	0	SENT_155	[p8l1849t2831r2113b2870],

1	Linear-by-linear	JJ	O	linear-by-linear	amod	3	SENT_156	[p8l1849t2831r2113b2870],
2	association	NN	O	association	nn	3	SENT_156	[p8l9t2896r372b2951],
3	test	NN	O	test	_	0	SENT_156	[p8l401t2900r528b2951],
4	for	IN	O	for	_	0	SENT_156	[p8l554t2894r649b2951],
5	trend	NN	O	trend	prep_for	3	SENT_156	[p8l674t2894r873b2964],
6	,	,	O	,	_	0	SENT_156	[p8l674t2894r873b2964],
7	lFisher	NN	O	lfisher	poss	10	SENT_156	[p8l906t2886r1183b2951],
8	’s	POS	O	’s	_	0	SENT_156	[p8l906t2886r1183b2951],
9	exact	JJ	O	exact	amod	10	SENT_156	[p8l1210t2900r1391b2951],
10	test	NN	O	test	appos	5	SENT_156	[p8l1417t2900r1564b2951],
11	.	.	O	.	_	0	SENT_156	[p8l1417t2900r1564b2951],

1	The	DT	O	the	det	3	SENT_157	[p8l6t3123r137b3182],
2	two	CD	NUMBER	two	num	3	SENT_157	[p8l172t3128r300b3182],
3	patients	NNS	O	patient	nsubj	10	SENT_157	[p8l339t3124r622b3198],
4	with	IN	O	with	_	0	SENT_157	[p8l655t3123r807b3182],
5	A859T	NN	O	a859t	prep_with	3	SENT_157	[p8l842t3123r1060b3182],
6	or	CC	O	or	_	0	SENT_157	[p8l1093t3139r1165b3182],
7	L861Q	NN	O	l861q	prep_with	3	SENT_157	[p8l1201t3123r1420b3193],
8	did	VBD	O	do	aux	10	SENT_157	[p8l1448t3123r1551b3182],
9	not	RB	O	not	neg	10	SENT_157	[p8l1592t3128r1703b3182],
10	respond	VB	O	respond	_	0	SENT_157	[p8l1742t3123r2012b3198],
11	to	TO	O	to	_	0	SENT_157	[p8l2050t3128r2119b3182],
12	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_157	[p8l9t3217r319b3292],
13	.	.	O	.	_	0	SENT_157	[p8l9t3217r319b3292],

1	Collectively	RB	O	collectively	advmod	8	SENT_158	[p8l363t3217r789b3292],
2	,	,	O	,	_	0	SENT_158	[p8l363t3217r789b3292],
3	patients	NNS	O	patient	nsubj	8	SENT_158	[p8l835t3218r1118b3292],
4	with	IN	O	with	_	0	SENT_158	[p8l1152t3217r1303b3277],
5	the	DT	O	the	det	7	SENT_158	[p8l1343t3217r1456b3276],
6	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	7	SENT_158	[p8l1492t3217r2119b3292],
7	mutations	NNS	O	mutation	prep_with	3	SENT_158	[p8l11t3314r358b3372],
8	(	VBP	O	(	_	0	SENT_158	[p8l391t3314r577b3387],
9	exon	NN	O	exon	nsubj	16	SENT_158	[p8l391t3314r577b3387],
10	19	CD	NUMBER	19	num	9	SENT_158	[p8l613t3313r710b3385],
11	,	,	O	,	_	0	SENT_158	[p8l613t3313r710b3385],
12	L858R	NN	O	l858r	conj_and	9	SENT_158	[p8l748t3313r953b3372],
13	and	CC	O	and	_	0	SENT_158	[p8l980t3312r1102b3372],
14	G719A	NN	O	g719a	nn	15	SENT_158	[p8l1133t3313r1380b3387],
15	)	NN	O	)	conj_and	9	SENT_158	[p8l1133t3313r1380b3387],
16	showed	VBD	O	show	ccomp	8	SENT_158	[p8l1411t3312r1668b3372],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_158	[p8l1699t3312r2121b3387],
18	higher	JJR	O	higher	amod	20	SENT_158	[p8l11t3408r229b3483],
19	response	NN	O	response	nn	20	SENT_158	[p8l258t3424r562b3483],
20	rate	NN	O	rate	dobj	16	SENT_158	[p8l593t3413r733b3467],
21	compared	VBN	O	compare	_	0	SENT_158	[p8l761t3408r1105b3483],
22	with	IN	O	with	prepc_compared_with	16	SENT_158	[p8l1134t3408r1286b3467],
23	the	DT	O	the	det	25	SENT_158	[p8l1316t3408r1429b3467],
24	remaining	VBG	O	remain	amod	25	SENT_158	[p8l1460t3409r1806b3483],
25	patients	NNS	O	patient	pobj	16	SENT_158	[p8l1836t3409r2119b3483],
26	(	CD	NUMBER	(	num	27	SENT_158	[p8l13t3503r159b3577],
27	Fig	NN	O	fig	dep	25	SENT_158	[p8l13t3503r159b3577],
28	.	.	O	.	_	0	SENT_158	[p8l13t3503r159b3577],

1	1B	NN	O	1b	_	0	SENT_159	[p8l207t3503r335b3577],
2	)	NN	O	)	dep	1	SENT_159	[p8l207t3503r335b3577],
3	.	.	O	.	_	0	SENT_159	[p8l207t3503r335b3577],

1	TTP	NN	O	ttp	nsubjpass	4	SENT_160	[p8l375t3503r509b3561],
2	was	VBD	O	be	auxpass	4	SENT_160	[p8l543t3518r673b3562],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_160	[p8l709t3502r1131b3577],
4	prolonged	VBN	O	prolong	_	0	SENT_160	[p8l1167t3502r1512b3577],
5	in	IN	O	in	_	0	SENT_160	[p8l1550t3503r1609b3561],
6	patients	NNS	O	patient	prep_in	4	SENT_160	[p8l1649t3503r1932b3577],
7	with	IN	O	with	_	0	SENT_160	[p8l1966t3502r2117b3562],
8	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	9	SENT_160	[p8l9t3597r636b3672],
9	mutations	NNS	O	mutation	prep_with	6	SENT_160	[p8l673t3599r1020b3657],
10	compared	VBN	O	compare	_	0	SENT_160	[p8l1055t3597r1399b3672],
11	with	IN	O	with	prepc_compared_with	4	SENT_160	[p8l1435t3597r1586b3657],
12	the	DT	O	the	det	14	SENT_160	[p8l1623t3597r1736b3657],
13	remaining	VBG	O	remain	amod	14	SENT_160	[p8l1774t3599r2120b3672],
14	patients	NNS	O	patient	pobj	4	SENT_160	[p9l11t18r294b92],
15	(	CD	NUMBER	(	num	16	SENT_160	[p9l327t18r441b92],
16	p	NN	O	p	npadvmod	17	SENT_160	[p9l327t18r441b92],
17	<	JJR	O	<	amod	14	SENT_160	[p9l327t18r441b92],
18	0.001	CD	NUMBER	0.001	dep	14	SENT_160	[p9l463t17r677b89],
19	;	:	O	;	_	0	SENT_160	[p9l463t17r677b89],
20	median	NN	O	median	dep	14	SENT_160	[p9l714t17r965b76],
21	13.8	CD	DURATION	13.8	num	22	SENT_160	[p9l1001t17r1145b76],
22	months	NNS	NUMBER	month	tmod	20	SENT_160	[p9l1176t17r1428b76],
23	versus	CC	O	versus	prep	20	SENT_160	[p9l1454t33r1672b76],
24	1.9	CD	DURATION	1.9	num	25	SENT_160	[p9l1706t17r1807b76],
25	months	NNS	NUMBER	month	dep	23	SENT_160	[p9l1839t17r2113b89],
26	,	,	O	,	_	0	SENT_160	[p9l1839t17r2113b89],
27	respectively	RB	O	respectively	advmod	14	SENT_160	[p9l11t112r462b187],
28	)	CD	NUMBER	)	number	29	SENT_160	[p9l11t112r462b187],
29	(	CD	NUMBER	(	num	30	SENT_160	[p9l507t113r653b187],
30	Fig	NN	O	fig	dep	14	SENT_160	[p9l507t113r653b187],
31	.	.	O	.	_	0	SENT_160	[p9l507t113r653b187],

1	2C	NN	O	2c	_	0	SENT_161	[p9l697t113r833b186],
2	)	NN	O	)	dep	1	SENT_161	[p9l697t113r833b186],
3	.	.	O	.	_	0	SENT_161	[p9l697t113r833b186],

1	OS	NNP	O	OS	tmod	3	SENT_162	[p9l878t113r964b171],
2	also	RB	O	also	advmod	3	SENT_162	[p9l1003t112r1138b171],
3	showed	VBD	O	show	_	0	SENT_162	[p9l1175t112r1432b171],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_162	[p9l1473t112r1831b187],
5	prolon	NN	O	prolon	dobj	3	SENT_162	[p9l1870t112r2116b187, p9l664t381r747b429],
6	‘	CD	NUMBER	‘	num	7	SENT_162	[p9l1870t112r2116b187, p9l664t381r747b429],
7	Lo	NN	O	lo	nsubj	3	SENT_162	[p9l1870t112r2116b187, p9l664t381r747b429],

1	_	NN	O	_	nn	3	SENT_163	[p9l766t411r807b413],
2	'	''	O	'	_	0	SENT_163	[p9l844t406r846b416],
3	Number	NN	O	number	_	0	SENT_163	[p9l1579t416r1779b458],
4	of	IN	O	of	prep	3	SENT_163	[p9l1795t416r1843b458],

1	‘	NN	O	‘	_	0	SENT_164	[p9l848t534r849b547],
2	clinical	JJ	O	clinical	amod	3	SENT_164	[p9l1578t486r1754b528],
3	predictors	NNS	O	predictor	dep	1	SENT_164	[p9l1773t486r2031b540],

1	%	NN	O	%	_	0	SENT_165	[p9l665t591r676b613],
2	.	.	O	.	_	0	SENT_165	[p9l665t591r676b613],

1	i	LS	O	i	dep	2	SENT_166	[p9l767t611r773b612],
2	—	NN	O	—	_	0	SENT_166	[p9l1578t575r1684b585],
3	=	JJ	O	=	amod	2	SENT_166	[p9l1578t575r1684b585],
4	{	CD	NUMBER	{	tmod	3	SENT_166	[p9l1725t559r1754b598],
5	I	PRP	O	I	nsubj	6	SENT_166	[p9l1725t559r1754b598],
6	(	VBP	O	(	rcmod	2	SENT_166	[p9l1770t556r1824b610],
7	M	NN	O	m	dep	6	SENT_166	[p9l1770t556r1824b610],
8	=	JJ	O	=	amod	9	SENT_166	[p9l1843t575r1872b595],
9	29	CD	NUMBER	29	dobj	7	SENT_166	[p9l1887t556r1961b610],
10	}	NN	O	}	prep	9	SENT_166	[p9l1887t556r1961b610],
11	0	CD	NUMBER	0	dep	10	SENT_166	[p9l667t591r750b639],
12	'	''	O	'	_	0	SENT_166	[p9l667t591r750b639],
13	8	CD	NUMBER	8	number	14	SENT_166	[p9l667t591r750b639],
14	3	CD	NUMBER	3	dep	9	SENT_166	[p9l876t649r878b652],
15	:	:	O	:	_	0	SENT_166	[p9l1578t645r1684b652],
16	1	CD	NUMBER	1	number	17	SENT_166	[p9l1728t629r1748b668],
17	(	CD	NUMBER	(	dep	18	SENT_166	[p9l1770t626r1824b680],
18	N	NN	O	n	dep	21	SENT_166	[p9l1770t626r1824b680],
19	=	JJ	O	=	amod	21	SENT_166	[p9l1843t642r1872b665],
20	35	CD	NUMBER	35	tmod	19	SENT_166	[p9l1887t626r1961b680],
21	}	NN	O	}	dep	14	SENT_166	[p9l1887t626r1961b680],
22	2	CD	NUMBER	2	dep	21	SENT_166	[p9l1581t715r1684b722],
23	-	:	O	-	_	0	SENT_166	[p9l1581t715r1684b722],
24	‘	CD	NUMBER	‘	number	25	SENT_166	[p9l1581t715r1684b722],
25	2	CD	NUMBER	2	dep	9	SENT_166	[p9l1725t699r1754b738],
26	(	CD	NUMBER	(	num	27	SENT_166	[p9l1770t696r1824b750],
27	N1	NN	O	n1	dep	25	SENT_166	[p9l1770t696r1824b750],
28	=	JJ	O	=	amod	29	SENT_166	[p9l1843t712r1872b735],
29	17	CD	NUMBER	17	dobj	2	SENT_166	[p9l1890t696r1961b750],
30	)	CD	NUMBER	)	number	31	SENT_166	[p9l1890t696r1961b750],
31	3	CD	NUMBER	3	num	33	SENT_166	[p9l1725t769r1754b808],
32	(	NN	O	(	nn	33	SENT_166	[p9l1770t766r1824b820],
33	HI	NN	O	hus	npadvmod	34	SENT_166	[p9l1770t766r1824b820],
34	=	JJ	O	=	amod	29	SENT_166	[p9l1843t782r1872b805],
35	39	CD	NUMBER	39	num	36	SENT_166	[p9l1887t766r1961b820],
36	]	NN	O	]	nsubj	2	SENT_166	[p9l1887t766r1961b820],

1	Pr	NN	O	pr	nsubj	2	SENT_167	[p9l476t779r547b1139],
2	~	NN	O	~	_	0	SENT_167	[p9l476t779r547b1139],
3	ehai	NNS	O	ehaus	dobj	2	SENT_167	[p9l476t779r547b1139],
4	:	:	O	:	_	0	SENT_167	[p9l476t779r547b1139],
5	'	''	O	'	_	0	SENT_167	[p9l476t779r547b1139],
6	.	.	O	.	_	0	SENT_167	[p9l476t779r547b1139],

1	~	NN	O	~	nn	2	SENT_168	[p9l476t779r547b1139],
2	iIity	NN	O	iiity	_	0	SENT_168	[p9l476t779r547b1139],
3	of	IN	O	of	_	0	SENT_168	[p9l476t690r534b757],
4	progression-free	JJ	O	progression-free	amod	5	SENT_168	[p9l563t779r636b1340],
5	suirvilval	JJ	O	suirvilval	amod	6	SENT_168	[p9l562t495r620b757],
6	i	FW	O	i	prep_of	2	SENT_168	[p9l1248t1476r1249b1518],
7	;	:	O	;	_	0	SENT_168	[p9l1448t1476r1459b1521],

1	o	NN	O	o	_	0	SENT_169	[p9l804t1543r836b1588],
2	*	CD	NUMBER	*	num	1	SENT_169	[p9l1015t1543r1050b1588],
3	5	CD	NUMBER	5	number	4	SENT_169	[p9l1015t1543r1050b1588],
4	1	CD	NUMBER	1	num	6	SENT_169	[p9l1212t1543r1232b1588],
5	2	CD	NUMBER	2	number	6	SENT_169	[p9l1244t1543r1276b1588],
6	1	CD	DATE	1	dep	1	SENT_169	[p9l1419t1540r1442b1588],
7	B	NN	DATE	b	dep	6	SENT_169	[p9l1454t1543r1486b1588],
8	24	CD	DATE	24	num	7	SENT_169	[p9l1629t1543r1697b1588],
9	30	CD	DATE	30	num	10	SENT_169	[p9l1840t1540r1907b1588],
10	35	CD	DATE	35	dep	1	SENT_169	[p9l2051t1543r2118b1588],

1	(	NN	O	(	nn	2	SENT_170	[p9l470t1617r559b1687],
2	A	NN	O	a	_	0	SENT_170	[p9l470t1617r559b1687],
3	)	CD	NUMBER	)	num	6	SENT_170	[p9l470t1617r559b1687],
4	Fa	NNP	O	Fa	nn	6	SENT_170	[p9l1078t1623r1407b1690],
5	|	CD	NUMBER	|	num	6	SENT_170	[p9l1078t1623r1407b1690],
6	Iew	NNP	O	Iew	dep	2	SENT_170	[p9l1078t1623r1407b1690],
7	—	CD	NUMBER	—	npadvmod	8	SENT_170	[p9l1078t1623r1407b1690],
8	up	IN	O	up	advmod	9	SENT_170	[p9l1078t1623r1407b1690],
9	time	NN	O	time	dep	6	SENT_170	[p9l1426t1620r1572b1677],
10	(	CD	NUMBER	(	num	11	SENT_170	[p9l1594t1620r1894b1690],
11	mcmths	NNS	O	mcmth	dobj	9	SENT_170	[p9l1594t1620r1894b1690],
12	)	IN	O	)	amod	11	SENT_170	[p9l1594t1620r1894b1690],

1	1	CD	NUMBER	1	nsubj	6	SENT_171	[p9l664t1887r687b1932],
2	'	''	O	'	_	0	SENT_171	[p9l699t1887r747b1935],
3	3	CD	NUMBER	3	dep	1	SENT_171	[p9l699t1887r747b1935],
4	“	NN	O	“	dep	1	SENT_171	[p9l699t1887r747b1935],
5	”	CD	NUMBER	”	num	4	SENT_171	[p9l797t1913r814b1914],
6	earn	VBP	O	earn	_	0	SENT_171	[p9l1521t1919r1665b1961],
7	mwtamrn	NN	O	mwtamrn	dobj	6	SENT_171	[p9l1683t1919r1904b1961],

1	—	SYM	O	—	dep	13	SENT_172	[p9l1518t2005r1626b2015],
2	-	:	O	-	_	0	SENT_172	[p9l1518t2005r1626b2015],
3	Positive	JJ	O	positive	amod	4	SENT_172	[p9l1655t1989r1856b2031],
4	(	NN	O	(	dep	13	SENT_172	[p9l1871t1989r1923b2043],
5	N	NN	O	n	dep	4	SENT_172	[p9l1871t1989r1923b2043],
6	=	JJ	O	=	rcmod	5	SENT_172	[p9l1942t2005r1971b2028],
7	21	CD	NUMBER	21	number	8	SENT_172	[p9l1986t1989r2064b2043],
8	}	CD	NUMBER	}	dobj	6	SENT_172	[p9l1986t1989r2064b2043],
9	3	CD	NUMBER	3	dep	8	SENT_172	[p9l731t2098r734b2099],
10	‘	SYM	O	‘	dep	8	SENT_172	[p9l918t2018r919b2099],
11	-	:	O	-	_	0	SENT_172	[p9l1518t2075r1626b2085],
12	Negative	JJ	O	negative	amod	13	SENT_172	[p9l1655t2059r1875b2113],
13	(	NN	O	(	_	0	SENT_172	[p9l1887t2059r1942b2114],
14	N	NN	O	n	prep	13	SENT_172	[p9l1887t2059r1942b2114],
15	=	JJ	O	=	amod	17	SENT_172	[p9l1961t2075r1990b2098],
16	99	CD	NUMBER	99	num	17	SENT_172	[p9l2005t2059r2080b2114],
17	)	CD	NUMBER	)	dep	14	SENT_172	[p9l2005t2059r2080b2114],

1	0-3	CD	NUMBER	0-3	num	4	SENT_173	[p9l667t2098r750b2146],
2	r	NN	O	r	nn	4	SENT_173	[p9l769t2128r773b2129],
3	hp	NN	O	hp	nn	4	SENT_173	[p9l1531t2129r1607b2174],
4	‘	NN	O	‘	_	0	SENT_173	[p9l1531t2129r1607b2174],
5	:	:	O	:	_	0	SENT_173	[p9l1531t2129r1607b2174],
6	MJCMJ1	NN	O	mjcmj1	dep	4	SENT_173	[p9l1620t2129r1757b2165],

1	F	NN	O	f	_	0	SENT_174	[p9l667t2317r712b2362],
2	’	CD	NUMBER	’	rcmod	1	SENT_174	[p9l667t2317r712b2362],
3	3	CD	NUMBER	3	dep	2	SENT_174	[p9l716t2314r750b2362],
4	;	:	O	;	_	0	SENT_174	[p9l716t2314r750b2362],
5	.	.	O	.	_	0	SENT_174	[p9l716t2314r750b2362],

1	Prehabiiity	NN	O	prehabiiity	_	0	SENT_175	[p9l476t2279r546b2640],
2	of	IN	O	of	_	0	SENT_175	[p9l476t2190r531b2257],
3	p	NN	O	p	prep_of	1	SENT_175	[p9l562t2282r633b2840],
4	:	:	O	:	_	0	SENT_175	[p9l562t2282r633b2840],
5	rog	NN	O	rog	dep	1	SENT_175	[p9l562t2282r633b2840],
6	=	JJ	O	=	amod	7	SENT_175	[p9l562t2282r633b2840],
7	re	NN	O	re	dep	5	SENT_175	[p9l562t2282r633b2840],
8	.	.	O	.	_	0	SENT_175	[p9l562t2282r633b2840],

1	ssie	NN	O	ssie	_	0	SENT_176	[p9l562t2282r633b2840],
2	:	:	O	:	_	0	SENT_176	[p9l562t2282r633b2840],
3	nafriee	NN	O	nafriee	nn	4	SENT_176	[p9l562t2282r633b2840],
4	survival	NN	O	survival	dep	1	SENT_176	[p9l562t1995r617b2257],

1	P	NN	O	p	nn	2	SENT_177	[p9l665t2738r712b2786],
2	P	NN	O	p	_	0	SENT_177	[p9l665t2528r712b2573],
3	3	CD	NUMBER	3	dep	2	SENT_177	[p9l665t2336r666b2341],
4	’	NN	O	’	nn	7	SENT_177	[p9l665t2117r666b2126],
5	‘	CD	NUMBER	‘	num	7	SENT_177	[p9l718t2738r750b2786],
6	M	NN	O	m	nn	7	SENT_177	[p9l718t2738r750b2786],
7	A	NN	O	a	dep	2	SENT_177	[p9l718t2528r751b2573],
8	F	NN	O	f	dep	7	SENT_177	[p9l667t2951r712b2997],
9	’	CD	NUMBER	’	num	8	SENT_177	[p9l667t2951r712b2997],
10	I	PRP	O	I	dep	7	SENT_177	[p9l718t2951r750b2996],
11	:	:	O	:	_	0	SENT_177	[p9l718t2951r750b2996],

1	5	CD	NUMBER	5	number	2	SENT_178	[p9l1014t3047r1047b3095],
2	1	CD	NUMBER	1	_	0	SENT_178	[p9l1212t3012r1276b3092],
3	is	VBZ	O	be	dep	2	SENT_178	[p9l1423t3017r1489b3095],
4	24	CD	NUMBER	24	npadvmod	5	SENT_178	[p9l1627t3047r1697b3092],
5	so	RB	O	so	advmod	3	SENT_178	[p9l1840t3047r1907b3095],
6	as	IN	O	as	prep	3	SENT_178	[p9l2051t3047r2118b3095],

1	(	NN	O	(	_	0	SENT_179	[p9l473t3127r566b3197],
2	C	NN	O	c	dep	1	SENT_179	[p9l473t3127r566b3197],
3	)	CD	NUMBER	)	dobj	2	SENT_179	[p9l473t3127r566b3197],
4	Fellow	NNP	O	Fellow	dep	3	SENT_179	[p9l1075t3127r1404b3197],
5	‘	SYM	O	‘	dep	3	SENT_179	[p9l1075t3127r1404b3197],
6	-	:	O	-	_	0	SENT_179	[p9l1075t3127r1404b3197],
7	up	RP	O	up	advmod	8	SENT_179	[p9l1075t3127r1404b3197],
8	time	NN	O	time	dep	1	SENT_179	[p9l1425t3127r1569b3184],
9	(	CD	NUMBER	(	num	10	SENT_179	[p9l1591t3127r1894b3197],
10	months	NNS	NUMBER	month	dep	1	SENT_179	[p9l1591t3127r1894b3197],
11	)	IN	O	)	amod	10	SENT_179	[p9l1591t3127r1894b3197],

1	gation	NN	O	gation	nn	3	SENT_180	[p9l7t3220r224b3296],
2	(	CD	NUMBER	(	num	3	SENT_180	[p9l270t3219r625b3296],
3	p	NN	O	p	dep	4	SENT_180	[p9l270t3219r625b3296],
4	<	JJR	O	<	_	0	SENT_180	[p9l270t3219r625b3296],
5	0.001	CD	NUMBER	0.001	dep	4	SENT_180	[p9l270t3219r625b3296],
6	;	:	O	;	_	0	SENT_180	[p9l270t3219r625b3296],
7	median	NN	O	median	dep	4	SENT_180	[p9l673t3219r928b3280],
8	26.3	CD	DURATION	26.3	num	9	SENT_180	[p9l970t3219r1119b3280],
9	months	NNS	NUMBER	month	tmod	7	SENT_180	[p9l1162t3219r1418b3280],
10	versus	CC	O	versus	_	0	SENT_180	[p9l1455t3235r1676b3280],
11	7.4	CD	DURATION	7.4	num	12	SENT_180	[p9l1715t3220r1825b3280],
12	months	NNS	NUMBER	month	dep	4	SENT_180	[p9l1865t3219r2144b3293],
13	,	,	O	,	_	0	SENT_180	[p9l1865t3219r2144b3293],
14	respectively	RB	O	respectively	advmod	17	SENT_180	[p9l9t3317r467b3394],
15	)	CD	NUMBER	)	number	16	SENT_180	[p9l9t3317r467b3394],
16	(	CD	NUMBER	(	num	17	SENT_180	[p9l503t3318r651b3394],
17	Fig	NN	O	fig	rcmod	12	SENT_180	[p9l503t3318r651b3394],
18	.	.	O	.	_	0	SENT_180	[p9l503t3318r651b3394],

1	2D	NN	O	2d	_	0	SENT_181	[p9l687t3318r827b3394],
2	)	NN	O	)	dep	1	SENT_181	[p9l687t3318r827b3394],
3	.	.	O	.	_	0	SENT_181	[p9l687t3318r827b3394],

1	3.3	CD	NUMBER	3.3	_	0	SENT_182	[p9l10t3425r165b3493],
2	.	.	O	.	_	0	SENT_182	[p9l10t3425r165b3493],

1	Clinical	JJ	O	clinical	amod	2	SENT_183	[p9l222t3423r524b3492],
2	predictors	NNS	O	predictor	nsubjpass	21	SENT_183	[p9l558t3423r980b3509],
3	versus	CC	O	versus	prep	2	SENT_183	[p9l1010t3442r1274b3491],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_183	[p9l1310t3425r1522b3492],
5	mutation	NN	O	mutation	dep	3	SENT_183	[p9l1554t3425r1922b3491],
6	In	IN	O	in	_	0	SENT_183	[p9l11t3546r65b3605],
7	multivariate	JJ	O	multivariate	amod	8	SENT_183	[p9l109t3544r546b3606],
8	analysis	NN	O	analysis	prep_in	21	SENT_183	[p9l586t3544r884b3621],
9	,	,	O	,	_	0	SENT_183	[p9l586t3544r884b3621],
10	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	12	SENT_183	[p9l930t3544r1567b3621],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_183	[p9l1609t3545r1791b3606],
12	mutation	NN	O	mutation	prep_in	21	SENT_183	[p9l1830t3546r2148b3606],
13	and	CC	O	and	_	0	SENT_183	[p9l7t3643r130b3704],
14	number	NN	O	number	prep_in	21	SENT_183	[p9l178t3643r448b3704],
15	of	IN	O	of	_	0	SENT_183	[p9l489t3643r560b3704],
16	clinical	JJ	O	clinical	amod	17	SENT_183	[p9l600t3643r855b3704],
17	predictors	NNS	O	predictor	prep_of	14	SENT_183	[p9l901t3643r1261b3720],
18	were	VBD	O	be	auxpass	21	SENT_183	[p9l1302t3659r1478b3704],
19	both	DT	O	both	dep	21	SENT_183	[p9l1524t3643r1678b3704],
20	signiﬁcantly	RB	O	signiﬁcantly	advmod	21	SENT_183	[p9l1724t3643r2152b3720],
21	associated	VBN	O	associate	_	0	SENT_183	[p10l7t17r375b78],
22	with	IN	O	with	_	0	SENT_183	[p10l403t17r557b78],
23	objective	JJ	O	objective	amod	24	SENT_183	[p10l586t17r922b94],
24	response	NN	O	response	prep_with	21	SENT_183	[p10l952t33r1261b94],
25	and	CC	O	and	_	0	SENT_183	[p10l1288t17r1411b78],
26	TTP	NN	O	ttp	nn	28	SENT_183	[p10l1439t18r1574b78],
27	(	CD	NUMBER	(	num	28	SENT_183	[p10l1607t17r1819b94],
28	Table	NNP	O	Table	prep_with	21	SENT_183	[p10l1607t17r1819b94],
29	3	CD	NUMBER	3	num	30	SENT_183	[p10l1848t18r1935b94],
30	)	NN	O	)	dep	28	SENT_183	[p10l1848t18r1935b94],
31	.	.	O	.	_	0	SENT_183	[p10l1848t18r1935b94],

1	HowNumlbar	NNP	O	HowNumlbar	_	0	SENT_184	[p10l1973t19r2147b78, p10l1097t327r1298b369],

1	uf	NN	O	uf	nn	3	SENT_185	[p10l1314t327r1366b369],
2	nliniii-cal	JJ	O	nliniii-cal	amod	3	SENT_185	[p10l1094t398r1275b441],
3	predlicta-rs	NNS	O	predlicta-r	_	0	SENT_185	[p10l1294t398r1554b453],
4	:	:	O	:	_	0	SENT_185	[p10l1094t489r1201b499],
5	=	JJ	O	=	advmod	8	SENT_185	[p10l1094t489r1201b499],
6	U	NNP	O	U	nn	8	SENT_185	[p10l1246t473r1275b512],
7	{	CD	NUMBER	{	num	8	SENT_185	[p10l1288t469r1343b525],
8	N	NN	O	n	dep	3	SENT_185	[p10l1288t469r1343b525],
9	=	JJ	O	=	amod	10	SENT_185	[p10l1362t488r1392b509],
10	|	NN	O	|	dep	8	SENT_185	[p10l1408t470r1485b525],
11	+	CC	O	+	_	0	SENT_185	[p10l1408t470r1485b525],
12	1	CD	NUMBER	1	dep	3	SENT_185	[p10l1094t560r1201b567],
13	"	``	O	"	punct	14	SENT_185	[p10l1246t544r1266b583],
14	I	PRP	O	I	dep	12	SENT_185	[p10l1246t544r1266b583],
15	@	IN	O	@	dep	16	SENT_185	[p10l1288t540r1343b595],
16	|	NN	O	|	amod	14	SENT_185	[p10l1288t540r1343b595],
17	+	CC	O	+	_	0	SENT_185	[p10l1288t540r1343b595],
18	=	JJ	O	=	amod	20	SENT_185	[p10l1362t557r1392b580],
19	}	CD	NUMBER	}	tmod	18	SENT_185	[p10l1408t540r1485b593],
20	|	NN	O	|	conj_+	14	SENT_185	[p10l1408t540r1485b593],
21	+	CC	O	+	_	0	SENT_185	[p10l1408t540r1485b593],
22	‘	NN	O	‘	nn	23	SENT_185	[p10l1097t631r1201b638],
23	j	NN	O	j	conj_+	14	SENT_185	[p10l1097t631r1201b638],
24	2	CD	NUMBER	2	num	25	SENT_185	[p10l1246t615r1272b654],
25	|	NN	O	|	dep	23	SENT_185	[p10l1288t612r1343b667],
26	+	CC	O	+	_	0	SENT_185	[p10l1288t612r1343b667],
27	=	JJ	O	=	amod	28	SENT_185	[p10l1362t628r1392b651],
28	17	CD	NUMBER	17	conj_+	14	SENT_185	[p10l1411t612r1485b667],
29	]	CD	NUMBER	]	num	30	SENT_185	[p10l1411t612r1485b667],
30	3	CD	NUMBER	3	dep	28	SENT_185	[p10l1094t699r1204b709],
31	'	''	O	'	_	0	SENT_185	[p10l1094t699r1204b709],
32	3	LS	NUMBER	3	dep	30	SENT_185	[p10l1246t686r1275b725],
33	-	:	O	-	_	0	SENT_185	[p10l1246t686r1275b725],
34	@	IN	O	@	dep	35	SENT_185	[p10l1288t683r1343b738],
35	|	NN	O	|	amod	30	SENT_185	[p10l1288t683r1343b738],
36	+	CC	O	+	_	0	SENT_185	[p10l1288t683r1343b738],
37	=	JJ	O	=	amod	41	SENT_185	[p10l1362t699r1392b722],
38	39	CD	NUMBER	39	number	39	SENT_185	[p10l1408t683r1485b738],
39	)	CD	NUMBER	)	dep	40	SENT_185	[p10l1408t683r1485b738],
40	pE	NN	O	pe	dep	41	SENT_185	[p10l1107t751r1182b800],
41	M19	NN	O	m19	conj_+	28	SENT_185	[p10l1197t754r1314b790],

1	[	NN	O	[	nn	2	SENT_186	[p10l172t505r256b551],
2	LB	NN	O	lb	_	0	SENT_186	[p10l172t505r256b551],

1	Pfﬂbﬂbil	NN	O	pfﬂbﬂbil	nn	2	SENT_187	[p10l56t1060r114b1327],
2	ity	NN	O	ity	_	0	SENT_187	[p10l56t961r127b1042],
3	of	IN	O	of	_	0	SENT_187	[p10l56t871r114b939],
4	mreralli	JJ	O	mreralli	amod	5	SENT_187	[p10l59t622r114b851],
5	siuzrvival	NN	O	siuzrvival	prep_of	2	SENT_187	[p10l56t333r114b599],

1	o	NN	O	o	_	0	SENT_188	[p10l311t1469r344b1518],
2	5	CD	NUMBER	5	number	3	SENT_188	[p10l496t1469r531b1518],
3	12	CD	NUMBER	12	dep	1	SENT_188	[p10l664t1469r732b1518],
4	13	CD	NUMBER	13	num	5	SENT_188	[p10l848t1469r913b1518],
5	:24	CD	NUMBER	:24	npadvmod	6	SENT_188	[p10l1026t1469r1097b1518],
6	so	RB	O	so	advmod	3	SENT_188	[p10l1211t1446r1279b1518],
7	as	IN	O	as	_	0	SENT_188	[p10l1392t1469r1460b1518],
8	42	CD	NUMBER	42	prep_as	3	SENT_188	[p10l1576t1469r1647b1518],

1	(	NN	O	(	nn	2	SENT_189	[p10l55t1546r143b1618],
2	B	NN	O	b	_	0	SENT_189	[p10l55t1546r143b1618],
3	)	CD	NUMBER	)	num	7	SENT_189	[p10l55t1546r143b1618],
4	Fullaweutp	NNP	O	Fullaweutp	nn	7	SENT_189	[p10l589t1553r923b1621],
5	time	NN	O	time	nn	7	SENT_189	[p10l942t1550r1091b1608],
6	(	NN	O	(	nn	7	SENT_189	[p10l1113t1550r1418b1621],
7	moinsths	NNS	O	moinsth	nsubj	8	SENT_189	[p10l1113t1550r1418b1621],
8	)	VBP	O	)	rcmod	2	SENT_189	[p10l1113t1550r1418b1621],

1	E	NN	O	e	_	0	SENT_190	[p10l56t1848r111b1903],
2	1	CD	NUMBER	1	number	3	SENT_190	[p10l172t1815r272b1861],
3	*	CD	NUMBER	*	num	1	SENT_190	[p10l172t1815r272b1861],
4	"	``	O	"	punct	1	SENT_190	[p10l172t1815r272b1861],
5	-	:	O	-	_	0	SENT_190	[p10l350t1851r409b1889],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_190	[p10l1039t1844r1185b1887],
7	mutation	NN	O	mutation	nn	8	SENT_190	[p10l1204t1844r1427b1887],
8	.3	NN	NUMBER	.3	dep	1	SENT_190	[p10l55t1906r111b1961],
9	l	NN	O	l	tmod	8	SENT_190	[p10l392t1948r394b1961],
10	—	CD	NUMBER	—	num	11	SENT_190	[p10l418t1946r446b1948],
11	W	NN	O	w	dep	8	SENT_190	[p10l1036t1932r1146b1942],
12	:	:	O	:	_	0	SENT_190	[p10l1036t1932r1146b1942],
13	Positive	JJ	O	positive	amod	15	SENT_190	[p10l1175t1916r1379b1958],
14	{	NN	O	{	nn	15	SENT_190	[p10l1392t1916r1447b1971],
15	N	NN	O	n	dep	8	SENT_190	[p10l1392t1916r1447b1971],
16	2	CD	NUMBER	2	number	17	SENT_190	[p10l1466t1932r1496b1955],
17	21	CD	NUMBER	21	num	18	SENT_190	[p10l1511t1916r1589b1971, p10l69t1967r111b2071],
18	}	NN	O	}	dep	15	SENT_190	[p10l1511t1916r1589b1971, p10l69t1967r111b2071],
19	;	:	O	;	_	0	SENT_190	[p10l1511t1916r1589b1971, p10l69t1967r111b2071],
20	i	FW	O	i	nn	21	SENT_190	[p10l405t2000r407b2016],
21	*	FW	O	*	dep	8	SENT_190	[p10l465t1990r547b2047],
22	a	DT	O	a	det	24	SENT_190	[p10l593t2029r596b2031],
23	E	NN	O	e	nn	24	SENT_190	[p10l1036t2003r1143b2013],
24	Hegativaini	NN	O	hegativainus	dep	21	SENT_190	[p10l1175t1987r1466b2042],
25	=	JJ	O	=	amod	24	SENT_190	[p10l1485t1987r1605b2042],
26	99	CD	NUMBER	99	tmod	25	SENT_190	[p10l1485t1987r1605b2042],
27	)	CD	NUMBER	)	number	28	SENT_190	[p10l1485t1987r1605b2042],
28	,5	CD	NUMBER	,5	num	24	SENT_190	[p10l69t2072r111b2116],
29	,	,	O	,	_	0	SENT_190	[p10l69t2072r111b2116],
30	“	CD	NUMBER	“	number	31	SENT_190	[p10l172t2032r276b2081],
31	-3	CD	NUMBER	-3	num	33	SENT_190	[p10l172t2032r276b2081],
32	o	NN	O	o	nn	33	SENT_190	[p10l311t2060r314b2061],
33	r	NN	O	r	appos	8	SENT_190	[p10l429t2061r431b2063],
34	‘	CD	NUMBER	‘	num	35	SENT_190	[p10l597t2059r599b2061],
35	pa	NN	O	pa	dep	33	SENT_190	[p10l1049t2058r1123b2106],
36	:	:	O	:	_	0	SENT_190	[p10l1049t2058r1123b2106],
37	a.	VB	O	a.	dep	55	SENT_190	[p10l1139t2058r1278b2094],
38	u	FW	O	u	nn	40	SENT_190	[p10l1139t2058r1278b2094],
39	«	FW	O	«	nn	40	SENT_190	[p10l1139t2058r1278b2094],
40	w1	NN	O	w1	dobj	37	SENT_190	[p10l1139t2058r1278b2094],
41	:	:	O	:	_	0	SENT_190	[p10l1139t2058r1278b2094],
42	‘	NN	O	‘	nn	44	SENT_190	[p10l56t2142r111b2217],
43	=	JJ	O	=	amod	44	SENT_190	[p10l56t2142r111b2217],
44	u	NN	O	u	dep	40	SENT_190	[p10l56t2142r111b2217],
45	,	,	O	,	_	0	SENT_190	[p10l738t2165r770b2167],
46	_	NN	O	_	appos	44	SENT_190	[p10l738t2165r770b2167],
47	'	''	O	'	_	0	SENT_190	[p10l69t2220r111b2285],
48	6	CD	NUMBER	6	num	49	SENT_190	[p10l69t2220r111b2285],
49	u	NN	O	u	dep	40	SENT_190	[p10l172t2245r204b2291],
50	5	CD	NUMBER	5	num	51	SENT_190	[p10l224t2245r272b2291],
51	A	NN	O	a	dep	49	SENT_190	[p10l853t2236r984b2238],
52	:	:	O	:	_	0	SENT_190	[p10l71t2285r111b2328],
53	_	CD	NUMBER	_	number	54	SENT_190	[p10l71t2285r111b2328],
54	’	CD	NUMBER	’	num	55	SENT_190	[p10l208t2281r243b2294],
55	>	JJR	O	>	dep	1	SENT_190	[p10l208t2281r243b2294],
56	o	NN	O	o	nn	58	SENT_190	[p10l69t2329r111b2369],
57	"	''	O	"	punct	58	SENT_190	[p10l55t2391r111b2419],
58	|	NN	O	|	dep	55	SENT_190	[p10l55t2391r111b2419],
59	.	.	O	.	_	0	SENT_190	[p10l55t2391r111b2419],

1	—	NN	O	—	_	0	SENT_191	[p10l55t2391r111b2419],
2	.	.	O	.	_	0	SENT_191	[p10l55t2391r111b2419],

1	-	:	O	-	_	0	SENT_192	[p10l55t2391r111b2419],
2	.	.	O	.	_	0	SENT_192	[p10l55t2391r111b2419],

1	n	NN	O	n	_	0	SENT_193	[p10l69t2417r111b2456],
2	:	:	O	:	_	0	SENT_193	[p10l71t2478r127b2518],
3	.	.	O	.	_	0	SENT_193	[p10l71t2478r127b2518],

1	s	NNS	O	s	_	0	SENT_194	[p10l71t2478r127b2518],
2	-	:	O	-	_	0	SENT_194	[p10l71t2478r127b2518],
3	.	.	O	.	_	0	SENT_194	[p10l71t2478r127b2518],

1	I14	NN	O	i14	_	0	SENT_195	[p10l172t2462r259b2511],
2	.	.	O	.	_	0	SENT_195	[p10l55t2520r111b2559],

1	=	JJ	O	=	amod	2	SENT_196	[p10l55t2520r111b2559],
2	g	NN	O	g	_	0	SENT_196	[p10l677t2565r679b2570],
3	I	PRP	O	I	dep	2	SENT_196	[p10l55t2585r111b2686],
4	.	.	O	.	_	0	SENT_196	[p10l687t2595r699b2601, p10l56t2688r111b2728],

1	.	.	O	.	_	0	SENT_197	[p10l687t2595r699b2601, p10l56t2688r111b2728],

1	:	:	O	:	_	0	SENT_198	[p10l687t2595r699b2601, p10l56t2688r111b2728],
2	I	PRP	O	I	dep	6	SENT_198	[p10l687t2595r699b2601, p10l56t2688r111b2728],
3	0.2	CD	NUMBER	0.2	num	6	SENT_198	[p10l172t2676r256b2725],
4	Q	NNP	O	Q	nn	6	SENT_198	[p10l69t2731r111b2773],
5	_	CD	NUMBER	_	num	6	SENT_198	[p10l783t2761r795b2763],
6	E	NN	O	e	_	0	SENT_198	[p10l69t2776r111b2799],
7	a.	IN	O	a.	amod	6	SENT_198	[p10l56t2805r111b2847],

1	o-D	JJ	O	o-d	amod	2	SENT_199	[p10l172t2896r256b2944],
2	‘	NN	O	‘	_	0	SENT_199	[p10l270t2922r272b2924],
3	i	FW	O	i	dep	2	SENT_199	[p10l504t2925r505b2972],

1	D	NN	O	d	nn	2	SENT_200	[p10l308t2993r340b3042],
2	E	NN	O	e	_	0	SENT_200	[p10l492t2993r525b3042],
3	12	CD	NUMBER	12	number	4	SENT_200	[p10l660t2993r725b3041],
4	13	CD	NUMBER	13	dep	2	SENT_200	[p10l842t2993r909b3042],
5	24	CD	NUMBER	24	num	6	SENT_200	[p10l1023t2993r1094b3041],
6	3E	NN	O	3e	dep	4	SENT_200	[p10l1207t2993r1275b3042],
7	!	.	O	!	_	0	SENT_200	[p10l1207t2993r1275b3042],

1	36	CD	NUMBER	36	num	2	SENT_201	[p10l1392t2993r1460b3042],
2	42	CD	NUMBER	42	_	0	SENT_201	[p10l1576t2993r1644b3041],

1	.	.	O	.	_	0	SENT_202	[p10l144t3087r146b3089],

1	vl	NN	O	vl	_	0	SENT_203	[p10l968t3074r981b3087],
2	_	SYM	O	_	dep	1	SENT_203	[p10l1079t3090r1081b3092],

1	(	NN	O	(	nsubj	2	SENT_204	[p10l55t3071r149b3142],
2	D	NN	O	d	_	0	SENT_204	[p10l55t3071r149b3142],
3	)	CD	NUMBER	)	num	4	SENT_204	[p10l55t3071r149b3142],
4	Follows-upt	NN	O	follows-upt	dobj	2	SENT_204	[p10l586t3074r1418b3145],
5	:	:	O	:	_	0	SENT_204	[p10l586t3074r1418b3145],
6	|	VB	O	|	dep	4	SENT_204	[p10l586t3074r1418b3145],
7	me	PRP	O	I	dobj	6	SENT_204	[p10l586t3074r1418b3145],
8	+	CC	O	+	_	0	SENT_204	[p10l586t3074r1418b3145],
9	(	CD	NUMBER	(	num	10	SENT_204	[p10l586t3074r1418b3145],
10	mm1ths	NNS	O	mm1th	conj_+	7	SENT_204	[p10l586t3074r1418b3145],
11	)	CD	NUMBER	)	num	12	SENT_204	[p10l586t3074r1418b3145],
12	Fig	NN	O	fig	dep	10	SENT_204	[p10l48t3187r104b3221],
13	.	.	O	.	_	0	SENT_204	[p10l48t3187r104b3221],

1	2	CD	NUMBER	2	_	0	SENT_205	[p10l118t3187r135b3214],
2	Kaplan	NNP	PERSON	Kaplan	dep	1	SENT_205	[p10l188t3187r406b3221],
3	.	.	O	.	_	0	SENT_205	[p10l188t3187r406b3221],

1	—	NN	O	—	_	0	SENT_206	[p10l188t3187r406b3221],
2	.	.	O	.	_	0	SENT_206	[p10l188t3187r406b3221],

1	Meier	JJR	PERSON	meier	amod	2	SENT_207	[p10l188t3187r406b3221],
2	plots	NNS	O	plot	_	0	SENT_207	[p10l416t3187r490b3221],
3	of	IN	O	of	_	0	SENT_207	[p10l500t3187r532b3214],
4	time	NN	O	time	prep_of	2	SENT_207	[p10l541t3187r611b3214],
5	to	TO	O	to	_	0	SENT_207	[p10l621t3189r652b3214],
6	progression	NN	O	progression	nn	8	SENT_207	[p10l663t3187r839b3221],
7	(	NN	O	(	nn	8	SENT_207	[p10l852t3187r883b3221],
8	A	NN	O	a	prep_to	4	SENT_207	[p10l852t3187r883b3221],
9	and	CC	O	and	_	0	SENT_207	[p10l892t3187r947b3214],
10	C	NN	O	c	nn	11	SENT_207	[p10l958t3187r989b3221],
11	)	NN	O	)	conj_and	8	SENT_207	[p10l958t3187r989b3221],
12	and	CC	O	and	_	0	SENT_207	[p10l1000t3187r1055b3214],
13	overall	JJ	O	overall	amod	16	SENT_207	[p10l1066t3187r1172b3214],
14	survival	NN	O	survival	nn	16	SENT_207	[p10l1182t3187r1301b3214],
15	(	NN	O	(	nn	16	SENT_207	[p10l1313t3187r1342b3221],
16	B	NN	O	b	conj_and	8	SENT_207	[p10l1313t3187r1342b3221],
17	and	CC	O	and	_	0	SENT_207	[p10l1353t3187r1407b3214],
18	D	NN	O	d	conj_and	4	SENT_207	[p10l1419t3187r1450b3221],
19	)	CD	NUMBER	)	num	18	SENT_207	[p10l1419t3187r1450b3221],
20	according	VBG	O	accord	_	0	SENT_207	[p10l1461t3187r1612b3221],
21	to	TO	O	to	prepc_according_to	18	SENT_207	[p10l1622t3189r1653b3214],
22	number	NN	O	number	pobj	18	SENT_207	[p10l1664t3187r1782b3214],
23	of	IN	O	of	_	0	SENT_207	[p10l1791t3187r1823b3214],
24	clinical	JJ	O	clinical	amod	25	SENT_207	[p10l1832t3187r1943b3214],
25	predictors	NNS	O	predictor	prep_of	22	SENT_207	[p10l1955t3187r2112b3221],
26	and	CC	O	and	_	0	SENT_207	[p10l47t3232r101b3259],
27	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_207	[p10l115t3232r194b3259],
28	mutational	JJ	O	mutational	amod	29	SENT_207	[p10l205t3232r374b3259],
29	status	NN	O	status	prep_of	22	SENT_207	[p10l386t3235r488b3259],
30	.	.	O	.	_	0	SENT_207	[p10l386t3235r488b3259],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_208	[p10l504t3232r584b3259],
2	mutation	NN	O	mutation	nsubj	3	SENT_208	[p10l595t3233r734b3259],
3	denotes	VBZ	O	denote	_	0	SENT_208	[p10l747t3232r869b3259],
4	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	6	SENT_208	[p10l881t3232r1160b3266],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_208	[p10l1172t3232r1252b3259],
6	mutation	NN	O	mutation	dobj	3	SENT_208	[p10l1263t3233r1413b3259],
7	.	.	O	.	_	0	SENT_208	[p10l1263t3233r1413b3259],

1	Positive	JJ	O	positive	nsubj	2	SENT_209	[p10l1429t3233r1548b3259],
2	includes	VBZ	O	include	_	0	SENT_209	[p10l1559t3232r1687b3259],
3	deletion	NN	O	deletion	dobj	2	SENT_209	[p10l1698t3232r1826b3259],
4	in	IN	O	in	_	0	SENT_209	[p10l1838t3233r1864b3259],
5	exon	NN	O	exon	prep_in	2	SENT_209	[p10l1877t3239r1949b3259],
6	19	CD	NUMBER	19	num	5	SENT_209	[p10l1963t3232r2006b3265],
7	,	,	O	,	_	0	SENT_209	[p10l1963t3232r2006b3265],
8	L858R	NN	O	l858r	prep_in	2	SENT_209	[p10l2022t3232r2113b3259],
9	and	CC	O	and	_	0	SENT_209	[p10l47t3278r101b3305],
10	G719A	NN	O	g719a	prep_in	2	SENT_209	[p10l115t3278r223b3311],
11	;	:	O	;	_	0	SENT_209	[p10l115t3278r223b3311],
12	negative	JJ	O	negative	nsubj	13	SENT_209	[p10l239t3278r372b3312],
13	includes	VBZ	O	include	parataxis	2	SENT_209	[p10l384t3278r512b3305],
14	wild-type	JJ	O	wild-type	amod	15	SENT_209	[p10l524t3278r672b3312],
15	EGFR	NN	ORGANIZATION	egfr	dobj	13	SENT_209	[p10l686t3278r775b3311],
16	,	,	O	,	_	0	SENT_209	[p10l686t3278r775b3311],
17	A859T	NN	O	a859t	conj_and	15	SENT_209	[p10l789t3278r886b3305],
18	and	CC	O	and	_	0	SENT_209	[p10l898t3278r952b3305],
19	L861Q	NN	O	l861q	dobj	13	SENT_209	[p10l967t3278r1071b3310],
20	.	.	O	.	_	0	SENT_209	[p10l967t3278r1071b3310],
21	"	''	O	"	punct	2	SENT_209	[p10l1086t3273r1233b3312],

1	Log-rank	JJ	O	log-rank	amod	2	SENT_210	[p10l1086t3273r1233b3312],
2	test	NN	O	test	_	0	SENT_210	[p10l1245t3280r1314b3305],
3	.	.	O	.	_	0	SENT_210	[p10l1245t3280r1314b3305],

1	Clinical	JJ	O	clinical	amod	2	SENT_211	[p10l47t3328r168b3357],
2	predictors	NNS	O	predictor	_	0	SENT_211	[p10l183t3328r350b3364],
3	versus	CC	O	versus	prep	2	SENT_211	[p10l362t3336r465b3357],
4	epidermal	JJ	O	epidermal	amod	7	SENT_211	[p10l478t3328r645b3364],
5	growth	NN	O	growth	nn	7	SENT_211	[p10l659t3328r772b3364],
6	factor	NN	O	factor	nn	7	SENT_211	[p10l786t3328r887b3357],
7	receptor	NN	O	receptor	dep	3	SENT_211	[p10l900t3331r1042b3364],
8	mutation	NN	O	mutation	dep	2	SENT_211	[p10l1055t3328r1202b3357],
9	205	CD	NUMBER	205	num	8	SENT_211	[p10l2058t3328r2114b3357],

1	Table	NNP	O	Table	_	0	SENT_212	[p10l71t3443r158b3470],
2	3	CD	NUMBER	3	num	4	SENT_212	[p10l172t3443r187b3470],
3	Multivariate	JJ	O	multivariate	amod	4	SENT_212	[p10l240t3443r429b3470],
4	analyses	NNS	O	analysis	dep	1	SENT_212	[p10l441t3443r571b3477],
5	of	IN	O	of	_	0	SENT_212	[p10l584t3443r615b3470],
6	response	NN	O	response	prep_of	4	SENT_212	[p10l628t3450r763b3477],
7	and	CC	O	and	_	0	SENT_212	[p10l776t3443r830b3470],
8	survival	NN	O	survival	prep_of	4	SENT_212	[p10l844t3443r962b3470],

1	Objective	NN	O	objective	nn	3	SENT_213	[p10l572t3518r724b3552],
2	response	NN	O	response	nn	3	SENT_213	[p10l738t3525r873b3552],
3	Time-to-progression	NN	O	time-to-progression	dep	19	SENT_213	[p10l1074t3518r1388b3552],
4	Overall	JJ	O	overall	amod	6	SENT_213	[p10l1621t3518r1732b3545],
5	survival	NN	O	survival	nn	6	SENT_213	[p10l1744t3518r1863b3545],
6	Odds	NNS	O	odds	dep	3	SENT_213	[p10l572t3593r648b3620],
7	ratio	NN	O	ratio	nn	9	SENT_213	[p10l661t3594r733b3620],
8	p-Value	NN	O	p-value	nn	9	SENT_213	[p10l878t3593r996b3627],
9	Hazard	NN	MISC	hazard	dep	6	SENT_213	[p10l1076t3593r1182b3620],
10	ratio	NN	O	ratio	dep	19	SENT_213	[p10l1197t3593r1282b3620],
11	“	CD	NUMBER	“	num	10	SENT_213	[p10l1197t3593r1282b3620],
12	p-Value	NN	O	p-value	nn	19	SENT_213	[p10l1424t3593r1542b3627],
13	Hazard	NN	O	hazard	nn	19	SENT_213	[p10l1622t3593r1728b3620],
14	ratioa	NN	O	ratioa	nn	19	SENT_213	[p10l1743t3593r1828b3620],
15	p-Value	NN	O	p-value	nn	19	SENT_213	[p10l1970t3593r2087b3627],
16	(	CD	PERCENT	(	num	19	SENT_213	[p10l574t3638r641b3672],
17	95	CD	PERCENT	95	num	19	SENT_213	[p10l574t3638r641b3672],
18	%	NN	PERCENT	%	nn	19	SENT_213	[p10l574t3638r641b3672],
19	CI	NN	O	ci	dep	30	SENT_213	[p10l654t3638r695b3672],
20	)	CD	PERCENT	)	num	24	SENT_213	[p10l654t3638r695b3672],
21	(	CD	PERCENT	(	number	22	SENT_213	[p10l1077t3638r1144b3672],
22	95	CD	PERCENT	95	dep	23	SENT_213	[p10l1077t3638r1144b3672],
23	%	NN	PERCENT	%	dep	24	SENT_213	[p10l1077t3638r1144b3672],
24	Cl	NN	O	cl	dep	19	SENT_213	[p10l1156t3638r1197b3672],
25	)	CD	PERCENT	)	number	26	SENT_213	[p10l1156t3638r1197b3672],
26	(	CD	PERCENT	(	amod	24	SENT_213	[p10l1622t3638r1689b3672],
27	95	CD	PERCENT	95	num	28	SENT_213	[p10l1622t3638r1689b3672],
28	%	NN	PERCENT	%	dep	26	SENT_213	[p10l1622t3638r1689b3672],
29	CI	NN	O	ci	nn	30	SENT_213	[p10l1702t3638r1743b3672],
30	)	NN	O	)	_	0	SENT_213	[p10l1702t3638r1743b3672],

1	Geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	2	SENT_214	[p11l72t17r357b44],
2	EGFR	NN	ORGANIZATION	egfr	dep	14	SENT_214	[p11l371t17r450b44],
3	9.6	CD	NUMBER	9.6	num	4	SENT_214	[p11l572t17r620b44],
4	(	NN	O	(	dep	2	SENT_214	[p11l635t17r800b51],
5	3.2	CD	NUMBER	3.2	number	6	SENT_214	[p11l635t17r800b51],
6	—	CD	NUMBER	—	dep	9	SENT_214	[p11l635t17r800b51],
7	28.7	CD	NUMBER	28.7	num	8	SENT_214	[p11l635t17r800b51],
8	)	NN	O	)	npadvmod	9	SENT_214	[p11l635t17r800b51],
9	<	JJR	O	<	amod	4	SENT_214	[p11l881t17r978b44],
10	o.	CD	NUMBER	o.	num	11	SENT_214	[p11l881t17r978b44],
11	0o1	NN	O	0o1	dep	14	SENT_214	[p11l881t17r978b44],
12	0.24	CD	NUMBER	0.24	num	14	SENT_214	[p11l1074t17r1142b44],
13	(	CD	NUMBER	(	num	14	SENT_214	[p11l1156t17r1339b51],
14	o.	NN	O	o.	dep	22	SENT_214	[p11l1156t17r1339b51],
15	12	CD	NUMBER	12	number	16	SENT_214	[p11l1156t17r1339b51],
16	—	CD	NUMBER	—	num	17	SENT_214	[p11l1156t17r1339b51],
17	o.	NN	O	o.	dep	14	SENT_214	[p11l1156t17r1339b51],
18	47	CD	NUMBER	47	num	19	SENT_214	[p11l1156t17r1339b51],
19	)	NN	O	)	npadvmod	20	SENT_214	[p11l1156t17r1339b51],
20	<	JJR	O	<	amod	17	SENT_214	[p11l1427t17r1524b44],
21	o.	CD	NUMBER	o.	num	22	SENT_214	[p11l1427t17r1524b44],
22	oo1	NN	O	oo1	dep	25	SENT_214	[p11l1427t17r1524b44],
23	0.25	CD	NUMBER	0.25	num	25	SENT_214	[p11l1620t17r1686b44],
24	(	CD	NUMBER	(	num	25	SENT_214	[p11l1701t17r1885b51],
25	o.	NN	O	o.	dep	34	SENT_214	[p11l1701t17r1885b51],
26	12	CD	NUMBER	12	number	27	SENT_214	[p11l1701t17r1885b51],
27	—	CD	NUMBER	—	num	28	SENT_214	[p11l1701t17r1885b51],
28	o.	NN	O	o.	dep	25	SENT_214	[p11l1701t17r1885b51],
29	52	CD	NUMBER	52	num	30	SENT_214	[p11l1701t17r1885b51],
30	)	NN	O	)	npadvmod	31	SENT_214	[p11l1701t17r1885b51],
31	<	JJR	O	<	amod	28	SENT_214	[p11l1973t17r2069b44],
32	o.	CD	NUMBER	o.	num	34	SENT_214	[p11l1973t17r2069b44],
33	oo1	NN	O	oo1	nn	34	SENT_214	[p11l1973t17r2069b44],
34	mutation	NN	O	mutation	dep	40	SENT_214	[p11l108t58r262b90],
35	”	CD	NUMBER	”	num	36	SENT_214	[p11l108t58r262b90],
36	Number	NN	O	number	dep	34	SENT_214	[p11l73t108r194b135],
37	of	IN	O	of	_	0	SENT_214	[p11l206t108r237b135],
38	clinical	JJ	O	clinical	amod	39	SENT_214	[p11l249t108r360b135],
39	1.7	CD	NUMBER	1.7	prep_of	36	SENT_214	[p11l574t108r621b135],
40	(	NN	O	(	dep	43	SENT_214	[p11l635t109r657b142],
41	1	CD	NUMBER	1	num	40	SENT_214	[p11l635t109r657b142],
42	.1	CD	NUMBER	.1	num	43	SENT_214	[p11l666t108r781b142],
43	—	NN	O	—	dep	48	SENT_214	[p11l666t108r781b142],
44	2.7	CD	NUMBER	2.7	number	45	SENT_214	[p11l666t108r781b142],
45	)	CD	NUMBER	)	dep	43	SENT_214	[p11l666t108r781b142],
46	0.027	CD	NUMBER	0.027	num	47	SENT_214	[p11l898t108r984b135],
47	0.83	CD	NUMBER	0.83	dep	45	SENT_214	[p11l1074t108r1140b135],
48	(	NN	O	(	dep	52	SENT_214	[p11l1156t108r1339b142],
49	0.69	CD	NUMBER	0.69	num	48	SENT_214	[p11l1156t108r1339b142],
50	—	CD	NUMBER	—	num	52	SENT_214	[p11l1156t108r1339b142],
51	0.99	CD	NUMBER	0.99	num	52	SENT_214	[p11l1156t108r1339b142],
52	)	NN	O	)	_	0	SENT_214	[p11l1156t108r1339b142],
53	0.039	CD	NUMBER	0.039	num	55	SENT_214	[p11l1444t108r1528b135],
54	N/S	NN	O	n/s	nn	55	SENT_214	[p11l1622t108r1676b135],
55	predictors	NNS	O	predictor	dep	52	SENT_214	[p11l108t153r266b187],

1	N/S	NN	O	n/s	_	0	SENT_215	[p11l63t262r195b328],
2	,	,	O	,	_	0	SENT_215	[p11l63t262r195b328],
3	not	RB	O	not	neg	4	SENT_215	[p11l228t267r328b316],
4	signiﬁcant	NN	O	signiﬁcant	appos	1	SENT_215	[p11l354t262r696b330],
5	.	.	O	.	_	0	SENT_215	[p11l354t262r696b330],

1	a	DT	O	a	det	2	SENT_216	[p11l102t347r127b377],
2	Adjusted	NNP	O	Adjusted	_	0	SENT_216	[p11l164t349r444b417],
3	for	IN	O	for	_	0	SENT_216	[p11l471t349r562b403],
4	performance	NN	O	performance	nn	5	SENT_216	[p11l588t349r992b417],
5	status	NN	O	status	prep_for	2	SENT_216	[p11l1017t354r1205b403],
6	(	CD	NUMBER	(	num	7	SENT_216	[p11l1235t349r1428b417],
7	ECOG	NN	ORGANIZATION	ecog	dep	2	SENT_216	[p11l1235t349r1428b417],
8	PS	NNP	O	PS	dep	7	SENT_216	[p11l1459t349r1526b403],
9	0-1	CD	NUMBER	0-1	num	8	SENT_216	[p11l1552t350r1665b403],
10	vs.	CC	O	vs.	prep	8	SENT_216	[p11l1700t363r1781b403],
11	2-3	CD	NUMBER	2-3	num	12	SENT_216	[p11l1813t349r1983b417],
12	)	NN	O	)	dep	10	SENT_216	[p11l1813t349r1983b417],
13	.	.	O	.	_	0	SENT_216	[p11l1813t349r1983b417],

1	b	NN	O	b	nsubj	8	SENT_217	[p11l102t424r127b465],
2	vs.	CC	O	vs.	prep	1	SENT_217	[p11l164t451r246b491],
3	wild-type	JJ	O	wild-type	amod	7	SENT_217	[p11l276t437r578b505],
4	and	CC	O	and	_	0	SENT_217	[p11l604t437r713b491],
5	other	JJ	O	other	amod	7	SENT_217	[p11l741t437r912b491],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_217	[p11l938t437r1100b491],
7	mutations	NNS	O	mutation	dep	2	SENT_217	[p11l1126t438r1439b491],
8	(	VBP	O	(	_	0	SENT_217	[p11l1469t437r1685b505],
9	A859T	NN	O	a859t	nn	12	SENT_217	[p11l1469t437r1685b505],
10	and	CC	O	and	_	0	SENT_217	[p11l1710t437r1819b491],
11	L861Q	NN	O	l861q	nn	12	SENT_217	[p11l1850t437r2086b505],
12	)	NN	O	)	dobj	8	SENT_217	[p11l1850t437r2086b505],
13	.	.	O	.	_	0	SENT_217	[p11l1850t437r2086b505],

1	ever	RB	O	ever	advmod	9	SENT_218	[p11l7t683r172b741],
2	,	,	O	,	_	0	SENT_218	[p11l7t683r172b741],
3	only	RB	O	only	advmod	9	SENT_218	[p11l200t667r348b744],
4	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	6	SENT_218	[p11l368t667r1005b744],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_218	[p11l1029t668r1210b728],
6	mutation	NN	O	mutation	nsubjpass	9	SENT_218	[p11l1232t668r1549b728],
7	was	VBD	O	be	auxpass	9	SENT_218	[p11l1571t683r1703b728],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_218	[p11l1725t667r2153b744],
9	associated	VBN	O	associate	_	0	SENT_218	[p11l8t764r376b825],
10	with	IN	O	with	_	0	SENT_218	[p11l407t764r560b825],
11	OS	NN	O	os	prep_with	9	SENT_218	[p11l593t765r704b826],
12	.	.	O	.	_	0	SENT_218	[p11l593t765r704b826],

1	This	DT	O	this	nsubj	2	SENT_219	[p11l739t764r882b825],
2	shows	VBZ	O	show	_	0	SENT_219	[p11l913t764r1120b825],
3	that	IN	O	that	complm	11	SENT_219	[p11l1150t764r1296b825],
4	analysis	NN	O	analysis	nsubj	11	SENT_219	[p11l1326t764r1601b841],
5	of	IN	O	of	_	0	SENT_219	[p11l1631t764r1702b825],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_219	[p11l1732t765r1913b826],
7	mutational	JJ	O	mutational	amod	8	SENT_219	[p11l1944t770r2147b825, p11l8t863r210b923],
8	status	NN	O	status	prep_of	4	SENT_219	[p11l240t868r450b923],
9	is	VBZ	O	be	cop	11	SENT_219	[p11l479t864r530b923],
10	more	RBR	O	more	advmod	11	SENT_219	[p11l561t879r739b923],
11	helpful	JJ	O	helpful	ccomp	2	SENT_219	[p11l771t863r1017b938],
12	in	IN	O	in	_	0	SENT_219	[p11l1047t864r1106b922],
13	prediction	NN	O	prediction	prep_in	11	SENT_219	[p11l1140t863r1501b938],
14	of	IN	O	of	_	0	SENT_219	[p11l1532t863r1603b923],
15	objective	JJ	O	objective	amod	16	SENT_219	[p11l1629t863r1964b938],
16	beneﬁt	NN	O	beneﬁt	prep_of	13	SENT_219	[p11l1996t863r2148b923, p11l7t960r126b1021],
17	from	IN	O	from	_	0	SENT_219	[p11l154t960r318b1021],
18	geﬁtinib	NN	O	geﬁtinib	prep_from	11	SENT_219	[p11l350t960r642b1037],
19	than	IN	O	than	_	0	SENT_219	[p11l672t960r826b1021],
20	the	DT	O	the	det	22	SENT_219	[p11l859t960r973b1021],
21	clinical	JJ	O	clinical	amod	22	SENT_219	[p11l1002t960r1256b1021],
22	predictors	NNS	O	predictor	prep_than	18	SENT_219	[p11l1288t960r1670b1037],
23	.	.	O	.	_	0	SENT_219	[p11l1288t960r1670b1037],

1	The	DT	O	the	det	2	SENT_220	[p11l115t1057r248b1118],
2	frequency	NN	O	frequency	nsubj	9	SENT_220	[p11l282t1057r640b1134],
3	of	IN	O	of	_	0	SENT_220	[p11l673t1057r744b1118],
4	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	6	SENT_220	[p11l776t1057r1413b1134],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_220	[p11l1451t1058r1631b1119],
6	mutation	NN	O	mutation	prep_of	2	SENT_220	[p11l1666t1059r1984b1118],
7	was	VBD	O	be	cop	9	SENT_220	[p11l2019t1074r2151b1118],
8	3.4	CD	PERCENT	3.4	num	9	SENT_220	[p11l9t1156r165b1216],
9	%	NN	PERCENT	%	_	0	SENT_220	[p11l9t1156r165b1216],
10	(	CD	NUMBER	(	number	11	SENT_220	[p11l209t1156r424b1231],
11	1/29	CD	NUMBER	1/29	num	9	SENT_220	[p11l209t1156r424b1231],
12	)	NN	O	)	dep	31	SENT_220	[p11l209t1156r424b1231],
13	in	IN	O	in	_	0	SENT_220	[p11l466t1157r526b1215],
14	zero	CD	NUMBER	zero	num	17	SENT_220	[p11l566t1172r719b1216],
15	clinical	JJ	O	clinical	amod	17	SENT_220	[p11l758t1156r1012b1216],
16	predictor	NN	O	predictor	nn	17	SENT_220	[p11l1055t1156r1384b1231],
17	group	NN	O	group	prep_in	12	SENT_220	[p11l1422t1170r1643b1231],
18	,	,	O	,	_	0	SENT_220	[p11l1422t1170r1643b1231],
19	17.1	CD	PERCENT	17.1	num	20	SENT_220	[p11l1694t1156r1888b1216],
20	%	NN	PERCENT	%	appos	17	SENT_220	[p11l1694t1156r1888b1216],
21	(	CD	NUMBER	(	number	22	SENT_220	[p11l1933t1156r2149b1231],
22	6/35	CD	NUMBER	6/35	num	23	SENT_220	[p11l1933t1156r2149b1231],
23	)	NN	O	)	dep	20	SENT_220	[p11l1933t1156r2149b1231],
24	in	IN	O	in	_	0	SENT_220	[p11l8t1254r67b1313],
25	one	CD	NUMBER	one	prep_in	23	SENT_220	[p11l116t1269r265b1327],
26	,	,	O	,	_	0	SENT_220	[p11l116t1269r265b1327],
27	17.6	CD	PERCENT	17.6	num	28	SENT_220	[p11l324t1254r518b1314],
28	%	NN	PERCENT	%	dep	31	SENT_220	[p11l324t1254r518b1314],
29	(	CD	NUMBER	(	number	30	SENT_220	[p11l570t1254r786b1330],
30	3/17	CD	NUMBER	3/17	num	31	SENT_220	[p11l570t1254r786b1330],
31	)	NN	O	)	dep	39	SENT_220	[p11l570t1254r786b1330],
32	in	IN	O	in	_	0	SENT_220	[p11l835t1254r894b1313],
33	two	CD	NUMBER	two	num	36	SENT_220	[p11l944t1259r1074b1314],
34	and	CC	O	and	_	0	SENT_220	[p11l1121t1253r1244b1314],
35	28.2	CD	PERCENT	28.2	num	36	SENT_220	[p11l1293t1254r1493b1314],
36	%	NN	PERCENT	%	prep_in	31	SENT_220	[p11l1293t1254r1493b1314],
37	(	CD	NUMBER	(	number	38	SENT_220	[p11l1545t1254r1803b1330],
38	11/39	CD	NUMBER	11/39	num	39	SENT_220	[p11l1545t1254r1803b1330],
39	)	NN	O	)	dep	9	SENT_220	[p11l1545t1254r1803b1330],
40	in	IN	O	in	_	0	SENT_220	[p11l1852t1254r1912b1313],
41	three	CD	NUMBER	three	number	42	SENT_220	[p11l1961t1253r2151b1314],
42	(	CD	NUMBER	(	num	43	SENT_220	[p11l12t1351r396b1427],
43	p	NN	O	p	prep_in	39	SENT_220	[p11l12t1351r396b1427],
44	=	JJ	O	=	advmod	9	SENT_220	[p11l12t1351r396b1427],
45	0.011	CD	NUMBER	0.011	num	46	SENT_220	[p11l12t1351r396b1427],
46	)	NN	O	)	dep	44	SENT_220	[p11l12t1351r396b1427],
47	.	.	O	.	_	0	SENT_220	[p11l12t1351r396b1427],

1	In	IN	O	in	_	0	SENT_221	[p11l441t1352r496b1411],
2	every	DT	O	every	det	5	SENT_221	[p11l532t1367r728b1427],
3	clinical	JJ	O	clinical	amod	5	SENT_221	[p11l759t1350r1013b1411],
4	predictor	NN	O	predictor	nn	5	SENT_221	[p11l1051t1350r1380b1427],
5	group	NN	O	group	prep_in	12	SENT_221	[p11l1412t1365r1633b1427],
6	,	,	O	,	_	0	SENT_221	[p11l1412t1365r1633b1427],
7	patients	NNS	O	patient	nsubj	12	SENT_221	[p11l1676t1352r1963b1427],
8	with	IN	O	with	_	0	SENT_221	[p11l1995t1350r2149b1411],
9	the	DT	O	the	det	11	SENT_221	[p11l8t1449r122b1509],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_221	[p11l151t1449r332b1509],
11	mutations	NNS	O	mutation	prep_with	7	SENT_221	[p11l358t1450r711b1509],
12	showed	VBD	O	show	_	0	SENT_221	[p11l737t1449r998b1509],
13	higher	JJR	O	higher	amod	15	SENT_221	[p11l1029t1449r1251b1524],
14	response	NN	O	response	nn	15	SENT_221	[p11l1277t1465r1586b1524],
15	rate	NN	O	rate	nsubj	38	SENT_221	[p11l1615t1454r1756b1509],
16	suggesting	VBG	O	suggest	partmod	15	SENT_221	[p11l1782t1450r2151b1524],
17	that	IN	O	that	complm	25	SENT_221	[p11l8t1546r153b1607],
18	identiﬁcation	NN	O	identiﬁcation	nsubj	25	SENT_221	[p11l186t1546r660b1607],
19	of	IN	O	of	_	0	SENT_221	[p11l695t1546r766b1607],
20	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_221	[p11l799t1547r980b1607],
21	mutational	JJ	O	mutational	amod	22	SENT_221	[p11l1014t1546r1399b1607],
22	status	NN	O	status	prep_of	18	SENT_221	[p11l1432t1551r1643b1607],
23	may	MD	O	may	aux	25	SENT_221	[p11l1678t1562r1822b1623],
24	be	VB	O	be	cop	25	SENT_221	[p11l1855t1546r1937b1607],
25	helpful	JJ	O	helpful	ccomp	16	SENT_221	[p11l1973t1546r2147b1623, p11l7t1644r99b1705],
26	in	IN	O	in	_	0	SENT_221	[p11l124t1645r183b1704],
27	prediction	NN	O	prediction	prep_in	25	SENT_221	[p11l212t1644r572b1721],
28	of	IN	O	of	_	0	SENT_221	[p11l598t1644r669b1705],
29	geﬁtinib	NN	O	geﬁtinib	nn	30	SENT_221	[p11l691t1644r983b1721],
30	responsiveness	NN	O	responsiveness	prep_of	27	SENT_221	[p11l1010t1645r1534b1721],
31	regardless	RB	O	regardless	_	0	SENT_221	[p11l1561t1644r1920b1721],
32	of	IN	O	of	_	0	SENT_221	[p11l1944t1644r2015b1705],
33	the	DT	O	the	det	34	SENT_221	[p11l2036t1644r2151b1705],
34	number	NN	O	number	prep_regardless_of	25	SENT_221	[p11l10t1742r280b1802],
35	of	IN	O	of	_	0	SENT_221	[p11l310t1742r381b1802],
36	clinical	JJ	O	clinical	amod	37	SENT_221	[p11l411t1742r666b1802],
37	predictors	NNS	O	predictor	prep_of	34	SENT_221	[p11l702t1742r1062b1817],
38	(	VBP	O	(	ccomp	12	SENT_221	[p11l1099t1743r1248b1817],
39	Fig	NN	O	fig	dobj	38	SENT_221	[p11l1099t1743r1248b1817],
40	.	.	O	.	_	0	SENT_221	[p11l1099t1743r1248b1817],

1	3	CD	NUMBER	3	_	0	SENT_222	[p11l1290t1742r1378b1817],
2	)	NN	O	)	dep	1	SENT_222	[p11l1290t1742r1378b1817],
3	.	.	O	.	_	0	SENT_222	[p11l1290t1742r1378b1817],

1	Moreover	RB	O	moreover	advmod	4	SENT_223	[p11l1416t1743r1758b1815],
2	,	,	O	,	_	0	SENT_223	[p11l1416t1743r1758b1815],
3	there	EX	O	there	expl	4	SENT_223	[p11l1798t1742r1988b1802],
4	was	VBD	O	be	_	0	SENT_223	[p11l2019t1758r2151b1802],
5	no	DT	O	no	det	7	SENT_223	[p11l10t1855r89b1900],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_223	[p11l131t1839r495b1916],
7	association	NN	O	association	nsubj	4	SENT_223	[p11l536t1840r926b1900],
8	between	IN	O	between	_	0	SENT_223	[p11l972t1839r1275b1900],
9	the	DT	O	the	det	10	SENT_223	[p11l1319t1839r1434b1900],
10	number	NN	O	number	prep_between	7	SENT_223	[p11l1478t1839r1748b1900],
11	of	IN	O	of	_	0	SENT_223	[p11l1786t1839r1858b1900],
12	clinical	JJ	O	clinical	amod	13	SENT_223	[p11l1896t1839r2150b1900],
13	predictors	NNS	O	predictor	prep_of	10	SENT_223	[p11l10t1937r369b2014],
14	and	CC	O	and	_	0	SENT_223	[p11l398t1937r522b1998],
15	response	NN	O	response	conj_and	10	SENT_223	[p11l556t1953r865b2014],
16	in	IN	O	in	_	0	SENT_223	[p11l893t1938r953b1998],
17	patients	NNS	O	patient	prep_in	15	SENT_223	[p11l986t1938r1273b2014],
18	with	IN	O	with	_	0	SENT_223	[p11l1300t1937r1453b1998],
19	geﬁtinib	NN	O	geﬁtinib	nn	22	SENT_223	[p11l1485t1937r2148b2014, p11l10t2035r192b2095],
20	—	CD	NUMBER	—	num	22	SENT_223	[p11l1485t1937r2148b2014, p11l10t2035r192b2095],
21	sensitiveEGFR	NN	O	sensitiveegfr	nn	22	SENT_223	[p11l1485t1937r2148b2014, p11l10t2035r192b2095],
22	mutation	NN	O	mutation	prep_with	17	SENT_223	[p11l217t2036r560b2095],
23	.	.	O	.	_	0	SENT_223	[p11l217t2036r560b2095],

1	In	IN	O	in	_	0	SENT_224	[p11l597t2036r652b2094],
2	contrast	NN	O	contrast	prep_in	5	SENT_224	[p11l680t2040r995b2108],
3	,	,	O	,	_	0	SENT_224	[p11l680t2040r995b2108],
4	RR	NN	O	rr	nsubj	5	SENT_224	[p11l1031t2036r1119b2094],
5	increased	VBD	O	increase	_	0	SENT_224	[p11l1143t2035r1481b2095],
6	as	IN	O	as	mark	11	SENT_224	[p11l1510t2051r1580b2095],
7	number	NN	O	number	nsubj	11	SENT_224	[p11l1608t2035r1878b2095],
8	of	IN	O	of	_	0	SENT_224	[p11l1902t2035r1972b2095],
9	clinical	JJ	O	clinical	amod	10	SENT_224	[p11l1995t2035r2148b2095, p11l8t2132r130b2193],
10	predictor	NN	O	predictor	prep_of	7	SENT_224	[p11l158t2132r487b2209],
11	increased	VBD	O	increase	advcl	5	SENT_224	[p11l510t2132r873b2193],
12	:	:	O	:	_	0	SENT_224	[p11l510t2132r873b2193],
13	o	NN	PERCENT	o	nn	14	SENT_224	[p11l904t2132r990b2193],
14	%	NN	PERCENT	%	dobj	11	SENT_224	[p11l904t2132r990b2193],
15	(	CD	NUMBER	(	number	16	SENT_224	[p11l1019t2132r1235b2208],
16	0/27	CD	NUMBER	0/27	dep	17	SENT_224	[p11l1019t2132r1235b2208],
17	)	NN	O	)	dep	14	SENT_224	[p11l1019t2132r1235b2208],
18	in	IN	O	in	_	0	SENT_224	[p11l1262t2133r1321b2192],
19	zero	CD	NUMBER	zero	num	21	SENT_224	[p11l1347t2148r1500b2193],
20	clinical	JJ	O	clinical	amod	21	SENT_224	[p11l1524t2132r1778b2193],
21	predictor	NN	O	predictor	prep_in	14	SENT_224	[p11l1806t2132r2145b2209],
22	,	,	O	,	_	0	SENT_224	[p11l1806t2132r2145b2209],
23	10.3	CD	PERCENT	10.3	number	24	SENT_224	[p11l12t2230r207b2290],
24	%	NN	PERCENT	%	amod	35	SENT_224	[p11l12t2230r207b2290],
25	(	CD	NUMBER	(	number	26	SENT_224	[p11l237t2230r453b2306],
26	3/29	CD	NUMBER	3/29	dep	27	SENT_224	[p11l237t2230r453b2306],
27	)	NN	O	)	amod	35	SENT_224	[p11l237t2230r453b2306],
28	in	IN	O	in	_	0	SENT_224	[p11l480t2230r540b2290],
29	one	CD	NUMBER	one	prep_in	27	SENT_224	[p11l567t2245r717b2303],
30	,	,	O	,	_	0	SENT_224	[p11l567t2245r717b2303],
31	15.4	CD	PERCENT	15.4	num	32	SENT_224	[p11l753t2230r948b2290],
32	%	NN	PERCENT	%	appos	29	SENT_224	[p11l753t2230r948b2290],
33	(	CD	NUMBER	(	number	34	SENT_224	[p11l978t2230r1194b2306],
34	2/13	CD	NUMBER	2/13	num	32	SENT_224	[p11l978t2230r1194b2306],
35	)	NN	O	)	appos	14	SENT_224	[p11l978t2230r1194b2306],
36	in	IN	O	in	_	0	SENT_224	[p11l1222t2230r1281b2290],
37	two	CD	NUMBER	two	prep_in	35	SENT_224	[p11l1309t2235r1439b2290],
38	and	CC	O	and	_	0	SENT_224	[p11l1465t2229r1588b2290],
39	25.0	CD	PERCENT	25.0	num	40	SENT_224	[p11l1616t2230r1816b2290],
40	%	NN	PERCENT	%	dobj	11	SENT_224	[p11l1616t2230r1816b2290],
41	(	CD	NUMBER	(	number	42	SENT_224	[p11l1845t2230r2061b2306],
42	7/28	CD	NUMBER	7/28	num	43	SENT_224	[p11l1845t2230r2061b2306],
43	)	NN	O	)	dep	40	SENT_224	[p11l1845t2230r2061b2306],
44	in	IN	O	in	_	0	SENT_224	[p11l2089t2230r2149b2290],
45	three	CD	NUMBER	three	number	46	SENT_224	[p11l8t2328r198b2389],
46	(	CD	NUMBER	(	dep	47	SENT_224	[p11l231t2328r591b2405],
47	p	NN	O	p	dep	50	SENT_224	[p11l231t2328r591b2405],
48	=	JJ	O	=	amod	50	SENT_224	[p11l231t2328r591b2405],
49	0.005	CD	NUMBER	0.005	tmod	48	SENT_224	[p11l231t2328r591b2405],
50	)	NN	O	)	prep_in	11	SENT_224	[p11l231t2328r591b2405],
51	in	IN	O	in	_	0	SENT_224	[p11l623t2329r682b2388],
52	patients	NNS	O	patient	prep_in	11	SENT_224	[p11l716t2329r1004b2404],
53	with	IN	O	with	_	0	SENT_224	[p11l1031t2328r1185b2389],
54	wild-type	JJ	O	wild-type	amod	55	SENT_224	[p11l1215t2328r1553b2404],
55	EGFR	NN	ORGANIZATION	egfr	prep_with	52	SENT_224	[p11l1586t2328r1787b2389],
56	.	.	O	.	_	0	SENT_224	[p11l1586t2328r1787b2389],

1	However	RB	O	however	advmod	7	SENT_225	[p11l1826t2329r2145b2402],
2	,	,	O	,	_	0	SENT_225	[p11l1826t2329r2145b2402],
3	these	DT	O	these	det	4	SENT_225	[p11l8t2426r199b2487],
4	differences	NNS	O	difference	nsubj	7	SENT_225	[p11l232t2426r635b2487],
5	did	VBD	O	do	aux	7	SENT_225	[p11l668t2426r773b2487],
6	not	RB	O	not	neg	7	SENT_225	[p11l812t2431r924b2487],
7	result	VB	O	result	_	0	SENT_225	[p11l960t2426r1161b2487],
8	in	IN	O	in	_	0	SENT_225	[p11l1194t2427r1253b2486],
9	signiﬁcant	NN	O	signiﬁcant	nn	10	SENT_225	[p11l1289t2426r1653b2502],
10	difference	NN	O	difference	prep_in	7	SENT_225	[p11l1686t2426r2055b2487],
11	in	IN	O	in	_	0	SENT_225	[p11l2089t2427r2149b2486],
12	terms	NNS	O	term	prep_in	7	SENT_225	[p11l8t2529r209b2584],
13	of	IN	O	of	_	0	SENT_225	[p11l238t2523r309b2584],
14	TTP	NN	O	ttp	prep_of	12	SENT_225	[p11l333t2524r469b2584],
15	or	CC	O	or	_	0	SENT_225	[p11l498t2539r570b2584],
16	OS	NN	O	os	conj_or	14	SENT_225	[p11l598t2524r684b2584],
17	(	CD	NUMBER	(	num	18	SENT_225	[p11l719t2523r900b2600],
18	data	NNS	O	datum	npadvmod	19	SENT_225	[p11l719t2523r900b2600],
19	not	RB	O	not	neg	20	SENT_225	[p11l932t2529r1045b2584],
20	shown	VBN	O	show	partmod	12	SENT_225	[p11l1073t2523r1344b2600],
21	)	NN	O	)	dobj	20	SENT_225	[p11l1073t2523r1344b2600],
22	.	.	O	.	_	0	SENT_225	[p11l1073t2523r1344b2600],

1	Patients	NNS	O	patient	nsubj	6	SENT_226	[p11l120t2623r403b2682],
2	with	IN	O	with	_	0	SENT_226	[p11l439t2621r593b2682],
3	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	5	SENT_226	[p11l633t2621r1270b2698],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_226	[p11l1311t2622r1491b2683],
5	mutation	NN	O	mutation	prep_with	1	SENT_226	[p11l1529t2623r1847b2682],
6	showed	VBD	O	show	_	0	SENT_226	[p11l1887t2621r2148b2682],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_226	[p11l7t2720r435b2796],
8	higher	JJR	O	higher	amod	10	SENT_226	[p11l462t2720r683b2796],
9	response	NN	O	response	nn	10	SENT_226	[p11l710t2736r1019b2797],
10	rate	NN	O	rate	dobj	6	SENT_226	[p11l1047t2725r1189b2781],
11	in	IN	O	in	_	0	SENT_226	[p11l1215t2721r1273b2780],
12	every	DT	O	every	det	15	SENT_226	[p11l1302t2736r1497b2796],
13	individual	JJ	O	individual	amod	15	SENT_226	[p11l1521t2720r1867b2781],
14	patient	NN	O	patient	nn	15	SENT_226	[p11l1896t2721r2152b2797],
15	group	NN	O	group	prep_in	6	SENT_226	[p11l8t2832r206b2894],
16	with	IN	O	with	_	0	SENT_226	[p11l225t2817r378b2878],
17	good	JJ	O	good	amod	18	SENT_226	[p11l402t2817r566b2894],
18	response	NN	O	response	prep_with	15	SENT_226	[p11l592t2833r924b2894],
19	:	:	O	:	_	0	SENT_226	[p11l592t2833r924b2894],
20	female	JJ	O	female	amod	21	SENT_226	[p11l951t2817r1197b2878],
21	[	JJ	O	[	amod	23	SENT_226	[p11l1223t2817r1447b2894],
22	64.3	CD	PERCENT	64.3	num	23	SENT_226	[p11l1223t2817r1447b2894],
23	%	NN	PERCENT	%	dep	15	SENT_226	[p11l1223t2817r1447b2894],
24	(	CD	NUMBER	(	number	25	SENT_226	[p11l1472t2818r1688b2894],
25	9/14	CD	NUMBER	9/14	num	23	SENT_226	[p11l1472t2818r1688b2894],
26	)	CD	NUMBER	)	dep	23	SENT_226	[p11l1472t2818r1688b2894],
27	versus	CC	O	versus	prep	6	SENT_226	[p11l1710t2833r1931b2878],
28	19.4	CD	PERCENT	19.4	num	29	SENT_226	[p11l1957t2818r2151b2878],
29	%	NN	PERCENT	%	dep	27	SENT_226	[p11l1957t2818r2151b2878],

1	0.0-3	CD	NUMBER	0.0-3	number	2	SENT_227	[p11l649t3056r775b3098],
2	*	CD	NUMBER	*	num	3	SENT_227	[p11l649t3056r775b3098],
3	0.05	CD	NUMBER	0.05	_	0	SENT_227	[p11l985t3056r1112b3098],
4	‘	CD	NUMBER	‘	num	5	SENT_227	[p11l985t3056r1112b3098],
5	D.	NNP	O	D.	dep	3	SENT_227	[p11l1332t3056r1455b3098],
6	02	CD	NUMBER	02	num	5	SENT_227	[p11l1332t3056r1455b3098],
7	:	:	O	:	_	0	SENT_227	[p11l1332t3056r1455b3098],
8	*	CD	NUMBER	*	num	9	SENT_227	[p11l1332t3056r1455b3098],
9	D.	NNP	O	D.	dep	3	SENT_227	[p11l1669t3056r1792b3098],
10	13	CD	NUMBER	13	num	9	SENT_227	[p11l1669t3056r1792b3098],
11	*	CD	NUMBER	*	num	12	SENT_227	[p11l1669t3056r1792b3098],
12	|	NN	O	|	dep	9	SENT_227	[p11l616t3111r775b3143],
13	.	.	O	.	_	0	SENT_227	[p11l616t3111r775b3143],

1	—	NN	O	—	_	0	SENT_228	[p11l616t3111r775b3143],
2	.	.	O	.	_	0	SENT_228	[p11l616t3111r775b3143],

1	.	.	O	.	_	0	SENT_229	[p11l616t3111r775b3143],

1	—	NN	O	—	_	0	SENT_230	[p11l616t3111r775b3143],
2	.	.	O	.	_	0	SENT_230	[p11l616t3111r775b3143],

1	I	PRP	O	I	_	0	SENT_231	[p11l616t3111r775b3143],
2	1	CD	NUMBER	1	number	3	SENT_231	[p11l953t3111r1113b3143],
3	*	CD	NUMBER	*	dep	1	SENT_231	[p11l953t3111r1113b3143],
4	’	NN	O	’	dep	3	SENT_231	[p11l953t3111r1113b3143],
5	!	.	O	!	_	0	SENT_231	[p11l953t3111r1113b3143],

1	I	PRP	O	I	_	0	SENT_232	[p11l1297t3111r1456b3143],
2	.	.	O	.	_	0	SENT_232	[p11l1297t3111r1456b3143],

1	—	NN	O	—	_	0	SENT_233	[p11l1297t3111r1456b3143],
2	.	.	O	.	_	0	SENT_233	[p11l1297t3111r1456b3143],

1	.	.	O	.	_	0	SENT_234	[p11l1297t3111r1456b3143],

1	—	NN	O	—	_	0	SENT_235	[p11l1297t3111r1456b3143],
2	.	.	O	.	_	0	SENT_235	[p11l1297t3111r1456b3143],

1	1	CD	NUMBER	1	_	0	SENT_236	[p11l1297t3111r1456b3143],
2	1:1	CD	NUMBER	1:1	num	3	SENT_236	[p11l1636t3114r1795b3143],
3	D95	NN	O	d95	dep	9	SENT_236	[p11l584t3165r662b3204],
4	100	CD	PERCENT	100	num	5	SENT_236	[p11l703t3165r837b3204],
5	%	NN	PERCENT	%	dep	3	SENT_236	[p11l703t3165r837b3204],
6	10	CD	PERCENT	10	num	7	SENT_236	[p11l907t3165r1011b3204],
7	%	NN	PERCENT	%	dep	9	SENT_236	[p11l907t3165r1011b3204],
8	50	CD	PERCENT	50	num	9	SENT_236	[p11l1057t3162r1164b3201],
9	%	NN	PERCENT	%	dep	1	SENT_236	[p11l1057t3162r1164b3201],
10	14926-10051	CD	NUMBER	14926-10051	dep	9	SENT_236	[p11l1251t3162r1507b3201],
11	:	:	O	:	_	0	SENT_236	[p11l1251t3162r1507b3201],
12	25	CD	PERCENT	25	num	13	SENT_236	[p11l1588t3162r1695b3201],
13	%	NN	PERCENT	%	dep	1	SENT_236	[p11l1588t3162r1695b3201],
14	55	CD	PERCENT	55	number	15	SENT_236	[p11l1740t3162r1844b3201],
15	%	NN	PERCENT	%	amod	13	SENT_236	[p11l1740t3162r1844b3201],

1	100	CD	NUMBER	100	nsubj	3	SENT_237	[p12l370t44r468b92],
2	(	CD	NUMBER	(	num	3	SENT_237	[p12l551t21r691b73],
3	N28	NN	O	n28	_	0	SENT_237	[p12l551t21r691b73],
4	)	CD	NUMBER	)	number	5	SENT_237	[p12l551t21r691b73],
5	(	CD	NUMBER	(	num	6	SENT_237	[p12l713t21r823b73],
6	H1	NN	O	h1	dep	3	SENT_237	[p12l713t21r823b73],
7	)	CD	NUMBER	)	number	8	SENT_237	[p12l713t21r823b73],
8	{	CD	NUMBER	{	dep	3	SENT_237	[p12l888t21r1027b73],
9	.3129	CD	NUMBER	.3129	dep	8	SENT_237	[p12l888t21r1027b73],
10	}	SYM	O	}	dep	3	SENT_237	[p12l888t21r1027b73],
11	-	:	O	-	_	0	SENT_237	[p12l1054t18r1164b70],
12	(	CD	NUMBER	(	nsubj	15	SENT_237	[p12l1054t18r1164b70],
13	3J	NN	O	3j	nn	15	SENT_237	[p12l1054t18r1164b70],
14	'	''	O	'	_	0	SENT_237	[p12l1054t18r1164b70],
15	E	NN	O	e	parataxis	3	SENT_237	[p12l1054t18r1164b70],
16	-	:	O	-	_	0	SENT_237	[p12l1054t18r1164b70],
17	]	CD	NUMBER	]	number	18	SENT_237	[p12l1054t18r1164b70],
18	[	CD	NUMBER	[	num	19	SENT_237	[p12l1232t18r1494b70],
19	H14	NN	O	h14	dep	15	SENT_237	[p12l1232t18r1494b70],
20	]	SYM	O	]	dep	15	SENT_237	[p12l1232t18r1494b70],
21	-	:	O	-	_	0	SENT_237	[p12l1232t18r1494b70],
22	(	NN	O	(	dep	25	SENT_237	[p12l1232t18r1494b70],
23	3/3	CD	NUMBER	3/3	number	24	SENT_237	[p12l1232t18r1494b70],
24	)	CD	NUMBER	)	num	25	SENT_237	[p12l1232t18r1494b70],
25	(	NN	O	(	parataxis	3	SENT_237	[p12l1569t18r1860b70],
26	7	CD	NUMBER	7	amod	25	SENT_237	[p12l1569t18r1860b70],
27	.	.	O	.	_	0	SENT_237	[p12l1569t18r1860b70],

1	-	:	O	-	_	0	SENT_238	[p12l1569t18r1860b70],
2	'	''	DATE	'	_	0	SENT_238	[p12l1569t18r1860b70],
3	28	CD	DATE	28	_	0	SENT_238	[p12l1569t18r1860b70],
4	)	CD	NUMBER	)	number	5	SENT_238	[p12l1569t18r1860b70],
5	(	CD	NUMBER	(	num	7	SENT_238	[p12l1569t18r1860b70],
6	1Ef11	NN	O	1ef11	nn	7	SENT_238	[p12l1569t18r1860b70],
7	)	NN	O	)	dep	3	SENT_238	[p12l1569t18r1860b70],

1	El	NNP	O	El	_	0	SENT_239	[p12l403t251r435b296],
2	.5	CD	NUMBER	.5	num	1	SENT_239	[p12l438t251r471b296],
3	U	NNP	O	U	nn	4	SENT_239	[p12l402t438r435b484],
4	’	NNP	O	’	dep	1	SENT_239	[p12l402t438r435b484],
5	!	.	O	!	_	0	SENT_239	[p12l402t438r435b484],

1	D	NN	O	d	_	0	SENT_240	[p12l438t438r468b484],

1	Flesponse	NNP	O	Flesponse	nn	2	SENT_241	[p12l280t467r348b806],
2	Hate	NNP	O	Hate	_	0	SENT_241	[p12l280t293r335b442],

1	M	NN	O	m	_	0	SENT_242	[p12l402t812r435b858],
2	Jan	NNP	DATE	Jan	nn	4	SENT_242	[p12l402t628r435b673],
3	D	NNP	O	D	nn	4	SENT_242	[p12l438t812r470b858],
4	D	NNP	O	D	dep	1	SENT_242	[p12l438t628r468b674],
5	(	NN	O	(	dep	4	SENT_242	[p12l590t1021r649b1123],
6	.	.	O	.	_	0	SENT_242	[p12l590t1021r649b1123],

1	—	NN	O	—	_	0	SENT_243	[p12l590t1021r649b1123],
2	.	.	O	.	_	0	SENT_243	[p12l590t1021r649b1123],
3	)	SYM	O	)	dep	1	SENT_243	[p12l590t1021r649b1123],

1	(	NN	O	(	_	0	SENT_244	[p12l733t1061r810b1123],
2	+	CC	O	+	_	0	SENT_244	[p12l733t1061r810b1123],
3	)	CD	NUMBER	)	number	4	SENT_244	[p12l733t1061r810b1123],
4	(	CD	NUMBER	(	conj_+	1	SENT_244	[p12l930t1061r989b1123],
5	-1	CD	NUMBER	-1	num	6	SENT_244	[p12l930t1061r989b1123],
6	(	NN	O	(	dep	4	SENT_244	[p12l1073t1061r1148b1123],
7	+	CC	O	+	_	0	SENT_244	[p12l1073t1061r1148b1123],
8	)	CD	NUMBER	)	number	9	SENT_244	[p12l1073t1061r1148b1123],
9	(	CD	NUMBER	(	conj_+	4	SENT_244	[p12l1271t1061r1329b1123],
10	-1	CD	NUMBER	-1	num	11	SENT_244	[p12l1271t1061r1329b1123],
11	(	NN	O	(	dep	9	SENT_244	[p12l1419t1062r1494b1123],
12	+1	CD	NUMBER	+1	num	13	SENT_244	[p12l1419t1062r1494b1123],
13	(	CD	NUMBER	(	dep	1	SENT_244	[p12l1614t1029r1672b1123],
14	-1	CD	NUMBER	-1	num	15	SENT_244	[p12l1614t1029r1672b1123],
15	(	NN	O	(	dep	13	SENT_244	[p12l1756t1061r1831b1123],
16	+	CC	O	+	_	0	SENT_244	[p12l1756t1061r1831b1123],
17	)	NN	O	)	dep	13	SENT_244	[p12l1756t1061r1831b1123],

1	o	NN	O	o	_	0	SENT_245	[p12l671t1149r704b1195],
2	1	CD	NUMBER	1	number	3	SENT_245	[p12l1017t1146r1037b1195],
3	2	CD	NUMBER	2	dep	1	SENT_245	[p12l1364t1149r1397b1195],
4	3	CD	NUMBER	3	num	5	SENT_245	[p12l1698t1149r1730b1195],
5	Number	NN	O	number	dep	1	SENT_245	[p12l703t1246r969b1301],
6	of	IN	O	of	_	0	SENT_245	[p12l992t1243r1061b1301],
7	~	NN	O	~	nn	8	SENT_245	[p12l1080t1243r1332b1301],
8	Clinic	NNP	O	Clinic	prep_of	5	SENT_245	[p12l1080t1243r1332b1301],
9	:	:	O	:	_	0	SENT_245	[p12l1080t1243r1332b1301],
10	_	CD	NUMBER	_	num	12	SENT_245	[p12l1080t1243r1332b1301],
11	al	NNP	O	al	nn	12	SENT_245	[p12l1080t1243r1332b1301],
12	Prediié-c	NNP	O	Prediié-c	dep	5	SENT_245	[p12l1361t1243r1708b1301],
13	:	:	O	:	_	0	SENT_245	[p12l1361t1243r1708b1301],
14	to	TO	O	to	_	0	SENT_245	[p12l1361t1243r1708b1301],
15	=	JJ	O	=	amod	16	SENT_245	[p12l1361t1243r1708b1301],
16	r5	NN	O	r5	prep_to	5	SENT_245	[p12l1361t1243r1708b1301],

1	Fig	NN	O	fig	_	0	SENT_246	[p12l10t1405r130b1476],
2	.	.	O	.	_	0	SENT_246	[p12l10t1405r130b1476],

1	3	CD	NUMBER	3	num	3	SENT_247	[p12l164t1405r197b1461],
2	Response	NN	O	response	nn	3	SENT_247	[p12l316t1405r619b1476],
3	rates	NNS	O	rate	_	0	SENT_247	[p12l647t1409r812b1461],
4	according	VBG	O	accord	_	0	SENT_247	[p12l837t1404r1162b1476],
5	to	TO	O	to	prepc_according_to	3	SENT_247	[p12l1188t1409r1254b1461],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_247	[p12l1282t1405r1453b1461],
7	mutational	JJ	O	mutational	amod	8	SENT_247	[p12l1479t1404r1843b1461],
8	status	NN	O	status	pobj	3	SENT_247	[p12l1868t1409r2067b1461],
9	in	IN	O	in	_	0	SENT_247	[p12l2093t1405r2149b1460],
10	clinical	JJ	O	clinical	amod	12	SENT_247	[p12l7t1501r247b1558],
11	predictor	NN	O	predictor	nn	12	SENT_247	[p12l285t1501r596b1573],
12	groups	NNS	O	group	prep_in	8	SENT_247	[p12l630t1515r870b1573],
13	.	.	O	.	_	0	SENT_247	[p12l630t1515r870b1573],

1	(	NN	O	(	_	0	SENT_248	[p12l916t1503r1000b1573],
2	+	CC	O	+	_	0	SENT_248	[p12l916t1503r1000b1573],
3	)	CD	NUMBER	)	num	4	SENT_248	[p12l916t1503r1000b1573],
4	Denotes	NNS	O	denote	conj_+	1	SENT_248	[p12l1041t1503r1307b1558],
5	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	8	SENT_248	[p12l1343t1501r1944b1573],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_248	[p12l1982t1502r2153b1559],
7	mutation	NN	O	mutation	nn	8	SENT_248	[p12l9t1601r309b1657],
8	cases	NNS	O	case	dep	1	SENT_248	[p12l339t1615r537b1669],
9	,	,	O	,	_	0	SENT_248	[p12l339t1615r537b1669],
10	(	NN	O	(	appos	8	SENT_248	[p12l575t1601r679b1671],
11	.	.	O	.	_	0	SENT_248	[p12l575t1601r679b1671],

1	—	NN	O	—	_	0	SENT_249	[p12l575t1601r679b1671],
2	.	.	O	.	_	0	SENT_249	[p12l575t1601r679b1671],
3	)	SYM	O	)	dep	1	SENT_249	[p12l575t1601r679b1671],

1	denotes	VBZ	O	denote	_	0	SENT_250	[p12l709t1600r973b1657],
2	wild-type	JJ	O	wild-type	amod	7	SENT_250	[p12l999t1600r1319b1671],
3	or	CC	O	or	_	0	SENT_250	[p12l1346t1615r1415b1657],
4	other	JJ	O	other	amod	7	SENT_250	[p12l1440t1600r1622b1657],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_250	[p12l1650t1600r1821b1657],
6	mutation	NN	O	mutation	nn	7	SENT_250	[p12l1849t1601r2149b1657],
7	cases	NNS	O	case	dobj	1	SENT_250	[p12l7t1713r204b1755],
8	.	.	O	.	_	0	SENT_250	[p12l7t1713r204b1755],

1	Numbers	NNS	O	number	nsubj	5	SENT_251	[p12l239t1698r529b1755],
2	in	IN	O	in	_	0	SENT_251	[p12l555t1699r610b1754],
3	the	DT	O	the	det	4	SENT_251	[p12l639t1698r747b1755],
4	parentheses	NNS	O	parenthesis	prep_in	1	SENT_251	[p12l774t1698r1178b1770],
5	indicate	VBP	O	indicate	_	0	SENT_251	[p12l1204t1698r1476b1755],
6	numbers	NNS	O	number	dobj	5	SENT_251	[p12l1503t1698r1787b1755],
7	of	IN	O	of	_	0	SENT_251	[p12l1811t1698r1879b1755],
8	responders	NNS	O	responder	prep_of	6	SENT_251	[p12l1904t1713r2148b1770, p12l7t1795r182b1852],
9	/	:	O	/	punct	11	SENT_251	[p12l1904t1713r2148b1770, p12l7t1795r182b1852],
10	total	JJ	O	total	amod	11	SENT_251	[p12l191t1795r349b1852],
11	patients	NNS	O	patient	dep	8	SENT_251	[p12l380t1797r651b1867],
12	in	IN	O	in	_	0	SENT_251	[p12l679t1797r735b1852],
13	each	DT	O	each	det	15	SENT_251	[p12l765t1795r919b1852],
14	patient	NN	O	patient	nn	15	SENT_251	[p12l951t1797r1192b1867],
15	group	NN	O	group	prep_in	11	SENT_251	[p12l1220t1809r1429b1867],
16	.	.	O	.	_	0	SENT_251	[p12l1220t1809r1429b1867],

1	*	NN	O	*	nn	2	SENT_252	[p12l1462t1785r1768b1867],
2	p-Values	NNS	O	p-value	_	0	SENT_252	[p12l1462t1785r1768b1867],
3	by	IN	O	by	_	0	SENT_252	[p12l1797t1795r1873b1867],
4	Fisher	NNP	PERSON	Fisher	poss	7	SENT_252	[p12l1901t1795r2151b1852],
5	’s	POS	O	’s	_	0	SENT_252	[p12l1901t1795r2151b1852],
6	exact	JJ	O	exact	amod	7	SENT_252	[p12l7t1900r190b1952],
7	test	NN	O	test	prep_by	2	SENT_252	[p12l217t1900r366b1952],
8	.	.	O	.	_	0	SENT_252	[p12l217t1900r366b1952],

1	(	NN	O	(	nn	3	SENT_253	[p12l14t1989r255b2063],
2	7/36	CD	NUMBER	7/36	num	3	SENT_253	[p12l14t1989r255b2063],
3	)	NN	O	)	_	0	SENT_253	[p12l14t1989r255b2063],
4	,	,	O	,	_	0	SENT_253	[p12l14t1989r255b2063],
5	p	NN	O	p	appos	3	SENT_253	[p12l294t1988r700b2064],
6	=	JJ	O	=	amod	8	SENT_253	[p12l294t1988r700b2064],
7	0.0005	CD	NUMBER	0.0005	tmod	6	SENT_253	[p12l294t1988r700b2064],
8	]	NN	O	]	dep	5	SENT_253	[p12l294t1988r700b2064],
9	,	,	O	,	_	0	SENT_253	[p12l294t1988r700b2064],
10	adenocarcinoma	NN	O	adenocarcinoma	appos	3	SENT_253	[p12l743t1988r1327b2048],
11	[	CD	PERCENT	[	num	10	SENT_253	[p12l1370t1988r1593b2064],
12	55.6	CD	PERCENT	55.6	number	13	SENT_253	[p12l1370t1988r1593b2064],
13	%	NN	PERCENT	%	amod	10	SENT_253	[p12l1370t1988r1593b2064],
14	(	CD	NUMBER	(	number	15	SENT_253	[p12l1635t1989r1892b2064],
15	10/18	CD	NUMBER	10/18	dep	3	SENT_253	[p12l1635t1989r1892b2064],
16	)	CD	NUMBER	)	dep	15	SENT_253	[p12l1635t1989r1892b2064],
17	versus	CC	O	versus	_	0	SENT_253	[p12l1929t2004r2150b2048],
18	18.5	CD	PERCENT	18.5	num	19	SENT_253	[p12l14t2084r209b2144],
19	%	NN	PERCENT	%	conj_versus	15	SENT_253	[p12l14t2084r209b2144],
20	(	CD	NUMBER	(	number	21	SENT_253	[p12l254t2084r538b2159],
21	12/65	CD	NUMBER	12/65	num	19	SENT_253	[p12l254t2084r538b2159],
22	)	NN	O	)	dep	3	SENT_253	[p12l254t2084r538b2159],
23	,	,	O	,	_	0	SENT_253	[p12l254t2084r538b2159],
24	p	NN	O	p	appos	22	SENT_253	[p12l582t2083r917b2159],
25	=	JJ	O	=	amod	27	SENT_253	[p12l582t2083r917b2159],
26	0.005	CD	NUMBER	0.005	tmod	25	SENT_253	[p12l582t2083r917b2159],
27	]	NN	O	]	dep	3	SENT_253	[p12l582t2083r917b2159],
28	and	CC	O	and	_	0	SENT_253	[p12l964t2083r1087b2143],
29	never-smoker	JJ	O	never-smoker	amod	30	SENT_253	[p12l1133t2083r1618b2143],
30	[	NN	O	[	dep	3	SENT_253	[p12l1662t2083r1886b2159],
31	61.5	CD	PERCENT	61.5	num	32	SENT_253	[p12l1662t2083r1886b2159],
32	%	NN	PERCENT	%	dep	30	SENT_253	[p12l1662t2083r1886b2159],
33	(	CD	NUMBER	(	number	34	SENT_253	[p12l1932t2084r2147b2159],
34	8/13	CD	NUMBER	8/13	num	32	SENT_253	[p12l1932t2084r2147b2159],
35	)	CD	NUMBER	)	dep	3	SENT_253	[p12l1932t2084r2147b2159],
36	versus	CC	O	versus	prep	35	SENT_253	[p12l7t2196r228b2240],
37	22.5	CD	PERCENT	22.5	num	38	SENT_253	[p12l270t2180r469b2240],
38	%	NN	PERCENT	%	dep	36	SENT_253	[p12l270t2180r469b2240],
39	(	CD	NUMBER	(	number	40	SENT_253	[p12l516t2180r757b2255],
40	9/40	CD	NUMBER	9/40	dep	3	SENT_253	[p12l516t2180r757b2255],
41	)	NN	O	)	dep	40	SENT_253	[p12l516t2180r757b2255],
42	,	,	O	,	_	0	SENT_253	[p12l516t2180r757b2255],
43	p	NN	O	p	appos	3	SENT_253	[p12l802t2180r1164b2256],
44	=	JJ	O	=	amod	46	SENT_253	[p12l802t2180r1164b2256],
45	0.016	CD	NUMBER	0.016	tmod	44	SENT_253	[p12l802t2180r1164b2256],
46	]	NN	O	]	dep	43	SENT_253	[p12l802t2180r1164b2256],
47	.	.	O	.	_	0	SENT_253	[p12l802t2180r1164b2256],

1	In	IN	O	in	_	0	SENT_254	[p12l1217t2181r1271b2239],
2	a	DT	O	a	det	4	SENT_254	[p12l1316t2196r1353b2240],
3	multivariate	JJ	O	multivariate	amod	4	SENT_254	[p12l1397t2180r1833b2240],
4	analysis	NN	O	analysis	prep_in	56	SENT_254	[p12l1875t2180r2150b2255],
5	where	WRB	O	where	advmod	11	SENT_254	[p12l7t2276r227b2336],
6	the	DT	O	the	det	9	SENT_254	[p12l249t2276r364b2336],
7	three	CD	NUMBER	three	num	9	SENT_254	[p12l386t2276r576b2336],
8	clinical	JJ	O	clinical	amod	9	SENT_254	[p12l598t2276r851b2336],
9	predictors	NNS	O	predictor	nsubjpass	11	SENT_254	[p12l877t2276r1236b2352],
10	were	VBD	O	be	auxpass	11	SENT_254	[p12l1256t2292r1432b2336],
11	included	VBN	O	include	advcl	56	SENT_254	[p12l1454t2276r1754b2336],
12	separately	RB	O	separately	advmod	11	SENT_254	[p12l1779t2276r2152b2352],
13	as	IN	O	as	_	0	SENT_254	[p12l10t2388r79b2431],
14	covariates	NNS	O	covariate	prep_as	11	SENT_254	[p12l103t2373r468b2432],
15	together	RB	O	together	_	0	SENT_254	[p12l492t2371r800b2447],
16	with	IN	O	with	_	0	SENT_254	[p12l820t2371r973b2432],
17	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	18	SENT_254	[p12l1000t2371r1635b2447],
18	mutation	NN	O	mutation	prep_together_with	11	SENT_254	[p12l1662t2373r2004b2444],
19	,	,	O	,	_	0	SENT_254	[p12l1662t2373r2004b2444],
20	the	DT	O	the	det	22	SENT_254	[p12l2035t2371r2150b2431],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_254	[p12l12t2468r193b2528],
22	mutation	NN	O	mutation	dep	32	SENT_254	[p12l234t2469r550b2528],
23	(	CD	NUMBER	(	num	24	SENT_254	[p12l598t2468r721b2543],
24	OR	NN	O	or	dep	22	SENT_254	[p12l598t2468r721b2543],
25	10.7	CD	NUMBER	10.7	dep	24	SENT_254	[p12l764t2468r933b2541],
26	,	,	O	,	_	0	SENT_254	[p12l764t2468r933b2541],
27	95	CD	PERCENT	95	number	28	SENT_254	[p12l980t2468r1108b2528],
28	%	NN	PERCENT	%	amod	24	SENT_254	[p12l980t2468r1108b2528],
29	CI	NN	O	ci	dep	32	SENT_254	[p12l1148t2468r1209b2528],
30	3.6	CD	NUMBER	3.6	num	29	SENT_254	[p12l1255t2468r1600b2541],
31	—	CD	NUMBER	—	number	32	SENT_254	[p12l1255t2468r1600b2541],
32	32.2	CD	NUMBER	32.2	dep	50	SENT_254	[p12l1255t2468r1600b2541],
33	;	:	O	;	_	0	SENT_254	[p12l1255t2468r1600b2541],
34	p	NN	O	p	dep	35	SENT_254	[p12l1644t2468r1981b2544],
35	<	JJR	O	<	dep	32	SENT_254	[p12l1644t2468r1981b2544],
36	0.001	CD	NUMBER	0.001	num	37	SENT_254	[p12l1644t2468r1981b2544],
37	)	NN	O	)	dep	35	SENT_254	[p12l1644t2468r1981b2544],
38	and	CC	O	and	_	0	SENT_254	[p12l2024t2468r2148b2528],
39	never-smoker	JJ	O	never-smoker	amod	41	SENT_254	[p12l12t2564r497b2624],
40	(	NN	O	(	nn	41	SENT_254	[p12l524t2565r647b2640],
41	OR	NN	O	or	conj_and	32	SENT_254	[p12l524t2565r647b2640],
42	3.0	CD	NUMBER	3.0	dep	41	SENT_254	[p12l671t2565r801b2637],
43	,	,	O	,	_	0	SENT_254	[p12l671t2565r801b2637],
44	95	CD	PERCENT	95	number	45	SENT_254	[p12l832t2565r960b2624],
45	%	NN	PERCENT	%	amod	46	SENT_254	[p12l832t2565r960b2624],
46	CI	NN	O	ci	appos	42	SENT_254	[p12l985t2565r1045b2624],
47	1.1-8	CD	NUMBER	1.1-8	num	48	SENT_254	[p12l1079t2565r1379b2637],
48	.5	CD	NUMBER	.5	dep	46	SENT_254	[p12l1079t2565r1379b2637],
49	,	,	O	,	_	0	SENT_254	[p12l1079t2565r1379b2637],
50	p	NN	O	p	dep	56	SENT_254	[p12l1407t2580r1451b2640],
51	=	JJ	O	=	amod	53	SENT_254	[p12l1470t2588r1504b2608],
52	0.038	CD	NUMBER	0.038	num	53	SENT_254	[p12l1524t2565r1744b2639],
53	)	NN	O	)	nsubj	56	SENT_254	[p12l1524t2565r1744b2639],
54	were	VBD	O	be	cop	56	SENT_254	[p12l1769t2580r1945b2624],
55	independent	JJ	O	independent	amod	56	SENT_254	[p12l1970t2564r2146b2624, p12l12t2659r302b2735],
56	predictors	NNS	O	predictor	_	0	SENT_254	[p12l333t2659r692b2735],
57	of	IN	O	of	_	0	SENT_254	[p12l721t2659r792b2719],
58	response	NN	O	response	prep_of	56	SENT_254	[p12l821t2676r1152b2735],
59	.	.	O	.	_	0	SENT_254	[p12l821t2676r1152b2735],

1	Among	IN	O	among	_	0	SENT_255	[p12l117t2757r356b2832],
2	female	JJ	O	female	amod	3	SENT_255	[p12l429t2757r675b2817],
3	never-smokers	NNS	O	never-smoker	prep_among	33	SENT_255	[p12l750t2757r1265b2817],
4	with	IN	O	with	_	0	SENT_255	[p12l1336t2757r1489b2817],
5	adenocarcinoma	NN	O	adenocarcinoma	prep_with	3	SENT_255	[p12l1565t2757r2149b2817],
6	(	CD	NUMBER	(	number	7	SENT_255	[p12l14t2853r229b2928],
7	three	CD	NUMBER	three	num	9	SENT_255	[p12l14t2853r229b2928],
8	clinical	JJ	O	clinical	amod	9	SENT_255	[p12l262t2853r516b2913],
9	predictors	NNS	O	predictor	dep	5	SENT_255	[p12l553t2853r964b2929],
10	)	RB	O	)	advmod	5	SENT_255	[p12l553t2853r964b2929],
11	,	,	O	,	_	0	SENT_255	[p12l553t2853r964b2929],
12	the	DT	O	the	det	13	SENT_255	[p12l1005t2853r1119b2913],
13	group	NN	O	group	nsubj	33	SENT_255	[p12l1153t2868r1351b2929],
14	of	IN	O	of	_	0	SENT_255	[p12l1385t2853r1456b2913],
15	patients	NNS	O	patient	prep_of	13	SENT_255	[p12l1489t2854r1776b2929],
16	who	WP	O	who	nsubj	17	SENT_255	[p12l1807t2853r1952b2913],
17	have	VBP	O	have	rcmod	15	SENT_255	[p12l1988t2853r2150b2913],
18	the	DT	O	the	det	21	SENT_255	[p12l10t2949r124b3009],
19	best	JJS	O	best	amod	21	SENT_255	[p12l158t2949r305b3009],
20	treatment	NN	O	treatment	nn	21	SENT_255	[p12l336t2955r699b3009],
21	outcome	NN	O	outcome	dobj	17	SENT_255	[p12l730t2955r1038b3009],
22	as	IN	O	as	_	0	SENT_255	[p12l1070t2965r1140b3009],
23	determined	VBN	O	determine	amod	30	SENT_255	[p12l1171t2949r1581b3009],
24	by	IN	O	by	_	0	SENT_255	[p12l1619t2949r1698b3025],
25	clinical	JJ	O	clinical	amod	26	SENT_255	[p12l1727t2949r1981b3009],
26	factors	NNS	O	factor	prep_by	23	SENT_255	[p12l2013t2949r2146b3009, p12l10t3051r166b3119],
27	,	,	O	,	_	0	SENT_255	[p12l2013t2949r2146b3009, p12l10t3051r166b3119],
28	EGFR	NN	ORGANIZATION	egfr	appos	26	SENT_255	[p12l198t3046r379b3106],
29	mutational	JJ	O	mutational	amod	30	SENT_255	[p12l401t3046r786b3106],
30	status	NN	O	status	prep_as	21	SENT_255	[p12l808t3051r1018b3106],
31	could	MD	O	could	aux	33	SENT_255	[p12l1040t3046r1228b3106],
32	additionally	RB	O	additionally	advmod	33	SENT_255	[p12l1253t3046r1676b3121],
33	improve	VB	O	improve	_	0	SENT_255	[p12l1696t3047r1984b3121],
34	prediction	NN	O	prediction	dobj	33	SENT_255	[p12l2007t3062r2146b3121, p12l9t3142r251b3202],
35	of	IN	O	of	_	0	SENT_255	[p12l280t3142r351b3202],
36	objective	JJ	O	objective	amod	37	SENT_255	[p12l374t3142r709b3218],
37	beneﬁt	NN	O	beneﬁt	prep_of	34	SENT_255	[p12l737t3142r1007b3202],
38	.	.	O	.	_	0	SENT_255	[p12l737t3142r1007b3202],

1	Response	NN	O	response	nn	2	SENT_256	[p12l1044t3143r1364b3218],
2	rates	NNS	O	rate	nsubj	11	SENT_256	[p12l1393t3148r1567b3202],
3	in	IN	O	in	_	0	SENT_256	[p12l1593t3143r1652b3201],
4	patients	NNS	O	patient	prep_in	2	SENT_256	[p12l1683t3143r1970b3218],
5	with	IN	O	with	_	0	SENT_256	[p12l1994t3142r2148b3202],
6	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	8	SENT_256	[p12l10t3237r646b3313],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_256	[p12l694t3238r875b3297],
8	mutation	NN	O	mutation	prep_with	4	SENT_256	[p12l921t3238r1238b3297],
9	was	VBD	O	be	cop	11	SENT_256	[p12l1284t3253r1416b3297],
10	54.5	CD	PERCENT	54.5	number	11	SENT_256	[p12l1464t3238r1661b3297],
11	%	NN	PERCENT	%	_	0	SENT_256	[p12l1464t3238r1661b3297],
12	(	CD	NUMBER	(	number	13	SENT_256	[p12l1711t3238r1927b3313],
13	6/11	CD	NUMBER	6/11	num	14	SENT_256	[p12l1711t3238r1927b3313],
14	)	NN	O	)	nsubj	20	SENT_256	[p12l1711t3238r1927b3313],
15	compared	VBN	O	compare	_	0	SENT_256	[p12l1975t3253r2146b3297, p12l12t3335r209b3410],
16	with	IN	O	with	prepc_compared_with	14	SENT_256	[p12l242t3335r395b3395],
17	25.0	CD	PERCENT	25.0	num	18	SENT_256	[p12l430t3335r630b3395],
18	%	NN	PERCENT	%	pobj	14	SENT_256	[p12l430t3335r630b3395],
19	(	CD	NUMBER	(	num	20	SENT_256	[p12l667t3335r883b3410],
20	7/28	CD	NUMBER	7/28	ccomp	11	SENT_256	[p12l667t3335r883b3410],
21	)	NN	O	)	dobj	20	SENT_256	[p12l667t3335r883b3410],
22	in	IN	O	in	_	0	SENT_256	[p12l919t3336r977b3394],
23	patients	NNS	O	patient	prep_in	21	SENT_256	[p12l1015t3336r1302b3410],
24	without	IN	O	without	_	0	SENT_256	[p12l1332t3335r1608b3395],
25	such	JJ	O	such	amod	26	SENT_256	[p12l1640t3335r1793b3395],
26	mutation	NN	O	mutation	prep_without	20	SENT_256	[p12l1831t3336r2148b3395],

1	(	NN	O	(	nn	2	SENT_257	[p13l14t17r331b93],
2	p	NN	O	p	nsubj	3	SENT_257	[p13l14t17r331b93],
3	=	JJ	O	=	_	0	SENT_257	[p13l14t17r331b93],
4	O.	NNP	O	O.	iobj	3	SENT_257	[p13l14t17r331b93],
5	13	CD	NUMBER	13	num	4	SENT_257	[p13l14t17r331b93],
6	)	CD	NUMBER	)	num	8	SENT_257	[p13l14t17r331b93],
7	(	CD	NUMBER	(	num	8	SENT_257	[p13l366t18r514b92],
8	Fig	NN	O	fig	dobj	3	SENT_257	[p13l366t18r514b92],
9	.	.	O	.	_	0	SENT_257	[p13l366t18r514b92],

1	3	CD	NUMBER	3	_	0	SENT_258	[p13l552t17r639b92],
2	)	NN	O	)	dep	1	SENT_258	[p13l552t17r639b92],
3	.	.	O	.	_	0	SENT_258	[p13l552t17r639b92],

1	Median	JJ	O	median	amod	2	SENT_259	[p13l672t17r921b77],
2	TTP	NN	O	ttp	nsubj	5	SENT_259	[p13l950t18r1085b76],
3	was	VBD	O	be	cop	5	SENT_259	[p13l1112t33r1244b77],
4	13.8	CD	DURATION	13.8	num	5	SENT_259	[p13l1277t17r1423b77],
5	months	NNS	NUMBER	month	_	0	SENT_259	[p13l1454t17r1709b77],
6	in	IN	O	in	_	0	SENT_259	[p13l1738t18r1797b76],
7	geﬁtinibsensitive	JJ	O	geﬁtinibsensitive	amod	8	SENT_259	[p13l1829t17r2146b92, p13l9t114r318b173],
8	mutations	NNS	O	mutation	prep_in	5	SENT_259	[p13l342t114r693b173],
9	and	CC	O	and	_	0	SENT_259	[p13l714t113r837b173],
10	1.9	CD	DURATION	1.9	num	11	SENT_259	[p13l866t114r969b173],
11	months	NNS	NUMBER	month	conj_and	5	SENT_259	[p13l993t113r1248b173],
12	in	IN	O	in	_	0	SENT_259	[p13l1269t114r1328b173],
13	the	DT	O	the	det	15	SENT_259	[p13l1352t113r1466b173],
14	remaining	VBG	O	remain	amod	15	SENT_259	[p13l1490t114r1840b189],
15	patients	NNS	O	patient	prep_in	11	SENT_259	[p13l1863t114r2150b189],
16	(	CD	NUMBER	(	num	17	SENT_259	[p13l14t209r387b285],
17	p	NN	O	p	dep	5	SENT_259	[p13l14t209r387b285],
18	=	JJ	O	=	amod	17	SENT_259	[p13l14t209r387b285],
19	0.0029	CD	NUMBER	0.0029	tmod	18	SENT_259	[p13l14t209r387b285],
20	by	IN	O	by	_	0	SENT_259	[p13l425t209r504b284],
21	log-rank	JJ	O	log-rank	amod	24	SENT_259	[p13l540t209r854b284],
22	)	NN	O	)	nn	24	SENT_259	[p13l540t209r854b284],
23	(	CD	NUMBER	(	num	24	SENT_259	[p13l896t210r1044b284],
24	Fig	NN	O	fig	prep_by	18	SENT_259	[p13l896t210r1044b284],
25	.	.	O	.	_	0	SENT_259	[p13l896t210r1044b284],

1	4A	NN	O	4a	_	0	SENT_260	[p13l1085t209r1223b284],
2	)	NN	O	)	dep	1	SENT_260	[p13l1085t209r1223b284],
3	.	.	O	.	_	0	SENT_260	[p13l1085t209r1223b284],

1	OS	NN	O	os	nsubj	5	SENT_261	[p13l1265t209r1352b269],
2	was	VBD	O	be	cop	5	SENT_261	[p13l1386t225r1518b269],
3	also	RB	O	also	advmod	5	SENT_261	[p13l1553t209r1689b269],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_261	[p13l1724t209r2152b284],
5	longer	RBR	O	longer	_	0	SENT_261	[p13l12t305r233b380],
6	in	IN	O	in	_	0	SENT_261	[p13l252t306r311b364],
7	patients	NNS	O	patient	prep_in	5	SENT_261	[p13l337t306r624b381],
8	with	IN	O	with	mark	11	SENT_261	[p13l643t305r796b365],
9	the	DT	O	the	det	10	SENT_261	[p13l820t305r934b365],
10	mutations	NNS	O	mutation	nsubj	11	SENT_261	[p13l958t306r1310b365],
11	(	VBP	O	(	advcl	5	SENT_261	[p13l1336t306r1402b381],
12	p	NN	O	p	dobj	11	SENT_261	[p13l1336t306r1402b381],
13	=	JJ	O	=	amod	12	SENT_261	[p13l1421t329r1454b349],
14	0.023	CD	NUMBER	0.023	tmod	13	SENT_261	[p13l1474t305r1690b378],
15	;	:	O	;	_	0	SENT_261	[p13l1474t305r1690b378],
16	median	NN	O	median	dep	12	SENT_261	[p13l1721t305r1975b365],
17	31.3	CD	DURATION	31.3	num	18	SENT_261	[p13l2001t305r2148b365],
18	months	NNS	NUMBER	month	tmod	16	SENT_261	[p13l12t400r267b460],
19	versus	CC	O	versus	_	0	SENT_261	[p13l293t416r514b460],
20	7.4	CD	DURATION	7.4	num	21	SENT_261	[p13l544t402r653b460],
21	months	NNS	NUMBER	month	dobj	11	SENT_261	[p13l684t400r962b473],
22	,	,	O	,	_	0	SENT_261	[p13l684t400r962b473],
23	respectively	RB	O	respectively	advmod	26	SENT_261	[p13l1001t400r1458b476],
24	)	CD	NUMBER	)	number	25	SENT_261	[p13l1001t400r1458b476],
25	(	CD	NUMBER	(	num	26	SENT_261	[p13l1494t401r1642b476],
26	Fig	NN	O	fig	rcmod	21	SENT_261	[p13l1494t401r1642b476],
27	.	.	O	.	_	0	SENT_261	[p13l1494t401r1642b476],

1	4B	NN	O	4b	_	0	SENT_262	[p13l1676t401r1813b476],
2	)	NN	O	)	dep	1	SENT_262	[p13l1676t401r1813b476],
3	.	.	O	.	_	0	SENT_262	[p13l1676t401r1813b476],

1	4	LS	NUMBER	4	_	0	SENT_263	[p13l10t638r90b711],
2	.	.	O	.	_	0	SENT_263	[p13l10t638r90b711],

1	Discussion	NN	O	discussion	_	0	SENT_264	[p13l152t638r610b710],

1	Previous	JJ	O	previous	amod	2	SENT_265	[p13l12t863r303b922],
2	studies	NNS	O	study	nsubj	4	SENT_265	[p13l328t861r576b921],
3	have	VBP	O	have	aux	4	SENT_265	[p13l603t861r765b922],
4	shown	VBN	O	show	ccomp	22	SENT_265	[p13l790t861r1006b922],
5	that	IN	O	that	complm	13	SENT_265	[p13l1034t861r1179b921],
6	objective	JJ	O	objective	amod	7	SENT_265	[p13l1203t861r1538b937],
7	response	NN	O	response	nsubjpass	13	SENT_265	[p13l1566t878r1874b937],
8	to	TO	O	to	_	0	SENT_265	[p13l1900t867r1969b921],
9	geﬁtinib	NN	O	geﬁtinib	prep_to	7	SENT_265	[p13l1995t861r2146b937, p13l10t958r171b1018],
10	is	VBZ	O	be	auxpass	13	SENT_265	[p13l202t959r252b1018],
11	more	RBR	O	more	advmod	12	SENT_265	[p13l285t974r463b1018],
12	frequently	RB	O	frequently	advmod	13	SENT_265	[p13l493t958r868b1033],
13	seen	VBN	O	see	ccomp	4	SENT_265	[p13l896t974r1053b1018],
14	in	IN	O	in	_	0	SENT_265	[p13l1087t959r1145b1017],
15	Asians	NNPS	MISC	Asians	prep_in	13	SENT_265	[p13l1176t959r1419b1031],
16	,	,	O	,	_	0	SENT_265	[p13l1176t959r1419b1031],
17	females	NNS	O	female	nsubj	22	SENT_265	[p13l1455t958r1757b1031],
18	,	,	O	,	_	0	SENT_265	[p13l1455t958r1757b1031],
19	adenocarcinomas	NNS	O	adenocarcinoma	conj_and	17	SENT_265	[p13l1794t958r2146b1018, p13l9t1055r296b1114],
20	and	CC	O	and	_	0	SENT_265	[p13l337t1054r461b1114],
21	never-smokers	NNS	O	never-smoker	conj_and	17	SENT_265	[p13l507t1054r1023b1114],
22	[	VBP	O	[	_	0	SENT_265	[p13l1069t1054r1326b1130],
23	4	CD	NUMBER	4	number	24	SENT_265	[p13l1069t1054r1326b1130],
24	—	CD	NUMBER	—	dobj	22	SENT_265	[p13l1069t1054r1326b1130],
25	12	CD	NUMBER	12	num	26	SENT_265	[p13l1069t1054r1326b1130],
26	]	NN	O	]	dep	24	SENT_265	[p13l1069t1054r1326b1130],
27	.	.	O	.	_	0	SENT_265	[p13l1069t1054r1326b1130],

1	In	IN	O	in	_	0	SENT_266	[p13l1379t1056r1434b1113],
2	the	DT	O	the	det	4	SENT_266	[p13l1478t1054r1592b1114],
3	present	JJ	DATE	present	amod	4	SENT_266	[p13l1636t1059r1901b1130],
4	study	NN	O	study	prep_in	8	SENT_266	[p13l1942t1054r2143b1130],
5	,	,	O	,	_	0	SENT_266	[p13l1942t1054r2143b1130],
6	response	NN	O	response	nn	7	SENT_266	[p13l12t1166r321b1225],
7	rate	NN	O	rate	nsubj	8	SENT_266	[p13l349t1155r490b1210],
8	showed	VBD	O	show	_	0	SENT_266	[p13l515t1149r776b1210],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_266	[p13l804t1149r1167b1225],
10	increase	NN	O	increase	dobj	8	SENT_266	[p13l1191t1151r1487b1209],
11	as	IN	O	as	_	0	SENT_266	[p13l1512t1166r1582b1209],
12	number	NN	O	number	prep_as	8	SENT_266	[p13l1609t1149r1879b1210],
13	of	IN	O	of	_	0	SENT_266	[p13l1901t1149r1972b1209],
14	clinical	JJ	O	clinical	amod	15	SENT_266	[p13l1995t1149r2146b1209, p13l10t1246r132b1306],
15	predictors	NNS	O	predictor	prep_of	12	SENT_266	[p13l181t1246r540b1322],
16	increased	VBN	O	increase	partmod	15	SENT_266	[p13l586t1246r948b1306],
17	.	.	O	.	_	0	SENT_266	[p13l586t1246r948b1306],

1	Moreover	RB	O	moreover	advmod	5	SENT_267	[p13l999t1247r1340b1319],
2	,	,	O	,	_	0	SENT_267	[p13l999t1247r1340b1319],
3	adjusted	VBN	O	adjust	amod	4	SENT_267	[p13l1393t1246r1699b1321],
4	HR	NN	DURATION	hr	nsubj	5	SENT_267	[p13l1749t1247r1843b1305],
5	showed	VBD	O	show	_	0	SENT_267	[p13l1887t1246r2147b1306],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_267	[p13l9t1342r372b1418],
7	improvement	NN	O	improvement	dobj	5	SENT_267	[p13l394t1343r869b1418],
8	of	IN	O	of	_	0	SENT_267	[p13l890t1342r961b1402],
9	TTP	NN	O	ttp	prep_of	7	SENT_267	[p13l979t1343r1114b1401],
10	and	CC	O	and	_	0	SENT_267	[p13l1137t1342r1260b1402],
11	OS	NN	O	os	prep_of	7	SENT_267	[p13l1286t1343r1373b1402],
12	according	VBG	O	accord	_	0	SENT_267	[p13l1396t1342r1740b1418],
13	to	TO	O	to	aux	14	SENT_267	[p13l1762t1348r1832b1402],
14	increase	VB	O	increase	prepc_according	5	SENT_267	[p13l1855t1343r2150b1402],
15	in	IN	O	in	_	0	SENT_267	[p13l10t1439r69b1497],
16	number	NN	O	number	prep_in	14	SENT_267	[p13l114t1437r384b1498],
17	of	IN	O	of	_	0	SENT_267	[p13l422t1437r493b1497],
18	clinical	JJ	O	clinical	amod	19	SENT_267	[p13l531t1437r785b1497],
19	predictors	NNS	O	predictor	prep_of	16	SENT_267	[p13l828t1437r1210b1513],
20	.	.	O	.	_	0	SENT_267	[p13l828t1437r1210b1513],

1	Our	PRP$	O	we	poss	2	SENT_268	[p13l1258t1438r1384b1498],
2	results	NNS	O	result	nsubj	3	SENT_268	[p13l1426t1437r1658b1498],
3	demonstrate	VBP	O	demonstrate	_	0	SENT_268	[p13l1699t1437r2150b1498],
4	that	IN	O	that	complm	11	SENT_268	[p13l10t1535r155b1595],
5	number	NN	O	number	nsubjpass	11	SENT_268	[p13l192t1535r462b1595],
6	of	IN	O	of	_	0	SENT_268	[p13l495t1535r566b1595],
7	clinical	JJ	O	clinical	amod	8	SENT_268	[p13l599t1535r852b1595],
8	predictors	NNS	O	predictor	prep_of	5	SENT_268	[p13l892t1535r1251b1610],
9	can	MD	O	can	aux	11	SENT_268	[p13l1286t1551r1405b1595],
10	be	VB	O	be	auxpass	11	SENT_268	[p13l1445t1535r1527b1595],
11	used	VBN	O	use	ccomp	3	SENT_268	[p13l1565t1535r1720b1595],
12	as	IN	O	as	_	0	SENT_268	[p13l1759t1551r1828b1595],
13	a	DT	O	a	det	15	SENT_268	[p13l1864t1551r1901b1595],
14	useful	JJ	O	useful	amod	15	SENT_268	[p13l1939t1535r2149b1595],
15	predictor	NN	O	predictor	prep_as	11	SENT_268	[p13l12t1631r341b1707],
16	of	IN	O	of	_	0	SENT_268	[p13l364t1631r435b1691],
17	objective	JJ	O	objective	amod	18	SENT_268	[p13l458t1631r793b1707],
18	beneﬁt	NN	O	beneﬁt	prep_of	15	SENT_268	[p13l821t1631r1069b1691],
19	from	IN	O	from	_	0	SENT_268	[p13l1094t1631r1258b1691],
20	geﬁtinib	NN	O	geﬁtinib	prep_from	11	SENT_268	[p13l1287t1631r1578b1707],
21	when	WRB	O	when	advmod	29	SENT_268	[p13l1603t1631r1789b1691],
22	adequate	JJ	O	adequate	amod	23	SENT_268	[p13l1818t1631r2150b1707],
23	tissue	NN	O	tissue	nsubj	29	SENT_268	[p13l10t1728r212b1786],
24	for	IN	O	for	_	0	SENT_268	[p13l241t1726r343b1786],
25	mutational	JJ	O	mutational	amod	26	SENT_268	[p13l372t1726r757b1787],
26	analysis	NN	O	analysis	prep_for	23	SENT_268	[p13l787t1726r1062b1802],
27	is	VBZ	O	be	cop	29	SENT_268	[p13l1091t1728r1141b1786],
28	not	RB	O	not	neg	29	SENT_268	[p13l1173t1732r1285b1786],
29	available	JJ	O	available	advcl	11	SENT_268	[p13l1314t1726r1656b1787],
30	.	.	O	.	_	0	SENT_268	[p13l1314t1726r1656b1787],

1	The	DT	O	the	det	3	SENT_269	[p13l117t1824r249b1884],
2	present	JJ	DATE	present	amod	3	SENT_269	[p13l286t1829r552b1899],
3	study	NN	O	study	nsubj	4	SENT_269	[p13l586t1824r776b1899],
4	shows	VBZ	O	show	_	0	SENT_269	[p13l810t1824r1017b1884],
5	the	DT	O	the	det	6	SENT_269	[p13l1052t1824r1167b1884],
6	superiority	NN	O	superiority	dobj	4	SENT_269	[p13l1202t1825r1587b1899],
7	of	IN	O	of	_	0	SENT_269	[p13l1620t1824r1691b1884],
8	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_269	[p13l1726t1824r1908b1884],
9	mutational	JJ	O	mutational	amod	10	SENT_269	[p13l1943t1829r2146b1884, p13l10t1920r212b1980],
10	status	NN	O	status	prep_of	6	SENT_269	[p13l250t1926r460b1980],
11	compared	VBN	O	compare	_	0	SENT_269	[p13l497t1920r847b1996],
12	to	TO	O	to	prepc_compared_to	10	SENT_269	[p13l888t1926r957b1980],
13	clinical	JJ	O	clinical	amod	14	SENT_269	[p13l994t1920r1248b1980],
14	predictors	NNS	O	predictor	pobj	10	SENT_269	[p13l1289t1920r1648b1996],
15	in	IN	O	in	_	0	SENT_269	[p13l1686t1921r1745b1979],
16	prediction	NN	O	prediction	prep_in	14	SENT_269	[p13l1788t1920r2147b1996],
17	of	IN	O	of	_	0	SENT_269	[p13l9t2015r80b2075],
18	geﬁtinib	NN	O	geﬁtinib	nn	19	SENT_269	[p13l108t2015r400b2091],
19	responsiveness	NN	O	responsiveness	prep_of	16	SENT_269	[p13l434t2017r980b2091],
20	.	.	O	.	_	0	SENT_269	[p13l434t2017r980b2091],

1	Although	IN	O	although	mark	7	SENT_270	[p13l1015t2015r1328b2091],
2	the	DT	O	the	det	4	SENT_270	[p13l1362t2015r1477b2075],
3	response	NN	O	response	nn	4	SENT_270	[p13l1510t2032r1818b2091],
4	rate	NN	O	rate	nsubj	7	SENT_270	[p13l1852t2021r1993b2075],
5	and	CC	O	and	_	0	SENT_270	[p13l2024t2015r2147b2075],
6	survival	NN	O	survival	conj_and	4	SENT_270	[p13l9t2113r279b2173],
7	showed	VBD	O	show	advcl	44	SENT_270	[p13l315t2113r576b2173],
8	improvement	NN	O	improvement	dobj	7	SENT_270	[p13l614t2114r1088b2188],
9	according	VBG	O	accord	_	0	SENT_270	[p13l1123t2113r1466b2188],
10	to	TO	O	to	aux	11	SENT_270	[p13l1502t2118r1572b2173],
11	increase	VB	O	increase	dep	19	SENT_270	[p13l1607t2114r1903b2173],
12	in	IN	O	in	_	0	SENT_270	[p13l1939t2114r1997b2172],
13	the	DT	O	the	det	14	SENT_270	[p13l2035t2113r2150b2173],
14	number	NN	O	number	prep_in	11	SENT_270	[p13l12t2209r282b2269],
15	of	IN	O	of	_	0	SENT_270	[p13l319t2209r391b2269],
16	clinical	JJ	O	clinical	amod	17	SENT_270	[p13l428t2209r682b2269],
17	predictors	NNS	O	predictor	prep_of	14	SENT_270	[p13l725t2209r1108b2285],
18	,	,	O	,	_	0	SENT_270	[p13l725t2209r1108b2285],
19	response	NN	O	response	prep_according	8	SENT_270	[p13l1158t2225r1466b2285],
20	rate	NN	O	rate	dep	19	SENT_270	[p13l1510t2214r1674b2282],
21	,	,	O	,	_	0	SENT_270	[p13l1510t2214r1674b2282],
22	TTP	NN	O	ttp	nsubj	44	SENT_270	[p13l1719t2210r1854b2268],
23	and	CC	O	and	_	0	SENT_270	[p13l1895t2209r2019b2269],
24	OS	NN	O	os	conj_and	22	SENT_270	[p13l2062t2210r2149b2269],
25	were	VBD	O	be	cop	44	SENT_270	[p13l7t2320r184b2364],
26	all	RB	O	all	advmod	44	SENT_270	[p13l211t2304r295b2364],
27	better	RB	O	better	advmod	44	SENT_270	[p13l326t2304r549b2364],
28	in	IN	O	in	_	0	SENT_270	[p13l574t2305r633b2364],
29	patients	NNS	O	patient	prep_in	27	SENT_270	[p13l666t2305r953b2380],
30	with	IN	O	with	_	0	SENT_270	[p13l978t2304r1131b2364],
31	the	DT	O	the	det	34	SENT_270	[p13l1162t2304r1277b2364],
32	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	34	SENT_270	[p13l1305t2304r1941b2380],
33	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_270	[p13l1971t2305r2152b2364],
34	mutations	NNS	O	mutation	prep_with	29	SENT_270	[p13l12t2403r364b2462],
35	than	IN	O	than	_	0	SENT_270	[p13l400t2402r554b2462],
36	the	DT	O	the	det	41	SENT_270	[p13l594t2402r708b2462],
37	three	CD	NUMBER	three	num	41	SENT_270	[p13l744t2402r934b2462],
38	clinical	JJ	O	clinical	amod	41	SENT_270	[p13l970t2402r1224b2462],
39	predictor	NN	O	predictor	nn	41	SENT_270	[p13l1263t2402r1592b2477],
40	group	NN	O	group	nn	41	SENT_270	[p13l1626t2416r1825b2477],
41	patients	NNS	O	patient	prep_than	34	SENT_270	[p13l1863t2403r2150b2477],
42	(	CD	NUMBER	(	num	44	SENT_270	[p13l14t2499r284b2574],
43	female	JJ	O	female	amod	44	SENT_270	[p13l14t2499r284b2574],
44	never-smokers	NNS	O	never-smoker	_	0	SENT_270	[p13l315t2499r830b2559],
45	with	IN	O	with	_	0	SENT_270	[p13l856t2499r1010b2559],
46	adenocarcinoma	NN	O	adenocarcinoma	nn	47	SENT_270	[p13l1041t2499r1678b2574],
47	)	NN	O	)	prep_with	44	SENT_270	[p13l1041t2499r1678b2574],
48	.	.	O	.	_	0	SENT_270	[p13l1041t2499r1678b2574],

1	Moreover	RB	O	moreover	advmod	11	SENT_271	[p13l1711t2501r2053b2572],
2	,	,	O	,	_	0	SENT_271	[p13l1711t2501r2053b2572],
3	in	IN	O	in	_	0	SENT_271	[p13l2088t2500r2148b2558],
4	the	DT	O	the	det	6	SENT_271	[p13l10t2594r124b2654],
5	multivariate	JJ	O	multivariate	amod	6	SENT_271	[p13l155t2594r591b2654],
6	analysis	NN	O	analysis	prep_in	11	SENT_271	[p13l620t2594r917b2670],
7	,	,	O	,	_	0	SENT_271	[p13l620t2594r917b2670],
8	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	10	SENT_271	[p13l953t2594r1589b2670],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_271	[p13l1621t2595r1801b2654],
10	mutation	NN	O	mutation	nsubj	11	SENT_271	[p13l1831t2595r2148b2654],
11	showed	VBD	O	show	_	0	SENT_271	[p13l9t2692r270b2752],
12	a	DT	O	a	det	14	SENT_271	[p13l320t2708r357b2752],
13	higher	JJR	O	higher	amod	14	SENT_271	[p13l407t2692r629b2767],
14	OR	NN	O	or	dobj	11	SENT_271	[p13l674t2692r772b2752],
15	of	IN	O	of	_	0	SENT_271	[p13l817t2692r888b2752],
16	9.6	CD	NUMBER	9.6	prep_of	14	SENT_271	[p13l933t2692r1041b2752],
17	in	IN	O	in	_	0	SENT_271	[p13l1089t2693r1149b2751],
18	objective	JJ	O	objective	amod	19	SENT_271	[p13l1198t2692r1533b2767],
19	response	NN	O	response	prep_in	14	SENT_271	[p13l1583t2708r1892b2767],
20	and	CC	O	and	_	0	SENT_271	[p13l1940t2692r2063b2752],
21	a	DT	O	a	det	23	SENT_271	[p13l2113t2708r2149b2752],
22	signiﬁcant	JJ	O	signiﬁcant	amod	23	SENT_271	[p13l9t2789r372b2864],
23	HR	NN	DURATION	hr	conj_and	14	SENT_271	[p13l416t2790r510b2848],
24	of	IN	O	of	_	0	SENT_271	[p13l549t2789r620b2849],
25	0.25	CD	NUMBER	0.25	prep_of	23	SENT_271	[p13l658t2789r808b2849],
26	in	IN	O	in	_	0	SENT_271	[p13l851t2790r911b2848],
27	terms	NNS	O	term	prep_in	11	SENT_271	[p13l955t2794r1156b2849],
28	of	IN	O	of	_	0	SENT_271	[p13l1197t2789r1268b2849],
29	OS	NNP	O	OS	prep_of	27	SENT_271	[p13l1308t2789r1394b2849],
30	whereas	IN	O	whereas	mark	35	SENT_271	[p13l1435t2789r1729b2849],
31	number	NN	O	number	nsubj	35	SENT_271	[p13l1773t2789r2043b2849],
32	of	IN	O	of	_	0	SENT_271	[p13l2082t2789r2153b2849],
33	clinical	JJ	O	clinical	amod	34	SENT_271	[p13l9t2884r263b2944],
34	predictors	NNS	O	predictor	prep_of	31	SENT_271	[p13l303t2884r663b2960],
35	showed	VBD	O	show	advcl	11	SENT_271	[p13l700t2884r960b2944],
36	an	DT	O	a	det	37	SENT_271	[p13l1001t2900r1079b2944],
37	OR	NN	O	or	dobj	35	SENT_271	[p13l1119t2885r1217b2944],
38	of	IN	O	of	_	0	SENT_271	[p13l1253t2884r1324b2944],
39	1.7	CD	NUMBER	1.7	prep_of	37	SENT_271	[p13l1363t2886r1468b2944],
40	and	CC	O	and	_	0	SENT_271	[p13l1505t2884r1628b2944],
41	no	DT	O	no	det	43	SENT_271	[p13l1670t2900r1750b2944],
42	signiﬁcant	JJ	O	signiﬁcant	amod	43	SENT_271	[p13l1788t2884r2151b2960],
43	association	NN	O	association	dep	49	SENT_271	[p13l10t2983r399b3042],
44	with	IN	O	with	_	0	SENT_271	[p13l425t2982r578b3042],
45	OS	NN	O	os	prep_with	43	SENT_271	[p13l606t2982r693b3042],
46	(	CD	NUMBER	(	num	49	SENT_271	[p13l723t2982r934b3057],
47	Table	NNP	O	Table	nn	49	SENT_271	[p13l723t2982r934b3057],
48	3	CD	NUMBER	3	num	49	SENT_271	[p13l961t2982r1048b3057],
49	)	NN	O	)	advcl	11	SENT_271	[p13l961t2982r1048b3057],
50	.	.	O	.	_	0	SENT_271	[p13l961t2982r1048b3057],

1	Presence	NN	O	presence	_	0	SENT_272	[p13l1084t2983r1396b3042],
2	of	IN	O	of	_	0	SENT_272	[p13l1421t2982r1492b3042],
3	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	4	SENT_272	[p13l1514t2982r2150b3057],
4	206	CD	NUMBER	206	prep_of	1	SENT_272	[p13l9t3101r125b3157],

1	_	NN	O	_	_	0	SENT_273	[p14l664t93r683b136],
2	|	NN	O	|	dep	1	SENT_273	[p14l664t93r683b136],
3	.	.	O	.	_	0	SENT_273	[p14l664t93r683b136],

1	Q	NNP	O	Q	_	0	SENT_274	[p14l713t93r744b139],

1	EGFFI	NN	O	egffus	nn	2	SENT_275	[p14l1478t136r1616b176],
2	mutation	NN	O	mutation	_	0	SENT_275	[p14l1634t136r1846b176],
3	:	:	O	:	_	0	SENT_275	[p14l1477t218r1579b228],
4	Positilve	NNP	O	Positilve	nsubj	7	SENT_275	[p14l1606t203r1800b243],
5	(	CD	NUMBER	(	num	4	SENT_275	[p14l1815t203r1865b256],
6	N	NN	O	n	dep	7	SENT_275	[p14l1815t203r1865b256],
7	=	JJ	O	=	dep	2	SENT_275	[p14l1883t219r1911b240],
8	11	CD	NUMBER	11	num	9	SENT_275	[p14l1929t203r2001b255],
9	}	CD	NUMBER	}	iobj	7	SENT_275	[p14l1929t203r2001b255],
10	M	NN	O	m	nn	17	SENT_275	[p14l1475t283r1573b295],
11	+	CC	O	+	_	0	SENT_275	[p14l1475t283r1573b295],
12	Negative	JJ	O	negative	amod	14	SENT_275	[p14l1606t270r1816b320],
13	[	NN	O	[	nn	14	SENT_275	[p14l1831t270r1883b320],
14	N	NN	O	n	conj_+	10	SENT_275	[p14l1831t270r1883b320],
15	=	JJ	O	=	amod	17	SENT_275	[p14l1901t286r1929b307],
16	25	CD	NUMBER	25	tmod	15	SENT_275	[p14l1944t271r2016b320],
17	)	NN	O	)	dobj	7	SENT_275	[p14l1944t271r2016b320],

1	F.	NNP	O	F.	nn	2	SENT_276	[p14l658t292r704b338],
2	m.	NNP	O	m.	_	0	SENT_276	[p14l707t292r738b338],

1	T	NN	O	t	_	0	SENT_277	[p14l562t203r615b256],
2	:	:	O	:	_	0	SENT_277	[p14l562t203r615b256],
3	.2	NN	NUMBER	.2	dep	1	SENT_277	[p14l560t258r615b315],
4	.	.	O	.	_	0	SENT_277	[p14l560t258r615b315],

1	E	NN	O	e	_	0	SENT_278	[p14l575t316r615b375],
2	:	:	O	:	_	0	SENT_278	[p14l575t316r615b375],
3	p	NN	O	p	nn	4	SENT_278	[p14l1490t332r1570b382],
4	*	NN	O	*	dep	1	SENT_278	[p14l1490t332r1570b382],
5	;	:	O	;	_	0	SENT_278	[p14l1490t332r1570b382],
6	muons	NNS	O	muon	dep	4	SENT_278	[p14l1585t335r1741b372],

1	-3	CD	NUMBER	-3	_	0	SENT_279	[p14l480t393r532b418],
2	-	:	O	-	_	0	SENT_279	[p14l480t393r532b418],
3	:	:	O	:	_	0	SENT_279	[p14l575t381r615b415],
4	D	NN	O	d	dep	1	SENT_279	[p14l492t418r532b458],
5	in	IN	O	in	_	0	SENT_279	[p14l575t421r615b455],
6	1	CD	NUMBER	1	prep_in	4	SENT_279	[p14l492t479r547b514],
7	.	.	O	.	_	0	SENT_279	[p14l492t479r547b514],
8	"	''	O	"	punct	4	SENT_279	[p14l492t479r547b514],

1	-	:	O	-	_	0	SENT_280	[p14l492t479r547b514],
2	H	NN	O	h	nn	4	SENT_280	[p14l492t479r547b514],
3	E	NN	O	e	nn	4	SENT_280	[p14l575t479r615b514],
4	)	NN	O	)	nsubj	10	SENT_280	[p14l575t479r615b514],
5	,	,	O	,	_	0	SENT_280	[p14l480t516r532b553],
6	-	:	O	-	_	0	SENT_280	[p14l480t516r532b553],
7	I	PRP	O	I	dep	4	SENT_280	[p14l480t516r532b553],
8	:	:	O	:	_	0	SENT_280	[p14l480t516r532b553],
9	9.5	CD	NUMBER	9.5	dep	7	SENT_280	[p14l658t501r738b547],
10	"	``	O	"	_	0	SENT_280	[p14l833t507r851b526],
11	'	''	O	'	_	0	SENT_280	[p14l833t507r851b526],

1	In	IN	O	in	_	0	SENT_281	[p14l492t639r532b673],
2	D	NN	O	d	nn	3	SENT_281	[p14l575t629r615b681],
3	M	NN	O	m	pobj	1	SENT_281	[p14l575t629r615b681],
4	+	CC	O	+	_	0	SENT_281	[p14l575t629r615b681],
5	D	NN	O	d	nn	6	SENT_281	[p14l866t624r879b682],
6	M	NN	O	m	conj_+	3	SENT_281	[p14l866t624r879b682],
7	+	CC	O	+	_	0	SENT_281	[p14l866t624r879b682],
8	-	:	O	-	_	0	SENT_281	[p14l480t676r532b713],
9	CI	NN	O	ci	nn	11	SENT_281	[p14l480t676r532b713],
10	.2	NN	NUMBER	.2	nn	11	SENT_281	[p14l560t667r615b722],
11	O	NN	O	o	conj_+	3	SENT_281	[p14l870t688r888b710, p14l492t716r532b756],
12	in	IN	O	in	prep	26	SENT_281	[p14l575t728r615b762],
13	0.4	CD	NUMBER	0.4	num	14	SENT_281	[p14l658t706r738b750],
14	r	NN	O	r	dep	15	SENT_281	[p14l789t736r793b737],
15	F.	NNP	O	F.	dep	18	SENT_281	[p14l879t715r894b755],
16	E	NNP	O	E	dep	15	SENT_281	[p14l480t786r532b826],
17	m	NN	O	m	dep	16	SENT_281	[p14l575t804r615b839],
18	:1	CD	NUMBER	:1	dep	12	SENT_281	[p14l903t790r1057b845],
19	:	:	O	:	_	0	SENT_281	[p14l903t790r1057b845],
20	-	:	O	-	_	0	SENT_281	[p14l903t790r1057b845],
21	*	SYM	O	*	dep	23	SENT_281	[p14l903t790r1057b845],
22	-	:	O	-	_	0	SENT_281	[p14l903t790r1057b845],
23	J-ICE	NN	O	j-ice	dep	18	SENT_281	[p14l903t790r1057b845],
24	hi	UH	O	hi	dep	12	SENT_281	[p14l575t842r615b866],
25	,	,	O	,	_	0	SENT_281	[p14l1079t854r1082b855],
26	gr	NN	O	gr	dep	11	SENT_281	[p14l575t869r630b949],
27	9	CD	NUMBER	9	number	28	SENT_281	[p14l658t915r689b959],
28	2	CD	NUMBER	2	num	29	SENT_281	[p14l707t915r738b958],
29	9ǽM	NN	O	9ǽm	dep	11	SENT_281	[p14l1047t845r1146b925],
30	+	CC	O	+	_	0	SENT_281	[p14l1047t845r1146b925],
31	E	NN	O	e	nn	33	SENT_281	[p14l575t952r627b1017],
32	'	''	O	'	_	0	SENT_281	[p14l692t949r704b958],
33	mt	NN	O	mt	conj_+	6	SENT_281	[p14l1134t964r1148b980],
34	....	NN	O	....	dep	33	SENT_281	[p14l1149t970r1210b980],
35	.	.	O	.	_	0	SENT_281	[p14l1214t955r1331b1034],

1	--	:	O	--	_	0	SENT_282	[p14l1214t955r1331b1034],
2	ﬂue-E	JJ	O	ﬂue-e	_	0	SENT_282	[p14l1214t955r1331b1034],
3	‘	NN	O	‘	dep	2	SENT_282	[p14l1214t955r1331b1034],

1	F	NN	O	f	_	0	SENT_283	[p14l658t1121r704b1164],
2	’	CD	NUMBER	’	number	3	SENT_283	[p14l658t1121r704b1164],
3	:3	CD	NUMBER	:3	num	4	SENT_283	[p14l707t1121r738b1164],
4	n	NN	O	n	nsubj	7	SENT_283	[p14l793t1213r821b1259],
5	6	CD	NUMBER	6	number	6	SENT_283	[p14l993t1213r1026b1259],
6	12	CD	NUMBER	12	amod	4	SENT_283	[p14l1183t1213r1244b1259],
7	is	VBZ	O	be	rcmod	1	SENT_283	[p14l1385t1213r1447b1259],
8	24	CD	NUMBER	24	num	9	SENT_283	[p14l1579t1213r1646b1259],
9	30	CD	NUMBER	30	npadvmod	10	SENT_283	[p14l1782t1213r1846b1259],
10	as	IN	O	as	advmod	7	SENT_283	[p14l1984t1188r2050b1259],

1	(	NN	O	(	nn	2	SENT_284	[p14l471t1290r557b1358],
2	A	NN	O	a	_	0	SENT_284	[p14l471t1290r557b1358],
3	)	CD	NUMBER	)	num	5	SENT_284	[p14l471t1290r557b1358],
4	Follow-ugp	JJ	O	follow-ugp	amod	5	SENT_284	[p14l1054t1290r1370b1358],
5	time	NN	O	time	dep	2	SENT_284	[p14l1389t1290r1530b1343],
6	(	CD	NUMBER	(	num	7	SENT_284	[p14l1551t1290r1840b1358],
7	months	NNS	NUMBER	month	dep	8	SENT_284	[p14l1551t1290r1840b1358],
8	)	IN	O	)	prep	5	SENT_284	[p14l1551t1290r1840b1358],

1	S.-W	NN	O	s.-w	_	0	SENT_285	[p14l1601t1395r1773b1453],
2	.	.	O	.	_	0	SENT_285	[p14l1601t1395r1773b1453],

1	Han	NNP	O	Han	_	0	SENT_286	[p14l1812t1396r1937b1453],
2	et	FW	O	et	nn	3	SENT_286	[p14l1968t1400r2038b1453],
3	al.	FW	O	al.	dep	1	SENT_286	[p14l2066t1394r2148b1453],
4	.	.	O	.	_	0	SENT_286	[p14l2066t1394r2148b1453],

1	1	CD	NUMBER	1	_	0	SENT_287	[p14l219t1621r298b1668],
2	'	''	O	'	_	0	SENT_287	[p14l219t1621r298b1668],
3	0	CD	NUMBER	0	dep	1	SENT_287	[p14l219t1621r298b1668],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_287	[p14l1056t1662r1199b1706],
5	mutation	NN	O	mutation	dep	1	SENT_287	[p14l1217t1662r1436b1703],

1	@W	NN	O	@w	_	0	SENT_288	[p14l1056t1747r1160b1760],
2	½	CD	NUMBER	½	num	3	SENT_288	[p14l1056t1747r1160b1760],
3	M	NN	O	m	dep	1	SENT_288	[p14l1056t1747r1160b1760],
4	+	CC	O	+	_	0	SENT_288	[p14l1056t1747r1160b1760],
5	Positive	JJ	O	positive	amod	7	SENT_288	[p14l1189t1731r1385b1773],
6	{	NN	O	{	nn	7	SENT_288	[p14l1401t1731r1455b1785],
7	N	NN	O	n	conj_+	3	SENT_288	[p14l1401t1731r1455b1785],
8	=	JJ	O	=	advmod	12	SENT_288	[p14l1473t1750r1502b1770],
9	11	CD	NUMBER	11	num	11	SENT_288	[p14l1521t1732r1591b1785],
10	)	NN	O	)	nn	11	SENT_288	[p14l1521t1732r1591b1785],
11	o	NN	O	o	dep	8	SENT_288	[p14l212t1832r244b1877],
12	B	NN	O	b	rcmod	7	SENT_288	[p14l263t1832r295b1877],
13	----	CD	NUMBER	----	num	12	SENT_288	[p14l1053t1816r1117b1826],
14	--	:	O	--	_	0	SENT_288	[p14l1123t1817r1154b1826],
15	Negative	JJ	O	negative	amod	17	SENT_288	[p14l1189t1801r1404b1852],
16	(	NN	O	(	nn	17	SENT_288	[p14l1420t1801r1471b1854],
17	N	NN	O	n	dep	7	SENT_288	[p14l1420t1801r1471b1854],
18	=	JJ	O	=	amod	17	SENT_288	[p14l1492t1817r1521b1839],
19	23	CD	NUMBER	23	number	20	SENT_288	[p14l1536t1801r1610b1852],
20	)	CD	NUMBER	)	dep	18	SENT_288	[p14l1536t1801r1610b1852],
21	"	``	O	"	punct	22	SENT_288	[p14l247t1864r260b1877],
22	0.10023	CD	NUMBER	0.10023	dep	1	SENT_288	[p14l1164t1867r1325b1905],

1	Prlobabiility	NN	O	prlobabiility	dep	11	SENT_289	[p14l105t2275r172b2633],
2	of	IN	O	of	_	0	SENT_289	[p14l105t2189r159b2253],
3	overall	JJ	O	overall	amod	4	SENT_289	[p14l105t1946r159b2168],
4	survival	NN	O	survival	prep_of	1	SENT_289	[p14l105t1662r159b1921],
5	at	IN	O	at	_	0	SENT_289	[p14l351t2775r383b2822],
6	5	CD	NUMBER	5	prep_at	4	SENT_289	[p14l557t2775r589b2822],
7	‘	CD	NUMBER	‘	num	8	SENT_289	[p14l753t2775r816b2822],
8	lg	NN	O	lg	dep	11	SENT_289	[p14l753t2775r816b2822],
9	13	CD	NUMBER	13	number	10	SENT_289	[p14l961t2775r1025b2822],
10	24	CD	NUMBER	24	num	11	SENT_289	[p14l1161t2775r1230b2822],
11	an	DT	O	a	dep	16	SENT_289	[p14l1366t2775r1433b2822],
12	as	IN	O	as	_	0	SENT_289	[p14l1578t2756r1644b2822],
13	fFu	NN	O	ffu	prep_as	11	SENT_289	[p14l617t2854r946b2924],
14	|	CD	NUMBER	|	num	16	SENT_289	[p14l617t2854r946b2924],
15	lIiow-up	JJ	O	liiow-up	amod	16	SENT_289	[p14l617t2854r946b2924],
16	time	NN	O	time	_	0	SENT_289	[p14l964t2854r1110b2911],
17	(	CD	NUMBER	(	num	18	SENT_289	[p14l1132t2854r1429b2924],
18	months	NNS	NUMBER	month	dep	16	SENT_289	[p14l1132t2854r1429b2924],
19	)	IN	O	)	dep	16	SENT_289	[p14l1132t2854r1429b2924],

1	@	IN	O	@	_	0	SENT_290	[p14l92t2854r178b2924],
2	Fig	NN	O	fig	pobj	1	SENT_290	[p14l49t2966r105b3000],
3	.	.	O	.	_	0	SENT_290	[p14l49t2966r105b3000],

1	4	CD	NUMBER	4	_	0	SENT_291	[p14l118t2966r137b2993],
2	Kaplan	NNP	PERSON	Kaplan	dep	1	SENT_291	[p14l190t2966r407b3000],
3	.	.	O	.	_	0	SENT_291	[p14l190t2966r407b3000],

1	—	NN	O	—	_	0	SENT_292	[p14l190t2966r407b3000],
2	.	.	O	.	_	0	SENT_292	[p14l190t2966r407b3000],

1	Meier	JJR	PERSON	meier	amod	2	SENT_293	[p14l190t2966r407b3000],
2	plots	NNS	O	plot	nsubj	12	SENT_293	[p14l418t2966r492b3000],
3	of	IN	O	of	_	0	SENT_293	[p14l502t2966r533b2993],
4	time-to-progression	JJ	O	time-to-progression	amod	5	SENT_293	[p14l543t2966r851b3000],
5	(	NN	O	(	prep_of	2	SENT_293	[p14l864t2966r906b3000],
6	A	DT	O	a	det	7	SENT_293	[p14l864t2966r906b3000],
7	)	NN	O	)	dep	5	SENT_293	[p14l864t2966r906b3000],
8	and	CC	O	and	_	0	SENT_293	[p14l917t2966r971b2993],
9	overall	JJ	O	overall	amod	11	SENT_293	[p14l983t2966r1089b2993],
10	survival	NN	O	survival	nn	11	SENT_293	[p14l1099t2966r1218b2993],
11	(	NN	O	(	dep	5	SENT_293	[p14l1231t2966r1271b3000],
12	B	NN	O	b	_	0	SENT_293	[p14l1231t2966r1271b3000],
13	)	CD	NUMBER	)	dobj	12	SENT_293	[p14l1231t2966r1271b3000],
14	according	VBG	O	accord	_	0	SENT_293	[p14l1283t2966r1434b3000],
15	to	TO	O	to	prepc_according_to	13	SENT_293	[p14l1444t2968r1475b2993],
16	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_293	[p14l1486t2966r1565b2993],
17	mutational	JJ	O	mutational	amod	18	SENT_293	[p14l1576t2966r1745b2993],
18	status	NN	O	status	pobj	13	SENT_293	[p14l1755t2968r1848b2993],
19	in	IN	O	in	_	0	SENT_293	[p14l1858t2966r1884b2993],
20	female	JJ	O	female	amod	21	SENT_293	[p14l1895t2966r2003b2993],
21	neversmokers	NNS	O	neversmoker	prep_in	18	SENT_293	[p14l2015t2973r2112b2993, p14l48t3011r174b3038],
22	with	IN	O	with	_	0	SENT_293	[p14l185t3011r252b3038],
23	adenocarcinoma	NN	O	adenocarcinoma	prep_with	21	SENT_293	[p14l265t3011r532b3038],
24	.	.	O	.	_	0	SENT_293	[p14l265t3011r532b3038],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_294	[p14l548t3011r627b3038],
2	mutation	NN	O	mutation	nsubj	3	SENT_294	[p14l639t3012r779b3038],
3	denotes	VBZ	O	denote	_	0	SENT_294	[p14l792t3011r914b3038],
4	geﬁtinib-sensitive	JJ	O	geﬁtinib-sensitive	amod	6	SENT_294	[p14l926t3011r1205b3045],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_294	[p14l1218t3011r1298b3038],
6	mutation	NN	O	mutation	dobj	3	SENT_294	[p14l1310t3011r1460b3038],
7	.	.	O	.	_	0	SENT_294	[p14l1310t3011r1460b3038],

1	Positive	JJ	O	positive	nsubj	2	SENT_295	[p14l1476t3011r1595b3038],
2	includes	VBZ	O	include	_	0	SENT_295	[p14l1607t3011r1734b3038],
3	deletion	NN	O	deletion	dobj	2	SENT_295	[p14l1746t3011r1874b3038],
4	in	IN	O	in	_	0	SENT_295	[p14l1887t3011r1913b3038],
5	exon	NN	O	exon	prep_in	2	SENT_295	[p14l1926t3018r1998b3038],
6	19	CD	NUMBER	19	num	5	SENT_295	[p14l2013t3011r2045b3038],
7	and	CC	O	and	_	0	SENT_295	[p14l2058t3011r2112b3038],
8	L858R	NN	O	l858r	prep_in	2	SENT_295	[p14l12t3072r229b3141],
9	;	:	O	;	_	0	SENT_295	[p14l12t3072r229b3141],
10	negative	JJ	O	negative	nsubj	11	SENT_295	[p14l264t3072r549b3143],
11	includes	VBZ	O	include	parataxis	2	SENT_295	[p14l577t3071r851b3128],
12	wild-type	JJ	O	wild-type	amod	13	SENT_295	[p14l877t3071r1196b3143],
13	EGFR	NN	ORGANIZATION	egfr	dobj	11	SENT_295	[p14l1226t3072r1416b3128],
14	.	.	O	.	_	0	SENT_295	[p14l1226t3072r1416b3128],

1	*	NN	O	*	_	0	SENT_296	[p14l1450t3061r1766b3143],
2	Log-rank	JJ	O	log-rank	amod	3	SENT_296	[p14l1450t3061r1766b3143],
3	test	NN	O	test	dep	1	SENT_296	[p14l1792t3076r1941b3128],
4	.	.	O	.	_	0	SENT_296	[p14l1792t3076r1941b3128],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_297	[p14l12t3278r193b3337],
2	mutation	NN	O	mutation	nsubj	3	SENT_297	[p14l245t3278r562b3337],
3	conferred	VBD	O	confer	_	0	SENT_297	[p14l615t3277r960b3337],
4	higher	JJR	O	higher	amod	6	SENT_297	[p14l1016t3277r1237b3353],
5	response	NN	O	response	nn	6	SENT_297	[p14l1289t3293r1598b3353],
6	rate	NN	O	rate	dobj	3	SENT_297	[p14l1651t3283r1793b3337],
7	in	IN	O	in	_	0	SENT_297	[p14l1844t3278r1903b3336],
8	every	DT	O	every	det	13	SENT_297	[p14l1957t3293r2152b3353],
9	clinical	JJ	O	clinical	amod	13	SENT_297	[p14l9t3372r263b3432],
10	predictor	NN	O	predictor	nn	13	SENT_297	[p14l304t3372r634b3448],
11	group	NN	O	group	nn	13	SENT_297	[p14l669t3387r867b3448],
12	(	CD	NUMBER	(	num	13	SENT_297	[p14l910t3373r1058b3448],
13	Fig	NN	O	fig	prep_in	3	SENT_297	[p14l910t3373r1058b3448],
14	.	.	O	.	_	0	SENT_297	[p14l910t3373r1058b3448],

1	3	CD	NUMBER	3	_	0	SENT_298	[p14l1105t3373r1193b3448],
2	)	NN	O	)	dep	1	SENT_298	[p14l1105t3373r1193b3448],
3	.	.	O	.	_	0	SENT_298	[p14l1105t3373r1193b3448],

1	Moreover	RB	O	moreover	advmod	16	SENT_299	[p14l1236t3374r1578b3445],
2	,	,	O	,	_	0	SENT_299	[p14l1236t3374r1578b3445],
3	analysis	NN	O	analysis	nsubj	16	SENT_299	[p14l1623t3372r1898b3448],
4	in	IN	O	in	_	0	SENT_299	[p14l1936t3373r1995b3432],
5	the	DT	O	the	det	9	SENT_299	[p14l2036t3372r2150b3432],
6	most	RBS	O	most	advmod	8	SENT_299	[p14l12t3474r180b3529],
7	clinically	RB	O	clinically	advmod	8	SENT_299	[p14l208t3469r527b3544],
8	favorable	JJ	O	favorable	amod	9	SENT_299	[p14l554t3468r890b3529],
9	group	NN	O	group	prep_in	3	SENT_299	[p14l919t3483r1117b3544],
10	(	CD	NUMBER	(	num	12	SENT_299	[p14l1151t3469r1421b3544],
11	female	JJ	O	female	amod	12	SENT_299	[p14l1151t3469r1421b3544],
12	never-smokers	NNS	O	never-smoker	dep	9	SENT_299	[p14l1452t3468r1968b3529],
13	with	IN	O	with	_	0	SENT_299	[p14l1994t3469r2148b3529],
14	adenocarcinoma	NN	O	adenocarcinoma	nn	15	SENT_299	[p14l10t3566r622b3641],
15	)	NN	O	)	prep_with	12	SENT_299	[p14l10t3566r622b3641],
16	shows	VBZ	O	show	_	0	SENT_299	[p14l658t3566r866b3626],
17	that	IN	O	that	complm	23	SENT_299	[p14l900t3566r1045b3626],
18	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_299	[p14l1081t3566r1263b3626],
19	mutational	JJ	O	mutational	amod	20	SENT_299	[p14l1296t3566r1681b3626],
20	status	NN	O	status	nsubj	23	SENT_299	[p14l1716t3571r1926b3626],
21	could	MD	O	could	aux	23	SENT_299	[p14l1959t3566r2148b3626],
22	further	RBR	O	further	advmod	23	SENT_299	[p15l9t17r263b77],
23	improve	VB	O	improve	ccomp	16	SENT_299	[p15l305t18r593b93],
24	response	NN	O	response	nn	27	SENT_299	[p15l640t33r948b93],
25	and	CC	O	and	_	0	SENT_299	[p15l992t17r1115b77],
26	survival	NN	O	survival	nn	27	SENT_299	[p15l1162t17r1433b77],
27	prediction	NN	O	prediction	dobj	23	SENT_299	[p15l1480t17r1865b93],
28	.	.	O	.	_	0	SENT_299	[p15l1480t17r1865b93],

1	Therefore	RB	O	therefore	advmod	6	SENT_300	[p15l1914t17r2147b77, p15l9t113r176b186],
2	,	,	O	,	_	0	SENT_300	[p15l1914t17r2147b77, p15l9t113r176b186],
3	it	PRP	O	it	nsubj	6	SENT_300	[p15l230t114r280b173],
4	would	MD	O	would	aux	6	SENT_300	[p15l325t112r534b173],
5	be	VB	O	be	cop	6	SENT_300	[p15l586t113r668b173],
6	reasonable	JJ	O	reasonable	_	0	SENT_300	[p15l718t112r1102b173],
7	to	TO	O	to	aux	8	SENT_300	[p15l1149t118r1219b173],
8	perform	VB	O	perform	xcomp	6	SENT_300	[p15l1269t113r1550b188],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_300	[p15l1603t113r1784b173],
10	mutation	NN	O	mutation	nn	11	SENT_300	[p15l1831t114r2148b173],
11	analysis	NN	O	analysis	dobj	8	SENT_300	[p15l10t209r285b284],
12	for	IN	O	for	_	0	SENT_300	[p15l322t209r425b269],
13	more	RBR	O	more	advmod	14	SENT_300	[p15l463t225r641b269],
14	precise	JJ	O	precise	amod	15	SENT_300	[p15l682t210r933b285],
15	prediction	NN	O	prediction	prep_for	11	SENT_300	[p15l974t209r1334b285],
16	of	IN	O	of	_	0	SENT_300	[p15l1374t209r1446b269],
17	better	JJR	O	better	amod	18	SENT_300	[p15l1483t209r1706b269],
18	outcome	NN	O	outcome	prep_of	15	SENT_300	[p15l1742t214r2050b269],
19	in	IN	O	in	_	0	SENT_300	[p15l2088t210r2148b268],
20	patients	NNS	O	patient	prep_in	18	SENT_300	[p15l12t305r299b380],
21	with	IN	O	with	_	0	SENT_300	[p15l342t304r495b364],
22	adequate	JJ	O	adequate	amod	23	SENT_300	[p15l543t304r876b380],
23	tissue	NN	O	tissue	prep_with	8	SENT_300	[p15l921t305r1124b364],
24	for	IN	O	for	_	0	SENT_300	[p15l1169t304r1270b364],
25	the	DT	O	the	det	26	SENT_300	[p15l1314t304r1428b364],
26	analysis	NN	O	analysis	prep_for	23	SENT_300	[p15l1473t304r1771b380],
27	.	.	O	.	_	0	SENT_300	[p15l1473t304r1771b380],

1	However	RB	O	however	advmod	20	SENT_301	[p15l1826t306r2143b377],
2	,	,	O	,	_	0	SENT_301	[p15l1826t306r2143b377],
3	considering	VBG	O	consider	dep	20	SENT_301	[p15l9t401r415b476],
4	the	DT	O	the	det	7	SENT_301	[p15l440t401r554b461],
5	low	JJ	O	low	amod	7	SENT_301	[p15l582t400r703b461],
6	mutational	JJ	O	mutational	amod	7	SENT_301	[p15l728t401r1113b461],
7	frequency	NN	O	frequency	dobj	3	SENT_301	[p15l1138t401r1496b476],
8	and	CC	O	and	_	0	SENT_301	[p15l1519t401r1642b461],
9	response	NN	O	response	nn	10	SENT_301	[p15l1673t417r1981b476],
10	rate	NN	O	rate	dobj	3	SENT_301	[p15l2009t406r2150b461],
11	and	CC	O	and	_	0	SENT_301	[p15l10t497r133b557],
12	poor	JJ	O	poor	amod	13	SENT_301	[p15l177t513r335b573],
13	survival	NN	O	survival	dobj	3	SENT_301	[p15l372t497r642b557],
14	in	IN	O	in	_	0	SENT_301	[p15l682t498r741b556],
15	patients	NNS	O	patient	prep_in	3	SENT_301	[p15l785t498r1072b573],
16	with	IN	O	with	_	0	SENT_301	[p15l1109t497r1263b557],
17	zero	CD	NUMBER	zero	prep_with	15	SENT_301	[p15l1303t513r1456b557],
18	clinical	JJ	O	clinical	amod	19	SENT_301	[p15l1495t497r1748b557],
19	predictors	NNS	O	predictor	nsubj	20	SENT_301	[p15l1791t497r2150b573],
20	(	VBP	O	(	ccomp	32	SENT_301	[p15l14t593r211b669],
21	male	JJ	O	male	amod	22	SENT_301	[p15l14t593r211b669],
22	smokers	NNS	O	smoker	dobj	20	SENT_301	[p15l239t593r525b653],
23	with	IN	O	with	_	0	SENT_301	[p15l552t593r705b653],
24	non-adenocarcinoma	JJ	O	non-adenocarcinoma	amod	25	SENT_301	[p15l739t593r1534b669],
25	)	NN	O	)	prep_with	20	SENT_301	[p15l739t593r1534b669],
26	,	,	O	,	_	0	SENT_301	[p15l739t593r1534b669],
27	other	JJ	O	other	amod	29	SENT_301	[p15l1569t593r1761b653],
28	treatment	NN	O	treatment	nn	29	SENT_301	[p15l1788t599r2151b653],
29	options	NNS	O	option	nsubjpass	32	SENT_301	[p15l9t690r267b764],
30	should	MD	O	should	aux	32	SENT_301	[p15l316t688r541b749],
31	be	VB	O	be	auxpass	32	SENT_301	[p15l596t688r677b749],
32	recommended	VBN	O	recommend	_	0	SENT_301	[p15l729t688r1232b749],
33	rather	RB	O	rather	advmod	32	SENT_301	[p15l1286t688r1506b749],
34	than	IN	O	than	_	0	SENT_301	[p15l1553t688r1707b749],
35	testing	NN	O	testing	prep_than	32	SENT_301	[p15l1759t690r2002b764],
36	for	IN	O	for	_	0	SENT_301	[p15l2051t688r2153b749],
37	EGFR	NN	ORGANIZATION	egfr	nn	38	SENT_301	[p15l12t785r194b845],
38	mutation	NN	O	mutation	prep_for	35	SENT_301	[p15l223t786r539b845],
39	or	CC	O	or	_	0	SENT_301	[p15l571t801r643b845],
40	giving	VBG	O	give	conj_or	32	SENT_301	[p15l670t786r875b860],
41	geﬁtinib	NN	O	geﬁtinib	dobj	40	SENT_301	[p15l905t785r1196b861],
42	in	IN	O	in	_	0	SENT_301	[p15l1226t786r1285b844],
43	these	DT	O	these	det	44	SENT_301	[p15l1317t785r1508b845],
44	patients	NNS	O	patient	prep_in	41	SENT_301	[p15l1540t786r1849b861],
45	.	.	O	.	_	0	SENT_301	[p15l1540t786r1849b861],

1	In	IN	O	in	_	0	SENT_302	[p15l124t882r178b940],
2	patients	NNS	O	patient	prep_in	12	SENT_302	[p15l205t881r491b956],
3	with	IN	O	with	_	0	SENT_302	[p15l510t880r664b940],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_302	[p15l690t881r871b940],
5	mutation	NN	O	mutation	prep_with	2	SENT_302	[p15l892t881r1235b953],
6	,	,	O	,	_	0	SENT_302	[p15l892t881r1235b953],
7	no	DT	O	no	det	8	SENT_302	[p15l1265t896r1345b940],
8	difference	NN	O	difference	nsubjpass	12	SENT_302	[p15l1366t880r1735b940],
9	in	IN	O	in	_	0	SENT_302	[p15l1756t881r1815b940],
10	response	NN	O	response	prep_in	8	SENT_302	[p15l1842t896r2150b956],
11	was	VBD	O	be	auxpass	12	SENT_302	[p15l8t993r140b1037],
12	found	VBN	O	find	_	0	SENT_302	[p15l176t976r375b1037],
13	according	VBG	O	accord	_	0	SENT_302	[p15l415t976r759b1052],
14	to	TO	O	to	prepc_according_to	12	SENT_302	[p15l796t982r866b1037],
15	the	DT	O	the	det	16	SENT_302	[p15l903t976r1018b1037],
16	number	NN	O	number	pobj	12	SENT_302	[p15l1058t976r1327b1037],
17	of	IN	O	of	_	0	SENT_302	[p15l1362t976r1433b1037],
18	clinical	JJ	O	clinical	amod	19	SENT_302	[p15l1467t976r1721b1037],
19	predictors	NNS	O	predictor	prep_of	16	SENT_302	[p15l1762t976r2143b1052],
20	,	,	O	,	_	0	SENT_302	[p15l1762t976r2143b1052],
21	which	WDT	O	which	nsubj	22	SENT_302	[p15l7t1073r213b1133],
22	suggests	VBZ	O	suggest	rcmod	19	SENT_302	[p15l241t1078r534b1149],
23	that	IN	O	that	complm	31	SENT_302	[p15l560t1073r706b1133],
24	presence	NN	O	presence	nsubj	31	SENT_302	[p15l734t1089r1050b1149],
25	of	IN	O	of	_	0	SENT_302	[p15l1075t1073r1147b1133],
26	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_302	[p15l1173t1073r1354b1133],
27	mutation	NN	O	mutation	prep_of	24	SENT_302	[p15l1380t1074r1697b1133],
28	is	VBZ	O	be	cop	31	SENT_302	[p15l1725t1074r1775b1133],
29	the	DT	O	the	det	31	SENT_302	[p15l1802t1073r1916b1133],
30	major	JJ	O	major	amod	31	SENT_302	[p15l1944t1074r2152b1148],
31	determinant	NN	O	determinant	ccomp	22	SENT_302	[p15l10t1169r453b1229],
32	of	IN	O	of	_	0	SENT_302	[p15l493t1169r565b1229],
33	geﬁtinib	NN	O	geﬁtinib	nn	34	SENT_302	[p15l603t1169r896b1245],
34	sensitivity	NN	O	sensitivity	prep_of	31	SENT_302	[p15l937t1170r1299b1245],
35	in	IN	O	in	_	0	SENT_302	[p15l1339t1170r1398b1228],
36	patients	NNS	O	patient	prep_in	34	SENT_302	[p15l1445t1170r1732b1245],
37	with	IN	O	with	_	0	SENT_302	[p15l1771t1169r1924b1229],
38	EGFR	NN	ORGANIZATION	egfr	nn	39	SENT_302	[p15l1971t1170r2152b1229],
39	mutation	NN	O	mutation	prep_with	36	SENT_302	[p15l12t1267r354b1326],
40	.	.	O	.	_	0	SENT_302	[p15l12t1267r354b1326],

1	In	IN	O	in	_	0	SENT_303	[p15l395t1267r450b1325],
2	contrast	NN	O	contrast	prep_in	5	SENT_303	[p15l482t1271r797b1339],
3	,	,	O	,	_	0	SENT_303	[p15l482t1271r797b1339],
4	RR	NN	O	rr	nsubj	5	SENT_303	[p15l837t1266r925b1325],
5	showed	VBD	O	show	_	0	SENT_303	[p15l952t1265r1213b1326],
6	an	DT	O	a	det	7	SENT_303	[p15l1246t1282r1324b1326],
7	increase	NN	O	increase	dobj	5	SENT_303	[p15l1357t1267r1653b1326],
8	as	IN	O	as	mark	13	SENT_303	[p15l1683t1282r1753b1326],
9	number	NN	O	number	nsubj	13	SENT_303	[p15l1785t1265r2054b1326],
10	of	IN	O	of	_	0	SENT_303	[p15l2082t1265r2153b1326],
11	clinical	JJ	O	clinical	amod	12	SENT_303	[p15l9t1362r263b1422],
12	predictors	NNS	O	predictor	prep_of	9	SENT_303	[p15l298t1362r657b1438],
13	increased	VBD	O	increase	advcl	5	SENT_303	[p15l688t1362r1026b1422],
14	among	IN	O	among	_	0	SENT_303	[p15l1060t1376r1292b1437],
15	the	DT	O	the	det	16	SENT_303	[p15l1323t1362r1438b1422],
16	patients	NNS	O	patient	prep_among	13	SENT_303	[p15l1471t1363r1758b1438],
17	with	IN	O	with	_	0	SENT_303	[p15l1787t1362r1940b1422],
18	wildtype	JJ	O	wildtype	amod	19	SENT_303	[p15l1972t1362r2147b1422, p15l10t1463r165b1534],
19	EGFR	NN	ORGANIZATION	egfr	prep_with	13	SENT_303	[p15l194t1459r396b1518],
20	.	.	O	.	_	0	SENT_303	[p15l194t1459r396b1518],

1	This	DT	O	this	det	2	SENT_304	[p15l427t1458r571b1518],
2	increase	NN	O	increase	nsubj	5	SENT_304	[p15l598t1459r893b1518],
3	may	MD	O	may	aux	5	SENT_304	[p15l922t1474r1066b1534],
4	be	VB	O	be	cop	5	SENT_304	[p15l1092t1458r1174b1518],
5	due	JJ	O	due	_	0	SENT_304	[p15l1201t1458r1329b1518],
6	to	TO	O	to	_	0	SENT_304	[p15l1355t1463r1425b1518],
7	geﬁtinib-sensitizing	JJ	O	geﬁtinib-sensitizing	amod	8	SENT_304	[p15l1452t1458r2150b1534],
8	mechanism	NN	O	mechanism	prep_to	5	SENT_304	[p15l12t1554r405b1615],
9	other	JJ	O	other	amod	8	SENT_304	[p15l450t1554r642b1615],
10	than	IN	O	than	_	0	SENT_304	[p15l682t1554r836b1615],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_304	[p15l884t1555r1065b1615],
12	mutation	NN	O	mutation	prep_than	9	SENT_304	[p15l1108t1556r1450b1628],
13	,	,	O	,	_	0	SENT_304	[p15l1108t1556r1450b1628],
14	such	JJ	O	such	_	0	SENT_304	[p15l1499t1554r1652b1615],
15	as	IN	O	as	_	0	SENT_304	[p15l1697t1571r1767b1615],
16	increased	VBN	O	increase	amod	19	SENT_304	[p15l1810t1554r2148b1615],
17	gene	NN	O	gene	nn	19	SENT_304	[p15l10t1666r177b1726],
18	copy	NN	O	copy	nn	19	SENT_304	[p15l209t1667r374b1727],
19	number	NN	O	number	prep_such_as	8	SENT_304	[p15l407t1651r677b1711],
20	potentially	RB	O	potentially	advmod	21	SENT_304	[p15l710t1651r1097b1727],
21	associated	VBN	O	associate	partmod	19	SENT_304	[p15l1128t1651r1496b1711],
22	with	IN	O	with	_	0	SENT_304	[p15l1530t1651r1683b1711],
23	clinical	JJ	O	clinical	amod	24	SENT_304	[p15l1718t1651r1972b1711],
24	predictors	NNS	O	predictor	prep_with	21	SENT_304	[p15l2008t1667r2147b1727, p15l10t1747r273b1807],
25	.	.	O	.	_	0	SENT_304	[p15l2008t1667r2147b1727, p15l10t1747r273b1807],

1	However	RB	O	however	advmod	14	SENT_305	[p15l313t1749r630b1820],
2	,	,	O	,	_	0	SENT_305	[p15l313t1749r630b1820],
3	association	NN	O	association	nsubj	14	SENT_305	[p15l666t1748r1055b1807],
4	between	IN	O	between	_	0	SENT_305	[p15l1089t1747r1391b1807],
5	increased	VBN	O	increase	amod	8	SENT_305	[p15l1423t1747r1760b1807],
6	gene	NN	O	gene	nn	8	SENT_305	[p15l1792t1762r1959b1823],
7	copy	NN	O	copy	nn	8	SENT_305	[p15l1987t1763r2152b1823],
8	number	NN	O	number	prep_between	3	SENT_305	[p15l12t1842r282b1903],
9	and	CC	O	and	_	0	SENT_305	[p15l316t1842r439b1903],
10	clinical	JJ	O	clinical	amod	11	SENT_305	[p15l478t1842r732b1903],
11	predictors	NNS	O	predictor	conj_and	8	SENT_305	[p15l771t1842r1130b1918],
12	is	VBZ	O	be	cop	14	SENT_305	[p15l1167t1844r1217b1903],
13	controversial	JJ	O	controversial	amod	14	SENT_305	[p15l1254t1842r1717b1903],
14	[	NN	O	[	_	0	SENT_305	[p15l1760t1842r2143b1918],
15	20,22,25	CD	NUMBER	20,22,25	num	16	SENT_305	[p15l1760t1842r2143b1918],
16	]	NN	O	]	dep	14	SENT_305	[p15l1760t1842r2143b1918],
17	.	.	O	.	_	0	SENT_305	[p15l1760t1842r2143b1918],

1	Another	DT	O	another	det	3	SENT_306	[p15l7t1939r293b1999],
2	possible	JJ	O	possible	amod	3	SENT_306	[p15l320t1938r602b2014],
3	explanation	NN	O	explanation	nsubj	13	SENT_306	[p15l628t1938r1044b2014],
4	for	IN	O	for	_	0	SENT_306	[p15l1074t1939r1176b1999],
5	the	DT	O	the	det	6	SENT_306	[p15l1201t1939r1316b1999],
6	association	NN	O	association	prep_for	3	SENT_306	[p15l1343t1940r1733b1999],
7	in	IN	O	in	_	0	SENT_306	[p15l1763t1940r1823b1998],
8	the	DT	O	the	det	9	SENT_306	[p15l1852t1938r1967b1999],
9	nonmutants	NNS	O	nonmutant	prep_in	6	SENT_306	[p15l1997t1955r2147b1999, p15l12t2040r298b2095],
10	is	VBZ	O	be	cop	13	SENT_306	[p15l331t2036r382b2095],
11	the	DT	O	the	det	13	SENT_306	[p15l415t2035r529b2095],
12	potential	JJ	O	potential	amod	13	SENT_306	[p15l564t2035r885b2111],
13	limitation	NN	O	limitation	_	0	SENT_306	[p15l921t2035r1288b2108],
14	,	,	O	,	_	0	SENT_306	[p15l921t2035r1288b2108],
15	false	JJ	O	false	amod	16	SENT_306	[p15l1327t2035r1495b2095],
16	negativity	NN	O	negativity	appos	13	SENT_306	[p15l1530t2036r1895b2111],
17	,	,	O	,	_	0	SENT_306	[p15l1530t2036r1895b2111],
18	of	IN	O	of	_	0	SENT_306	[p15l1934t2035r2006b2095],
19	the	DT	O	the	det	21	SENT_306	[p15l2036t2035r2150b2095],
20	mutational	JJ	O	mutational	amod	21	SENT_306	[p15l12t2130r397b2191],
21	analysis	NN	O	analysis	prep_of	13	SENT_306	[p15l423t2130r697b2206],
22	in	IN	O	in	_	0	SENT_306	[p15l723t2132r781b2190],
23	the	DT	O	the	det	25	SENT_306	[p15l809t2130r924b2191],
24	present	JJ	DATE	present	amod	25	SENT_306	[p15l951t2136r1217b2206],
25	study	NN	O	study	prep_in	21	SENT_306	[p15l1241t2130r1431b2206],
26	which	WDT	O	which	nsubj	27	SENT_306	[p15l1452t2130r1657b2191],
27	used	VBD	O	use	rcmod	25	SENT_306	[p15l1687t2130r1842b2191],
28	archival	JJ	O	archival	amod	30	SENT_306	[p15l1870t2130r2150b2191],
29	parafﬁn-embedded	JJ	O	parafﬁn-embedded	amod	30	SENT_306	[p15l12t2226r690b2302],
30	tissue	NN	O	tissue	dobj	27	SENT_306	[p15l729t2228r932b2287],
31	most	JJS	O	most	nsubjpass	35	SENT_306	[p15l971t2232r1139b2287],
32	of	IN	O	of	_	0	SENT_306	[p15l1174t2227r1245b2287],
33	which	WDT	O	which	prep_of	31	SENT_306	[p15l1277t2226r1482b2287],
34	were	VBD	O	be	auxpass	35	SENT_306	[p15l1519t2243r1696b2287],
35	obtained	VBN	O	obtain	rcmod	30	SENT_306	[p15l1732t2227r2042b2287],
36	at	IN	O	at	_	0	SENT_306	[p15l2082t2232r2151b2287],
37	initial	JJ	O	initial	amod	38	SENT_306	[p15l10t2323r215b2383],
38	diagnosis	NN	O	diagnosis	prep_at	35	SENT_306	[p15l245t2323r587b2399],
39	.	.	O	.	_	0	SENT_306	[p15l245t2323r587b2399],

1	The	DT	O	the	det	3	SENT_307	[p15l118t2419r249b2479],
2	present	JJ	DATE	present	amod	3	SENT_307	[p15l276t2425r541b2495],
3	study	NN	O	study	nsubjpass	5	SENT_307	[p15l565t2419r755b2495],
4	was	VBD	O	be	auxpass	5	SENT_307	[p15l775t2435r907b2479],
5	performed	VBN	O	perform	_	0	SENT_307	[p15l934t2419r1303b2495],
6	by	IN	O	by	_	0	SENT_307	[p15l1332t2419r1411b2495],
7	retrospective	JJ	O	retrospective	amod	8	SENT_307	[p15l1437t2420r1910b2495],
8	analysis	NN	O	analysis	agent	5	SENT_307	[p15l1934t2419r2147b2495, p15l9t2516r93b2575],
9	of	IN	O	of	_	0	SENT_307	[p15l117t2515r188b2575],
10	consecutive	JJ	O	consecutive	amod	11	SENT_307	[p15l210t2516r631b2575],
11	patients	NNS	O	patient	prep_of	8	SENT_307	[p15l657t2516r944b2590],
12	treated	VBN	O	treat	partmod	11	SENT_307	[p15l969t2514r1231b2575],
13	at	IN	O	at	_	0	SENT_307	[p15l1259t2520r1328b2575],
14	our	PRP$	O	we	poss	15	SENT_307	[p15l1352t2531r1468b2575],
15	institutions	NNS	O	institution	prep_at	12	SENT_307	[p15l1491t2516r1912b2575],
16	.	.	O	.	_	0	SENT_307	[p15l1491t2516r1912b2575],

1	These	DT	O	these	det	2	SENT_308	[p15l1942t2515r2150b2575],
2	results	NNS	O	result	nsubj	3	SENT_308	[p15l12t2611r245b2671],
3	need	VBP	O	need	_	0	SENT_308	[p15l278t2611r445b2671],
4	to	TO	O	to	aux	6	SENT_308	[p15l479t2617r549b2671],
5	be	VB	O	be	auxpass	6	SENT_308	[p15l583t2611r665b2671],
6	validated	VBN	O	validate	xcomp	3	SENT_308	[p15l694t2611r1024b2671],
7	in	IN	O	in	_	0	SENT_308	[p15l1059t2612r1118b2670],
8	future	JJ	DATE	future	amod	10	SENT_308	[p15l1151t2611r1372b2671],
9	prospective	JJ	O	prospective	amod	10	SENT_308	[p15l1406t2612r1817b2687],
10	trials	NNS	O	trial	prep_in	6	SENT_308	[p15l1848t2611r2050b2671],
11	.	.	O	.	_	0	SENT_308	[p15l1848t2611r2050b2671],

1	In	IN	O	in	_	0	SENT_309	[p15l2093t2613r2148b2670],
2	addition	NN	O	addition	prep_in	15	SENT_309	[p15l10t2706r324b2779],
3	,	,	O	,	_	0	SENT_309	[p15l10t2706r324b2779],
4	as	IN	O	as	mark	10	SENT_309	[p15l365t2722r435b2766],
5	all	PDT	O	all	predet	8	SENT_309	[p15l469t2706r553b2766],
6	the	DT	O	the	det	8	SENT_309	[p15l587t2706r702b2766],
7	study	NN	O	study	nn	8	SENT_309	[p15l735t2706r925b2782],
8	patients	NNS	O	patient	nsubj	10	SENT_309	[p15l960t2707r1246b2782],
9	were	VBD	O	be	cop	10	SENT_309	[p15l1278t2722r1454b2766],
10	Koreans	NNPS	MISC	Koreans	advcl	15	SENT_309	[p15l1491t2708r1786b2780],
11	,	,	O	,	_	0	SENT_309	[p15l1491t2708r1786b2780],
12	we	PRP	O	we	nsubj	15	SENT_309	[p15l1825t2722r1926b2766],
13	could	MD	O	could	aux	15	SENT_309	[p15l1959t2706r2148b2766],
14	not	RB	O	not	neg	15	SENT_309	[p15l12t2808r124b2863],
15	analyze	VB	O	analyze	_	0	SENT_309	[p15l161t2802r430b2878],
16	the	DT	O	the	det	17	SENT_309	[p15l467t2803r582b2863],
17	effect	NN	O	effect	dobj	15	SENT_309	[p15l618t2803r833b2863],
18	of	IN	O	of	_	0	SENT_309	[p15l869t2803r941b2863],
19	ethnicity	NN	O	ethnicity	prep_of	17	SENT_309	[p15l975t2803r1304b2878],
20	.	.	O	.	_	0	SENT_309	[p15l975t2803r1304b2878],

1	Whether	IN	O	whether	complm	6	SENT_310	[p15l1345t2802r1652b2863],
2	these	DT	O	these	det	3	SENT_310	[p15l1687t2803r1878b2863],
3	results	NNS	O	result	nsubjpass	6	SENT_310	[p15l1918t2803r2150b2863],
4	could	MD	O	could	aux	6	SENT_310	[p15l9t2899r198b2959],
5	be	VB	O	be	auxpass	6	SENT_310	[p15l231t2899r313b2959],
6	applied	VBN	O	apply	csubjpass	13	SENT_310	[p15l342t2899r601b2975],
7	to	TO	O	to	_	0	SENT_310	[p15l633t2904r703b2959],
8	other	JJ	O	other	amod	9	SENT_310	[p15l731t2899r923b2959],
9	ethnicities	NNS	O	ethnicity	prep_to	6	SENT_310	[p15l949t2899r1325b2959],
10	should	MD	O	should	aux	13	SENT_310	[p15l1354t2899r1578b2959],
11	also	RB	O	also	advmod	13	SENT_310	[p15l1610t2899r1747b2959],
12	be	VB	O	be	auxpass	13	SENT_310	[p15l1778t2899r1859b2959],
13	investigated	VBN	O	investigate	_	0	SENT_310	[p15l1888t2900r2147b2959, p15l10t2994r230b3070],
14	.	.	O	.	_	0	SENT_310	[p15l1888t2900r2147b2959, p15l10t2994r230b3070],

1	In	IN	O	in	_	0	SENT_311	[p15l124t3092r178b3150],
2	conclusion	NN	O	conclusion	prep_in	8	SENT_311	[p15l234t3091r630b3164],
3	,	,	O	,	_	0	SENT_311	[p15l234t3091r630b3164],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_311	[p15l694t3091r875b3151],
5	mutation	NN	O	mutation	nsubjpass	8	SENT_311	[p15l928t3092r1245b3151],
6	should	MD	O	should	aux	8	SENT_311	[p15l1302t3090r1526b3151],
7	be	VB	O	be	auxpass	8	SENT_311	[p15l1585t3090r1667b3151],
8	analyzed	VBN	O	analyze	_	0	SENT_311	[p15l1721t3090r2032b3166],
9	in	IN	O	in	_	0	SENT_311	[p15l2088t3092r2148b3150],
10	patients	NNS	O	patient	prep_in	8	SENT_311	[p15l12t3188r299b3263],
11	with	IN	O	with	_	0	SENT_311	[p15l348t3187r501b3247],
12	one	CD	NUMBER	one	num	16	SENT_311	[p15l555t3203r682b3247],
13	or	CC	O	or	_	0	SENT_311	[p15l733t3203r805b3247],
14	more	JJR	O	more	num	16	SENT_311	[p15l857t3203r1035b3247],
15	clinical	JJ	O	clinical	amod	16	SENT_311	[p15l1086t3187r1340b3247],
16	predictors	NNS	O	predictor	prep_with	10	SENT_311	[p15l1394t3187r1754b3263],
17	whenever	WRB	O	whenever	advmod	18	SENT_311	[p15l1803t3187r2153b3247],
18	possible	JJ	O	possible	advmod	16	SENT_311	[p15l12t3283r293b3359],
19	for	IN	O	for	_	0	SENT_311	[p15l329t3283r431b3343],
20	effective	JJ	O	effective	amod	21	SENT_311	[p15l465t3283r786b3343],
21	prediction	NN	O	prediction	prep_for	18	SENT_311	[p15l824t3283r1184b3359],
22	of	IN	O	of	_	0	SENT_311	[p15l1222t3283r1294b3343],
23	objective	JJ	O	objective	amod	24	SENT_311	[p15l1327t3283r1661b3359],
24	beneﬁt	NN	O	beneﬁt	prep_of	21	SENT_311	[p15l1700t3283r1949b3343],
25	from	IN	O	from	_	0	SENT_311	[p15l1984t3283r2148b3343],
26	geﬁtinib	NN	O	geﬁtinib	prep_from	8	SENT_311	[p15l10t3379r302b3454],
27	in	IN	O	in	_	0	SENT_311	[p15l341t3380r400b3438],
28	NSCLC	NN	O	nsclc	nn	29	SENT_311	[p15l444t3379r662b3439],
29	patients	NNS	O	patient	prep_in	26	SENT_311	[p15l704t3380r1013b3454],
30	.	.	O	.	_	0	SENT_311	[p15l704t3380r1013b3454],

1	In	IN	O	in	_	0	SENT_312	[p15l1063t3380r1117b3438],
2	case	NN	O	case	prep_in	19	SENT_312	[p15l1159t3395r1312b3439],
3	when	WRB	O	when	advmod	13	SENT_312	[p15l1349t3379r1535b3439],
4	adequate	JJ	O	adequate	amod	5	SENT_312	[p15l1577t3378r1909b3454],
5	tissue	NN	O	tissue	nsubjpass	13	SENT_312	[p15l1947t3380r2150b3439],
6	for	IN	O	for	_	0	SENT_312	[p15l9t3475r112b3535],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_312	[p15l143t3475r324b3535],
8	mutational	JJ	O	mutational	amod	9	SENT_312	[p15l356t3475r740b3535],
9	analysis	NN	O	analysis	prep_for	5	SENT_312	[p15l773t3475r1047b3550],
10	can	MD	O	can	aux	13	SENT_312	[p15l1078t3480r1320b3535],
11	not	RB	O	not	neg	13	SENT_312	[p15l1078t3480r1320b3535],
12	be	VB	O	be	auxpass	13	SENT_312	[p15l1353t3475r1434b3535],
13	obtained	VBN	O	obtain	dep	2	SENT_312	[p15l1465t3475r1801b3548],
14	,	,	O	,	_	0	SENT_312	[p15l1465t3475r1801b3548],
15	response	NN	O	response	nn	16	SENT_312	[p15l1842t3491r2150b3551],
16	prediction	NN	O	prediction	nsubjpass	19	SENT_312	[p15l12t3571r371b3647],
17	can	MD	O	can	aux	19	SENT_312	[p15l439t3587r557b3631],
18	be	VB	O	be	auxpass	19	SENT_312	[p15l627t3571r709b3631],
19	made	VBN	O	make	_	0	SENT_312	[p15l776t3571r966b3631],
20	with	IN	O	with	_	0	SENT_312	[p15l1029t3571r1182b3631],
21	the	DT	O	the	det	22	SENT_312	[p15l1249t3571r1364b3631],
22	number	NN	O	number	prep_with	19	SENT_312	[p15l1431t3571r1701b3631],
23	of	IN	O	of	_	0	SENT_312	[p15l1763t3571r1834b3631],
24	clinical	JJ	O	clinical	amod	25	SENT_312	[p15l1896t3571r2150b3631],
25	predictors	NNS	O	predictor	prep_of	22	SENT_312	[p15l12t3666r394b3742],
26	.	.	O	.	_	0	SENT_312	[p15l12t3666r394b3742],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_313	[p16l7t122r848b216],

1	This	DT	O	this	det	2	SENT_314	[p16l7t349r151b409],
2	study	NN	O	study	nsubjpass	4	SENT_314	[p16l177t349r368b424],
3	was	VBD	O	be	auxpass	4	SENT_314	[p16l390t365r522b409],
4	supported	VBN	O	support	_	0	SENT_314	[p16l548t349r902b425],
5	in	IN	O	in	_	0	SENT_314	[p16l931t350r990b408],
6	part	NN	O	part	prep_in	4	SENT_314	[p16l1022t354r1166b425],
7	by	IN	O	by	_	0	SENT_314	[p16l1194t349r1273b425],
8	a	DT	O	a	det	9	SENT_314	[p16l1298t365r1335b409],
9	grant	NN	O	grant	agent	4	SENT_314	[p16l1362t354r1547b424],
10	from	IN	O	from	_	0	SENT_314	[p16l1573t349r1736b409],
11	the	DT	O	the	det	16	SENT_314	[p16l1765t349r1880b409],
12	Korean	NNP	ORGANIZATION	Korean	nn	16	SENT_314	[p16l1910t350r2148b409],
13	Health	NNP	ORGANIZATION	Health	nn	16	SENT_314	[p16l12t445r240b505],
14	21	CD	NUMBER	21	num	16	SENT_314	[p16l266t446r334b505],
15	R&D	NNP	O	R&D	nn	16	SENT_314	[p16l373t446r517b505],
16	Project	NNP	O	Project	prep_from	9	SENT_314	[p16l545t446r820b521],
17	,	,	O	,	_	0	SENT_314	[p16l545t446r820b521],
18	Ministry	NNP	ORGANIZATION	Ministry	appos	9	SENT_314	[p16l849t446r1130b521],
19	of	IN	ORGANIZATION	of	_	0	SENT_314	[p16l1152t445r1223b505],
20	Health	NNP	ORGANIZATION	Health	prep_of	18	SENT_314	[p16l1247t445r1475b505],
21	&	CC	ORGANIZATION	&	_	0	SENT_314	[p16l1504t446r1551b505],
22	Welfare	NNP	ORGANIZATION	Welfare	prep_of	18	SENT_314	[p16l1575t445r1874b518],
23	,	,	O	,	_	0	SENT_314	[p16l1575t445r1874b518],
24	Republic	NNP	O	Republic	appos	9	SENT_314	[p16l1908t445r2147b521, p16l12t541r91b602],
25	of	IN	O	of	_	0	SENT_314	[p16l120t541r191b602],
26	Korea	NNP	LOCATION	Korea	prep_of	24	SENT_314	[p16l220t543r416b602],
27	(	CD	NUMBER	(	num	26	SENT_314	[p16l451t542r1433b617],
28	03-PJ10-PG13-GD01-0002	NN	O	03-pj10-pg13-gd01-0002	nn	29	SENT_314	[p16l451t542r1433b617],
29	)	NN	O	)	dep	24	SENT_314	[p16l451t542r1433b617],
30	.	.	O	.	_	0	SENT_314	[p16l451t542r1433b617],

1	References	NNS	O	reference	_	0	SENT_315	[p16l14t779r520b853],

1	[	NN	O	[	_	0	SENT_316	[p16l48t1006r124b1074],
2	1	CD	NUMBER	1	number	3	SENT_316	[p16l48t1006r124b1074],
3	]	CD	NUMBER	]	dep	1	SENT_316	[p16l48t1006r124b1074],
4	Rowinsky	NNP	PERSON	Rowinsky	nn	5	SENT_316	[p16l165t1006r450b1074],
5	EK	NNP	PERSON	EK	dep	3	SENT_316	[p16l481t1007r574b1060],
6	.	.	O	.	_	0	SENT_316	[p16l481t1007r574b1060],

1	The	DT	O	the	det	3	SENT_317	[p16l609t1006r726b1060],
2	erbB	NN	O	erbb	nn	3	SENT_317	[p16l757t1006r899b1060],
3	family	NN	O	family	_	0	SENT_317	[p16l930t1006r1146b1074],
4	:	:	O	:	_	0	SENT_317	[p16l930t1006r1146b1074],
5	targets	NNS	O	target	dep	3	SENT_317	[p16l1184t1011r1405b1074],
6	for	IN	O	for	_	0	SENT_317	[p16l1435t1006r1526b1060],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_317	[p16l1555t1006r1924b1074],
8	development	NN	O	development	prep_for	5	SENT_317	[p16l1955t1006r2147b1060, p16l162t1100r403b1163],
9	against	IN	O	against	_	0	SENT_317	[p16l426t1096r650b1163],
10	cancer	NN	O	cancer	prep_against	8	SENT_317	[p16l673t1109r886b1149],
11	and	CC	O	and	_	0	SENT_317	[p16l907t1095r1017b1149],
12	therapeutic	JJ	O	therapeutic	amod	13	SENT_317	[p16l1044t1095r1412b1163],
13	strategies	NNS	O	strategy	prep_for	5	SENT_317	[p16l1437t1096r1746b1163],
14	using	VBG	O	use	partmod	13	SENT_317	[p16l1772t1096r1929b1163],
15	monoclonal	JJ	O	monoclonal	amod	16	SENT_317	[p16l1956t1109r2147b1149, p16l162t1184r350b1238],
16	antibodies	NNS	O	antibody	dobj	14	SENT_317	[p16l376t1184r703b1238],
17	and	CC	O	and	_	0	SENT_317	[p16l728t1184r837b1238],
18	tyrosine	NN	O	tyrosine	nn	20	SENT_317	[p16l864t1185r1117b1252],
19	kinase	NN	O	kinase	nn	20	SENT_317	[p16l1144t1184r1338b1238],
20	inhibitors	NNS	O	inhibitor	dobj	14	SENT_317	[p16l1364t1184r1682b1238],
21	.	.	O	.	_	0	SENT_317	[p16l1364t1184r1682b1238],

1	Annu	NNP	PERSON	Annu	nn	2	SENT_318	[p16l1710t1185r1866b1238],
2	Rev	NN	PERSON	rev	nsubj	3	SENT_318	[p16l1895t1185r2002b1238],
3	Med	VBD	O	med	_	0	SENT_318	[p16l2024t1184r2148b1238],
4	2004	CD	DATE	2004	dobj	3	SENT_318	[p16l162t1273r695b1339],
5	;	:	O	;	_	0	SENT_318	[p16l162t1273r695b1339],
6	55:433	CD	NUMBER	55:433	number	7	SENT_318	[p16l162t1273r695b1339],
7	—	CD	NUMBER	—	dep	4	SENT_318	[p16l162t1273r695b1339],
8	57	CD	NUMBER	57	dep	7	SENT_318	[p16l162t1273r695b1339],
9	.	.	O	.	_	0	SENT_318	[p16l162t1273r695b1339],

1	[	NN	O	[	nsubj	13	SENT_319	[p16l48t1362r124b1430],
2	2	CD	NUMBER	2	num	1	SENT_319	[p16l48t1362r124b1430],
3	]	CD	NUMBER	]	num	5	SENT_319	[p16l48t1362r124b1430],
4	Herbst	NNP	ORGANIZATION	Herbst	nn	5	SENT_319	[p16l165t1362r369b1416],
5	RS	NN	ORGANIZATION	r	dep	1	SENT_319	[p16l402t1362r491b1428],
6	,	,	O	,	_	0	SENT_319	[p16l402t1362r491b1428],
7	Fukuoka	NNP	LOCATION	Fukuoka	nn	8	SENT_319	[p16l530t1362r787b1416],
8	M	NNP	O	M	appos	1	SENT_319	[p16l816t1363r885b1428],
9	,	,	O	,	_	0	SENT_319	[p16l816t1363r885b1428],
10	Baselga	NNP	PERSON	Baselga	nn	12	SENT_319	[p16l924t1362r1157b1430],
11	J.	NNP	PERSON	J.	nn	12	SENT_319	[p16l1187t1363r1238b1416],
12	Geﬁtinib	NNP	PERSON	Geﬁtinib	appos	8	SENT_319	[p16l1274t1362r1649b1416],
13	—	VBD	O	—	_	0	SENT_319	[p16l1274t1362r1649b1416],
14	a	DT	O	a	det	17	SENT_319	[p16l1274t1362r1649b1416],
15	novel	JJ	O	novel	dep	16	SENT_319	[p16l1682t1362r1848b1416],
16	targeted	VBN	O	target	amod	17	SENT_319	[p16l1879t1362r2148b1430],
17	approach	NN	O	approach	dobj	13	SENT_319	[p16l163t1451r451b1519],
18	to	TO	O	to	_	0	SENT_319	[p16l480t1456r542b1505],
19	treating	VBG	O	treat	prepc_to	13	SENT_319	[p16l568t1452r820b1519],
20	cancer	NN	O	cancer	dobj	19	SENT_319	[p16l845t1465r1066b1505],
21	.	.	O	.	_	0	SENT_319	[p16l845t1465r1066b1505],

1	Nat	NNP	O	Nat	nn	3	SENT_320	[p16l1101t1452r1206b1505],
2	Rev	NN	O	rev	nn	3	SENT_320	[p16l1234t1452r1341b1505],
3	Cancer	NN	O	cancer	_	0	SENT_320	[p16l1366t1451r1585b1505],
4	2004	CD	DATE	2004	dep	3	SENT_320	[p16l1608t1451r2104b1517],
5	;	:	O	;	_	0	SENT_320	[p16l1608t1451r2104b1517],
6	4:956	CD	NUMBER	4:956	number	7	SENT_320	[p16l1608t1451r2104b1517],
7	—	CD	NUMBER	—	dep	3	SENT_320	[p16l1608t1451r2104b1517],
8	65	CD	NUMBER	65	dep	7	SENT_320	[p16l1608t1451r2104b1517],
9	.	.	O	.	_	0	SENT_320	[p16l1608t1451r2104b1517],

1	[	NN	O	[	nn	3	SENT_321	[p16l48t1540r124b1608],
2	3	CD	NUMBER	3	num	3	SENT_321	[p16l48t1540r124b1608],
3	]	NN	O	]	_	0	SENT_321	[p16l48t1540r124b1608],
4	Giaccone	NNP	PERSON	Giaccone	nn	10	SENT_321	[p16l163t1541r452b1594],
5	G.	NNP	O	G.	nn	10	SENT_321	[p16l491t1541r555b1594],
6	Epidermal	NNP	O	Epidermal	nn	10	SENT_321	[p16l603t1540r919b1608],
7	growth	NN	O	growth	nn	10	SENT_321	[p16l960t1540r1176b1608],
8	factor	NN	O	factor	nn	10	SENT_321	[p16l1217t1540r1409b1594],
9	receptor	NN	O	receptor	nn	10	SENT_321	[p16l1450t1545r1720b1608],
10	inhibitors	NNS	O	inhibitor	dep	3	SENT_321	[p16l1758t1540r2056b1594],
11	in	IN	O	in	_	0	SENT_321	[p16l2096t1541r2148b1593],
12	the	DT	O	the	det	13	SENT_321	[p16l163t1629r265b1683],
13	treatment	NN	O	treatment	prep_in	10	SENT_321	[p16l311t1634r634b1683],
14	of	IN	O	of	_	0	SENT_321	[p16l679t1629r743b1683],
15	non-small-cell	JJ	O	non-small-cell	amod	17	SENT_321	[p16l788t1629r1235b1683],
16	lung	NN	O	lung	nn	17	SENT_321	[p16l1284t1629r1413b1697],
17	cancer	NN	O	cancer	prep_of	13	SENT_321	[p16l1458t1644r1679b1683],
18	.	.	O	.	_	0	SENT_321	[p16l1458t1644r1679b1683],

1	J	NNP	O	J	nn	3	SENT_322	[p16l1731t1630r1758b1683],
2	Clin	NNP	O	Clin	nn	3	SENT_322	[p16l1808t1629r1924b1683],
3	Oncol	NNP	O	Oncol	_	0	SENT_322	[p16l1973t1629r2150b1683],
4	2005	CD	DATE	2005	num	3	SENT_322	[p16l162t1719r733b1784],
5	;	:	O	;	_	0	SENT_322	[p16l162t1719r733b1784],
6	23:3235	CD	NUMBER	23:3235	number	7	SENT_322	[p16l162t1719r733b1784],
7	—	CD	NUMBER	—	dep	3	SENT_322	[p16l162t1719r733b1784],
8	42	CD	NUMBER	42	dep	7	SENT_322	[p16l162t1719r733b1784],
9	.	.	O	.	_	0	SENT_322	[p16l162t1719r733b1784],

1	[	NN	O	[	_	0	SENT_323	[p16l48t1807r124b1875],
2	4	CD	NUMBER	4	num	1	SENT_323	[p16l48t1807r124b1875],
3	]	CD	NUMBER	]	num	5	SENT_323	[p16l48t1807r124b1875],
4	Fukuoka	NNP	LOCATION	Fukuoka	nn	5	SENT_323	[p16l165t1807r421b1861],
5	M	NN	O	m	dep	1	SENT_323	[p16l445t1808r513b1873],
6	,	,	O	,	_	0	SENT_323	[p16l445t1808r513b1873],
7	Yano	NNP	PERSON	Yano	nn	8	SENT_323	[p16l543t1808r689b1861],
8	S	NNP	O	S	appos	5	SENT_323	[p16l714t1808r764b1873],
9	,	,	O	,	_	0	SENT_323	[p16l714t1808r764b1873],
10	Giaccone	NNP	PERSON	Giaccone	nn	11	SENT_323	[p16l796t1808r1085b1861],
11	G	NNP	PERSON	G	appos	5	SENT_323	[p16l1110t1808r1174b1873],
12	,	,	O	,	_	0	SENT_323	[p16l1110t1808r1174b1873],
13	Tamura	NNP	PERSON	Tamura	nn	14	SENT_323	[p16l1203t1808r1434b1861],
14	T	NN	O	t	appos	5	SENT_323	[p16l1457t1808r1505b1873],
15	,	,	O	,	_	0	SENT_323	[p16l1457t1808r1505b1873],
16	Nakagawa	NNP	PERSON	Nakagawa	nn	17	SENT_323	[p16l1538t1807r1853b1875],
17	K	NNP	PERSON	K	appos	5	SENT_323	[p16l1880t1808r1935b1873],
18	,	,	O	,	_	0	SENT_323	[p16l1880t1808r1935b1873],
19	Douillard	NNP	ORGANIZATION	Douillard	nn	20	SENT_323	[p16l1969t1807r2147b1861, p16l165t1896r282b1950],
20	JY	NN	O	jy	appos	5	SENT_323	[p16l327t1897r408b1962],
21	,	,	O	,	_	0	SENT_323	[p16l327t1897r408b1962],
22	et	FW	O	et	nn	23	SENT_323	[p16l457t1901r521b1950],
23	al.	FW	O	al.	appos	5	SENT_323	[p16l564t1896r638b1950],
24	.	.	O	.	_	0	SENT_323	[p16l564t1896r638b1950],

1	Multi-institutional	JJ	O	multi-institutional	nsubj	10	SENT_324	[p16l686t1896r1258b1950],
2	randomized	VBN	O	randomize	partmod	1	SENT_324	[p16l1305t1896r1671b1950],
3	phase	NN	O	phase	nn	5	SENT_324	[p16l1719t1896r1897b1964],
4	II	CD	NUMBER	ii	num	5	SENT_324	[p16l1944t1897r1972b1949],
5	trial	NN	O	trial	dobj	2	SENT_324	[p16l2020t1896r2150b1950],
6	of	IN	O	of	_	0	SENT_324	[p16l162t1985r226b2039],
7	geﬁtinib	NN	O	geﬁtinib	prep_of	5	SENT_324	[p16l271t1985r530b2053],
8	for	IN	O	for	prep	2	SENT_324	[p16l577t1985r668b2039],
9	previously	RB	DATE	previously	advmod	10	SENT_324	[p16l715t1985r1035b2053],
10	treated	VBN	O	treat	_	0	SENT_324	[p16l1081t1985r1314b2039],
11	patients	NNS	O	patient	dobj	10	SENT_324	[p16l1366t1986r1620b2053],
12	with	IN	O	with	_	0	SENT_324	[p16l1666t1985r1802b2039],
13	advanced	JJ	O	advanced	amod	16	SENT_324	[p16l1852t1985r2148b2039],
14	non-small-cell	JJ	O	non-small-cell	amod	16	SENT_324	[p16l164t2074r611b2128],
15	lung	NN	O	lung	nn	16	SENT_324	[p16l651t2074r780b2142],
16	cancer	NN	O	cancer	prep_with	10	SENT_324	[p16l816t2089r1028b2128],
17	(	CD	NUMBER	(	dep	16	SENT_324	[p16l1067t2074r1205b2142],
18	The	DT	O	the	det	22	SENT_324	[p16l1067t2074r1205b2142],
19	IDEAL	NN	O	ideal	nn	22	SENT_324	[p16l1245t2075r1419b2127],
20	1	CD	NUMBER	1	num	22	SENT_324	[p16l1459t2075r1477b2127],
21	Trial	NN	O	trial	nn	22	SENT_324	[p16l1523t2074r1707b2142],
22	)	NN	O	)	dep	17	SENT_324	[p16l1523t2074r1707b2142],
23	.	.	O	.	_	0	SENT_324	[p16l1523t2074r1707b2142],

1	J	NNP	O	J	nn	3	SENT_325	[p16l1749t2076r1777b2128],
2	Clin	NNP	O	Clin	nn	3	SENT_325	[p16l1817t2074r1934b2128],
3	Oncol	NNP	O	Oncol	_	0	SENT_325	[p16l1973t2074r2150b2128],
4	2003	CD	DATE	2003	num	3	SENT_325	[p16l162t2164r733b2229],
5	;	:	O	;	_	0	SENT_325	[p16l162t2164r733b2229],
6	21:2237	CD	NUMBER	21:2237	number	7	SENT_325	[p16l162t2164r733b2229],
7	—	CD	NUMBER	—	dep	3	SENT_325	[p16l162t2164r733b2229],
8	46	CD	NUMBER	46	dep	7	SENT_325	[p16l162t2164r733b2229],
9	.	.	O	.	_	0	SENT_325	[p16l162t2164r733b2229],

1	[	NN	O	[	_	0	SENT_326	[p16l48t2252r124b2320],
2	5	CD	NUMBER	5	num	1	SENT_326	[p16l48t2252r124b2320],
3	]	CD	NUMBER	]	num	5	SENT_326	[p16l48t2252r124b2320],
4	Kris	NNP	PERSON	Kris	nn	5	SENT_326	[p16l165t2253r276b2306],
5	MG	NN	PERSON	mg	dep	1	SENT_326	[p16l306t2253r424b2318],
6	,	,	O	,	_	0	SENT_326	[p16l306t2253r424b2318],
7	Natale	NNP	ORGANIZATION	Natale	nn	8	SENT_326	[p16l464t2252r666b2306],
8	RB	NN	ORGANIZATION	rb	appos	5	SENT_326	[p16l701t2253r796b2318],
9	,	,	O	,	_	0	SENT_326	[p16l701t2253r796b2318],
10	Herbst	NNP	ORGANIZATION	Herbst	nn	11	SENT_326	[p16l836t2252r1041b2306],
11	RS	NN	ORGANIZATION	r	appos	5	SENT_326	[p16l1075t2253r1164b2318],
12	,	,	O	,	_	0	SENT_326	[p16l1075t2253r1164b2318],
13	Lynch	NNP	PERSON	Lynch	nn	15	SENT_326	[p16l1204t2252r1375b2320],
14	Jr	NNP	PERSON	Jr	nn	15	SENT_326	[p16l1408t2254r1468b2306],
15	TJ	NNP	PERSON	TJ	appos	5	SENT_326	[p16l1496t2253r1590b2318],
16	,	,	O	,	_	0	SENT_326	[p16l1496t2253r1590b2318],
17	Prager	NNP	PERSON	Prager	nn	18	SENT_326	[p16l1630t2253r1830b2320],
18	D	NNP	O	D	appos	5	SENT_326	[p16l1862t2253r1920b2318],
19	,	,	O	,	_	0	SENT_326	[p16l1862t2253r1920b2318],
20	Belani	NNP	PERSON	Belani	nn	21	SENT_326	[p16l1960t2252r2148b2306],
21	CP	NNP	O	CP	appos	5	SENT_326	[p16l163t2341r247b2406],
22	,	,	O	,	_	0	SENT_326	[p16l163t2341r247b2406],
23	et	FW	O	et	nn	24	SENT_326	[p16l296t2345r360b2394],
24	al.	FW	O	al.	appos	5	SENT_326	[p16l402t2340r476b2394],
25	.	.	O	.	_	0	SENT_326	[p16l402t2340r476b2394],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_327	[p16l528t2340r773b2408],
2	of	IN	O	of	_	0	SENT_327	[p16l814t2340r877b2394],
3	geﬁtinib	NN	O	geﬁtinib	prep_of	1	SENT_327	[p16l918t2340r1198b2408],
4	,	,	O	,	_	0	SENT_327	[p16l918t2340r1198b2408],
5	an	DT	O	a	det	6	SENT_327	[p16l1247t2355r1317b2394],
6	inhibitor	NN	O	inhibitor	appos	3	SENT_327	[p16l1362t2340r1633b2394],
7	of	IN	O	of	_	0	SENT_327	[p16l1674t2340r1738b2394],
8	the	DT	O	the	det	14	SENT_327	[p16l1778t2340r1880b2394],
9	epidermal	JJ	O	epidermal	amod	14	SENT_327	[p16l1922t2340r2147b2408, p16l164t2430r275b2484],
10	growth	NN	O	growth	nn	14	SENT_327	[p16l313t2430r529b2498],
11	factor	NN	O	factor	nn	14	SENT_327	[p16l568t2430r760b2484],
12	receptor	NN	O	receptor	nn	14	SENT_327	[p16l797t2435r1068b2498],
13	tyrosine	NN	O	tyrosine	nn	14	SENT_327	[p16l1103t2431r1355b2498],
14	kinase	NN	O	kinase	prep_of	6	SENT_327	[p16l1394t2430r1609b2496],
15	,	,	O	,	_	0	SENT_327	[p16l1394t2430r1609b2496],
16	in	IN	O	in	_	0	SENT_327	[p16l1652t2431r1704b2484],
17	symptomatic	JJ	O	symptomatic	amod	18	SENT_327	[p16l1744t2431r2150b2498],
18	patients	NNS	O	patient	prep_in	3	SENT_327	[p16l164t2519r420b2586],
19	with	IN	O	with	_	0	SENT_327	[p16l449t2518r585b2572],
20	non-small	JJ	O	non-small	amod	23	SENT_327	[p16l620t2518r924b2572],
21	cell	NN	O	cell	nn	23	SENT_327	[p16l955t2518r1067b2572],
22	lung	NN	O	lung	nn	23	SENT_327	[p16l1101t2518r1230b2586],
23	cancer	NN	O	cancer	prep_with	18	SENT_327	[p16l1260t2533r1490b2572],
24	:	:	O	:	_	0	SENT_327	[p16l1260t2533r1490b2572],
25	a	DT	O	a	det	27	SENT_327	[p16l1527t2533r1560b2572],
26	randomized	JJ	O	randomized	amod	27	SENT_327	[p16l1594t2518r1960b2572],
27	trial	NN	O	trial	dep	1	SENT_327	[p16l1994t2518r2144b2572],
28	.	.	O	.	_	0	SENT_327	[p16l1994t2518r2144b2572],

1	JAMA	NNP	O	JAMA	_	0	SENT_328	[p16l162t2608r329b2661],
2	2003	CD	DATE	2003	num	1	SENT_328	[p16l353t2608r961b2673],
3	;	:	O	;	_	0	SENT_328	[p16l353t2608r961b2673],
4	290	CD	NUMBER	290	dep	1	SENT_328	[p16l353t2608r961b2673],
5	:	:	O	:	_	0	SENT_328	[p16l353t2608r961b2673],
6	Z149	NN	O	z149	dep	4	SENT_328	[p16l353t2608r961b2673],
7	—	CD	NUMBER	—	number	8	SENT_328	[p16l353t2608r961b2673],
8	58	CD	NUMBER	58	dep	6	SENT_328	[p16l353t2608r961b2673],
9	.	.	O	.	_	0	SENT_328	[p16l353t2608r961b2673],

1	[	NN	O	[	nn	5	SENT_329	[p16l48t2696r124b2764],
2	6	CD	NUMBER	6	num	5	SENT_329	[p16l48t2696r124b2764],
3	]	CD	NUMBER	]	num	5	SENT_329	[p16l48t2696r124b2764],
4	Miller	NNP	ORGANIZATION	Miller	nn	5	SENT_329	[p16l161t2696r340b2750],
5	VA	NNP	ORGANIZATION	VA	_	0	SENT_329	[p16l375t2697r470b2762],
6	,	,	O	,	_	0	SENT_329	[p16l375t2697r470b2762],
7	Kris	NNP	PERSON	Kris	nn	8	SENT_329	[p16l517t2697r629b2750],
8	MG	NN	PERSON	mg	appos	5	SENT_329	[p16l666t2697r783b2762],
9	,	,	O	,	_	0	SENT_329	[p16l666t2697r783b2762],
10	Shah	NNP	PERSON	Shah	nn	11	SENT_329	[p16l828t2696r971b2750],
11	N	NNP	O	N	appos	8	SENT_329	[p16l1015t2698r1074b2762],
12	,	,	O	,	_	0	SENT_329	[p16l1015t2698r1074b2762],
13	Patel	NNP	PERSON	Patel	nn	14	SENT_329	[p16l1121t2696r1276b2750],
14	J	NNP	PERSON	J	appos	8	SENT_329	[p16l1315t2698r1366b2762],
15	,	,	O	,	_	0	SENT_329	[p16l1315t2698r1366b2762],
16	Azzoli	NNP	PERSON	Azzoli	nn	17	SENT_329	[p16l1409t2696r1594b2750],
17	C	NNP	O	C	appos	8	SENT_329	[p16l1635t2697r1694b2762],
18	,	,	O	,	_	0	SENT_329	[p16l1635t2697r1694b2762],
19	Gomez	NNP	PERSON	Gomez	nn	20	SENT_329	[p16l1739t2697r1955b2750],
20	J	NNP	PERSON	J	appos	8	SENT_329	[p16l1992t2698r2043b2762],
21	,	,	O	,	_	0	SENT_329	[p16l1992t2698r2043b2762],
22	et	FW	O	et	nn	23	SENT_329	[p16l2087t2701r2151b2750],
23	al.	FW	O	al.	appos	8	SENT_329	[p16l163t2785r237b2839],
24	.	.	O	.	_	0	SENT_329	[p16l163t2785r237b2839],

1	Bronchioloalveolar	JJ	O	bronchioloalveolar	amod	3	SENT_330	[p16l272t2785r863b2839],
2	pathologic	JJ	O	pathologic	amod	3	SENT_330	[p16l890t2785r1218b2853],
3	subtype	NN	O	subtype	nsubj	7	SENT_330	[p16l1245t2785r1491b2853],
4	and	CC	O	and	_	0	SENT_330	[p16l1518t2785r1627b2839],
5	smoking	NN	O	smoking	nn	6	SENT_330	[p16l1656t2785r1910b2853],
6	history	NN	O	history	conj_and	3	SENT_330	[p16l1939t2785r2152b2853],
7	predict	VBP	O	predict	_	0	SENT_330	[p16l164t2874r389b2942],
8	sensitivity	NN	O	sensitivity	dobj	7	SENT_330	[p16l415t2875r736b2942],
9	to	TO	O	to	_	0	SENT_330	[p16l762t2879r824b2928],
10	geﬁtinib	NN	O	geﬁtinib	prep_to	7	SENT_330	[p16l850t2874r1110b2942],
11	in	IN	O	in	_	0	SENT_330	[p16l1137t2875r1190b2928],
12	advanced	JJ	O	advanced	amod	15	SENT_330	[p16l1219t2874r1515b2928],
13	non-small-cell	JJ	O	non-small-cell	amod	15	SENT_330	[p16l1546t2874r1993b2928],
14	lung	NN	O	lung	nn	15	SENT_330	[p16l2022t2874r2151b2942],
15	cancer	NN	O	cancer	prep_in	10	SENT_330	[p16l162t2978r383b3017],
16	.	.	O	.	_	0	SENT_330	[p16l162t2978r383b3017],

1	J	NNP	O	J	nn	3	SENT_331	[p16l414t2965r442b3017],
2	Clin	NNP	O	Clin	nn	3	SENT_331	[p16l471t2963r587b3017],
3	Oncol	NNP	O	Oncol	_	0	SENT_331	[p16l615t2963r792b3017],
4	2004	CD	DATE	2004	num	3	SENT_331	[p16l819t2964r1352b3029],
5	;	:	O	;	_	0	SENT_331	[p16l819t2964r1352b3029],
6	22:1103	CD	NUMBER	22:1103	number	7	SENT_331	[p16l819t2964r1352b3029],
7	—	CD	NUMBER	—	dep	3	SENT_331	[p16l819t2964r1352b3029],
8	9	CD	NUMBER	9	dep	7	SENT_331	[p16l819t2964r1352b3029],
9	.	.	O	.	_	0	SENT_331	[p16l819t2964r1352b3029],

1	[	NN	O	[	nn	5	SENT_332	[p16l48t3052r124b3120],
2	7	CD	NUMBER	7	num	5	SENT_332	[p16l48t3052r124b3120],
3	]	CD	NUMBER	]	num	5	SENT_332	[p16l48t3052r124b3120],
4	Han	NNP	O	Han	nn	5	SENT_332	[p16l165t3054r279b3106],
5	SW	NNP	O	SW	_	0	SENT_332	[p16l300t3053r405b3118],
6	,	,	O	,	_	0	SENT_332	[p16l300t3053r405b3118],
7	Hwang	NNP	PERSON	Hwang	nn	8	SENT_332	[p16l431t3054r637b3120],
8	PG	NNP	O	PG	appos	5	SENT_332	[p16l658t3053r760b3118],
9	,	,	O	,	_	0	SENT_332	[p16l658t3053r760b3118],
10	Chung	NNP	PERSON	Chung	nn	11	SENT_332	[p16l784t3052r976b3120],
11	DH	NNP	O	DH	appos	8	SENT_332	[p16l996t3053r1100b3118],
12	,	,	O	,	_	0	SENT_332	[p16l996t3053r1100b3118],
13	Kim	NNP	PERSON	Kim	nn	14	SENT_332	[p16l1128t3053r1237b3106],
14	DW	NNP	O	DW	appos	8	SENT_332	[p16l1260t3053r1372b3118],
15	,	,	O	,	_	0	SENT_332	[p16l1260t3053r1372b3118],
16	Im	NNP	O	Im	nn	17	SENT_332	[p16l1400t3054r1469b3106],
17	SA	NNP	O	SA	appos	8	SENT_332	[p16l1490t3053r1582b3118],
18	,	,	O	,	_	0	SENT_332	[p16l1490t3053r1582b3118],
19	Kim	NNP	PERSON	Kim	nn	20	SENT_332	[p16l1609t3053r1718b3106],
20	YT	NNP	PERSON	YT	appos	8	SENT_332	[p16l1737t3054r1826b3118],
21	,	,	O	,	_	0	SENT_332	[p16l1737t3054r1826b3118],
22	et	FW	O	et	nn	23	SENT_332	[p16l1849t3057r1913b3106],
23	al.	FW	O	al.	appos	8	SENT_332	[p16l1931t3052r2005b3106],
24	.	.	O	.	_	0	SENT_332	[p16l1931t3052r2005b3106],

1	Epidermal	JJ	O	epidermal	amod	2	SENT_333	[p16l2032t3053r2147b3120, p16l162t3141r382b3195],
2	growth	NN	O	growth	_	0	SENT_333	[p16l412t3141r627b3209],
3	factor	NN	O	factor	nn	4	SENT_333	[p16l657t3141r849b3195],
4	receptor	NN	O	receptor	dep	2	SENT_333	[p16l878t3147r1149b3209],
5	(	CD	NUMBER	(	num	6	SENT_333	[p16l1180t3142r1387b3209],
6	EGFR	NN	ORGANIZATION	egfr	dep	4	SENT_333	[p16l1180t3142r1387b3209],
7	)	CD	NUMBER	)	num	9	SENT_333	[p16l1180t3142r1387b3209],
8	downstream	JJ	O	downstream	amod	9	SENT_333	[p16l1418t3141r1803b3195],
9	molecules	NNS	O	molecule	dep	2	SENT_333	[p16l1835t3141r2151b3195],
10	as	IN	O	as	_	0	SENT_333	[p16l163t3245r225b3284],
11	response	NN	O	response	prep_as	9	SENT_333	[p16l251t3245r525b3298],
12	predictive	JJ	O	predictive	amod	13	SENT_333	[p16l550t3230r869b3298],
13	markers	NNS	O	marker	dep	2	SENT_333	[p16l894t3230r1144b3284],
14	for	IN	O	for	_	0	SENT_333	[p16l1168t3230r1258b3284],
15	geﬁtinib	NN	O	geﬁtinib	nn	17	SENT_333	[p16l1280t3230r1540b3298],
16	(	NN	O	(	nn	17	SENT_333	[p16l1567t3232r1787b3298],
17	lressa	NN	O	lressa	prep_for	13	SENT_333	[p16l1567t3232r1787b3298],
18	,	,	O	,	_	0	SENT_333	[p16l1567t3232r1787b3298],
19	ZD1839	NN	O	zd1839	nn	20	SENT_333	[p16l1818t3231r2069b3298],
20	)	NN	O	)	appos	2	SENT_333	[p16l1818t3231r2069b3298],
21	in	IN	O	in	_	0	SENT_333	[p16l2096t3232r2148b3284],
22	chemotherapy-resistant	JJ	O	chemotherapy-resistant	amod	26	SENT_333	[p16l162t3319r921b3387],
23	non-small	JJ	O	non-small	amod	26	SENT_333	[p16l951t3319r1255b3373],
24	cell	NN	O	cell	nn	26	SENT_333	[p16l1284t3319r1396b3373],
25	lung	NN	O	lung	nn	26	SENT_333	[p16l1428t3319r1556b3387],
26	cancer	NN	O	cancer	prep_in	20	SENT_333	[p16l1584t3334r1804b3373],
27	.	.	O	.	_	0	SENT_333	[p16l1584t3334r1804b3373],

1	Int	NN	O	int	nn	3	SENT_334	[p16l1843t3321r1923b3373],
2	J	NN	O	j	nn	3	SENT_334	[p16l1950t3321r1978b3373],
3	Cancer	NN	O	cancer	_	0	SENT_334	[p16l2010t3320r2147b3374, p16l162t3423r262b3463],
4	2005	CD	DATE	2005	dep	3	SENT_334	[p16l286t3409r857b3474],
5	;	:	O	;	_	0	SENT_334	[p16l286t3409r857b3474],
6	113:109	CD	NUMBER	113:109	number	7	SENT_334	[p16l286t3409r857b3474],
7	—	CD	NUMBER	—	dep	3	SENT_334	[p16l286t3409r857b3474],
8	15	CD	NUMBER	15	dep	7	SENT_334	[p16l286t3409r857b3474],
9	.	.	O	.	_	0	SENT_334	[p16l286t3409r857b3474],

1	[	NN	O	[	nn	4	SENT_335	[p16l48t3497r124b3565],
2	8	CD	NUMBER	8	num	4	SENT_335	[p16l48t3497r124b3565],
3	]	NN	O	]	nn	4	SENT_335	[p16l48t3497r124b3565],
4	Haringhuizen	NN	O	haringhuizen	_	0	SENT_335	[p16l165t3497r574b3565],
5	A	NN	O	a	dep	4	SENT_335	[p16l599t3498r660b3563],
6	,	,	O	,	_	0	SENT_335	[p16l599t3498r660b3563],
7	van	NN	O	van	nn	9	SENT_335	[p16l690t3512r796b3551],
8	Tinteren	NN	O	tinteren	nn	9	SENT_335	[p16l822t3499r1089b3551],
9	H	NN	O	h	appos	5	SENT_335	[p16l1119t3499r1180b3563],
10	,	,	O	,	_	0	SENT_335	[p16l1119t3499r1180b3563],
11	Vaessen	NNP	ORGANIZATION	Vaessen	nn	12	SENT_335	[p16l1209t3499r1453b3551],
12	HF	NN	ORGANIZATION	hf	appos	5	SENT_335	[p16l1484t3499r1569b3563],
13	,	,	O	,	_	0	SENT_335	[p16l1484t3499r1569b3563],
14	Baas	NNP	PERSON	Baas	nn	15	SENT_335	[p16l1603t3498r1741b3551],
15	P	NN	PERSON	p	appos	5	SENT_335	[p16l1769t3499r1808b3563],
16	,	,	O	,	_	0	SENT_335	[p16l1769t3499r1808b3563],
17	van	NN	PERSON	van	nn	20	SENT_335	[p16l1838t3512r1945b3551],
18	Zandwijk	NNP	PERSON	Zandwijk	nn	20	SENT_335	[p16l1974t3497r2147b3551, p16l161t3586r296b3654],
19	N.	NNP	PERSON	N.	nn	20	SENT_335	[p16l324t3588r383b3640],
20	Geﬁtinib	NNP	PERSON	Geﬁtinib	appos	5	SENT_335	[p16l417t3586r689b3641],
21	as	IN	O	as	_	0	SENT_335	[p16l717t3601r779b3640],
22	a	DT	O	a	det	25	SENT_335	[p16l807t3601r840b3640],
23	last	JJ	O	last	amod	25	SENT_335	[p16l870t3586r980b3640],
24	treatment	NN	O	treatment	nn	25	SENT_335	[p16l1007t3592r1330b3640],
25	option	NN	O	option	prep_as	20	SENT_335	[p16l1357t3588r1555b3654],
26	for	IN	O	for	_	0	SENT_335	[p16l1585t3586r1675b3640],
27	non-small-cell	JJ	O	non-small-cell	amod	29	SENT_335	[p16l1703t3586r2150b3640],
28	lung	NN	O	lung	nn	29	SENT_335	[p16l165t3675r294b3743],
29	cancer	NN	O	cancer	prep_for	25	SENT_335	[p16l326t3690r556b3729],
30	:	:	O	:	_	0	SENT_335	[p16l326t3690r556b3729],
31	durable	JJ	O	durable	amod	33	SENT_335	[p16l595t3675r835b3729],
32	disease	NN	O	disease	nn	33	SENT_335	[p16l868t3675r1097b3729],
33	control	NN	O	control	dep	4	SENT_335	[p16l1130t3675r1353b3729],
34	in	IN	O	in	_	0	SENT_335	[p16l1387t3677r1440b3729],
35	a	DT	O	a	det	36	SENT_335	[p16l1475t3690r1508b3729],
36	subset	NN	O	subset	prep_in	33	SENT_335	[p16l1541t3675r1742b3729],
37	of	IN	O	of	_	0	SENT_335	[p16l1774t3675r1837b3729],
38	patients	NNS	O	patient	prep_of	36	SENT_335	[p16l1869t3677r2144b3743],
39	.	.	O	.	_	0	SENT_335	[p16l1869t3677r2144b3743],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_336	[p17l160t18r276b71],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_336	[p17l304t17r482b72],
3	2004	CD	DATE	2004	num	2	SENT_336	[p17l508t18r1041b83],
4	;	:	O	;	_	0	SENT_336	[p17l508t18r1041b83],
5	15:786	CD	NUMBER	15:786	number	6	SENT_336	[p17l508t18r1041b83],
6	—	CD	NUMBER	—	dep	2	SENT_336	[p17l508t18r1041b83],
7	92	CD	NUMBER	92	dep	6	SENT_336	[p17l508t18r1041b83],
8	.	.	O	.	_	0	SENT_336	[p17l508t18r1041b83],

1	[	NN	O	[	nn	3	SENT_337	[p17l48t106r124b174],
2	9	CD	NUMBER	9	num	3	SENT_337	[p17l48t106r124b174],
3	]	NN	O	]	_	0	SENT_337	[p17l48t106r124b174],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_337	[p17l162t108r347b160],
5	PA	NN	PERSON	pa	dep	3	SENT_337	[p17l371t107r458b172],
6	,	,	O	,	_	0	SENT_337	[p17l371t107r458b172],
7	Gurubhagavatula	NNP	LOCATION	Gurubhagavatula	nn	8	SENT_337	[p17l486t106r1024b174],
8	S	NNP	LOCATION	S	appos	5	SENT_337	[p17l1045t107r1096b172],
9	,	,	O	,	_	0	SENT_337	[p17l1045t107r1096b172],
10	Yeap	NNP	PERSON	Yeap	nn	11	SENT_337	[p17l1121t108r1268b174],
11	BY	NNP	O	BY	appos	5	SENT_337	[p17l1292t107r1375b172],
12	,	,	O	,	_	0	SENT_337	[p17l1292t107r1375b172],
13	Lucca	NNP	LOCATION	Lucca	nn	14	SENT_337	[p17l1405t108r1581b160],
14	J	NNP	O	J	appos	5	SENT_337	[p17l1602t108r1653b172],
15	,	,	O	,	_	0	SENT_337	[p17l1602t108r1653b172],
16	Ostler	NNP	PERSON	Ostler	nn	17	SENT_337	[p17l1680t106r1871b161],
17	P	NN	O	p	appos	5	SENT_337	[p17l1893t108r1932b172],
18	,	,	O	,	_	0	SENT_337	[p17l1893t108r1932b172],
19	Skarin	NNP	PERSON	Skarin	nn	20	SENT_337	[p17l1960t106r2148b161],
20	AT	NNP	O	AT	appos	5	SENT_337	[p17l160t196r243b261],
21	,	,	O	,	_	0	SENT_337	[p17l160t196r243b261],
22	et	FW	O	et	nn	23	SENT_337	[p17l279t201r343b250],
23	al.	FW	O	al.	appos	5	SENT_337	[p17l373t196r447b250],
24	.	.	O	.	_	0	SENT_337	[p17l373t196r447b250],

1	Outcomes	NNS	O	outcome	nsubj	10	SENT_338	[p17l484t196r796b250],
2	of	IN	O	of	_	0	SENT_338	[p17l826t196r890b250],
3	patients	NNS	O	patient	prep_of	1	SENT_338	[p17l920t197r1175b264],
4	with	IN	O	with	_	0	SENT_338	[p17l1203t196r1339b250],
5	advanced	JJ	O	advanced	amod	9	SENT_338	[p17l1372t196r1669b250],
6	non-small	JJ	O	non-small	amod	9	SENT_338	[p17l1704t196r2007b250],
7	cell	NN	O	cell	nn	9	SENT_338	[p17l2038t196r2150b250],
8	lung	NN	O	lung	nn	9	SENT_338	[p17l165t285r294b353],
9	cancer	NN	O	cancer	prep_with	3	SENT_338	[p17l328t299r540b339],
10	treated	VBN	O	treat	_	0	SENT_338	[p17l573t285r806b339],
11	with	IN	O	with	_	0	SENT_338	[p17l841t285r978b339],
12	geﬁtinib	NN	O	geﬁtinib	nn	14	SENT_338	[p17l1015t285r1275b353],
13	(	CD	NUMBER	(	num	14	SENT_338	[p17l1314t285r1585b352],
14	ZD1839	NN	O	zd1839	prep_with	10	SENT_338	[p17l1314t285r1585b352],
15	,	,	O	,	_	0	SENT_338	[p17l1314t285r1585b352],
16	"	``	O	"	punct	14	SENT_338	[p17l1632t285r1933b352],
17	|	NN	O	|	nn	18	SENT_338	[p17l1632t285r1933b352],
18	ressa	NN	O	ressa	dep	14	SENT_338	[p17l1632t285r1933b352],
19	”	CD	NUMBER	”	num	20	SENT_338	[p17l1632t285r1933b352],
20	)	NN	O	)	dobj	10	SENT_338	[p17l1632t285r1933b352],
21	on	IN	O	on	_	0	SENT_338	[p17l1970t299r2041b339],
22	expanded	JJ	O	expanded	amod	24	SENT_338	[p17l162t374r466b442],
23	access	NN	O	access	nn	24	SENT_338	[p17l494t388r695b428],
24	study	NN	O	study	prep_on	20	SENT_338	[p17l721t374r899b442],
25	.	.	O	.	_	0	SENT_338	[p17l721t374r899b442],

1	Lung	NN	O	lung	nn	2	SENT_339	[p17l934t375r1077b442],
2	Cancer	NN	O	cancer	_	0	SENT_339	[p17l1103t374r1322b428],
3	2004	CD	DATE	2004	dep	2	SENT_339	[p17l1346t374r1879b439],
4	;	:	O	;	_	0	SENT_339	[p17l1346t374r1879b439],
5	44:221	CD	NUMBER	44:221	number	6	SENT_339	[p17l1346t374r1879b439],
6	—	CD	NUMBER	—	dep	2	SENT_339	[p17l1346t374r1879b439],
7	30	CD	NUMBER	30	dep	6	SENT_339	[p17l1346t374r1879b439],
8	.	.	O	.	_	0	SENT_339	[p17l1346t374r1879b439],

1	Clinical	JJ	O	clinical	amod	2	SENT_340	[p17l45t517r167b546],
2	predictors	NNS	O	predictor	_	0	SENT_340	[p17l181t517r348b553],
3	versus	CC	O	versus	prep	2	SENT_340	[p17l361t525r464b546],
4	epidermal	JJ	O	epidermal	amod	8	SENT_340	[p17l477t517r644b553],
5	growth	NN	O	growth	nn	8	SENT_340	[p17l657t517r770b553],
6	factor	NN	O	factor	nn	8	SENT_340	[p17l785t517r885b546],
7	receptor	NN	O	receptor	nn	8	SENT_340	[p17l899t520r1040b553],
8	mutation	NN	O	mutation	dep	3	SENT_340	[p17l1054t517r1201b546],

1	[	NN	O	[	nn	5	SENT_341	[p17l9t674r117b738],
2	10	CD	NUMBER	10	num	5	SENT_341	[p17l9t674r117b738],
3	]	CD	NUMBER	]	num	5	SENT_341	[p17l9t674r117b738],
4	Park	NNP	O	Park	nn	5	SENT_341	[p17l156t674r282b725],
5	J	NNP	O	J	_	0	SENT_341	[p17l311t675r359b736],
6	,	,	O	,	_	0	SENT_341	[p17l311t675r359b736],
7	Park	NNP	O	Park	nn	8	SENT_341	[p17l398t674r525b725],
8	BB	NNP	O	BB	appos	5	SENT_341	[p17l556t675r646b736],
9	,	,	O	,	_	0	SENT_341	[p17l556t675r646b736],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_341	[p17l685t675r789b724],
11	JY	NN	PERSON	jy	appos	8	SENT_341	[p17l822t675r898b736],
12	,	,	O	,	_	0	SENT_341	[p17l822t675r898b736],
13	Lee	NNP	PERSON	Lee	nn	14	SENT_341	[p17l937t675r1039b725],
14	SH	NNP	O	SH	appos	8	SENT_341	[p17l1070t675r1162b736],
15	,	,	O	,	_	0	SENT_341	[p17l1070t675r1162b736],
16	Lee	NNP	PERSON	Lee	nn	17	SENT_341	[p17l1201t675r1303b725],
17	SI	NNP	O	SI	appos	8	SENT_341	[p17l1334t675r1401b736],
18	,	,	O	,	_	0	SENT_341	[p17l1334t675r1401b736],
19	Kim	NNP	PERSON	Kim	nn	20	SENT_341	[p17l1440t675r1544b724],
20	HY	NNP	PERSON	HY	appos	8	SENT_341	[p17l1580t675r1665b736],
21	,	,	O	,	_	0	SENT_341	[p17l1580t675r1665b736],
22	et	FW	O	et	nn	23	SENT_341	[p17l1701t679r1761b725],
23	al.	FW	O	al.	appos	8	SENT_341	[p17l1792t674r1863b725],
24	.	.	O	.	_	0	SENT_341	[p17l1792t674r1863b725],

1	Geﬁtinib	JJ	O	geﬁtinib	amod	3	SENT_342	[p17l1900t674r2040b725, p17l154t757r290b808],
2	(	NN	O	(	nn	3	SENT_342	[p17l312t758r573b821],
3	ZD1839	NN	O	zd1839	_	0	SENT_342	[p17l312t758r573b821],
4	)	CD	NUMBER	)	num	5	SENT_342	[p17l312t758r573b821],
5	monotherapy	NN	O	monotherapy	advmod	12	SENT_342	[p17l596t757r993b821],
6	as	IN	O	as	_	0	SENT_342	[p17l1010t771r1068b808],
7	a	DT	O	a	det	9	SENT_342	[p17l1087t771r1118b808],
8	salvage	NN	O	salvage	nn	9	SENT_342	[p17l1137t757r1356b821],
9	regimen	NN	O	regimen	prep_as	5	SENT_342	[p17l1377t758r1616b821],
10	for	IN	O	for	prep	5	SENT_342	[p17l1636t757r1722b808],
11	previously	RB	DATE	previously	pcomp	10	SENT_342	[p17l1740t757r2045b821],
12	treated	VBN	O	treat	partmod	3	SENT_342	[p17l153t840r375b891],
13	advanced	JJ	O	advanced	amod	17	SENT_342	[p17l406t840r688b891],
14	non-small	JJ	O	non-small	amod	17	SENT_342	[p17l720t840r1009b891],
15	cell	NN	O	cell	nn	17	SENT_342	[p17l1037t840r1144b891],
16	lung	NN	O	lung	nn	17	SENT_342	[p17l1175t840r1298b904],
17	cancer	NN	O	cancer	dobj	12	SENT_342	[p17l1325t854r1535b891],
18	.	.	O	.	_	0	SENT_342	[p17l1325t854r1535b891],

1	Clin	NNP	O	Clin	nn	3	SENT_343	[p17l1570t840r1680b891],
2	Cancer	NNP	O	Cancer	nn	3	SENT_343	[p17l1711t841r1919b891],
3	Res	NNP	O	Res	_	0	SENT_343	[p17l1948t841r2043b891],
4	2004	CD	DATE	2004	num	3	SENT_343	[p17l153t924r660b985],
5	;	:	O	;	_	0	SENT_343	[p17l153t924r660b985],
6	10:4383	CD	NUMBER	10:4383	number	7	SENT_343	[p17l153t924r660b985],
7	—	CD	NUMBER	—	dep	3	SENT_343	[p17l153t924r660b985],
8	8	CD	NUMBER	8	dep	7	SENT_343	[p17l153t924r660b985],
9	.	.	O	.	_	0	SENT_343	[p17l153t924r660b985],

1	[	NN	O	[	nn	5	SENT_344	[p17l9t1006r117b1070],
2	11	CD	NUMBER	11	num	5	SENT_344	[p17l9t1006r117b1070],
3	]	CD	NUMBER	]	num	5	SENT_344	[p17l9t1006r117b1070],
4	Thatcher	NNP	PERSON	Thatcher	nn	5	SENT_344	[p17l151t1006r425b1057],
5	N	NNP	PERSON	N	_	0	SENT_344	[p17l448t1007r504b1068],
6	,	,	O	,	_	0	SENT_344	[p17l448t1007r504b1068],
7	Chang	NNP	PERSON	Chang	nn	8	SENT_344	[p17l532t1006r712b1070],
8	A	NNP	O	A	appos	5	SENT_344	[p17l732t1007r789b1068],
9	,	,	O	,	_	0	SENT_344	[p17l732t1007r789b1068],
10	Parikh	NNP	ORGANIZATION	Parikh	nn	11	SENT_344	[p17l819t1006r999b1057],
11	P	NN	ORGANIZATION	p	appos	8	SENT_344	[p17l1025t1007r1063b1068],
12	,	,	O	,	_	0	SENT_344	[p17l1025t1007r1063b1068],
13	Rodrigues	NNP	PERSON	Rodrigues	nn	15	SENT_344	[p17l1094t1006r1379b1070],
14	Pereira	NNP	PERSON	Pereira	nn	15	SENT_344	[p17l1404t1007r1614b1057],
15	J	NNP	PERSON	J	appos	8	SENT_344	[p17l1636t1007r1684b1068],
16	,	,	O	,	_	0	SENT_344	[p17l1636t1007r1684b1068],
17	Ciuleanu	NNP	O	Ciuleanu	nn	18	SENT_344	[p17l1712t1006r1970b1057],
18	T	NN	O	t	appos	8	SENT_344	[p17l1992t1007r2037b1068],
19	,	,	O	,	_	0	SENT_344	[p17l1992t1007r2037b1068],
20	von	NN	O	von	nn	22	SENT_344	[p17l152t1103r254b1140],
21	Pawel	NNP	PERSON	Pawel	nn	22	SENT_344	[p17l281t1089r452b1140],
22	J	NNP	PERSON	J	appos	8	SENT_344	[p17l475t1090r523b1151],
23	,	,	O	,	_	0	SENT_344	[p17l475t1090r523b1151],
24	et	FW	O	et	nn	25	SENT_344	[p17l551t1094r612b1140],
25	al.	FW	O	al.	appos	8	SENT_344	[p17l634t1089r704b1140],
26	.	.	O	.	_	0	SENT_344	[p17l634t1089r704b1140],

1	Geﬁtinib	NN	O	geﬁtinib	nsubj	8	SENT_345	[p17l733t1089r992b1140],
2	plus	CC	O	plus	prep	1	SENT_345	[p17l1017t1089r1133b1153],
3	best	JJS	O	best	dep	4	SENT_345	[p17l1157t1089r1281b1140],
4	supportive	JJ	O	supportive	amod	5	SENT_345	[p17l1303t1090r1619b1153],
5	care	NN	O	care	dep	2	SENT_345	[p17l1641t1103r1771b1140],
6	in	IN	O	in	prep	5	SENT_345	[p17l1793t1090r1843b1139],
7	previously	RB	DATE	previously	pcomp	6	SENT_345	[p17l1870t1090r2040b1153, p17l153t1172r306b1236],
8	treated	VBN	O	treat	_	0	SENT_345	[p17l325t1172r547b1223],
9	patients	NNS	O	patient	dobj	8	SENT_345	[p17l572t1173r814b1236],
10	with	IN	O	with	_	0	SENT_345	[p17l834t1172r963b1223],
11	refractory	JJ	O	refractory	amod	15	SENT_345	[p17l988t1172r1291b1236],
12	advanced	JJ	O	advanced	amod	15	SENT_345	[p17l1311t1172r1593b1223],
13	non-small-cell	JJ	O	non-small-cell	amod	15	SENT_345	[p17l1618t1172r2042b1223],
14	lung	NN	O	lung	nn	15	SENT_345	[p17l156t1254r278b1318],
15	cancer	NN	O	cancer	prep_with	9	SENT_345	[p17l311t1268r530b1305],
16	:	:	O	:	_	0	SENT_345	[p17l311t1268r530b1305],
17	results	NNS	O	result	dep	9	SENT_345	[p17l572t1254r768b1305],
18	from	IN	O	from	advmod	20	SENT_345	[p17l801t1254r939b1305],
19	a	DT	O	a	dep	18	SENT_345	[p17l975t1268r1006b1305],
20	randomised	VBN	O	randomise	partmod	17	SENT_345	[p17l1043t1254r1407b1316],
21	,	,	O	,	_	0	SENT_345	[p17l1043t1254r1407b1316],
22	placebo-controlled	JJ	O	placebo-controlled	amod	29	SENT_345	[p17l1448t1254r2037b1318],
23	,	,	O	,	_	0	SENT_345	[p17l1448t1254r2037b1318],
24	multicentre	JJ	O	multicentre	amod	29	SENT_345	[p17l155t1337r508b1388],
25	study	NN	O	study	nn	29	SENT_345	[p17l534t1337r695b1401],
26	(	NN	O	(	nn	29	SENT_345	[p17l724t1339r914b1401],
27	lressa	NN	O	lressa	nn	29	SENT_345	[p17l724t1339r914b1401],
28	Survival	NNP	O	Survival	nn	29	SENT_345	[p17l941t1337r1174b1388],
29	Evaluation	NN	O	evaluation	dobj	8	SENT_345	[p17l1204t1337r1513b1388],
30	in	IN	O	in	_	0	SENT_345	[p17l1542t1338r1592b1388],
31	Lung	NN	O	lung	nn	33	SENT_345	[p17l1624t1339r1760b1401],
32	Cancer	NN	O	cancer	nn	33	SENT_345	[p17l1787t1338r2037b1401],
33	)	NN	O	)	prep_in	29	SENT_345	[p17l1787t1338r2037b1401],
34	.	.	O	.	_	0	SENT_345	[p17l1787t1338r2037b1401],

1	Lancet	NNP	O	Lancet	_	0	SENT_346	[p17l156t1422r355b1471],
2	2005	CD	DATE	2005	num	1	SENT_346	[p17l378t1421r957b1482],
3	;	:	O	;	_	0	SENT_346	[p17l378t1421r957b1482],
4	366:1527	CD	NUMBER	366:1527	number	5	SENT_346	[p17l378t1421r957b1482],
5	—	CD	NUMBER	—	dep	1	SENT_346	[p17l378t1421r957b1482],
6	37	CD	NUMBER	37	dep	5	SENT_346	[p17l378t1421r957b1482],
7	.	.	O	.	_	0	SENT_346	[p17l378t1421r957b1482],

1	[	NN	O	[	nn	5	SENT_347	[p17l9t1503r117b1567],
2	12	CD	NUMBER	12	num	5	SENT_347	[p17l9t1503r117b1567],
3	]	CD	NUMBER	]	num	5	SENT_347	[p17l9t1503r117b1567],
4	Shepherd	NNP	O	Shepherd	nn	5	SENT_347	[p17l154t1503r430b1567],
5	FA	NNP	O	FA	_	0	SENT_347	[p17l460t1504r542b1565],
6	,	,	O	,	_	0	SENT_347	[p17l460t1504r542b1565],
7	Rodrigues	NNP	PERSON	Rodrigues	nn	9	SENT_347	[p17l576t1503r862b1567],
8	Pereira	NNP	PERSON	Pereira	nn	9	SENT_347	[p17l889t1504r1099b1554],
9	J	NNP	PERSON	J	appos	5	SENT_347	[p17l1124t1505r1173b1565],
10	,	,	O	,	_	0	SENT_347	[p17l1124t1505r1173b1565],
11	Ciuleanu	NNP	O	Ciuleanu	nn	12	SENT_347	[p17l1204t1503r1462b1554],
12	T	NN	O	t	appos	9	SENT_347	[p17l1487t1505r1533b1565],
13	,	,	O	,	_	0	SENT_347	[p17l1487t1505r1533b1565],
14	Tan	NNP	O	Tan	nn	15	SENT_347	[p17l1562t1505r1661b1554],
15	EH	NNP	O	EH	appos	9	SENT_347	[p17l1691t1505r1785b1565],
16	,	,	O	,	_	0	SENT_347	[p17l1691t1505r1785b1565],
17	Hirsh	NNP	PERSON	Hirsh	nn	18	SENT_347	[p17l1818t1503r1965b1554],
18	V	NNP	O	V	appos	9	SENT_347	[p17l1990t1505r2037b1565],
19	,	,	O	,	_	0	SENT_347	[p17l1990t1505r2037b1565],
20	Thongprasert	NNP	O	Thongprasert	nn	21	SENT_347	[p17l151t1586r552b1650],
21	S	NNP	O	S	appos	9	SENT_347	[p17l571t1587r618b1648],
22	,	,	O	,	_	0	SENT_347	[p17l571t1587r618b1648],
23	et	FW	O	et	nn	24	SENT_347	[p17l642t1591r703b1637],
24	al.	FW	O	al.	appos	9	SENT_347	[p17l721t1586r791b1637],
25	.	.	O	.	_	0	SENT_347	[p17l721t1586r791b1637],

1	Erlotinib	NNP	O	Erlotinib	nsubj	4	SENT_348	[p17l818t1586r1072b1637],
2	in	IN	O	in	prep	1	SENT_348	[p17l1091t1587r1140b1637],
3	previously	RB	DATE	previously	pcomp	2	SENT_348	[p17l1163t1586r1467b1650],
4	treated	VBN	O	treat	_	0	SENT_348	[p17l1485t1586r1706b1637],
5	nonsmallcell	JJ	O	nonsmallcell	amod	7	SENT_348	[p17l1729t1586r2040b1637, p17l153t1669r260b1720],
6	lung	NN	O	lung	nn	7	SENT_348	[p17l287t1669r409b1733],
7	cancer	NN	O	cancer	dobj	4	SENT_348	[p17l434t1683r643b1720],
8	.	.	O	.	_	0	SENT_348	[p17l434t1683r643b1720],

1	N	NN	O	n	nn	3	SENT_349	[p17l676t1671r710b1720],
2	Engl	NNP	O	Engl	nn	3	SENT_349	[p17l740t1669r861b1733],
3	J	NNP	O	J	nsubj	4	SENT_349	[p17l885t1671r911b1720],
4	Med	VBD	O	med	_	0	SENT_349	[p17l937t1669r1055b1720],
5	2005	CD	DATE	2005	dobj	4	SENT_349	[p17l1082t1670r1624b1731],
6	;	:	O	;	_	0	SENT_349	[p17l1082t1670r1624b1731],
7	353:123	CD	NUMBER	353:123	number	8	SENT_349	[p17l1082t1670r1624b1731],
8	—	CD	NUMBER	—	dep	5	SENT_349	[p17l1082t1670r1624b1731],
9	32	CD	NUMBER	32	dep	8	SENT_349	[p17l1082t1670r1624b1731],
10	.	.	O	.	_	0	SENT_349	[p17l1082t1670r1624b1731],

1	[	RB	O	[	dep	5	SENT_350	[p17l9t1752r117b1816],
2	13	CD	NUMBER	13	num	5	SENT_350	[p17l9t1752r117b1816],
3	]	CD	NUMBER	]	num	5	SENT_350	[p17l9t1752r117b1816],
4	Lee	NNP	O	Lee	nn	5	SENT_350	[p17l156t1754r258b1803],
5	DH	NNP	O	DH	_	0	SENT_350	[p17l288t1753r388b1814],
6	,	,	O	,	_	0	SENT_350	[p17l288t1753r388b1814],
7	Han	NNP	PERSON	Han	nn	8	SENT_350	[p17l424t1754r532b1803],
8	JY	NN	PERSON	jy	appos	5	SENT_350	[p17l562t1754r638b1814],
9	,	,	O	,	_	0	SENT_350	[p17l562t1754r638b1814],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_350	[p17l674t1754r777b1803],
11	HG	NNP	PERSON	HG	appos	5	SENT_350	[p17l807t1753r910b1814],
12	,	,	O	,	_	0	SENT_350	[p17l807t1753r910b1814],
13	Lee	NNP	PERSON	Lee	nn	14	SENT_350	[p17l947t1754r1049b1803],
14	JJ	NN	PERSON	jj	appos	11	SENT_350	[p17l1076t1754r1157b1814],
15	,	,	O	,	_	0	SENT_350	[p17l1076t1754r1157b1814],
16	Lee	NNP	PERSON	Lee	nn	17	SENT_350	[p17l1193t1754r1296b1803],
17	EK	NNP	PERSON	EK	appos	11	SENT_350	[p17l1326t1754r1414b1814],
18	,	,	O	,	_	0	SENT_350	[p17l1326t1754r1414b1814],
19	Kim	NNP	PERSON	Kim	nn	20	SENT_350	[p17l1451t1753r1555b1803],
20	HY	NNP	PERSON	HY	appos	11	SENT_350	[p17l1588t1754r1673b1814],
21	,	,	O	,	_	0	SENT_350	[p17l1588t1754r1673b1814],
22	et	FW	O	et	nn	23	SENT_350	[p17l1707t1757r1767b1803],
23	al.	FW	O	al.	appos	11	SENT_350	[p17l1795t1752r1865b1803],
24	.	.	O	.	_	0	SENT_350	[p17l1795t1752r1865b1803],

1	Geﬁtinib	NNP	O	Geﬁtinib	_	0	SENT_351	[p17l1900t1752r2040b1803, p17l154t1835r290b1886],
2	as	IN	O	as	_	0	SENT_351	[p17l326t1849r385b1886],
3	a	DT	O	a	det	5	SENT_351	[p17l421t1849r452b1886],
4	ﬁrst-line	JJ	O	ﬁrst-line	amod	5	SENT_351	[p17l488t1835r743b1886],
5	therapy	NN	O	therapy	prep_as	1	SENT_351	[p17l779t1835r1011b1899],
6	of	IN	O	of	_	0	SENT_351	[p17l1045t1835r1105b1886],
7	advanced	JJ	O	advanced	amod	10	SENT_351	[p17l1139t1835r1421b1886],
8	or	CC	O	or	_	0	SENT_351	[p17l1459t1849r1520b1886],
9	metastatic	JJ	O	metastatic	amod	10	SENT_351	[p17l1555t1836r1876b1886],
10	adenocarcinoma	NN	O	adenocarcinoma	prep_of	5	SENT_351	[p17l1912t1835r2040b1886, p17l155t1919r537b1969],
11	of	IN	O	of	_	0	SENT_351	[p17l574t1918r634b1969],
12	the	DT	O	the	det	13	SENT_351	[p17l669t1918r766b1969],
13	lung	NN	O	lung	prep_of	1	SENT_351	[p17l805t1918r927b1982],
14	in	IN	O	in	_	0	SENT_351	[p17l964t1919r1014b1969],
15	never-smokers	NNS	O	never-smoker	prep_in	13	SENT_351	[p17l1055t1918r1509b1969],
16	.	.	O	.	_	0	SENT_351	[p17l1055t1918r1509b1969],

1	Clin	NNP	O	Clin	nn	3	SENT_352	[p17l1553t1918r1663b1969],
2	Cancer	NNP	O	Cancer	nn	3	SENT_352	[p17l1703t1919r1911b1969],
3	Res	NNP	O	Res	_	0	SENT_352	[p17l1948t1919r2043b1969],
4	2005	CD	DATE	2005	num	3	SENT_352	[p17l153t2002r660b2063],
5	;	:	O	;	_	0	SENT_352	[p17l153t2002r660b2063],
6	11:3032	CD	NUMBER	11:3032	num	7	SENT_352	[p17l153t2002r660b2063],
7	—	NN	O	—	dep	3	SENT_352	[p17l153t2002r660b2063],
8	7	CD	NUMBER	7	dep	7	SENT_352	[p17l153t2002r660b2063],
9	.	.	O	.	_	0	SENT_352	[p17l153t2002r660b2063],

1	[	NN	O	[	_	0	SENT_353	[p17l9t2084r117b2148],
2	14	CD	NUMBER	14	num	1	SENT_353	[p17l9t2084r117b2148],
3	]	NNP	O	]	nn	5	SENT_353	[p17l9t2084r117b2148],
4	Lynch	NNP	PERSON	Lynch	nn	5	SENT_353	[p17l156t2084r317b2148],
5	TJ	NNP	PERSON	TJ	dep	1	SENT_353	[p17l353t2086r442b2146],
6	,	,	O	,	_	0	SENT_353	[p17l353t2086r442b2146],
7	Bell	NNP	ORGANIZATION	Bell	nn	8	SENT_353	[p17l486t2084r595b2135],
8	DW	NNP	ORGANIZATION	DW	appos	5	SENT_353	[p17l633t2086r739b2146],
9	,	,	O	,	_	0	SENT_353	[p17l633t2086r739b2146],
10	Sordella	NNP	PERSON	Sordella	nn	11	SENT_353	[p17l781t2084r1022b2136],
11	R	NNP	PERSON	R	appos	5	SENT_353	[p17l1061t2085r1113b2146],
12	,	,	O	,	_	0	SENT_353	[p17l1061t2085r1113b2146],
13	Gurubhagavatula	NNP	LOCATION	Gurubhagavatula	nn	14	SENT_353	[p17l1155t2084r1666b2148],
14	S	NNP	LOCATION	S	appos	5	SENT_353	[p17l1702t2085r1750b2146],
15	,	,	O	,	_	0	SENT_353	[p17l1702t2085r1750b2146],
16	Okimoto	NNP	PERSON	Okimoto	nn	17	SENT_353	[p17l1792t2084r2043b2135],
17	RA	NN	O	ra	appos	5	SENT_353	[p17l156t2168r249b2229],
18	,	,	O	,	_	0	SENT_353	[p17l156t2168r249b2229],
19	Brannigan	NNP	PERSON	Brannigan	nn	20	SENT_353	[p17l277t2168r570b2231],
20	BW	NN	O	bw	appos	5	SENT_353	[p17l595t2168r699b2229],
21	,	,	O	,	_	0	SENT_353	[p17l595t2168r699b2229],
22	et	FW	O	et	nn	23	SENT_353	[p17l725t2172r786b2218],
23	al.	FW	O	al.	appos	5	SENT_353	[p17l806t2167r877b2218],
24	.	.	O	.	_	0	SENT_353	[p17l806t2167r877b2218],

1	Activating	VBG	O	activate	amod	2	SENT_354	[p17l902t2168r1207b2231],
2	mutations	NNS	O	mutation	_	0	SENT_354	[p17l1229t2169r1527b2218],
3	in	IN	O	in	_	0	SENT_354	[p17l1548t2169r1598b2218],
4	the	DT	O	the	det	7	SENT_354	[p17l1621t2167r1718b2218],
5	epidermal	JJ	O	epidermal	amod	7	SENT_354	[p17l1739t2167r2043b2231],
6	growth	NN	O	growth	nn	7	SENT_354	[p17l154t2250r359b2314],
7	factor	NN	O	factor	prep_in	2	SENT_354	[p17l379t2250r562b2301],
8	receptor	NN	O	receptor	nn	10	SENT_354	[p17l580t2255r838b2314],
9	underlying	VBG	O	underlie	amod	10	SENT_354	[p17l855t2250r1170b2314],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_354	[p17l1190t2252r1632b2314],
11	of	IN	O	of	_	0	SENT_354	[p17l1650t2250r1711b2301],
12	nonsmallcell	JJ	O	nonsmallcell	amod	14	SENT_354	[p17l1728t2250r2040b2301, p17l153t2333r260b2384],
13	lung	NN	O	lung	nn	14	SENT_354	[p17l287t2333r409b2397],
14	cancer	NN	O	cancer	prep_of	10	SENT_354	[p17l434t2347r635b2384],
15	to	TO	O	to	_	0	SENT_354	[p17l658t2338r717b2384],
16	geﬁtinib	NN	O	geﬁtinib	prep_to	14	SENT_354	[p17l742t2333r1008b2397],
17	.	.	O	.	_	0	SENT_354	[p17l742t2333r1008b2397],

1	N	NN	O	n	nn	3	SENT_355	[p17l1040t2335r1075b2384],
2	Engl	NNP	O	Engl	nn	3	SENT_355	[p17l1104t2333r1225b2397],
3	J	NNP	O	J	nsubj	4	SENT_355	[p17l1249t2335r1276b2384],
4	Med	VBD	O	med	_	0	SENT_355	[p17l1301t2333r1420b2384],
5	2004	CD	DATE	2004	dobj	4	SENT_355	[p17l1446t2334r2024b2395],
6	;	:	O	;	_	0	SENT_355	[p17l1446t2334r2024b2395],
7	350:2129	CD	NUMBER	350:2129	number	8	SENT_355	[p17l1446t2334r2024b2395],
8	—	CD	NUMBER	—	dep	5	SENT_355	[p17l1446t2334r2024b2395],
9	39	CD	NUMBER	39	dep	8	SENT_355	[p17l1446t2334r2024b2395],
10	.	.	O	.	_	0	SENT_355	[p17l1446t2334r2024b2395],

1	[	RB	O	[	dep	5	SENT_356	[p17l9t2416r117b2480],
2	15	CD	NUMBER	15	num	5	SENT_356	[p17l9t2416r117b2480],
3	]	CD	NUMBER	]	num	5	SENT_356	[p17l9t2416r117b2480],
4	Paez	NNP	O	Paez	nn	5	SENT_356	[p17l156t2418r290b2467],
5	JG	NNP	O	JG	_	0	SENT_356	[p17l316t2417r410b2478],
6	,	,	O	,	_	0	SENT_356	[p17l316t2417r410b2478],
7	Janne	NNP	PERSON	Janne	nn	8	SENT_356	[p17l443t2418r619b2467],
8	PA	NN	PERSON	pa	appos	5	SENT_356	[p17l648t2417r732b2478],
9	,	,	O	,	_	0	SENT_356	[p17l648t2417r732b2478],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_356	[p17l767t2418r869b2467],
11	JC	NNP	PERSON	JC	appos	5	SENT_356	[p17l896t2417r985b2478],
12	,	,	O	,	_	0	SENT_356	[p17l896t2417r985b2478],
13	Tracy	NNP	PERSON	Tracy	nn	14	SENT_356	[p17l1016t2418r1177b2480],
14	S	NNP	PERSON	S	appos	11	SENT_356	[p17l1203t2417r1250b2478],
15	,	,	O	,	_	0	SENT_356	[p17l1203t2417r1250b2478],
16	Greulich	NNP	PERSON	Greulich	nn	17	SENT_356	[p17l1284t2416r1534b2467],
17	H	NNP	PERSON	H	appos	11	SENT_356	[p17l1566t2418r1623b2478],
18	,	,	O	,	_	0	SENT_356	[p17l1566t2418r1623b2478],
19	Gabriel	NNP	PERSON	Gabriel	nn	20	SENT_356	[p17l1657t2416r1874b2468],
20	S	NNP	PERSON	S	appos	11	SENT_356	[p17l1902t2417r1950b2478],
21	,	,	O	,	_	0	SENT_356	[p17l1902t2417r1950b2478],
22	et	FW	O	et	nn	23	SENT_356	[p17l1983t2421r2044b2467],
23	al.	FW	O	al.	appos	11	SENT_356	[p17l154t2499r224b2550],
24	.	.	O	.	_	0	SENT_356	[p17l154t2499r224b2550],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_357	[p17l268t2500r421b2550],
2	mutations	NNS	O	mutation	_	0	SENT_357	[p17l456t2501r754b2550],
3	in	IN	O	in	_	0	SENT_357	[p17l789t2501r839b2550],
4	lung	NN	O	lung	nn	5	SENT_357	[p17l879t2499r1001b2563],
5	cancer	NN	O	cancer	prep_in	2	SENT_357	[p17l1036t2513r1255b2550],
6	:	:	O	:	_	0	SENT_357	[p17l1036t2513r1255b2550],
7	correlation	NN	O	correlation	dep	2	SENT_357	[p17l1296t2499r1625b2550],
8	with	IN	O	with	_	0	SENT_357	[p17l1661t2499r1791b2550],
9	clinical	JJ	O	clinical	amod	10	SENT_357	[p17l1828t2499r2043b2550],
10	response	NN	O	response	prep_with	7	SENT_357	[p17l156t2596r417b2646],
11	to	TO	O	to	_	0	SENT_357	[p17l441t2587r500b2633],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_357	[p17l525t2582r772b2646],
13	therapy	NN	O	therapy	prep_to	10	SENT_357	[p17l797t2582r1038b2646],
14	.	.	O	.	_	0	SENT_357	[p17l797t2582r1038b2646],

1	Science	NNP	O	Science	_	0	SENT_358	[p17l1068t2583r1295b2633],
2	2004	CD	DATE	2004	num	1	SENT_358	[p17l1319t2583r1932b2644],
3	;	:	O	;	_	0	SENT_358	[p17l1319t2583r1932b2644],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_358	[p17l1319t2583r1932b2644],
5	—	CD	NUMBER	—	dep	1	SENT_358	[p17l1319t2583r1932b2644],
6	500	CD	NUMBER	500	dep	5	SENT_358	[p17l1319t2583r1932b2644],
7	.	.	O	.	_	0	SENT_358	[p17l1319t2583r1932b2644],

1	[	RB	O	[	dep	5	SENT_359	[p17l9t2665r117b2729],
2	16	CD	NUMBER	16	num	5	SENT_359	[p17l9t2665r117b2729],
3	]	CD	NUMBER	]	num	5	SENT_359	[p17l9t2665r117b2729],
4	Pao	NNP	O	Pao	nn	5	SENT_359	[p17l156t2667r256b2716],
5	W	NNP	O	W	_	0	SENT_359	[p17l288t2667r357b2727],
6	,	,	O	,	_	0	SENT_359	[p17l288t2667r357b2727],
7	Miller	NNP	PERSON	Miller	nn	8	SENT_359	[p17l395t2665r566b2716],
8	V	NNP	O	V	appos	5	SENT_359	[p17l596t2667r643b2727],
9	,	,	O	,	_	0	SENT_359	[p17l596t2667r643b2727],
10	Zakowski	NNP	O	Zakowski	nn	11	SENT_359	[p17l683t2665r952b2716],
11	M	NNP	O	M	appos	5	SENT_359	[p17l986t2667r1051b2727],
12	,	,	O	,	_	0	SENT_359	[p17l986t2667r1051b2727],
13	Doherty	NNP	PERSON	Doherty	nn	14	SENT_359	[p17l1093t2665r1327b2729],
14	J	NNP	PERSON	J	appos	11	SENT_359	[p17l1359t2667r1407b2727],
15	,	,	O	,	_	0	SENT_359	[p17l1359t2667r1407b2727],
16	Politi	NNP	PERSON	Politi	nn	17	SENT_359	[p17l1449t2665r1597b2716],
17	K	NNP	PERSON	K	appos	11	SENT_359	[p17l1636t2667r1688b2727],
18	,	,	O	,	_	0	SENT_359	[p17l1636t2667r1688b2727],
19	Sarkaria	NNP	O	Sarkaria	appos	11	SENT_359	[p17l1727t2665r1969b2717],
20	I	PRP	O	I	dep	19	SENT_359	[p17l2007t2667r2037b2727],
21	,	,	O	,	_	0	SENT_359	[p17l2007t2667r2037b2727],
22	et	FW	O	et	nn	23	SENT_359	[p17l153t2753r214b2799],
23	al.	FW	O	al.	appos	11	SENT_359	[p17l242t2748r313b2799],
24	.	.	O	.	_	0	SENT_359	[p17l242t2748r313b2799],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_360	[p17l350t2749r464b2800],
2	receptor	NN	O	receptor	nn	4	SENT_360	[p17l493t2753r750b2812],
3	gene	NN	O	gene	nn	4	SENT_360	[p17l777t2761r919b2812],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_360	[p17l949t2750r1247b2799],
5	are	VBP	O	be	cop	6	SENT_360	[p17l1276t2762r1371b2799],
6	common	JJ	O	common	_	0	SENT_360	[p17l1400t2762r1650b2799],
7	in	IN	O	in	_	0	SENT_360	[p17l1681t2750r1731b2799],
8	lung	NN	O	lung	nn	9	SENT_360	[p17l1765t2748r1887b2812],
9	cancers	NNS	O	cancer	prep_in	6	SENT_360	[p17l1915t2762r2040b2799, p17l153t2845r274b2883],
10	from	IN	O	from	prep	9	SENT_360	[p17l295t2832r434b2883],
11	"	``	O	"	punct	9	SENT_360	[p17l462t2832r676b2883],
12	never	RB	O	never	advmod	13	SENT_360	[p17l462t2832r676b2883],
13	smokers	NNS	O	smoker	dep	9	SENT_360	[p17l695t2832r982b2883],
14	”	CD	NUMBER	”	dep	13	SENT_360	[p17l695t2832r982b2883],
15	and	CC	O	and	_	0	SENT_360	[p17l1009t2832r1112b2883],
16	are	VBP	O	be	auxpass	17	SENT_360	[p17l1137t2845r1231b2883],
17	associated	VBN	O	associate	conj_and	6	SENT_360	[p17l1253t2832r1564b2883],
18	with	IN	O	with	_	0	SENT_360	[p17l1586t2832r1715b2883],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_360	[p17l1739t2833r2045b2896],
20	of	IN	O	of	_	0	SENT_360	[p17l153t2915r214b2966],
21	tumors	NNS	O	tumor	prep_of	19	SENT_360	[p17l246t2920r452b2966],
22	to	TO	O	to	_	0	SENT_360	[p17l487t2920r546b2966],
23	geﬁtinib	NN	O	geﬁtinib	prep_to	17	SENT_360	[p17l581t2915r827b2979],
24	and	CC	O	and	_	0	SENT_360	[p17l862t2915r966b2966],
25	erlotinib	NN	O	erlotinib	conj_and	23	SENT_360	[p17l1003t2915r1278b2966],
26	.	.	O	.	_	0	SENT_360	[p17l1003t2915r1278b2966],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_361	[p17l1321t2916r1446b2966],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_361	[p17l1483t2915r1602b2966],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_361	[p17l1634t2915r1778b2966],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_361	[p17l1814t2915r1893b2966],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_361	[p17l1933t2915r2045b2966],
6	2004	CD	DATE	2004	num	5	SENT_361	[p17l153t2998r767b3059],
7	;	:	O	;	_	0	SENT_361	[p17l153t2998r767b3059],
8	101:13306	CD	NUMBER	101:13306	number	9	SENT_361	[p17l153t2998r767b3059],
9	—	CD	NUMBER	—	dep	5	SENT_361	[p17l153t2998r767b3059],
10	11	CD	NUMBER	11	dep	9	SENT_361	[p17l153t2998r767b3059],
11	.	.	O	.	_	0	SENT_361	[p17l153t2998r767b3059],

1	[	NN	O	[	nn	5	SENT_362	[p17l9t3081r117b3145],
2	17	CD	NUMBER	17	num	5	SENT_362	[p17l9t3081r117b3145],
3	]	CD	NUMBER	]	num	5	SENT_362	[p17l9t3081r117b3145],
4	Han	NNP	O	Han	nn	5	SENT_362	[p17l156t3082r264b3132],
5	SW	NNP	O	SW	nsubj	23	SENT_362	[p17l301t3081r400b3142],
6	,	,	O	,	_	0	SENT_362	[p17l301t3081r400b3142],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_362	[p17l443t3082r547b3131],
8	TY	NNP	PERSON	TY	appos	5	SENT_362	[p17l581t3082r665b3142],
9	,	,	O	,	_	0	SENT_362	[p17l581t3082r665b3142],
10	Hwang	NNP	PERSON	Hwang	nn	11	SENT_362	[p17l708t3082r904b3145],
11	PG	NNP	O	PG	appos	5	SENT_362	[p17l940t3081r1037b3142],
12	,	,	O	,	_	0	SENT_362	[p17l940t3081r1037b3142],
13	Jeong	NNP	PERSON	Jeong	nn	14	SENT_362	[p17l1076t3082r1250b3145],
14	S	NNP	O	S	appos	5	SENT_362	[p17l1284t3081r1331b3143],
15	,	,	O	,	_	0	SENT_362	[p17l1284t3081r1331b3143],
16	Kim	NNP	PERSON	Kim	nn	17	SENT_362	[p17l1374t3082r1478b3131],
17	J	NNP	PERSON	J	appos	5	SENT_362	[p17l1514t3082r1562b3142],
18	,	,	O	,	_	0	SENT_362	[p17l1514t3082r1562b3142],
19	Choi	NNP	PERSON	Choi	appos	5	SENT_362	[p17l1602t3081r1729b3132],
20	IS	VBZ	O	be	cop	23	SENT_362	[p17l1769t3081r1833b3142],
21	,	,	O	,	_	0	SENT_362	[p17l1769t3081r1833b3142],
22	et	FW	O	et	nn	23	SENT_362	[p17l1872t3086r1933b3132],
23	al.	FW	O	al.	_	0	SENT_362	[p17l1967t3081r2037b3132],
24	.	.	O	.	_	0	SENT_362	[p17l1967t3081r2037b3132],

1	Predictive	JJ	O	predictive	amod	4	SENT_363	[p17l156t3164r455b3215],
2	and	CC	O	and	_	0	SENT_363	[p17l495t3164r600b3215],
3	prognostic	JJ	O	prognostic	conj_and	1	SENT_363	[p17l643t3165r953b3228],
4	impact	NN	O	impact	nsubj	16	SENT_363	[p17l993t3165r1200b3228],
5	of	IN	O	of	_	0	SENT_363	[p17l1239t3164r1299b3215],
6	epidermal	JJ	O	epidermal	amod	10	SENT_363	[p17l1336t3164r1639b3228],
7	growth	NN	O	growth	nn	10	SENT_363	[p17l1680t3164r1886b3228],
8	factor	NN	O	factor	nn	10	SENT_363	[p17l1927t3164r2040b3215, p17l154t3252r241b3298],
9	receptor	NN	O	receptor	nn	10	SENT_363	[p17l274t3252r531b3311],
10	mutation	NN	O	mutation	prep_of	4	SENT_363	[p17l564t3248r831b3298],
11	in	IN	O	in	_	0	SENT_363	[p17l866t3248r916b3297],
12	non-small-cell	JJ	O	non-small-cell	amod	15	SENT_363	[p17l953t3247r1377b3298],
13	lung	NN	O	lung	nn	15	SENT_363	[p17l1413t3247r1535b3311],
14	cancer	NN	O	cancer	nn	15	SENT_363	[p17l1566t3260r1768b3298],
15	patients	NNS	O	patient	prep_in	10	SENT_363	[p17l1801t3248r2043b3311],
16	treated	VBN	O	treat	_	0	SENT_363	[p17l153t3330r375b3381],
17	with	IN	O	with	_	0	SENT_363	[p17l400t3330r530b3381],
18	geﬁtinib	NN	O	geﬁtinib	prep_with	16	SENT_363	[p17l556t3330r823b3394],
19	.	.	O	.	_	0	SENT_363	[p17l556t3330r823b3394],

1	J	NNP	O	J	nn	3	SENT_364	[p17l852t3331r879b3381],
2	Clin	NNP	O	Clin	nn	3	SENT_364	[p17l906t3330r1017b3381],
3	Oncol	NNP	O	Oncol	_	0	SENT_364	[p17l1044t3330r1212b3381],
4	2005	CD	DATE	2005	num	3	SENT_364	[p17l1237t3330r1815b3391],
5	;	:	O	;	_	0	SENT_364	[p17l1237t3330r1815b3391],
6	23:2493	CD	NUMBER	23:2493	num	7	SENT_364	[p17l1237t3330r1815b3391],
7	—	NN	O	—	dep	3	SENT_364	[p17l1237t3330r1815b3391],
8	501	CD	NUMBER	501	dep	7	SENT_364	[p17l1237t3330r1815b3391],
9	.	.	O	.	_	0	SENT_364	[p17l1237t3330r1815b3391],

1	[	NN	O	[	nn	4	SENT_365	[p17l9t3413r117b3477],
2	18	CD	NUMBER	18	num	4	SENT_365	[p17l9t3413r117b3477],
3	]	NN	O	]	nn	4	SENT_365	[p17l9t3413r117b3477],
4	Mitsudomi	NN	ORGANIZATION	mitsudomus	_	0	SENT_365	[p17l152t3413r456b3464],
5	T	NN	ORGANIZATION	t	dep	4	SENT_365	[p17l491t3414r536b3474],
6	,	,	O	,	_	0	SENT_365	[p17l491t3414r536b3474],
7	Kosaka	NNP	ORGANIZATION	Kosaka	nn	8	SENT_365	[p17l578t3413r778b3464],
8	T	NN	ORGANIZATION	t	appos	5	SENT_365	[p17l810t3414r856b3475],
9	,	,	O	,	_	0	SENT_365	[p17l810t3414r856b3475],
10	Endoh	NN	PERSON	endoh	nn	11	SENT_365	[p17l898t3413r1074b3464],
11	H	NN	PERSON	h	appos	5	SENT_365	[p17l1112t3414r1170b3474],
12	,	,	O	,	_	0	SENT_365	[p17l1112t3414r1170b3474],
13	Horio	NNP	ORGANIZATION	Horio	nn	14	SENT_365	[p17l1212t3414r1368b3464],
14	Y	NN	ORGANIZATION	y	appos	5	SENT_365	[p17l1401t3414r1445b3474],
15	,	,	O	,	_	0	SENT_365	[p17l1401t3414r1445b3474],
16	Hida	NN	LOCATION	hida	nn	17	SENT_365	[p17l1488t3413r1618b3464],
17	T	NN	LOCATION	t	appos	5	SENT_365	[p17l1650t3414r1696b3474],
18	,	,	O	,	_	0	SENT_365	[p17l1650t3414r1696b3474],
19	Mori	NNP	LOCATION	Mori	nn	20	SENT_365	[p17l1733t3414r1859b3464],
20	S	NNP	LOCATION	S	appos	5	SENT_365	[p17l1896t3413r1943b3475],
21	,	,	O	,	_	0	SENT_365	[p17l1896t3413r1943b3475],
22	et	FW	O	et	nn	23	SENT_365	[p17l1983t3417r2044b3464],
23	al.	FW	O	al.	appos	5	SENT_365	[p17l154t3496r224b3547],
24	.	.	O	.	_	0	SENT_365	[p17l154t3496r224b3547],

1	Mutations	NNS	O	mutation	nsubj	9	SENT_366	[p17l263t3497r556b3547],
2	of	IN	O	of	_	0	SENT_366	[p17l590t3496r651b3547],
3	the	DT	O	the	det	8	SENT_366	[p17l683t3496r780b3547],
4	epidermal	JJ	O	epidermal	amod	8	SENT_366	[p17l814t3496r1117b3560],
5	growth	NN	O	growth	nn	8	SENT_366	[p17l1153t3496r1358b3560],
6	factor	NN	O	factor	nn	8	SENT_366	[p17l1394t3496r1577b3547],
7	receptor	NN	O	receptor	nn	8	SENT_366	[p17l1612t3501r1869b3560],
8	gene	NN	O	gene	prep_of	1	SENT_366	[p17l1902t3508r2043b3560],
9	predict	VBP	O	predict	_	0	SENT_366	[p17l155t3579r369b3643],
10	prolonged	JJ	O	prolonged	amod	11	SENT_366	[p17l392t3579r687b3643],
11	survival	NN	O	survival	dobj	9	SENT_366	[p17l711t3579r938b3630],
12	after	IN	O	after	_	0	SENT_366	[p17l961t3579r1110b3630],
13	geﬁtinib	NN	O	geﬁtinib	nn	14	SENT_366	[p17l1129t3579r1376b3643],
14	treatment	NN	O	treatment	prep_after	9	SENT_366	[p17l1398t3584r1704b3630],
15	in	IN	O	in	_	0	SENT_366	[p17l1725t3580r1775b3629],
16	patients	NNS	O	patient	prep_in	14	SENT_366	[p17l1801t3580r2043b3643],
17	an	DT	O	a	dep	9	SENT_366	[p17l2079t299r2148b339],
18	with	IN	O	with	_	0	SENT_366	[p18l202t104r335b157],
19	non-small-cell	JJ	O	non-small-cell	amod	21	SENT_366	[p18l358t104r796b157],
20	lung	NN	O	lung	nn	21	SENT_366	[p18l818t104r944b170],
21	cancer	NN	O	cancer	prep_with	9	SENT_366	[p18l963t118r1171b157],
22	with	IN	O	with	_	0	SENT_366	[p18l1186t104r1320b157],
23	postoperative	JJ	O	postoperative	amod	24	SENT_366	[p18l1343t105r1768b170],
24	recurrence	NN	O	recurrence	prep_with	21	SENT_366	[p18l1790t118r2145b157],
25	.	.	O	.	_	0	SENT_366	[p18l1790t118r2145b157],

1	J	NNP	O	J	nn	3	SENT_367	[p18l203t192r230b243],
2	Clin	NNP	O	Clin	nn	3	SENT_367	[p18l258t190r372b243],
3	Oncol	NNP	O	Oncol	_	0	SENT_367	[p18l400t190r574b243],
4	2005	CD	DATE	2005	num	3	SENT_367	[p18l599t191r1158b254],
5	;	:	O	;	_	0	SENT_367	[p18l599t191r1158b254],
6	23:2513	CD	NUMBER	23:2513	number	7	SENT_367	[p18l599t191r1158b254],
7	—	CD	NUMBER	—	dep	3	SENT_367	[p18l599t191r1158b254],
8	20	CD	NUMBER	20	dep	7	SENT_367	[p18l599t191r1158b254],
9	.	.	O	.	_	0	SENT_367	[p18l599t191r1158b254],

1	[	NN	O	[	_	0	SENT_368	[p18l54t276r166b342],
2	19	CD	NUMBER	19	num	1	SENT_368	[p18l54t276r166b342],
3	]	CD	NUMBER	]	num	5	SENT_368	[p18l54t276r166b342],
4	Takano	NNP	PERSON	Takano	nn	5	SENT_368	[p18l201t276r416b329],
5	T	NN	O	t	dep	1	SENT_368	[p18l453t277r500b340],
6	,	,	O	,	_	0	SENT_368	[p18l453t277r500b340],
7	Ohe	NN	O	ohe	nn	8	SENT_368	[p18l544t276r663b329],
8	Y	NN	O	y	appos	5	SENT_368	[p18l700t277r747b340],
9	,	,	O	,	_	0	SENT_368	[p18l700t277r747b340],
10	Sakamoto	NNP	PERSON	Sakamoto	nn	11	SENT_368	[p18l791t276r1091b329],
11	H	NNP	O	H	appos	5	SENT_368	[p18l1132t277r1191b340],
12	,	,	O	,	_	0	SENT_368	[p18l1132t277r1191b340],
13	Tsuta	NNP	LOCATION	Tsuta	nn	14	SENT_368	[p18l1234t277r1394b329],
14	K	NNP	LOCATION	K	appos	5	SENT_368	[p18l1436t277r1489b340],
15	,	,	O	,	_	0	SENT_368	[p18l1436t277r1489b340],
16	Matsuno	NNP	PERSON	Matsuno	nn	17	SENT_368	[p18l1532t277r1787b329],
17	Y	NN	PERSON	y	appos	5	SENT_368	[p18l1824t277r1870b340],
18	,	,	O	,	_	0	SENT_368	[p18l1824t277r1870b340],
19	Tateishi	NNP	PERSON	Tateishi	nn	20	SENT_368	[p18l1912t276r2149b329],
20	U	NNP	PERSON	U	appos	5	SENT_368	[p18l206t363r265b426],
21	,	,	O	,	_	0	SENT_368	[p18l206t363r265b426],
22	et	FW	O	et	nn	23	SENT_368	[p18l309t367r371b415],
23	al.	FW	O	al.	appos	5	SENT_368	[p18l409t362r482b415],
24	.	.	O	.	_	0	SENT_368	[p18l409t362r482b415],

1	Epidermal	JJ	O	epidermal	amod	6	SENT_369	[p18l529t362r838b428],
2	growth	NN	O	growth	nn	6	SENT_369	[p18l877t362r1089b428],
3	factor	NN	O	factor	nn	6	SENT_369	[p18l1129t362r1318b415],
4	receptor	NN	O	receptor	nn	6	SENT_369	[p18l1357t367r1622b428],
5	gene	NN	O	gene	nn	6	SENT_369	[p18l1659t375r1804b428],
6	mutations	NNS	O	mutation	nsubj	11	SENT_369	[p18l1845t363r2151b415],
7	and	CC	O	and	_	0	SENT_369	[p18l204t448r311b501],
8	increased	VBD	O	increase	amod	9	SENT_369	[p18l355t448r649b501],
9	copy	NN	O	copy	nsubj	11	SENT_369	[p18l693t462r837b514],
10	numbers	NNS	O	number	dep	6	SENT_369	[p18l879t448r1140b501],
11	predict	VBP	O	predict	_	0	SENT_369	[p18l1184t448r1404b514],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_369	[p18l1446t448r1700b514],
13	sensitivity	NN	O	sensitivity	dobj	11	SENT_369	[p18l1742t449r2057b514],
14	in	IN	O	in	_	0	SENT_369	[p18l2098t449r2149b500],
15	patients	NNS	O	patient	prep_in	11	SENT_369	[p18l205t535r455b600],
16	with	IN	O	with	_	0	SENT_369	[p18l473t534r607b587],
17	recurrent	JJ	O	recurrent	amod	20	SENT_369	[p18l631t539r922b587],
18	non-small-cell	JJ	O	non-small-cell	amod	20	SENT_369	[p18l944t534r1381b587],
19	lung	NN	O	lung	nn	20	SENT_369	[p18l1404t534r1530b600],
20	cancer	NN	O	cancer	prep_with	15	SENT_369	[p18l1549t548r1766b587],
21	.	.	O	.	_	0	SENT_369	[p18l1549t548r1766b587],

1	J	NNP	O	J	nn	3	SENT_370	[p18l1791t535r1818b587],
2	Clin	NNP	O	Clin	nn	3	SENT_370	[p18l1841t534r1955b587],
3	Oncol	NNP	O	Oncol	_	0	SENT_370	[p18l1977t534r2151b587],
4	2005	CD	DATE	2005	num	3	SENT_370	[p18l203t621r762b684],
5	;	:	O	;	_	0	SENT_370	[p18l203t621r762b684],
6	23:6829	CD	NUMBER	23:6829	number	7	SENT_370	[p18l203t621r762b684],
7	—	CD	NUMBER	—	dep	3	SENT_370	[p18l203t621r762b684],
8	37	CD	NUMBER	37	dep	7	SENT_370	[p18l203t621r762b684],
9	.	.	O	.	_	0	SENT_370	[p18l203t621r762b684],

1	[	RB	O	[	advmod	2	SENT_371	[p18l54t705r166b771],
2	20	CD	NUMBER	20	_	0	SENT_371	[p18l54t705r166b771],
3	]	CD	NUMBER	]	num	5	SENT_371	[p18l54t705r166b771],
4	Cappuzzo	NNP	O	Cappuzzo	nn	5	SENT_371	[p18l204t706r499b771],
5	F	NN	O	f	dep	2	SENT_371	[p18l527t707r564b769],
6	,	,	O	,	_	0	SENT_371	[p18l527t707r564b769],
7	Hirsch	NNP	PERSON	Hirsch	nn	8	SENT_371	[p18l599t705r784b758],
8	FR	NN	O	fr	appos	5	SENT_371	[p18l815t706r905b769],
9	,	,	O	,	_	0	SENT_371	[p18l815t706r905b769],
10	Rossi	NNP	PERSON	Rossi	nn	11	SENT_371	[p18l940t706r1083b758],
11	E	NNP	O	E	appos	5	SENT_371	[p18l1114t707r1164b769],
12	,	,	O	,	_	0	SENT_371	[p18l1114t707r1164b769],
13	Bartolini	NNP	PERSON	Bartolini	nn	14	SENT_371	[p18l1199t705r1458b758],
14	S	NNP	O	S	appos	5	SENT_371	[p18l1486t706r1535b769],
15	,	,	O	,	_	0	SENT_371	[p18l1486t706r1535b769],
16	Ceresoli	NNP	ORGANIZATION	Ceresoli	nn	17	SENT_371	[p18l1567t705r1812b758],
17	GL	NNP	ORGANIZATION	GL	appos	5	SENT_371	[p18l1841t706r1939b769],
18	,	,	O	,	_	0	SENT_371	[p18l1841t706r1939b769],
19	Bemis	NNP	PERSON	Bemis	nn	20	SENT_371	[p18l1974t706r2151b758],
20	L	NNP	PERSON	L	appos	5	SENT_371	[p18l206t793r254b855],
21	,	,	O	,	_	0	SENT_371	[p18l206t793r254b855],
22	et	FW	O	et	nn	23	SENT_371	[p18l293t796r355b844],
23	al.	FW	O	al.	appos	5	SENT_371	[p18l388t791r460b844],
24	.	.	O	.	_	0	SENT_371	[p18l388t791r460b844],

1	Epidermal	JJ	O	epidermal	amod	3	SENT_372	[p18l501t791r810b857],
2	growth	NN	O	growth	nn	3	SENT_372	[p18l844t791r1055b857],
3	factor	NN	O	factor	_	0	SENT_372	[p18l1090t791r1278b844],
4	receptor	NN	O	receptor	nn	5	SENT_372	[p18l1311t796r1576b857],
5	gene	NN	O	gene	dep	3	SENT_372	[p18l1607t804r1752b857],
6	and	CC	O	and	_	0	SENT_372	[p18l1785t791r1892b844],
7	protein	NN	O	protein	nn	10	SENT_372	[p18l1929t792r2149b857],
8	and	CC	O	and	_	0	SENT_372	[p18l204t877r311b930],
9	geﬁtinib	NN	O	geﬁtinib	nn	10	SENT_372	[p18l347t877r602b943],
10	sensitivity	NN	O	sensitivity	dep	3	SENT_372	[p18l636t878r950b943],
11	in	IN	O	in	_	0	SENT_372	[p18l983t878r1035b929],
12	non-small-cell	JJ	O	non-small-cell	amod	14	SENT_372	[p18l1073t877r1511b930],
13	lung	NN	O	lung	nn	14	SENT_372	[p18l1547t877r1673b943],
14	cancer	NN	O	cancer	prep_in	3	SENT_372	[p18l1706t891r1922b930],
15	.	.	O	.	_	0	SENT_372	[p18l1706t891r1922b930],

1	J	NNP	O	J	nn	4	SENT_373	[p18l1962t879r1989b930],
2	Natl	NNP	O	Natl	nn	4	SENT_373	[p18l2028t877r2151b930],
3	Cancer	NNP	O	Cancer	nn	4	SENT_373	[p18l204t964r418b1016],
4	Inst	NNP	O	Inst	_	0	SENT_373	[p18l445t965r552b1016],
5	2005	CD	DATE	2005	num	4	SENT_373	[p18l577t964r1098b1027],
6	;	:	O	;	_	0	SENT_373	[p18l577t964r1098b1027],
7	97:643	CD	NUMBER	97:643	number	8	SENT_373	[p18l577t964r1098b1027],
8	—	CD	NUMBER	—	dep	4	SENT_373	[p18l577t964r1098b1027],
9	55	CD	NUMBER	55	dep	8	SENT_373	[p18l577t964r1098b1027],
10	.	.	O	.	_	0	SENT_373	[p18l577t964r1098b1027],

1	[	NN	O	[	_	0	SENT_374	[p18l54t1049r166b1115],
2	21	CD	NUMBER	21	num	1	SENT_374	[p18l54t1049r166b1115],
3	]	CD	NUMBER	]	num	5	SENT_374	[p18l54t1049r166b1115],
4	Hirsch	NNP	PERSON	Hirsch	nn	5	SENT_374	[p18l206t1049r391b1102],
5	FR	NN	O	fr	dep	1	SENT_374	[p18l439t1050r530b1113],
6	,	,	O	,	_	0	SENT_374	[p18l439t1050r530b1113],
7	Varella-Garcia	NNP	O	Varella-Garcia	nn	8	SENT_374	[p18l577t1049r1019b1102],
8	M	NNP	O	M	appos	5	SENT_374	[p18l1061t1051r1128b1113],
9	,	,	O	,	_	0	SENT_374	[p18l1061t1051r1128b1113],
10	McCoy	NNP	PERSON	McCoy	nn	11	SENT_374	[p18l1175t1050r1372b1115],
11	J	NNP	PERSON	J	appos	5	SENT_374	[p18l1413t1051r1463b1113],
12	,	,	O	,	_	0	SENT_374	[p18l1413t1051r1463b1113],
13	West	NNP	O	West	nn	14	SENT_374	[p18l1510t1051r1659b1102],
14	H	NNP	O	H	appos	5	SENT_374	[p18l1704t1051r1763b1113],
15	,	,	O	,	_	0	SENT_374	[p18l1704t1051r1763b1113],
16	Xavier	NNP	ORGANIZATION	Xavier	nn	17	SENT_374	[p18l1810t1050r2005b1102],
17	AC	NN	ORGANIZATION	ac	appos	5	SENT_374	[p18l2044t1050r2146b1113],
18	,	,	O	,	_	0	SENT_374	[p18l2044t1050r2146b1113],
19	Gumerlock	NN	O	gumerlock	nn	20	SENT_374	[p18l204t1135r538b1188],
20	P	NN	O	p	appos	5	SENT_374	[p18l558t1136r597b1199],
21	,	,	O	,	_	0	SENT_374	[p18l558t1136r597b1199],
22	et	FW	O	et	nn	23	SENT_374	[p18l622t1140r684b1188],
23	al.	FW	O	al.	appos	5	SENT_374	[p18l703t1135r775b1188],
24	.	.	O	.	_	0	SENT_374	[p18l703t1135r775b1188],

1	Increased	VBN	O	increase	amod	4	SENT_375	[p18l804t1135r1094b1188],
2	epidermal	JJ	O	epidermal	amod	4	SENT_375	[p18l1115t1135r1428b1201],
3	growth	NN	O	growth	nn	4	SENT_375	[p18l1448t1135r1659b1201],
4	factor	NN	O	factor	nsubj	15	SENT_375	[p18l1680t1135r1868b1188],
5	receptor	NN	O	receptor	nn	8	SENT_375	[p18l1888t1140r2153b1201],
6	gene	NN	O	gene	nn	8	SENT_375	[p18l204t1234r349b1287],
7	copy	NN	O	copy	nn	8	SENT_375	[p18l375t1235r519b1287],
8	number	NN	O	number	dobj	9	SENT_375	[p18l546t1221r781b1274],
9	detected	VBN	O	detect	partmod	4	SENT_375	[p18l805t1221r1081b1274],
10	by	IN	O	by	_	0	SENT_375	[p18l1112t1221r1181b1287],
11	ﬂuorescence	NN	O	ﬂuorescence	agent	9	SENT_375	[p18l1206t1221r1598b1274],
12	in	FW	O	in	nn	13	SENT_375	[p18l1625t1222r1676b1273],
13	situ	FW	O	situ	advmod	14	SENT_375	[p18l1705t1222r1813b1274],
14	hybridization	NN	O	hybridization	rcmod	11	SENT_375	[p18l1844t1221r2148b1287, p18l203t1308r321b1360],
15	associates	VBZ	O	associate	_	0	SENT_375	[p18l342t1308r654b1360],
16	with	IN	O	with	_	0	SENT_375	[p18l671t1307r805b1360],
17	increased	VBN	O	increase	amod	18	SENT_375	[p18l826t1307r1120b1360],
18	sensitivity	NN	O	sensitivity	prep_with	15	SENT_375	[p18l1141t1308r1456b1373],
19	to	TO	O	to	_	0	SENT_375	[p18l1473t1312r1534b1360],
20	geﬁtinib	NN	O	geﬁtinib	prep_to	18	SENT_375	[p18l1553t1307r1808b1373],
21	in	IN	O	in	_	0	SENT_375	[p18l1827t1308r1878b1359],
22	patients	NNS	O	patient	prep_in	20	SENT_375	[p18l1902t1308r2151b1373],
23	with	IN	O	with	_	0	SENT_375	[p18l202t1393r335b1446],
24	bronchioloalveolar	JJ	O	bronchioloalveolar	amod	26	SENT_375	[p18l393t1393r972b1446],
25	carcinoma	NN	O	carcinoma	nn	26	SENT_375	[p18l1024t1394r1344b1446],
26	subtypes	NNS	O	subtype	prep_with	22	SENT_375	[p18l1398t1393r1687b1459],
27	:	:	O	:	_	0	SENT_375	[p18l1398t1393r1687b1459],
28	a	DT	O	a	det	32	SENT_375	[p18l1747t1407r1779b1446],
29	Southwest	NNP	ORGANIZATION	Southwest	nn	32	SENT_375	[p18l1834t1393r2152b1446],
30	Oncology	NNP	ORGANIZATION	Oncology	nn	32	SENT_375	[p18l204t1479r486b1545],
31	Group	NNP	ORGANIZATION	Group	nn	32	SENT_375	[p18l511t1480r695b1545],
32	Study	NNP	O	Study	dep	22	SENT_375	[p18l721t1479r901b1545],
33	.	.	O	.	_	0	SENT_375	[p18l721t1479r901b1545],

1	J	NNP	O	J	nn	3	SENT_376	[p18l932t1481r959b1532],
2	Clin	NNP	O	Clin	nn	3	SENT_376	[p18l987t1479r1101b1532],
3	Oncol	NNP	O	Oncol	_	0	SENT_376	[p18l1129t1479r1303b1532],
4	2005	CD	DATE	2005	num	3	SENT_376	[p18l1328t1480r1887b1543],
5	;	:	O	;	_	0	SENT_376	[p18l1328t1480r1887b1543],
6	23:6838	CD	NUMBER	23:6838	number	7	SENT_376	[p18l1328t1480r1887b1543],
7	—	CD	NUMBER	—	dep	3	SENT_376	[p18l1328t1480r1887b1543],
8	45	CD	NUMBER	45	dep	7	SENT_376	[p18l1328t1480r1887b1543],
9	.	.	O	.	_	0	SENT_376	[p18l1328t1480r1887b1543],

1	[	NN	O	[	nn	5	SENT_377	[p18l54t1565r166b1631],
2	22	CD	NUMBER	22	num	5	SENT_377	[p18l54t1565r166b1631],
3	]	CD	NUMBER	]	num	5	SENT_377	[p18l54t1565r166b1631],
4	Han	NNP	O	Han	nn	5	SENT_377	[p18l206t1567r318b1618],
5	SW	NNP	O	SW	_	0	SENT_377	[p18l354t1566r456b1629],
6	,	,	O	,	_	0	SENT_377	[p18l354t1566r456b1629],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_377	[p18l498t1567r605b1617],
8	TY	NNP	PERSON	TY	appos	5	SENT_377	[p18l640t1567r727b1629],
9	,	,	O	,	_	0	SENT_377	[p18l640t1567r727b1629],
10	Jeon	NNP	PERSON	Jeon	nn	11	SENT_377	[p18l765t1567r907b1618],
11	YK	NNP	PERSON	YK	appos	8	SENT_377	[p18l941t1567r1039b1629],
12	,	,	O	,	_	0	SENT_377	[p18l941t1567r1039b1629],
13	Hwang	NNP	PERSON	Hwang	nn	14	SENT_377	[p18l1081t1567r1283b1631],
14	PG	NNP	O	PG	appos	8	SENT_377	[p18l1318t1566r1418b1629],
15	,	,	O	,	_	0	SENT_377	[p18l1318t1566r1418b1629],
16	Im	NNP	O	Im	nn	17	SENT_377	[p18l1461t1567r1529b1617],
17	SA	NNP	O	SA	appos	8	SENT_377	[p18l1565t1566r1655b1629],
18	,	,	O	,	_	0	SENT_377	[p18l1565t1566r1655b1629],
19	Lee	NNP	PERSON	Lee	nn	20	SENT_377	[p18l1697t1567r1802b1618],
20	KH	NNP	O	KH	appos	8	SENT_377	[p18l1838t1567r1938b1629],
21	,	,	O	,	_	0	SENT_377	[p18l1838t1567r1938b1629],
22	et	FW	O	et	nn	23	SENT_377	[p18l1977t1570r2039b1618],
23	al.	FW	O	al.	appos	8	SENT_377	[p18l2073t1565r2145b1618],
24	.	.	O	.	_	0	SENT_377	[p18l2073t1565r2145b1618],

1	Optimization	NN	O	optimization	_	0	SENT_378	[p18l204t1652r603b1717],
2	of	IN	O	of	_	0	SENT_378	[p18l627t1651r689b1704],
3	patient	NN	O	patient	nn	4	SENT_378	[p18l711t1653r933b1717],
4	selection	NN	O	selection	prep_of	1	SENT_378	[p18l955t1651r1232b1704],
5	for	IN	O	for	_	0	SENT_378	[p18l1256t1651r1345b1704],
6	geﬁtinib	NN	O	geﬁtinib	prep_for	1	SENT_378	[p18l1366t1651r1620b1717],
7	in	IN	O	in	_	0	SENT_378	[p18l1642t1653r1694b1703],
8	non-small	JJ	O	non-small	amod	11	SENT_378	[p18l1720t1651r2018b1704],
9	cell	NN	O	cell	nn	11	SENT_378	[p18l2041t1651r2151b1704],
10	lung	NN	O	lung	nn	11	SENT_378	[p18l206t1737r332b1803],
11	cancer	NN	O	cancer	prep_in	1	SENT_378	[p18l360t1752r568b1790],
12	by	IN	O	by	_	0	SENT_378	[p18l597t1737r666b1803],
13	combined	JJ	O	combined	amod	14	SENT_378	[p18l693t1737r992b1790],
14	analysis	NN	O	analysis	prep_by	11	SENT_378	[p18l1024t1737r1263b1803],
15	of	IN	O	of	_	0	SENT_378	[p18l1292t1737r1353b1790],
16	epidermal	JJ	O	epidermal	amod	20	SENT_378	[p18l1380t1737r1693b1803],
17	growth	NN	O	growth	nn	20	SENT_378	[p18l1722t1737r1934b1803],
18	factor	NN	O	factor	nn	20	SENT_378	[p18l1965t1737r2153b1790],
19	receptor	NN	O	receptor	nn	20	SENT_378	[p18l206t1828r471b1889],
20	mutation	NN	O	mutation	prep_of	14	SENT_378	[p18l502t1825r800b1887],
21	,	,	O	,	_	0	SENT_378	[p18l502t1825r800b1887],
22	K-ras	NN	O	k-ra	nn	23	SENT_378	[p18l839t1825r991b1876],
23	mutation	NN	O	mutation	prep_of	14	SENT_378	[p18l1023t1825r1321b1887],
24	,	,	O	,	_	0	SENT_378	[p18l1023t1825r1321b1887],
25	and	CC	O	and	_	0	SENT_378	[p18l1358t1823r1465b1876],
26	Akt	NN	O	akt	nn	27	SENT_378	[p18l1496t1823r1599b1876],
27	phosphorylation	NN	O	phosphorylation	prep_of	14	SENT_378	[p18l1631t1823r2145b1889],
28	.	.	O	.	_	0	SENT_378	[p18l1631t1823r2145b1889],

1	Clin	NNP	O	Clin	nn	3	SENT_379	[p18l204t1909r317b1962],
2	Cancer	NNP	O	Cancer	nn	3	SENT_379	[p18l346t1910r560b1962],
3	Res	NNP	O	Res	_	0	SENT_379	[p18l586t1910r684b1962],
4	2006	CD	DATE	2006	num	3	SENT_379	[p18l709t1910r1268b1973],
5	;	:	O	;	_	0	SENT_379	[p18l709t1910r1268b1973],
6	12:2538	CD	NUMBER	12:2538	number	7	SENT_379	[p18l709t1910r1268b1973],
7	—	CD	NUMBER	—	dep	3	SENT_379	[p18l709t1910r1268b1973],
8	44	CD	NUMBER	44	dep	7	SENT_379	[p18l709t1910r1268b1973],
9	.	.	O	.	_	0	SENT_379	[p18l709t1910r1268b1973],

1	[	NN	O	[	nn	5	SENT_380	[p18l54t1995r166b2061],
2	23	CD	NUMBER	23	num	5	SENT_380	[p18l54t1995r166b2061],
3	]	CD	NUMBER	]	num	5	SENT_380	[p18l54t1995r166b2061],
4	Pao	NNP	O	Pao	nn	5	SENT_380	[p18l206t1997r309b2048],
5	W	NNP	O	W	_	0	SENT_380	[p18l336t1997r407b2059],
6	,	,	O	,	_	0	SENT_380	[p18l336t1997r407b2059],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_380	[p18l439t1997r603b2061],
8	TY	NNP	PERSON	TY	appos	5	SENT_380	[p18l629t1997r716b2059],
9	,	,	O	,	_	0	SENT_380	[p18l629t1997r716b2059],
10	Riely	NNP	PERSON	Riely	nn	11	SENT_380	[p18l754t1995r902b2061],
11	GJ	NNP	O	GJ	appos	8	SENT_380	[p18l929t1996r1025b2059],
12	,	,	O	,	_	0	SENT_380	[p18l929t1996r1025b2059],
13	Miller	NNP	ORGANIZATION	Miller	nn	14	SENT_380	[p18l1058t1995r1233b2048],
14	VA	NNP	ORGANIZATION	VA	appos	8	SENT_380	[p18l1258t1996r1351b2059],
15	,	,	O	,	_	0	SENT_380	[p18l1258t1996r1351b2059],
16	Pan	NNP	O	Pan	nn	17	SENT_380	[p18l1388t1997r1490b2048],
17	Q	NNP	O	Q	appos	8	SENT_380	[p18l1521t1996r1583b2059],
18	,	,	O	,	_	0	SENT_380	[p18l1521t1996r1583b2059],
19	Ladanyi	NNP	PERSON	Ladanyi	nn	20	SENT_380	[p18l1620t1995r1852b2061],
20	M	NNP	PERSON	M	appos	8	SENT_380	[p18l1881t1997r1948b2059],
21	,	,	O	,	_	0	SENT_380	[p18l1881t1997r1948b2059],
22	et	FW	O	et	nn	23	SENT_380	[p18l1982t2000r2044b2048],
23	al.	FW	O	al.	appos	8	SENT_380	[p18l2073t1995r2145b2048],
24	.	.	O	.	_	0	SENT_380	[p18l2073t1995r2145b2048],

1	KRAS	NNP	ORGANIZATION	KRAS	_	0	SENT_381	[p18l206t2082r355b2134],
2	mutations	NNS	O	mutation	dep	1	SENT_381	[p18l386t2083r692b2134],
3	and	CC	O	and	_	0	SENT_381	[p18l721t2081r828b2134],
4	primary	JJ	O	primary	amod	5	SENT_381	[p18l860t2083r1099b2147],
5	resistance	NN	O	resistance	dep	1	SENT_381	[p18l1128t2083r1439b2134],
6	of	IN	O	of	_	0	SENT_381	[p18l1467t2081r1529b2134],
7	lung	NN	O	lung	nn	8	SENT_381	[p18l1557t2081r1683b2147],
8	adenocarcinomas	NNS	O	adenocarcinoma	prep_of	1	SENT_381	[p18l1711t2081r2148b2134, p18l205t2182r323b2220],
9	to	TO	O	to	_	0	SENT_381	[p18l348t2172r409b2220],
10	geﬁtinib	NN	O	geﬁtinib	prep_to	8	SENT_381	[p18l434t2167r689b2233],
11	or	CC	O	or	_	0	SENT_381	[p18l714t2182r777b2220],
12	erlotinib	NN	O	erlotinib	conj_or	10	SENT_381	[p18l800t2167r1084b2220],
13	.	.	O	.	_	0	SENT_381	[p18l800t2167r1084b2220],

1	PLoS	NNP	O	PLoS	nn	2	SENT_382	[p18l1119t2168r1257b2220],
2	Med	NNP	O	Med	_	0	SENT_382	[p18l1281t2167r1403b2220],
3	2005	CD	DATE	2005	num	5	SENT_382	[p18l1431t2168r1793b2231],
4	;	:	O	;	_	0	SENT_382	[p18l1431t2168r1793b2231],
5	2	CD	NUMBER	2	dep	2	SENT_382	[p18l1431t2168r1793b2231],
6	:	:	O	:	_	0	SENT_382	[p18l1431t2168r1793b2231],
7	e17	NN	O	e17	dep	2	SENT_382	[p18l1431t2168r1793b2231],
8	.	.	O	.	_	0	SENT_382	[p18l1431t2168r1793b2231],

1	[	NN	O	[	nn	5	SENT_383	[p18l54t2253r166b2319],
2	24	CD	NUMBER	24	num	5	SENT_383	[p18l54t2253r166b2319],
3	]	CD	NUMBER	]	num	5	SENT_383	[p18l54t2253r166b2319],
4	Eberhard	NNP	PERSON	Eberhard	nn	5	SENT_383	[p18l206t2253r480b2306],
5	DA	NNP	PERSON	DA	_	0	SENT_383	[p18l511t2254r609b2317],
6	,	,	O	,	_	0	SENT_383	[p18l511t2254r609b2317],
7	Johnson	NNP	PERSON	Johnson	nsubj	8	SENT_383	[p18l640t2253r886b2306],
8	BE	VBP	O	be	dep	5	SENT_383	[p18l916t2254r1007b2317],
9	,	,	O	,	_	0	SENT_383	[p18l916t2254r1007b2317],
10	Amler	NNP	ORGANIZATION	Amler	nn	11	SENT_383	[p18l1037t2253r1222b2306],
11	LC	NNP	ORGANIZATION	LC	appos	5	SENT_383	[p18l1249t2254r1339b2317],
12	,	,	O	,	_	0	SENT_383	[p18l1249t2254r1339b2317],
13	Goddard	NNP	ORGANIZATION	Goddard	nn	14	SENT_383	[p18l1371t2253r1630b2306],
14	AD	NN	ORGANIZATION	ad	appos	5	SENT_383	[p18l1656t2254r1759b2317],
15	,	,	O	,	_	0	SENT_383	[p18l1656t2254r1759b2317],
16	Heldens	NNP	ORGANIZATION	Heldens	nn	17	SENT_383	[p18l1793t2253r2035b2306],
17	SL	NNP	ORGANIZATION	SL	appos	5	SENT_383	[p18l2061t2254r2145b2317],
18	,	,	O	,	_	0	SENT_383	[p18l2061t2254r2145b2317],
19	Herbst	NNP	ORGANIZATION	Herbst	nn	20	SENT_383	[p18l206t2340r406b2392],
20	RS	NN	ORGANIZATION	r	appos	5	SENT_383	[p18l447t2340r534b2403],
21	,	,	O	,	_	0	SENT_383	[p18l447t2340r534b2403],
22	et	FW	O	et	nn	23	SENT_383	[p18l577t2345r640b2392],
23	al.	FW	O	al.	appos	5	SENT_383	[p18l678t2340r750b2392],
24	.	.	O	.	_	0	SENT_383	[p18l678t2340r750b2392],

1	Mutations	NNS	O	mutation	nsubj	15	SENT_384	[p18l793t2341r1095b2392],
2	in	IN	O	in	_	0	SENT_384	[p18l1133t2341r1184b2392],
3	the	DT	O	the	det	7	SENT_384	[p18l1224t2340r1325b2392],
4	epidermal	JJ	O	epidermal	amod	7	SENT_384	[p18l1362t2340r1675b2406],
5	growth	NN	O	growth	nn	7	SENT_384	[p18l1714t2340r1925b2406],
6	factor	NN	O	factor	nn	7	SENT_384	[p18l1965t2340r2153b2392],
7	receptor	NN	O	receptor	prep_in	1	SENT_384	[p18l206t2430r471b2492],
8	and	CC	O	and	_	0	SENT_384	[p18l508t2426r616b2478],
9	in	IN	O	in	_	0	SENT_384	[p18l658t2427r709b2477],
10	KRAS	NNP	ORGANIZATION	KRAS	prep_in	1	SENT_384	[p18l753t2426r902b2478],
11	are	VBP	O	be	cop	15	SENT_384	[p18l942t2440r1039b2478],
12	predictive	JJ	O	predictive	amod	15	SENT_384	[p18l1081t2426r1393b2492],
13	and	CC	O	and	_	0	SENT_384	[p18l1432t2426r1539b2478],
14	prognostic	JJ	O	prognostic	conj_and	12	SENT_384	[p18l1582t2427r1902b2492],
15	indicators	NNS	O	indicator	_	0	SENT_384	[p18l1941t2426r2148b2478, p18l203t2516r320b2564],
16	in	IN	O	in	_	0	SENT_384	[p18l352t2513r404b2563],
17	patients	NNS	O	patient	prep_in	15	SENT_384	[p18l439t2513r689b2578],
18	with	IN	O	with	_	0	SENT_384	[p18l719t2512r852b2564],
19	non-small-cell	JJ	O	non-small-cell	amod	21	SENT_384	[p18l889t2512r1326b2564],
20	lung	NN	O	lung	nn	21	SENT_384	[p18l1361t2512r1486b2578],
21	cancer	NN	O	cancer	prep_with	17	SENT_384	[p18l1518t2526r1726b2564],
22	treated	VBN	O	treat	conj_and	22	SENT_384	[p18l1755t2512r1983b2564],
23	with	IN	O	with	_	0	SENT_384	[p18l2016t2512r2149b2564],
24	chemotherapy	NN	O	chemotherapy	prep_with	22	SENT_384	[p18l203t2598r650b2664],
25	alone	RB	O	alone	advmod	22	SENT_384	[p18l676t2598r843b2650],
26	and	CC	O	and	_	0	SENT_384	[p18l870t2598r978b2650],
27	in	IN	O	in	_	0	SENT_384	[p18l1007t2599r1059b2649],
28	combination	NN	O	combination	prep_in	22	SENT_384	[p18l1088t2598r1470b2650],
29	with	IN	O	with	_	0	SENT_384	[p18l1498t2598r1631b2650],
30	erlotinib	NN	O	erlotinib	prep_with	22	SENT_384	[p18l1660t2598r1945b2650],
31	.	.	O	.	_	0	SENT_384	[p18l1660t2598r1945b2650],

1	J	NNP	O	J	nn	3	SENT_385	[p18l1978t2599r2004b2650],
2	Clin	NNP	O	Clin	nn	3	SENT_385	[p18l2035t2598r2149b2650],
3	Oncol	NNP	O	Oncol	_	0	SENT_385	[p18l204t2684r377b2736],
4	2005	CD	DATE	2005	num	3	SENT_385	[p18l403t2684r925b2747],
5	;	:	O	;	_	0	SENT_385	[p18l403t2684r925b2747],
6	23:5900	CD	NUMBER	23:5900	number	7	SENT_385	[p18l403t2684r925b2747],
7	—	CD	NUMBER	—	dep	3	SENT_385	[p18l403t2684r925b2747],
8	9	CD	NUMBER	9	dep	7	SENT_385	[p18l403t2684r925b2747],
9	.	.	O	.	_	0	SENT_385	[p18l403t2684r925b2747],

1	[	NN	O	[	_	0	SENT_386	[p18l54t2770r166b2836],
2	25	CD	NUMBER	25	num	1	SENT_386	[p18l54t2770r166b2836],
3	]	CD	NUMBER	]	num	5	SENT_386	[p18l54t2770r166b2836],
4	Hirsch	NNP	PERSON	Hirsch	nn	5	SENT_386	[p18l206t2770r391b2822],
5	FR	NN	O	fr	dep	1	SENT_386	[p18l434t2771r524b2833],
6	,	,	O	,	_	0	SENT_386	[p18l434t2771r524b2833],
7	Varella-Garcia	NNP	O	Varella-Garcia	nn	8	SENT_386	[p18l566t2770r1008b2822],
8	M	NNP	O	M	appos	5	SENT_386	[p18l1044t2771r1111b2833],
9	,	,	O	,	_	0	SENT_386	[p18l1044t2771r1111b2833],
10	Bunn	NNP	PERSON	Bunn	nn	12	SENT_386	[p18l1157t2771r1303b2822],
11	Jr	NNP	PERSON	Jr	nn	12	SENT_386	[p18l1342t2771r1401b2822],
12	PA	NN	PERSON	pa	appos	5	SENT_386	[p18l1439t2770r1525b2833],
13	,	,	O	,	_	0	SENT_386	[p18l1439t2770r1525b2833],
14	Di	NNP	LOCATION	Di	nn	16	SENT_386	[p18l1571t2771r1625b2822],
15	Maria	NNP	LOCATION	Maria	nn	16	SENT_386	[p18l1663t2771r1830b2822],
16	MV	NNP	LOCATION	MV	appos	5	SENT_386	[p18l1867t2771r1965b2833],
17	,	,	O	,	_	0	SENT_386	[p18l1867t2771r1965b2833],
18	Veve	NNP	O	Veve	nn	19	SENT_386	[p18l2006t2771r2151b2822],
19	R	NNP	O	R	appos	5	SENT_386	[p18l206t2857r260b2919],
20	,	,	O	,	_	0	SENT_386	[p18l206t2857r260b2919],
21	Bremmes	NNP	O	Bremmes	nn	22	SENT_386	[p18l303t2857r585b2908],
22	RM	NN	O	rm	appos	5	SENT_386	[p18l623t2857r726b2919],
23	,	,	O	,	_	0	SENT_386	[p18l623t2857r726b2919],
24	et	FW	O	et	nn	25	SENT_386	[p18l767t2861r829b2908],
25	al.	FW	O	al.	appos	5	SENT_386	[p18l864t2856r937b2908],
26	.	.	O	.	_	0	SENT_386	[p18l864t2856r937b2908],

1	Epidermal	JJ	O	epidermal	amod	4	SENT_387	[p18l981t2856r1290b2922],
2	growth	NN	O	growth	nn	4	SENT_387	[p18l1326t2856r1538b2922],
3	factor	NN	O	factor	nn	4	SENT_387	[p18l1575t2856r1763b2908],
4	receptor	NN	O	receptor	_	0	SENT_387	[p18l1799t2861r2064b2922],
5	in	IN	O	in	_	0	SENT_387	[p18l2098t2857r2149b2907],
6	non-small-cell	JJ	O	non-small-cell	amod	8	SENT_387	[p18l205t2942r643b2994],
7	lung	NN	O	lung	nn	8	SENT_387	[p18l664t2942r790b3008],
8	carcinomas	NNS	O	carcinoma	prep_in	4	SENT_387	[p18l808t2943r1176b2994],
9	:	:	O	:	_	0	SENT_387	[p18l808t2943r1176b2994],
10	correlation	NN	O	correlation	dep	4	SENT_387	[p18l1200t2942r1540b2994],
11	between	IN	O	between	_	0	SENT_387	[p18l1562t2942r1825b2994],
12	gene	NN	O	gene	nn	14	SENT_387	[p18l1846t2954r1992b3008],
13	copy	NN	O	copy	nn	14	SENT_387	[p18l2009t2956r2153b3008],
14	number	NN	O	number	prep_between	10	SENT_387	[p18l205t3028r440b3080],
15	and	CC	O	and	_	0	SENT_387	[p18l461t3028r568b3080],
16	protein	NN	O	protein	nn	17	SENT_387	[p18l595t3029r814b3094],
17	expression	NN	O	expression	prep_between	10	SENT_387	[p18l839t3029r1163b3094],
18	and	CC	O	and	_	0	SENT_387	[p18l1187t3028r1295b3080],
19	impact	NN	O	impact	prep_between	10	SENT_387	[p18l1319t3029r1532b3094],
20	on	IN	O	on	_	0	SENT_387	[p18l1554t3042r1623b3080],
21	prognosis	NN	O	prognosis	prep_on	14	SENT_387	[p18l1650t3029r1955b3094],
22	.	.	O	.	_	0	SENT_387	[p18l1650t3029r1955b3094],

1	J	NNP	O	J	nn	3	SENT_388	[p18l1982t3029r2010b3080],
2	Clin	NNP	O	Clin	nn	3	SENT_388	[p18l2035t3028r2149b3080],
3	Oncol	NNP	O	Oncol	_	0	SENT_388	[p18l204t3114r377b3167],
4	2003	CD	DATE	2003	num	3	SENT_388	[p18l403t3114r999b3177],
5	;	:	O	;	_	0	SENT_388	[p18l403t3114r999b3177],
6	21:3798	CD	NUMBER	21:3798	num	7	SENT_388	[p18l403t3114r999b3177],
7	—	NN	O	—	dep	3	SENT_388	[p18l403t3114r999b3177],
8	807	CD	NUMBER	807	dep	7	SENT_388	[p18l403t3114r999b3177],
9	.	.	O	.	_	0	SENT_388	[p18l403t3114r999b3177],

